Часть 2 MAPS Psychedelic Bibliography - 2011.11.08 [PDF]

Abramson, Harold A. - Reassociation of Dreams. III. An LSD Study of Sexual Conflicts in Eczema and Asthma - 1977
Abramson, Harold A. - Reassociation of Dreams. IV. A Second LSD Analysis of the Beetle Bug Dream: Its Relation to a Shark Dream and Fear of Lesbianism. - 1977
Aghajanian GK - Psychotogenic drug action on chemically defined neurons - 1977
Andre JC, Baudot P, Niclause M - Application of Synchronous Excitation Spectrofluorimetry to Drug Analysis - 1977
Anton PG, Duncan ME, McGrath JC - An Analysis of the Anatomical Basis for the Mechanical Response to Motor Nerve Stimulation of the Rat Vas Deferens. - 1977
Barker, E. T.; Buck, M. F. - LSD in a Coercive Milieu Therapy Program. - 1977
Bedard P, Pycock CJ - 'Wet-Dog' Behaviour in the Rat: A Possible Quantitative Model of Central 5-Hydroxytryptamine Activity. - 1977
Brandrup, E.; Vanggaard, T. - LSD Treatment in a Severe Case of Compulsive Neurosis - 1977
Braun U, Shulgin AT, Braun G, Sargent T - Synthesis and Body Distribution of Several Iodine-131 Labeled Centrally Acting Drugs - 1977
Bury RW, Mashford ML - A Pharmacological Investigation of Synthetic Substance P on the Isolated Guinea-Pig Ileum - 1977
Cavanagh RL, Tilson HA, Gylys JA - Neurochemical Properties of Dimoxamine (D), A New Psycho-Therapeutic Agent - 1977
Chekman IS, Potemkina NN, Tumanov VA - Nicotinamide Coenzymes as the Object of Action of Medicines and Poisons - 1977
Choong TC, Shough HRT - The Synthesis of Lysergic Acid Derivatives from Elymoclavine - 1977
Clark, Walter Houston - Art and Psychotherapy in Mexico - 1977
Domelsmith LN, Munchhausen LL, Elouk KN - Lysergic Acid Diethylamide. Photoelectron Ionization Potentials as Indices of Behavioral Activity - 1977
Fillion G, Fillion MP, Rousselle JC, Beaudion D, Goiny M - Liaisons de haute affinite de la 5 hydroxytryptamine (5 HT) sur diverges preparations membranaires de cerveau de Bovin. Relations avec le diethylamide de l'acide lysergique [Binding affinity of 5-Hydroxytryptamine (5-HT) in Prepared Bovine Microsomal Membranes. Relationship to Lysergic Acid Diethylamide (LSD)] - 1977
Guven KC, Guneri T - Identification of LSD and Ergot Alkaloids by Thin-Layer Chromatography. - 1977
Gessner PR, Dankova JR - The Role Of Serotonin Antagonism In The Tremorgenic Action Of Bufotenine In Mice - 1977
Girault JM, Macob J - Differenciation Pharmacologique des Hyperthermies Induites par la Serotonine, le LSD, le Cerm 1841 [2-(3-Trifluoromethyl)-phenyl-tetrahydro-1,4-oxazine], la Quipazine et la N,N-Dimethyltrypamine Chez le Lapin - 1977
Greengard P - Cyclic Nucleotides and Phosphorylated Proteins as Targets for Drug Action. - 1977
Grof, Stanislav - Perinatal Roots of Wars, Totalitarism, and Revolutions: Observations from LSD Research. - 1977
Grof, Stanislav - The Implications of Psychedelic Research for Anthropology: Observations from LSD Psychotherapy. - 1977
Harvey JA, Gormezano I, Gimpl MP - Effect of D-lysergic Acid Diethylamide (LSD) and 2-Bromo-LSD (BOL) on Classical (Pavlovian) Conditioning of The Rabbit Nictitating Membrane-Response. - 1977
Hirschhorn ID - Pentazocine, Cyclazacine, and Nalorphine as Discriminative Stimuli. - 1977
Huber-Weidmann H, Dittrich A, Scharfetter C - Schlafentzug. Psychopathologische Wirkungen beim Menschen [Sleep Deprivation. Psychopathological Effects on Humans] - 6 May 1977
Itil M, Akpinar S - Quantitative Pharmaco-EEG With Antimigraine Compounds. - 1977
Jacob P, Anderson G, Meshul CK, Shulgin AT, Castagnoli N - Monomethylthio Analogues of 1-(2,4,5-Trimethoxyphenyl) 2-aminopropane - 1977
Kapturkiewicz Z, Sowinska H - The Effect of Piribedil on Body Temperature in Mice and Rats - 1977
Kehr W - Effect of Lisuride and Other Ergot Derivatives on Monoaminergic Neurotransmission in Rat Brain - 1977
Klinge E, Sjostrand N O - Comparative Study of Some Isolated Mammalian Smooth Muscle Effectors of Penile Erection - 1977
Kocur J, Jurkowski A, Kedziora J - The Influence of Haloperidol and Propranolol on Behavior and Biochemical Changes in the Brain of Mice treated with LSD - 1977
Kraus L, Stahl E, Thies W, Arnold W - Dunnschichtchromatographie von Illegalen LSD-Praparaten und die Moglichkeit einer Direktauswertung im Nanogrammbereich - 1977
Levin RM, Weiss B - Specificity of Binding of Antipsychotics to the Activator of Cyclic Nucleotide Phosphodieterase - 1977
Lurie I - Application of Reverse Phase Ion-Pair Partition Chromatography to Drugs of Forensic Interest - 1977
Maj J, Baran L, Rawlow A, Sowinska HS - Central Effects of Miaserin and Danitracen - New Antidepressants of Unknown Mechanism of Action - 1977
Maj J, Gancarczyk L, Goraszczyk E, Rawlow A - Doxepin as a Blocker of Central Serotonin Receptors - 1977
Mansour TE, Mansour JM - Phosphodiesterase in the Liver Fluke. Fasciola hevatica - 1977
Martindale, Colin; Fischer, Roland - The Effects of Psilocybin on Primary Process Content in Language - 1977
McCabe, Oliver Lee; Hanlon, T. E. - The Use of LSD-Type Drugs in Psychotherapy: Progress and Promise - 1977
Messier PE - The Effect of LSD on the Surface of Neuroepithelial Cells - 1977
Messiha FS - Dopamine, the Psyche, and Extrapyramidal Disorders - 1977
Nakahara Y, Niwaguchi T, Ishii H - Studies on-Lysergic Acid Diethylamides and Related Compounds. VI. Syntheses of Dihydrolysergic Acid Diethylamides and Related Compounds - 1977
Nichols DE, Shulgin AT, Dyer DC - Directional Lipophilic Character in a Series of Psychotomimetic Phenethylamine Derivatives - 1977
Nozaki M, Bell JA, Vaupel DB, Martin WR - Responses of the Flexor Reflex to LSD, Tryptamine, 5-Hydroxytryptophan, Methoxamine, and d-Amphetamine in Acute and Chronic Spinal Rats - 1977
Palider W, Rawlow A - Effect of Serotonin Uptake Blocking Agents on the Flexor Reflex of Hind Limb of the Spinal Rat - 1977
Palmer GC, Jones DJ, Medina MA, Stavinoha WB - Influence of Injected Psychoactive Drugs on Cyclic AMP Levels in Mouse Brain and following Microwave Irradiation - 1977
Pieri M, Schaffner R, Haefely W - Central Dopamine-Receptor Stimulation bv LSD and Lisuride - 1977
Ratcliffe WA, Fletcher SM, Moffat AC, Ratcliffe JG, Harland WA, Levitt TE - Radioimmunoassay of Lysergic Acid Diethylamide (LSD) in Serum and Urine by Using Antisera of Different Specificities - 1977
Rhead, John C.; Soskin, Robert A.; Turek, Ibrahim; Richards, William A.; Yensen, Richard; Kurland, Albert A.; Ota, Kay - Psychedelic Drug (DPT)-Assisted Psychotherapy with Alcoholics: A Controlled Study - 1977
Richards, William A.; Berendes, Margret - LSD-Assisted Psychotherapy and Dynamics of Creativity: A Case Report. - 1977/78
Richards, William A.; Rhead, John C.; Di Leo, Francesco B.; Yensen, Richard; Kurland, Albert A. - The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients - 1977
Schwarcz R, Bennett JP, Coyle JT - Loss of Striatal Serotonin Synaptic Receptor Binding Induced by Kainic Acid Lesions: Correlations with Huntington's Disease - 1977
Shih JC, Rho J - The Specific Interaction Between LSD and Serotonin-Binding Protein - 1977
Sietnieks A, Meyerson BJ - The Influence Of Progesterone On The Inhibitory Effect Of Lysergic Acid Diethylamide On Copulatory Behaviour In The Female Rat - 1977
Strahlendorf JR, Goldstein FJ, Rossi GV, Malseed RT - Differential Effects Of Subcortical Lysergic Acid Diethylamide And Serotonin On Visual Cortical Evoked Potentials - 1977
Trulson ME, Ross C A, Jacobs BL - Lack of Tolerance to the Depression of Raphe Unit Activity by Lysergic Acid Diethylamide - 1977
U'Prichard DC, Greenberg DA, Snyder SH - Binding Characteristics of a Radiolabeled Agonist and Antagonist at Central Nervous System Alpha Noradrenergic Receptors - 1977
Vaupel DB, Martin WR - A Comparison of the Effects of 4-Bromo-2,5-Dimethoxyamphetamine (DOB), 3,4,5-Trimethoxyamphetamine (TMA), Para-Methoxyamphetamine (PMA), D-Amphetamine (A) and LSD in Nontolerant and LSD tolerant Chronic Spinal Dogs - 1977
Weinstein H, Johnson CL, Green JP - Molecular Determinants for the Action of Tryptamines on an LSD Receptor - 1977
Whitaker PM, Seeman P - Hallucinogen Binding to Dopamine/Neuroleptic Receptors - 1977
White TJ, Goodman D, Shulgin AT, Castagnoli N Jr., Lee R, Petrakis NL - Mutagenic Activity of Some Centrally Active Aromatic Amines in 'Salmonella typhimurium' - 1977
White FJ, Kuhn DM, Appel JB - Discriminative Stimulus Properties of Quipazine - 1977
Aghajanian GK - Psychotogenic drug action on chemically defined neurons - 1977
Andre JC, Baudot P, Niclause M - Application of Synchronous Excitation Spectrofluorimetry to Drug Analysis - 1977
Anton PG, Duncan ME, McGrath JC - An Analysis of the Anatomical Basis for the Mechanical Response to Motor Nerve Stimulation of the Rat Vas Deferens. - 1977
Arushanyan EB - The Mesolimbic System of the Brain and its Participation in the Action of Psychotropic Substances.(Literature Review). - 1977
Back DJ, Singh JKG - LSD: the Distribution of [3H]LSD in the Reproductive System of the Male Rat and Placental Transfer in the Female Rat - 1977
Barker ET, Buck MF - LSD In A Coercive Milieu Therapy Program - 1977
Baudry M, Martres MP, Schwartz JC - In Vivo Binding of 3H-Pimozide in Mouse Striatum: Effects of Dopamine Agonists and Antagonists - 1977
Bedard P, Pycock CJ - 'Wet-Dog' Behaviour in the Rat: A Possible Quantitative Model of Central 5-Hydroxytryptamine Activity. - 1977
Bedard P, Pycock C - The 'Wet Dog Shake? Behaviour in the Rat and 5-Hydroxytryptamine - 1977
Borisenko SA - The Effect of Psychotropic Agents on Self-Stimulation - 1977
Bourgoin S, Artaud F, Enjalbert A, Hery F, Glowinski J, Hamon M - Acute Changes In Central Serotonin Metabolism Induced By The Blockade Or Stimulation Of Serotoninergic Receptors During Ontogenesis In The Rat - 1977
Bouver JJ, Dedet L, Verdeaux J, Rougeul A - Selective Modification of Spontaneous ECoG Rhythms of the Cat Somesthetic Cortex by Psychoactive Drugs: Behavioral Correlates - 1977
Bowers MB - Psychoses Precipitated by Psychotomimetic Drugs: A Follow-up Study - 1977
Brandrup E, Vanggaard T - LSD Treatment in a Severe Case of Compulsive Neurosis - 1977
Briggs I - Excitatory Responses of Neurones in Rat Bulbar Reticular Formation to Bulbar Raphe Stimulation and to Iontophoretically Applied, 5-Hydroxytryptarnine and Their Blockade by LSD 25 - 1977
Bron B, Frцscher W, Gehlen W - Analyse chronischer psychotischer Zustandsbilder bei jugendlichen Drogenkonsumenten - 1977
Bury RW, Mashford ML - A Pharmacological Investigation of Synthetic Substance P on the Isolated Guinea-Pig Ileum - 1977
Carino MA, Horita A - Rapid Development Of Tolerance Upon Central Injection Of LSD - 1977
Carlini EA - Further Studies of the Aggressive Behavior Induced by delta-9-Tetrahydrocannabinol in REM Sleep-Deprived Rats - 1977
Cavanagh RL, Tilson HA, Gylys JA - Neurochemical Properties of Dimoxamine (D), A New Psycho-Therapeutic Agent - 1977
Chadwick D, Hallett M, Jenner P, Marsden CD - 5-Hydroxytophan-Induced Behaviour in Guinea-Pigs: Its Relevance to Human Myoclonus - 1977
Chekman IS, Potemkina NN, Tumanov VA - Nicotinamide Coenzymes as the Object of Action of Medicines and Poisons - 1977
Choong TC, Shough HRT - The Synthesis of Lysergic Acid Derivatives from Elymoclavine - 1977
Christoph GR, Kuhn DM, Jacobs BL - Electrophysiological Evidence for a Dopaminergic Action of LSD: Depression of Unit Activity in the Substantia Nigra of the Rat - 1977
Cohen MM, Shiloh Y - Genetic Toxicology Of Lysergic Acid Diethylamide (LSD-25) - 1977
de Montigny C, Aghajanian GK - Preferential Action of 5-Methoxytryptamine and 5-Methoxydimethyltryptamine on Presynaptic Serotonin Receptors: A Comparative Iontophretic Study with LSD and Serotonin - 1977
Domelsmith LN, Munchhausen LL, Elouk KN - Lysergic Acid Diethylamide. Photoelectron Ionization Potentials as Indices of Behavioral Activity - 1977
Domelsmith LN, Munchhausen LL, Houk KN - Photoelectron Spectra of Psychotropic Drugs. 1. Phenethylamines, Tryptamines, and LSD - 1977
Editorial - Is this how LSD makes cats hallucinate? - 1977
Eliasson M, Meyerson BJ - The Effects of Lysergic Acid Diethylamide on Copulatory Behaviour in the Female Rat - 1977
Fanciullacci M, del Bene E, Franchi G, Sicuteri F - Phantom Limb Pain: Sub-Hallucinogenic Treatment With Lysergic Acid Diethylamide (LSD-25) - 1977
Faust V, Leutner V - Drogen-ABC. Rauschgift - Alkohol - Nikotin - Medikamente - 1977
Fertziger AP, Fischer R - Interaction Between Narcotic Antagonist (Naloxone) and Lysergic Acid Diethylamide (LSD) in the Rat - 1977
Fillion G, Fillion MP, Rousselle JC, Beaudion D, Goiny M - Liaisons de haute affinite de la 5 hydroxytryptamine (5 HT) sur diverges preparations membranaires de cerveau de Bovin. Relations avec le diethylamide de l'acide lysergique [Binding affinity of 5-Hydroxytryptamine (5-HT) in Prepared Bovine Microsomal Membranes. Relationship to Lysergic Acid Diethylamide (LSD)] - 1977
Guven KC, Guneri T - Identification of LSD and Ergot Alkaloids by Thin-Layer Chromatography. - 1977
Gallager DW, Aghajanian GK - Tricyclic Antidepressant Drugs: Attenuation of Excitatory Effects of d-Lysergic Acid Diethylamide (LSD) on Acoustic Startle Response - 1977
Gatzke HD - Autoradiographische Untersuchungen zur Frage der Beeinflussbarkeit den 3H-Leucin-Einbauraten in differente Areale des Rattenhirns durch LSD - 1977
Gessner PR, Dankova JR - The Role Of Serotonin Antagonism In The Tremorgenic Action Of Bufotenine In Mice - 1977
Girault JM, Macob J - Differenciation Pharmacologique des Hyperthermies Induites par la Serotonine, le LSD, le Cerm 1841 [2-(3-Trifluoromethyl)-phenyl-tetrahydro-1,4-oxazine], la Quipazine et la N,N-Dimethyltrypamine Chez le Lapin - 1977
Gould LC, Berberian RM, Kasl SV - Sequential Patterns of Multiple-Drug Use Among High School Students - 1977
Govoni S, Loddo P, Spano PF, Trabucchi M - Dopamine receptor sensitivity in brain and retina of rats during aging - 1977
Green JP, Johnson CL, Weinstein H, Maayani S - Antagonism of Histamine-Activated Adenylate Cyclase in Brain by D-Lysergic Acid Diethylamide - 1977
Greengard P - Cyclic Nucleotides and Phosphorylated Proteins as Targets for Drug Action. - 1977
Halaris AE, Freedman DX - Vesicular And Juxtavesicular Serotonin: Effects Of Lysergic Acid Diethylamide And Reserpine - 1977
Harvey JA, Gormezano I, Gimpl MP - Effect of D-lysergic Acid Diethylamide (LSD) and 2-Bromo-LSD (BOL) on Classical (Pavlovian) Conditioning of The Rabbit Nictitating Membrane-Response. - 1977
Hashimoto H, Hayashi M, Nakahara Y, Niwaguchi T, Ishii H - Actions Of D-lysergic Acid Diethylamide (LSD) And Its Derivatives On 5-hydroxytryptamine Receptors In The Isolated Uterine Smooth Muscle Of The Rat - 1977
Hasimoto H, Hayashi M, Nakahara Y, Niwaguchi T, Ishii H - Hyperthermic Effects of D-Lysergic Acid Diethylamide (LSD) and its Derivatives in Rabbits and Rats - 1977
Hirschhorn ID - Pentazocine, Cyclazacine, and Nalorphine as Discriminative Stimuli. - 1977
Holbrook L, Brown IR - Disaggregation Of Brain Polysomes After D-lysergic Acid Diethylamide Administration In Vivo: Mechanism And Effect Of Age And Environment - 1977
Holbrook L, Brown I - Antipsychotic Drugs Block LSD-Induced Disaggregation of Brain Polysomes. - 1977
Hsu LL, Paul SM, Halaris AE, Freedman D X - Rat Brain Aryl Acylamidase: Multiple Forms and Inhibition Effects of LSD. Serotonin and Related Compounds. - 1977
Huber-Weidmann H, Dittrich A, Scharfetter C - Schlafentzug. Psychopathologische Wirkungen beim Menschen [Sleep Deprivation. Psychopathological Effects on Humans] - 6 May 1977
Itil M, Akpinar S - Quantitative Pharmaco-EEG With Antimigraine Compounds. - 1977
Jacobs BL, Trulson ME, Stern WC - Behavioral Effects Of LSD In The Cat: Proposal Of An Animal Behavior Model For Studying The Actions Of Hallucinogenic Drugs - 1977
Jacoby JH, Poulakos JJ - The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations. - 1977
Jaton AL, Loew DM, Vigouret JM - Turning Behaviour Elicited by Apomorphine, (+)-Amphetamine and Three Ergot Derivatives in Rats Treated with a Unilateral Injection of Ethanolamine-O-sulphate in the Substantia Nigra - 1977
Kapturkiewicz Z, Sowinska H - The Effect of Piribedil on Body Temperature in Mice and Rats - 1977
Kehr W - Effect of Lisuride and Other Ergot Derivatives on Monoaminergic Neurotransmission in Rat Brain - 1977
Keller HH, Burkard WP, da Prada M - Lisuride and D-LSD: Effects on the monoaminergic system in the rat brain - 1977
Klinge E, Sjostrand N O - Comparative Study of Some Isolated Mammalian Smooth Muscle Effectors of Penile Erection - 1977
Kocur J, Jurkowski A, Kedziora J - The Influence of Haloperidol and Propranolol on Behavior and Biochemical Changes in the Brain of Mice treated with LSD - 1977
Kraus L, Stahl E, Thies W, Arnold W - Dunnschichtchromatographie von illegalen LSD-Praparaten und die Moglichkeit einer Direktauswertung im Nanogrammbereich - 1977
Kraus L, Stahl E, Thies W, Arnold W - Dunnschichtchromatographie von Illegalen LSD-Praparaten und die Moglichkeit einer Direktauswertung im Nanogrammbereich - 1977
Levin RM, Weiss B - Specificity of Binding of Antipsychotics to the Activator of Cyclic Nucleotide Phosphodieterase - 1977
Leysen JE, Laduron PM - A serotonergic component of neuroleptic receptors - 1977
Lurie I - Application of Reverse Phase Ion-Pair Partition Chromatography to Drugs of Forensic Interest - 1977
Maj J, Gancarczyk L, Goraszczyk E, Rawlow A - Doxepin as a Blocker of Central Serotonin Receptors - 1977
Mansour TE, Mansour JM - Phosphodiesterase in the Liver Fluke. Fasciola hevatica - 1977
Mehl E, Rьther E, Redemann J - Endogenous Ligands of a Putative LSD-Serotonin Receptor in the Cerebrospinal Fluid: Higher Level of LSD-Displacing Factors (LDF) in Unmedicated Psychotic Patients - 1977
Meltzer HY, Fessler RG, Simonovic M, Doherty J, Fang VS - Lysergic Acid Diethylamide: Evidence for Stimulation of Pituitary Dopamine Receptors - 1977
Messier PE - The Effect of LSD on the Surface of Neuroepithelial Cells - 1977
Messiha FS - Dopamine, the Psyche, and Extrapyramidal Disorders - 1977
Mitra G, Poddar MK, Ghosh JJ - Interaction of delta-9-Tetrahydrocannabinol with Reserpine, Phenobarbital, and LSD-25 on Plasma and Adrenal Corticosterone - 1977
de Montigny C, Aghajanian GK - Preferential Action of 5-Methoxytryptamine and 5-Methoxydimethyltryptamine on Presynaptic Serotonin Receptors: A Comparative Iontophretic Study with LSD and Serotonin - 1977
Morimoto K, Sato M - Is Serotonin a Chemical Transmitter in the Frog Taste Organ? - 1977
Morvay J, Toth D - Radioimmune-analytical assay of drugs - 1977
Nakahara Y, Niwaguchi T, Ishii H - Studies on-Lysergic Acid Diethylamides and Related Compounds. VI. Syntheses of Dihydrolysergic Acid Diethylamides and Related Compounds - 1977
Nakahara Y, Niwaguchi T, Ishii H - Studies on Lysergic Acid Diethylamide and Related Compounds. VI Steric Requirements of von Braun Reaction - 1977
Nozaki M, Bell JA, Vaupel DB, Martin WR - Responses of the Flexor Reflex to LSD, Tryptamine, 5-Hydroxytryptophan, Methoxamine, and d-Amphetamine in Acute and Chronic Spinal Rats - 1977
Nozaki M, Vaupel DB, Martin WR - A Pharmacologic Comparison of 3,4-Methylenedioxyamphetamine and LSD in the Chronic Spinal Dog - 1977
Palider W, Rawlow A - Effect of Serotonin Uptake Blocking Agents on the Flexor Reflex of Hind Limb of the Spinal Rat - 1977
Palmer GC, Jones DJ, Medina MA, Stavinoha WB - Influence of Injected Psychoactive Drugs on Cyclic AMP Levels in Mouse Brain and following Microwave Irradiation - 1977
Persson SA - The Effect of LSD and 2-Bromo LSD on the Striatal Dopa Accumulation after Decarboxylase Inhibition in Rats - 1977
Persson SA - Effects Of LSD And 2-Bromo LSD On Striatal Dopac Levels - 1977
Peters DAV, Tang S - The Effects of Repeated D-Lysergic Acid Diethylamide Injection on Catecholamine Levels and Tyrosine Hydroxylase Activity in Rat Brain Regions - 1977
Peters DAV, Tang S - Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels - 1977
Pickworth WB, Sharpe LG, Martin WR - Transcallosally Evoked Potentials And the EEG In The Decerebrate Dog: Actions Of Tryptaminergic, Dopaminergic And Adrenergic Agonists - 1977
Pieri M, Schaffner R, Haefely W - Central Dopamine-Receptor Stimulation bv LSD and Lisuride - 1977
Poffenbarger M, Fuller GM - Effects of Psychotropic Drugs on Neurotubule Assembly - 1977
Rose D, Horn G - Effects of LSD on the Responses of Single Units in Cat Visual Cortex - 1977
Roubicek J - Expression under the influence of dysleptic drugs - 1977
Sallam LAR, Naim N, El Refai AH - Thin Chromatography of Some Ergot Alkaloids - 1977
Schmidt MJ, Hill LE - Effects of Ergots on Adenylate Cyclase Activity in the Corpus Striatum and Pituitary - 1977
Schwarcz R, Bennett JP, Coyle JT - Loss of Striatal Serotonin Synaptic Receptor Binding Induced by Kainic Acid Lesions: Correlations with Huntington's Disease - 1977
Sheard MH, Astrachan DI, Davis M - The Effect of D-Lysergic Acid Diethylamide (LSD) upon Shock Elicited Fighting in Rats - 1977
Shih JC, Rho J - The Specific Interaction Between LSD and Serotonin-Binding Protein - 1977
Sicuteri F - Headache As Metonymy Of Non Organic Central Pain - 1977
Sietnieks A, Meyerson BJ - The Influence Of Progesterone On The Inhibitory Effect Of Lysergic Acid Diethylamide On Copulatory Behaviour In The Female Rat - 1977
Spano PF, Govoni S, Hofmann M, Kumakura K, Trabucchi M - Physiological and Pharmacological Influences on Dopaminergic Receptors in the Retina - 1977
Strahlendorf JR, Goldstein FJ, Rossi GV, Malseed RT - Differential Effects Of Subcortical Lysergic Acid Diethylamide And Serotonin On Visual Cortical Evoked Potentials - 1977
Trulson ME, Ross C A, Jacobs BL - Lack of Tolerance to the Depression of Raphe Unit Activity by Lysergic Acid Diethylamide - 1977
Trulson ME, Stark AD, Jacobs BL - Comparative Effects of Hallucinogenic Drugs in Rats with Unilateral 6-hydroxydopamine Lesions - 1977
Vaupel DB, Martin WR - A Comparison of the Effects of 4-Bromo-2,5-Dimethoxyamphetamine (DOB), 3,4,5-Trimethoxyamphetamine (TMA), Para-Methoxyamphetamine (PMA), D-Amphetamine (A) and LSD in Nontolerant and LSD tolerant Chronic Spinal Dogs - 1977
Vogel WH, Evans BD - Structure-Activity-Relationship Of Certain Hallucinogenic Substances Based on Brain Levels - 1977
Waldmeier PC, Maоtre L - Neurochemical Investigations of the Interaction of N,N-Dimethyltryptamine with the Dopaminergic System in Rat Brain - 1977
Weinstein H, Johnson CL, Green JP - Molecular Determinants for the Action of Tryptamines on an LSD Receptor - 1977
Whitaker PM, Seeman P - Hallucinogen Binding to Dopamine/Neuroleptic Receptors - 1977
White FJ, Kuhn DM, Appel JB - Discriminative Stimulus Properties of Quipazine - 1977
Adams WB, Drummond AH, Levitan IB - Dopamine Currents in Cell R15 of Aplysia - 1978
Anderson GM, Braun G, Braun U, Nichols DE, Shulgin AT - Absolute Configuration and Psychotomimetic Activity - 1978
Anderson III GM, Braun G, Braun U, Nichols DE, Shulgin AT - Absolute Configuration and Psychotomimetic Activity - 1978
Anlezark G. Meldrum B - Blockade of Photically Induced Epilepsy by 'Dopamine' Agonist' Ergot Alkaloids - 1978
Appel JB, White FJ - Behavioral and Neuropharmacological Aspects of the Discrimtnative Stimulus Properties of Quipazine - 1978
Appel JB, White FJ, Kuhn DM - The Use of Drugs as Discriminative Stimuli in Behavioral Pharmacodynamics - 1978
Berde B - Pharmacology of Ergot Alkaloids in Clinical Use - 1978
Boullin DJ, Glenton PAM - Characterization of Receptors Mediating 5-Hydroxytryptamine and Catecholamine-Induced Platelet Aggregation, Assessed by the Actions of a- and p-Blockers, Butyrophenones, 5-HT Antagonists and Chlorpromazine - 1978
Bourgoin S, Artaud F, Bockaert J, Hery F, Glowinski J, Hamon JM - Paradoxical Decrease of Brain 5-HT Turnover by Metergoline, a Central 5-HT Receptor Blocker - 1978
Braun G, Shulgin AT, Sargent T III - Synthesis of 123-I-Labelled 4-Iodo-2,5-Dimethoxyphenylisopropylamine - 1978
Braun U, Braun G, Jacob P III, Nichols DE, Shulgin AT - Mescaline Analogs: Substitutions at the 4-position - 1978
Burki HR, Asper H, Ruch W, Zueger PE - Bromocriptine, Dihydroergotoxine, Methysergide, d-LSD, CF-25-397, and 29-712: Effects on the Metabolism of the Biogenic Amines in the Brain of the Rat - 1978
Da Prada M, Pieri L, Keller HH, Pieri M, Bonetti EP - Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the Rat Central Nervous System After Intraventricular or Intracerebral Application and on Blood Platelets In Vitro - 1978
Degtyarev V P - Influence of Serotoninergic Substances on the Brain Potentials Evoked by Stimulation of the Dental Pulp - 1978
Dolphin A, Enjalbert A, Tassin JP, Lucas M, Bockaert J - Direct Interaction of LSD with Central "Beta"-Adrenergic Receptors - 1978
Dray A, Connors B, Fox PC, Hilmy H, Moore C, Somjen GG - Effects Of LSD On Unit Activity And Extracellular Potassium Responses In Cat Cortex During Visual Stimulation - 1978
Drummond AH, Bucher F, Levitan IB - 3H-LSD Labels a Novel Dopamine Receptor in Molluscan Ganglia - 1978
Edvinsson L, Hardebo JE, Owman C - Pharmacological Analysis of 5-Hydroxytryptamine Receptors in Isolated Intracranial and Extracranial Vessels of Cat and Man - 1978
Fanchamps, A. - Some Compounds with Hallucinogenic Activity - 1978
Fanchamps A - Some Compounds With Hallucinogenic Activity - 1978
Fuxe K, Fredhaolm BB, Agnat LF, Ogren SO, Everit BJ, Jonsson GU, Gustafsson JA - Interaction of Ergot Drugs with Central Monamine System. Evidence for a High Potential in the Treatment of Mental and Neurological Disorders - 1978
Fuxe K, Ogren SO, Agnati LF, Jonssen G, Gustafsson JA - 5,7-Dihydroxytryptamine as a Tool to Study the Functional Role of Central 5-Hydroxytryptamine Neurons - 1978
Gallager DW - Benzodiazopines: Potentiation of a GABA Inhibitory Response in the Dorsal Raphe Nucleus - 1978
Glennon RA, Kier LB - LSD Analogs as Serotonin Antagonists: a Molecular Connectivity SAR analysis - 1978
Graf M, Pletscher A - Pharmacological Characterization of the 5-Hydroxytryptamine (5HT) Receptor of Blood Platelets. - 1978
Grof, Stanislav - LSD and the Human Unconscious: Observations from Psychedelic Research. - 1978
Grossman, T.M. - Post-Anesthesia Catalepsy In an L.S.D. User - 1978
Hartley JPR, Nogrady SG, Seaton A, Graham JDP - Bronchodilator Effect of delta-9-THC - 1978
Hofmann A - Historical View On Ergot Alkaloids. - 1978
Horowski R - Differences in the Dopaminergic Effects of the Ergot Derivatives Bromocriptine, Lisuride and d-LSD as compared with Apomorphine - 1978
Isbell, William H - Cosmological Order Expressed in Prehistoric Ceremonial Centers - 1978
Kataoka Y, Shibata K, Fujiwara M, Ueki S - Effects of Psychotropic Drugs on Labor Division Between Rats - 1978
Kay DC, Martin WR - LSD and Tryptamine Effects on Sleep/Wakefulness and Electrocorticogram Patterns in Intact Cats - 1978
Kehr W, Speckenbach W - Effect of Lisuride and LSD on Monoamine Synthesis after Axotomy or Reserpine Treatment in Rat Brain - 1978
Ksir CJ - Rate-Dependent and Stimulus Control Effect of Drugs - 1978
Kuhn DM - Discriminative Stimulus Properties of LSD: Behavioral Assay of the Mechanism of Action of LSD - 1978
Kuhn DM, White FJ, Appel JB - The Discriminative Stimulus Properties of LSD: Mechanisms of Action - 1978
Kumbar M - Conformational Study of Lysergic Acid Derivatives in Relation to Their Hallucinogenic and Antiserotonin Activities - 1978
Laurent JP, Pieri L - Lisuride and LSD Decrease Spontaneous Firing of Neurons in the Raphe - 1978
Lullmann H, Lullmann-Rauch R, Wassermann O - Lipidosis Induced By Amiphiphilic Drugs - 1978
Maayani S, Green JP, Weinstein H - LSD, Tricyclic Antidepressants And Neuroleptics Inhibit Histamine Stimulated Adenylate Cyclase In Brain - 1978
MacDonald JF, Berry MS - Further Identification of Multiple Responses Mediated by Dopamine in the CNS of Planorbis corneas - 1978
Maj J, Baran L, Michaluk J, Palider W, Rawlow A - The Central Antiserotonin Activity of Neuroleptics - 1978
Marquardt GM, DiStefano V, Ling LL - Pharmacological and Toxicological Effects of B-3,4-Methylenedioxyamphetamine Isomers - 1978
McGrath JC - Adrenergic and 'Non-Adrenergic' Components in the Contractile Response of the Vas Deferens to a Single Indirect Stimulus - 1978
Moffat A C - Analytical Chemistry and Drug Metabolism. - 1978
Nalin DR, Levine MM, Rhead J, Bergquist E, Rennels M, Hughes T, O'Donnel S, Hornick RB - Cannabis, Hypochlrohydria and Cholera - 1978
Natale, Michael; Kowitt, Michael; Dahlberg, Charles C.; Jaffe, Joseph - Effect of Psychotomimetics (LSD and Dextroamphetamine) on the Use of Figurative Language During Psychoanalysis. - 1978
Partyka RA, Standridge RT, Howell HG, Shulgin AT - 2-Amino-1-(2,5-Dimethoxyphenyl)butanes - Aug. 8, 1978
Pieri, Margherita; Sehaffner, R, Pieri L, Da Prada M, Haefely W - Turning in MFB-Lesioned Rats and Antagonism of Neuroleptic-Induced Catalepsy after Lisuride and LSD - 1978
Przegalinski E, Baran L, Palider W, Bigajska K - On the Central Antiserotonin Activity of Benzoctamine and Opipramal - 1978
Rappolt RT, Gay G, Inaba DS, Rappolt N - Use of Inderal (Propranolol-Ayerst) in 1-a (Early Stimulative) and 1-b (Advanced Stimulative) Classification of Cocaine and Other Sympathomimetic Reactions - 1978
Rech RH - Brain Lesions and Psychostimulant Drugs - 1978
Rosecrans JA, Chance WT, Spencer RM - The Discriminative Stimulus Properties of Cyclazocine: Generalization Studies Involving Nalorphine, Morphine and LSD - 1978
Rosecrans JA, Krynock GM, Newlon P, Chance WT, Kallman M - Central Mechanisms of Drugs as Discriminative Stimuli; Involvement of Serotonin Pathways - 1978
Rosenberg CM, Gerrein JR, Schnell C - Cannabis in the Treatment of Alcoholism - 1978
Sapper H, Lohmann W - Association of Some Psychotomimetic Compounds with 6-Methylpurine in Aqueous Solutions - 1978
Sargent T, Budinger TF, Braun G, Shulgin AT, Braun U - An Iodated Catecholamine Congener for Brain Imaging and Metabolic Studies - 1978
Sargent T III, Braun G, Braun U, Budinger TF, Shulgin AT - Brain and Retina Uptake of a Radio-Iodine Labeled Psychotomimetic in Dog and Monkey - 1978
Schlemmer RF, Tyler CB, Narasimhachari N, Davis JM - The Comparitive Effects Of LSD, Mescaline, And DMT On Primate Social And Solitary Behavior - 1978
Shulgin AT - Psychotomimetic Drugs: Structure-Activity Relationships - 1978
Silverman PB, Ho BT - Stimulus Properties of DOM: Commonality with Other Hallucinogens - 1978
Stolzki B, Kaiser HO, Mehl EL - Heterogeneity of LSD Displacing Factors and Multiple Types of High Affinity LSD-Binding Sites - 1978
Sullivan AT, Twitchett PJk Fletcher SM, Moffat AC - The Fate of LSD in the Body: Forensic Considerations - 1978
Trabucchi M, Hofmann M, Montefusco O, Spano PF - Ergot Alkaloids and Cyclic Nucleotides in the CNS - 1978
Trulson ME, Jacobs BL - Effects Of LSD On Behavior And Raphe Unit Activity In Freely-moving Cats - 1978
Trulson NE, Jacobs BL - Behavioral Evidence for Denervation Supersensitivity After Destruction of Serotoninergic Nerve Terminals - 1978
Twitchett PJ, Fletcher SM, Sullivan AT, Moffat AC - Analysis of LSD in human body fluids by high-performance liquid chromatography, fluoresence spectroscopy and radioimmunoassay - 1978
Vaupel DB, Martin WR - LSD-like Hallucinogens In The Dog: Validation Studies With Mescaline (MES), Psilocin (PSI) And Dimethyltryptamine (DMT) - 1978
Winter JC - Stimulus Properties of Phenethylamine Hallucinogens and Lysergic Acid Diethylamide: The Role of 5-Hydroxtryptamine - 1978
Winter JC - LSD-Induced Stimulus Control: A Comparison of SCH12,679, Fenfluramine, P-Methoxyamphetamine, and BL-3912 - 1978
Winter JC - Yohimbine-induced Stimulus Control in the Rat - 1978
Yim GKW, Nichols DE, Pfister WR - Stereoselective Actions of Hallucinogen Analogues - 1978
Adams WB, Drummond AH, Levitan IB - Dopamine Currents in Cell R15 of Aplysia - 1978
Ahn HS, Makman MH - Stimulation of Adenylate Cyclase Activity in Monkey Anterior Limbic Cortex by Serotonin - 1978
Anderson GM, Braun G, Braun U, Nichols DE, Shulgin AT - Absolute Configuration and Psychotomimetic Activity - 1978
Anlezark GM, Horton RW, Meldrum BS - Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism - 1978
Anlezark G. Meldrum B - Blockade of Photically Induced Epilepsy by 'Dopamine' Agonist' Ergot Alkaloids - 1978
Appel JB, White FJ, Kuhn DM - The Use of Drugs as Discriminative Stimuli in Behavioral Pharmacodynamics - 1978
Appel JB, White FJ - Behavioral and Neuropharmacological Aspects of the Discrimtnative Stimulus Properties of Quipazine - 1978
Bastecky J, Podrouzek V, Vinar O - Alosteric Changes in Plasma Proteins in Healthy Volunteers After Administration of Lysergamide - 1978
Bennett JP, Snyder SH - Serotonin synaptic receptors in the mammalian central nervous system - 1978
Berde B - Pharmacology of Ergot Alkaloids in Clinical Use - 1978
Boullin DJ, Glenton PAM - Characterization of Receptors Mediating 5-Hydroxytryptamine and Catecholamine-Induced Platelet Aggregation, Assessed by the Actions of a- and p-Blockers, Butyrophenones, 5-HT Antagonists and Chlorpromazine - 1978
Bourgoin S, Artaud F, Bockaert J, Hery F, Glowinski J, Hamon JM - Paradoxical Decrease of Brain 5-HT Turnover by Metergoline, a Central 5-HT Receptor Blocker - 1978
Brandon JM - Failure of Indomethacin and d-2-Bromolysergic Acid Diethylamide to Modify the Acute Oedematous Reaction to Oestradiol in the Uterus of the Immature Rat - 1978
Burki HR, Asper H, Ruch W, Zueger PE - Bromocriptine, Dihydroergotoxine, Methysergide, d-LSD, CF-25-397, and 29-712: Effects on the Metabolism of the Biogenic Amines in the Brain of the Rat - 1978
CaLil HM - Screening Hallucinogenic Drugs. II. Systemic Study of Two Behavioral Tests - 1978
Caponeri MA, Charles Nicholas AJ, Maio D - Urgenze e Tossicomanie - 1978
Carr DM - Cytological and Cytogenetical Effect of Hallucinogenic Drugs on Virally Induced Murine Erythroleukemia - 1978
Carter RB. Appel JB - LSD and 5-HTP: Tolerance and Cross-Tolerance Relationships - 1978
Chan CC, Fishman M, Egbert PR - Multiple Ocular Anomalies Associated With Maternal LSD Injestion - 1978
Chan YL, Lien EJ, Shih JC - QSAR of Agents Involved in Serotonin and LSD Binding Sites - 1978
Christoph GR, Kuhn DM, Jacobs BL - Dopamine Agonist Pretreatment Alters LSD's Electrophysiological Action from Dopamine Agonist to Antagonist - 1978
Claridge G - Animal models of schizophrenia: the case for LSD-25 - 1978
Cohen D - LSD in Leiden - 1978
Colpaert FC - Discriminative stimulus properties of narcotic analgesic drugs - 1978
Cowan A, Watson T - Lysergic acid diethylamide antagonizes shaking induced in rats by five chemically different compounds - 1978
Cunha JM, Masur J - Evaluation of psychotropic drugs with a modified open field test - 1978
Da Prada M, Pieri L, Keller HH, Pieri M, Bonetti EP - Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the Rat Central Nervous System After Intraventricular or Intracerebral Application and on Blood Platelets In Vitro - 1978
Decker WJ, Brandes WB - LSD Misadventure in Middle Age - 1978
Degrell I - Specificity and interaction of the neurotransmitter on the basis of clinical observations - 1978
Degtyarev V P - Influence of Serotoninergic Substances on the Brain Potentials Evoked by Stimulation of the Dental Pulp - 1978
Dolphin A, Enjalbert A, Tassin JP, Lucas M, Bockaert J - Direct Interaction of LSD with Central "Beta"-Adrenergic Receptors - 1978
Dray A, Connors B, Fox PC, Hilmy H, Moore C, Somjen GG - Effects Of LSD On Unit Activity And Extracellular Potassium Responses In Cat Cortex During Visual Stimulation - 1978
Drew GM - Pharmacological Characterization of the Presynaptic a-Adrenoreceptors Regulating Cholinergic Activity in the Guinea-Pig Ileum - 1978
Drummond AH, Bucher F, Levitan IB - LSD Labels a Novel Dopamine Receptor in Molluscan Nervous System - 1978
Drummond AH, Bucher F, Levitan IB - 3H-LSD Labels a Novel Dopamine Receptor in Molluscan Ganglia - 1978
Dube KC, Kumar A, Kumar N, Gupta SP - Prevalence and pattern of drug use amongst college students - 1978
Edvinsson L, Hardebo JE, Owman C - Pharmacological Analysis of 5-Hydroxytryptamine Receptors in Isolated Intracranial and Extracranial Vessels of Cat and Man - 1978
Enjalbert A, Bourgoin S, Hamon M, Adrien J, Bockaert J - Postsynaptic Serotonin-Sensitive Adenylate Cyclase in the Central Nervous System. II. Comparison with Dopamine- and Isoproterenol-Sensitive Adenylate Cyclases in Rat Brain - 1978
Fillion G, Goiny M, Fillion M P, Jacob J - Influence d'ions et de divers reactifs des proteins sur les liaisons de haute affinite de la 5-hydroxytryptamine et du diethylamide de l'acide lysergique par des membranes synaptosomales de cerveau. - 1978
Fillion G, Fillion MP, Goiny M, Jacob J - Au sujet des interactions du Propranolol et des recepteurs de la 5-hydroxytryptamine - 1978
Fillion GMB - High-Affinity Binding of 3H 5-Hydroxytryptamine to Brain Synaptosomal Membranes; Comparison with 3H Lysergic Acid Diethylamide Binding - 1978
Fink H, Oelssner W - Die Wirkung van Psychotomimetika und Haloperidol auf das Kopfzucken nach Alkoholentzug bet Mausen - 1978
Fleisher LN - Hallucinogen-Induced Rotational Behavior in Rats - 1978
Friedman H, Carey RJ - Long-Term Effects of LSD-25 on Easy and Hard Visual Discrimination in Rat - 1978
Frischknecht HR, Waser PG - Actions of Hallucinogens on Ants (Formica Pratensis)-I. Brain Levels of LSD and THC Following Oral Administration - 1978
Frischknecht HR, Waser PG - Actions of Hallucinogens on Ants (Formica Pratensis)-II. Effects of Amphetamine), LSD and Delta-9-Tetrahydrocannabinol - 1978
Fuxe K, Ogren SO, Agnati LF, Jonssen G, Gustafsson JA - 5,7-Dihydroxytryptamine as a Tool to Study the Functional Role of Central 5-Hydroxytryptamine Neurons - 1978
Fuxe K, Fredhaolm BB, Agnat LF, Ogren SO, Everit BJ, Jonsson GU, Gustafsson JA - Interaction of Ergot Drugs with Central Monamine System. Evidence for a High Potential in the Treatment of Mental and Neurological Disorders - 1978
Gallager DW - Benzodiazopines: Potentiation of a GABA Inhibitory Response in the Dorsal Raphe Nucleus - 1978
George JE - Law and the Emergency Nurse - 1978
Gever MA, Dawsey WJ, Mandell AJ - Fading: A New Cytofluorimetric Measure Quantifying Serotonin in the Presence of Cacholamines at the Cellular Level in Brain - 1978
Geyer MA, Petersen LR, Rose GJ, Horwitt DD, Light RK, Adams LM, Zook JA, Hawkins RL, Mandell AJ - The Effects of Lysergic Acid Diethylamide and Mescaline-derived Hallucinogens on Sensory-integrative Function: Tactile Startle - 1978
Gillespie JS, McKnight AT - The Actions Of Some Vasoactive Polypeptides And Their Antagonists On The Anococcygeus Muscle - 1978
Glennon RA, Kier LB - LSD Analogs as Serotonin Antagonists: a Molecular Connectivity SAR analysis - 1978
Goh K, Bauman AW - Lysergic Acid Diethylamide and Acute Leukemia - 1978
Graf M, Pletscher A - Pharmacological Characterization of the 5-Hydroxytryptamine (5HT) Receptor of Blood Platelets. - 1978
Green JP, Weinstein H, Maayani S - Defining the Histamine H2- Receptor in Brain: The Interaction With LSD - 1978
Green JP, Johnson CL, Weinstein H, Kang S, Chou D - Molecular Determinants For Interaction With The LSD Receptor: Biological Studies And Quantum Chemical Analysis - 1978
Grillo N, Cirillo B - Sindrome da asinenza da tossicomania materna. Considerazioni clinico-patologiche su due casi. [Abstinence Syndrome Due to Maternal Toxicomania. Clinico-pathogenetic Remarks on Two Cases] - 1978
Grillo N, Cirillo B - Sindrome da asinenza da tossicomania materna. Considerazioni clinico-patologiche su due casi. [Deprivation Syndrome in Newborn from Drug Addicted Mothers. Clinical and Pathogenetical Considerations About Two Cases] - 1978
Grossman TM - Post-Anesthesia Catalepsy In an LSD User - 1978
Harris RA, Snell D, Loh HH - Effects of d-Amphetamine, Monomethoxy-amphetamines and Hallucinogens on Schedule-controlled Behaviour - 1978
Heikkila J, Holbrook L, Brown I - Stress-Accentuation of the LSD-Induced Disaggregation of Brain Polysomes - 1978
Hofmann A - Historical View On Ergot Alkaloids. - 1978
Horowski R - Differences in the Dopaminergic Effects of the Ergot Derivatives Bromocriptine, Lisuride and d-LSD as compared with Apomorphine - 1978
Jacobs BL, Trulson ME, Stern WC - An Animal Behavior Model for Studying the Actions of LSD and Related Hallucinogens. - 1978
Jonsson G, Pollare T, Hallman H, Sachs C - Developmental Plasticity Of Central Serotonin Neurons After 5,7-dihydroxytryptamine Treatment - 1978
Kataoka Y, Shibata K, Fujiwara M, Ueki S - Effects of Psychotropic Drugs on Labor Division Between Rats - 1978
Kay DC, Martin WR - LSD and Tryptamine Effects on Sleep/Wakefulness and Electrocorticogram Patterns in Intact Cats - 1978
Kehr W, Speckenbach W - Effect of Lisuride and LSD on Monoamine Synthesis after Axotomy or Reserpine Treatment in Rat Brain - 1978
Keller HH, Burkard WP, Pieri L, Bonetti EP, Da Prada M - Lisuride- and D-LSD-Induced Changes of Monoamine Turnover in the Rat Brain - 1978
Kovacic B, Wang-Lu LJ, Ruffing D, Domino EF - Interactions of Partial LSD Analogs Behavioral Disrupting Effects of LSD and DMT in the Rat - 1978
Krдuchi K, Lichtsteiner M, Feer H, Wirz-Justice A - Demonstration of an in vivo d-LSD-binding method - 1978
Krдuchi K, Feer H, Lichtsteiner M, Wirz-Justice A - Specific in vivo Binding of d-LSD in Rat Brain - 1978
Ksir CJ - Rate-Dependent and Stimulus Control Effect of Drugs - 1978
Kuhn DM, White FJ, Appel JB - The Discriminative Stimulus Properties of LSD: Mechanisms of Action - 1978
Kuhn DM - Discriminative Stimulus Properties of LSD: Behavioral Assay of the Mechanism of Action of LSD - 1978
Kumbar M - Conformational Study of Lysergic Acid Derivatives in Relation to Their Hallucinogenic and Antiserotonin Activities - 1978
Lofstrom A, Agnati LF, Fuxe K, Hokfelt T - Evidence for an Inhibitory Dopaminergic and Stimulatory Noradrenergic Hypothalamic Influence on PMS-Induced Ovulation in the Immature Rat. II. A Pharmacological Analysis - 1978
Laurent JP, Pieri L - Lisuride and LSD Decrease Spontaneous Firing of Neurons in the Raphe - 1978
Levi S, Reisfeld R - Ultramcrodetermination of Cholesterol, Testosterone and LSD by Fluorescence Measurements of TLC Spots - 1978
Leysen JE, Niemegeers CE, Tollenaere JP, Laduron PM - Serotonergic component of neuroleptic receptors - 1978
Lojenga JCK - Farmacologische aspecten van drugs - 1978
Longo VG, Loizzo A - Evaluation of the Central Effects of Ergot Alkaloids by Means of Electroencephalography - 1978
Lullmann H, Lullmann-Rauch R, Wassermann O - Lipidosis Induced By Amiphiphilic Drugs - 1978
Maayani S, Green JP, Weinstein H - LSD, Tricyclic Antidepressants And Neuroleptics Inhibit Histamine Stimulated Adenylate Cyclase In Brain - 1978
MacDonald JF, Berry MS - Further Identification of Multiple Responses Mediated by Dopamine in the CNS of Planorbis corneas - 1978
Maj J, Baran L, Michaluk J, Palider W, Rawlow A - The Central Antiserotonin Activity of Neuroleptics - 1978
Maj J, Sowinska H, Baran L Gancarczyk L, Rawlow A - The Central Antiserotonergic Action of Mianserin - 1978
Maj J, Palider W, Rawlow A - The Effect of Haloperidol, Spiperone and Pimozide on the Flexor Reflex of the Hind Limb of the Spinal Rat - 1978
Man PL, Chen CH - Plasma levels of neuroleptics vs clinical response - 1978
Marquardt GM, DiStefano V, Ling LL - Pharmacological and Toxicological Effects of B-3,4-Methylenedioxyamphetamine Isomers - 1978
Marshall DJ, Petersen BA, Vouros P - Some Considerations on Quantitative Methodology and Detection Limits in Organic Mass-Spectrometry - 1978
Martin WR - The Nature of Opioid and LSD Receptors: Structural Activity Relationship Implications - 1978
Martin WR, Vaupel DB, Nozaki M, Bright LD - The Identification Of LSD-like Hallucinogens Using The Chronic Spinal Dog - 1978
McGrath JC - Adrenergic and 'Non-Adrenergic' Components in the Contractile Response of the Vas Deferens to a Single Indirect Stimulus - 1978
Mcgrath JC, Olverman HJ - Release Of [3h]-Noradrenaline From The Motor Adrenergic Nerves Of The Anococcygeus Muscle By Lysergic Acid Diethylamide, Tyramine Or Nerve Stimulation - 1978
Mehl E, Guiard L - Physiological Ligands of Putative LSD-Serotonin Receptors: Heterogeneity of LSD-Displacing Factors in Human Body Fluids and Nervous Tissue - 1978
Miller DD - Steric aspects of dopaminergic drugs - 1978
Moore RH, Domino EF - Modification of the Effects of LSD-25, d-Amphetamine and Tryptamine on Electrically Evoked Responses in the Visual System by Methiothepin and Octoclothepin - 1978
Muneer RS - The effects of LSD on human chromosomes - 1978
Natale M, Dahlberg CC, Jaffe J - Effect of Psychotomimetics (LSD and Dextroamphetamine) on the Use of Primary- and Secondary-Process Language - 1978
Natale M, Kowitt M, Dahlberg CC, Jaffe J - Effect of Psychotomimetics (LSD and Dextroamphetamine) on the Use of Figurative Language During Psychoanalysis - 1978
Nichols DE - Phenethylamine Hallucinogens: New Structural Analogy and Implications for Receptor Geometry - 1978
Northup JK, Mansour TE - Adenylate Cyclase from Fasciola Hepatica. 2. Role of Guanine Nucleotides in Coupling Adenylate Cyclase and Serotonin Receptors - 1978
Northup JK, Mansour TE - Adenylate Cyclase from Fasciola hepatica. 1. Ligand Specificity of Adenylate Cyclase-Coupled Serotonin Receptors - 1978
Nozaki M, Vaupel DB, Bright LD, Martin WR - A Pharmacological Comparison Of 3-methoxy-4,5-methylenedioxyamphetamine And LSD In The Dog - 1978
Olgart L, Gazelius B - Inhibition of compound 48/80-induced intradental sensory nerve activity by disodium cromoglycate and serotonin antagonists - 1978
Otis LS, Pryor GT, Marquis WJ, Jensen R, Petersen K - Preclinical Identification Of Hallucinogenic Compounds - 1978
Owman C, Edvinsson L, Hardebo - Pharmacological in vitro Analysis of Amine-Mediated Vasomotor Functions in the Intracranial and Extracranial Vascular Beds - 1978
Persson SA - LSD And Related Drugs As DA Antagonists: Receptor-mediated Effects On the Synthesis And Turnover Of DA - 1978
Persson SA - Effects of LSD and BOL on the Catecholamine Synthesis and Turnover in Various Brain Regions - 1978
Persson SЕ, Johansson H - The Effect Of Lysergic Acid Diethylam1de (LSD) and 2-bromo-lysergic Acid Diethylamide (BOL) On The Striatal Dopa Accumulation: Influence Of Central 5-hydroxy-tryptaminergic Pathways - 1978
Pieri, Margherita; Sehaffner, R, Pieri L, Da Prada M, Haefely W - Turning in MFB-Lesioned Rats and Antagonism of Neuroleptic-Induced Catalepsy after Lisuride and LSD - 1978
Pieri L, Keller HH, Burkard W, Da Prada M - Effects of lisuride and LSD on cerebral monamine systems and hallucinosis - 1978
Pietrowicz D, Kocur J, Porczynski P - The Effects Of LSD And Propranolol On The Motor Activity In Rabbits - 1978
Poling AD, Appel JB - Drug Effects Under Automaintenance and Negative Automaintenance Procedures - 1978
Przegalinski E, Baran L, Palider W, Bigajska K - On the Central Antiserotonin Activity of Benzoctamine and Opipramal - 1978
Ranbom W - Synthetic approaches to lysergic acid - 1978
Rappolt RT, Gay G, Inaba DS, Rappolt N - Use of Inderal (Propranolol-Ayerst) in 1-a (Early Stimulative) and 1-b (Advanced Stimulative) Classification of Cocaine and Other Sympathomimetic Reactions - 1978
Rech RH - Brain Lesions and Psychostimulant Drugs - 1978
Rosecrans JA, Chance WT, Spencer RM - The Discriminative Stimulus Properties of Cyclazocine: Generalization Studies Involving Nalorphine, Morphine and LSD - 1978
Rosecrans JA, Krynock GM, Newlon P, Chance WT, Kallman M - Central Mechanisms of Drugs as Discriminative Stimuli; Involvement of Serotonin Pathways - 1978
Sapper H, Lohmann W - Association of Some Psychotomimetic Compounds with 6-Methylpurine in Aqueous Solutions - 1978
Schlemmer RF, Tyler CB, Narasimhachari N, Davis JM - The Comparitive Effects Of LSD, Mescaline, And DMT On Primate Social And Solitary Behavior - 1978
Seeman P, Tedesco J,L, Chau-Wong M, Muller P, Bowles J, Whitaker PM, McManus C, Tittler M, Weinreich P, Friend WC, Brown GM - Dopamine Receptors in the Central Nervous System - 1978
Shulgin AT, Nichols DE - Characterization of Three New Psychotomimetics - 1978
Siegel RK - Pharmacology of Hallucinogens: HALLUCINOGENS AND ATTENTIONAL DYSFUNCTION: A MODEL FOR DRUG EFFECTS AND REALITY TESTING - 1978
Silverman PB, Ho BT - Stimulus Properties of DOM: Commonality with Other Hallucinogens - 1978
Singh MP, Kalia CS - LSD induced chlorophyll mutations in barley - 1978
Sizaret P, Degiovanni A, Barthelemy L - Schizophrenie et Toxicomanie - 1978
Smythies JR - On The Molecular Mechanism Of Action Of Hallucinogens - 1978
Spano PF, Govoni S, Trabucchi M - Studies on the Pharmacological Properties of Dopamine Receptors in Various Areas of the Central Nervous System - 1978
Stolzki B, Kaiser HO, Mehl EL - Heterogeneity of LSD Displacing Factors and Multiple Types of High Affinity LSD-Binding Sites - 1978
Szepesy L, Feher I, Szepesi G, Gazdag M - High-Performance Liquid Chromatography of Ergot Alkaloids - 1978
Trabucchi M, Hofmann M, Montefusco O, Spano PF - Ergot Alkaloids and Cyclic Nucleotides in the CNS - 1978
Trulson ME, Jacobs BL - Effects Of LSD On Behavior And Raphe Unit Activity In Freely-moving Cats - 1978
Trulson NE, Jacobs BL - Behavioral Evidence for Denervation Supersensitivity After Destruction of Serotoninergic Nerve Terminals - 1978
Uebelhack R, Franke L, Seidel K - Wirkung von LSD und 5-Methoxy-N, N-dimethyltryptamin auf die aktive Aufnahme von [3H]-Serotonin in Synaptosomenfraktionen aus Rattenhirn - 1978
Uebelhack R, Franke L, Seidel K - Zur Wirkung von LSD auf die synaptosomale Mg++ (Na+, K+) -ATPase - 1978
Uyeno ET - Effects of Psychodysleptics on Aggressive Behavior of Animals - 1978
Valette G, Leclair MF - du lysergide sur les rйponses mйcaniques des organes isolйs de Rat aux catйcholamines et rфle des йchanges de calcium dans ces phйnomиnes - 1978
Van Went GF - Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and d 9-THC, using the micronucleus test - 1978
Vaupel DB, Nozaki M, Martin WR, Bright D - Single Dose and Cross Tolerance Studies of beta-Phenethylamine, d-Amphetamine and LSD in the Chronic Spinal Dog - 1978
Vaupel DB, Martin WR - LSD-like Hallucinogens In The Dog: Validation Studies With Mescaline (MES), Psilocin (PSI) And Dimethyltryptamine (DMT) - 1978
Vetulani J, Bednarczyk B, Reichenberg K - Inhibition of "Wet Shakes" During Morphine Abstinence by an Antagonist of Opiate analgesia - 1978
Whitaker PM, Seeman P - Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate - 1978
Whitaker PM, Seeman P - High-Affinity 3H-Serotonin Binding to Caudate: Inhibition by Hallucinogens and Serotoninergic Drugs - 1978
Winter JC - Stimulus Properties of Phenethylamine Hallucinogens and Lysergic Acid Diethylamide: The Role of 5-Hydroxtryptamine - 1978
Winter JC - LSD-Induced Stimulus Control: A Comparison of SCH12,679, Fenfluramine, P-Methoxyamphetamine, and BL-3912 - 1978
Winter JC - Yohimbine-induced Stimulus Control in the Rat - 1978
Yim GKW, Nichols DE, Pfister WR - Stereoselective Actions of Hallucinogen Analogues - 1978
Ogren SO, Fuxe K, Agnati LF, Gustafsson JA, Jonsson G, Holmt AC - Reevaluation of the Indoleamine Hypothesis of Depression. Evidence for a Reduction of Functional Activity of Central 5-HT Systems by Antidepressant Drugs - 1979
Corrent G, McAdoo DJ, Eskin A - A Transmitter Role For Serotonin In The Aplysia Eye? - 1979
Dolphin A, Adrien J, Hamon M, Bockaert J - Identity of (3H)-Dibydroalprenolol Binding Sites and p-Adrenergic Receptors Coupled with Adenylate Cyclase in the Central Nervous System: Pharmacological Properties, Distribution and Adaptive Responsiveness - 1979
Freedman DX - LSD, Psychotogenic Procedures, and Brain Neurohumors - 1979
Glennon RA, Kier LB, Shulgin AT - Molecular Connectivity Analysis of Hallucinogenic Mescaline Analogs - 1979
Greengard P - Cyclic Nucleotides, Phosphorylated Proteins and the Nervous System - 1979
Grinspoon, Lester; Bakalar, James B. - Therapeutic Uses - 1979
Grinspoon, Lester; Bakalar, James B. - Psychedelic Drugs Reconsidered - 1979
Horowski R, Graef KJ - Neuroendocrine Effects of Neuropsychotropic Drugs and Their Possible Influence On Toxic Reactions in Animals and Man - The Role of the Dopamine-Prolactin System - 1979
Hyvarinen J, Laakso M, Roine R, Leinonen L - Effects of Phencyclidine, LSD and Amphetamine on Neuronal Activity in the Posterior Parietal Association Cortex of the Monkey - 1979
Ishii H, Hayashi M, Niwaguchi T, Nakahara Y - Studies on Lysergic Acid Diethylamide and Related Compounds. IX. Microbial Transformation of Amides Related to Lysergic Acid Diethylamide by Streptomyces Roseochromogenes - 1979
Krauchi K, M. Lichtsteiner M, Gentsch C, Feer H - In Vivo 3H-d-LSD-Binding in Punched Out Brain Regions - 1979
Krsiak M - Effects of Drugs on Behaviour of Aggressive Mice - 1979
Maayani S, Weinstein H, Green JP - Brain 5-HT and LSD Binding Sites - 1979
Mansour TE - Biochemical Effects of Psychopharmacological Agents - 1979
Marin J, Salaices M, Marco EJ, Gomez B, Lluch S - Analysis of the Contractile Effect of 5-Hydroxytryptamine on the Isolated Posterior Communicating Artery of the Cat - 1979
Miskiewicz M, Rokosz-Pelc A, Vetulani J - The Effect of Quipazine and LSD on Monoamines in the Rat Striatum - 1979
Poling AD, White FJ, Appel JB - Discriminative Stimulus Properties of Phencyclidine - 1979
Raphael, Girard - Esotericism of the Popol Vuh. Trans. Blair A. Moffett. - 1979
Richards, William A. - Psychedelic Drug-Assisted Psychotherapy with Persons Suffering from Terminal Cancer - 1979/80
Richards, William A.; Rhead, John C.; Grof, Stanislav; Goodman, Louisa E.; Di Leo, Francesco; Rush, Lockwood - DPT as an Adjunct in Brief Psychotherapy with Cancer Patients - 1979
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S - m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful Anorexia in Rats - 1979
Schlemmer RF, Heinze WJ, Davis JM - Evidence For Serotonin Mediation Of LSD-Induced Abnormal Behavior In Monkeys - 1979
Shulgin AT - Chemistry of Phenethylamines Related to Mescaline - 1979
Shulgin AT - Profiles of Psychedelic Drugs. 6. alpha-O-DMS - 1979
Shulgin AT - Profiles of Psychedelic Drugs. 7. Mescaline - 1979
Sloviter RS - Serotonin Neuropharmacology: Behavior and Hippocampal Electrophysiology - 1979
Sovilla JY, Magistretti P, Schorderet M - Potentiation of Apomorphine-Induced Climbing Behaviour in Mice by d-LSD - 1979
Sovilla JY, Schorderet M - Potentiation of Apomorphine-Induced Climbing in Mice by d-LSD - 1979
Sypniewska M - The Effect of Baclofen on the Hind Limb Flexor Reflex of the Spinal Rat - 1979
Weinstein H, Osman R, Green JP - The Molecular Basis of Structure-Activity Relationships: Quantum Chemical Recognition Mechanisms in Drug Receptor Interactions - 1979
Whitaker, Patricia Mack - Brain Receptors for LSD and Serotonin - 1979
Williams JM - Distortions of Vision and Pain: Two Functional Facets of d-Lysergic Acid Diethylamide - 1979
Williams JM, Yarbrough GG - Enhancement of in Vitro Binding and Some of the Pharmacological Properties of Diazepam by a Novel Anthelmintic Agent, Avermectic B1a - 1979
Abramson HA, Gettner HH, Carone PA, Rolo A, Krinsky L - The intracranial injection of drugs in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity - 1979
Abramson HA, Gettner HH - Double Bonds, Aliphatic Chains, and Hallucinogens, Update - 1979
Aghajanian GK - Psychotogenic Drug Action on Chemically Defined Neurons - 1979
Ahn HS, Makman MH - Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences - 1979
Altman JL, Appel JB, McGowan WT - Drugs and the discrimination of duration - 1979
Andreas K, Dude C, Dude G - Interaction of morphine and 5-hydroxytryptamine in the raphe-hippocampus system - 1979
Anlezark GM, Horton RW, Meldrum BS - Dopamine Agonists and Reflex Epilepsy - 1979
Appel JB - Neurohumoral Determinants of Sensitivity to LSD - 1979
Ardrey RE, Moffat AC - A compilation of analytical data for the identification of lysergide and its analogues in illict preparations - 1979
Arnt J, Scheel-Krьger J - GABAergic and Glycinergic Mechanisms Within the Substantia Nigra: Pharmacological Specificity of Dopamine-Independent Contralateral Turning Behavior and Interactions With Other Neurotransmitters - 1979
Baker PB, Gough TA - The rapid determination of cocaine and other local anesthetics using field tests and chromatography - 1979
Bennet JP, Salvatore JE, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH - Neurotransmitter Receptors in Frontal Cortex of Schizophrenics - 1979
Blakely AGH, Cunnane TC, Muir TC - The Electrical Responses of the Rabbit Rectococcygeus Following Extrinsic Parasympathetic Nerve Stimulation - 1979
Castellano C - Effects of LSD-25 on Avoidance Behavior and Locomotor Activity in Mice - 1979
Cheng SH, Shih JC - Photoaffinity Labeling of Serotonin-Binding Proteins - 1979
Choulis NH, Krall JM, Clarke NG - Computers in drug analysis. Part I: Identification of drugs of abuse via IR spectroscopy - 1979
Colpaert FC, Niemegeers CJE, Janssen PAJ - In Vivo Evidence of Partial Agonist Activity Exerted by Purported 5-Hydroxytryptamine Antagonists - 1979
Costa M, Furness JB - On the Possibility that an Indoleamine is a Neurotransmitter in the Gastrointestinal Tract - 1979
Dolphin A, Adrien J, Hamon M, Bockaert J - Identity of (3H)-Dibydroalprenolol Binding Sites and p-Adrenergic Receptors Coupled with Adenylate Cyclase in the Central Nervous System: Pharmacological Properties, Distribution and Adaptive Responsiveness - 1979
Duchemin AM, Quach TT, Rose C, Schwartz JC - Pharmacological Characterization of 3H-LSD Binding Sites in Mouse Brain In Viva - 1979
Fillion G, Rousselle JC, Beaudoin D, Pradelles P, Goiny M, Dray F, Jacob J - Serotonin Sensitive Adenylate Cyclase In Horse Brain Synaptosomal Membranes - 1979
Fleisher LN, Glick SD - Hallucinogen-Induced Rotational Behavior in Rats - 1979
Fox PC, Dray A - Iontophoresis of LSD: Effects on Responses of Single Cortical Neurones to Visual Stimulation - 1979
Fredrickson PA, Richelson E - Hallucinogens Antagonize Histamine H1 Receptors Of Cultured Mouse Neuroblastoma Cells - 1979
Freedman DX - LSD, Psychotogenic Procedures, and Brain Neurohumors - 1979
Gebhart E - Zur Frage der erbgutschдdigenden Nebenwirkungen von psychotropen Substanzen. Teil 2: Rausch- und Suchtdrogen - 1979
Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL - A Characteristic Effect of Hallucinogens on Investigatory Responding in Rats - 1979
Geyer MA, Light RK - LSD-Induced Alterations of Investigatory Responding in Rats - 1979
Gimpl MP, Gormezano I, Harvey JA - Effects on Learning as Measured by Classical Conditioning of the Rabbit Nictitating Membrane Response - 1979
Glennon RA, Rosecrans JA, Young R, Gaines J - Hallucinogens As A Discriminative Stimuli: Generalizations Of Dom To A 5-methoxy-N, N-dimethyltryptamine Stimulus - 1979
Graf M, Pletscher A - Shape Change Of Blood Platelets - a Model For Cerebral 5-hydroxytryptamine Receptors? - 1979
Greengard P - Cyclic Nucleotides, Phosphorylated Proteins and the Nervous System - 1979
Hйry F, Simonnet G, Bourgoin S, Soubriй P, Artaud F, Hamon M, Glowinski J - Effect Of Nerve Activity On The In Vivo Release Of [3H]serotonin Continuously Formed From L-[3H]tryptophan In The Caudate Nucleus Of The Cat - 1979
Haigler HJ, Spring DD - Drugs that Antagonize Limb Flick Behavior Induced by D-Lysergic Acid Diethylamide (LSD) in Cats - 1979
Heikkila JJ, Holbrook L, Brown IR - Disaggregation of Polysomes in Fetal Organs and Maternal Brain After Administration of d-Lysergic Acid Diethylamide in Vivo - 1979
Heikkila JJ, Brown IR - Disaggregation of brain polysomes after LSD in vivo. Involvement of LSD-induced hyperthermia - 1979
Hernandez LL, Appel JB - An Analysis of Some Perceptual Effects of Morphine, Chlorpromazine, and LSD - 1979
Hoffman, Albert - How LSD Originated - 1979
Holbrook LA - Transient Decrease in Brain Protein Synthesis after in vivo Administration of a Psychotropic Drug: Mechanism and Developmental Effects - 1979
Horowski R, Graef KJ - Neuroendocrine Effects of Neuropsychotropic Drugs and Their Possible Influence On Toxic Reactions in Animals and Man - The Role of the Dopamine-Prolactin System - 1979
Horowski R, Wachtel H - Pharmacological Effects Of Lisuride In Rodents Mediated By Dopaminergic Receptors: Mechanism Of Action And Influence Of Chronic Treatment With Lisuride - 1979
Hyvarinen J, Laakso M, Roine R, Leinonen L - Effects of Phencyclidine, LSD and Amphetamine on Neuronal Activity in the Posterior Parietal Association Cortex of the Monkey - 1979
Ishii H, Hayashi M, Niwaguchi T, Nalcahara Y - Studies on Lysergic Acid Diethylamide and Related Compounds. VII. Microbial Transformation of Lysergic Acid Diethylamide and Related Compounds - 1979
Ishii H, Hayashi M, Niwaguchi T, Nakahara Y - Studies on Lysergic Acid Diethylamide and Related Compounds. IX. Microbial Transformation of Amides Related to Lysergic Acid Diethylamide by Streptomyces Roseochromogenes - 1979
Kemali M, Kemali D - Observations on Central Nervous System Structures Following the Administration of A Psychotomimetic Substance - 1979
Kiechel JR - Pharmacocinйtique et mйtabolisme des dйrivйs de l'ergot - 1979
Kiechel JR - Pharmacocinйtique et Mйtabolisme des Dйrives de l'Ergot - 1979
Kielholz P, Rьmmele W, Ladewig D, Hobi V - Auswirkungen von Drogen auf das Verhalten von Motorfahrzeugfьhrern. Ein Gutachten fьr das Schweizerische Bundesgericht vom 7. April 1978 - 1979
Krauchi K, M. Lichtsteiner M, Gentsch C, Feer H - In Vivo 3H-d-LSD-Binding in Punched Out Brain Regions - 1979
Krsiak M - Effects of Drugs on Behaviour of Aggressive Mice - 1979
Lamberts SWJ, Macleod RM - Metergoline and Other Peripheral Serotonin Antagonists Inhibit Prolactin Secretion Through Mechanisms Unrelated to Serotonin - 1979
Laubscher A, Pletscher A - Shape Change and Uptake Of 5-hydroxytryptamine In Human Blood Platelets: Action of Neuropsychotropic Drugs - 1979
Levin RM, Weiss B - Selective Binding of Antipsychotics and Other Psychoactive Agents to the Calcium-Dependent Activator of Cyclic Nucleotide Phosphodiesterase - 1979
Leyland CM, Gwyther RJ, Rylands JM - An Improved Method for Detecting Drug Effects in the Open Field - 1979
Lukaszewski T - 3,4-Methylenedioxyamphetamine Overdose - 1979
Maayani S, Weinstein H, Green JP - Brain 5-HT and LSD Binding Sites - 1979
MacDermot J, Higashida H, Wilson SP, Matsuzawa H, Minna J, Nirenberg M - Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids - 1979
Macdermot J, Higashida H - Independent Regulation of Receptor-Mediated Cell Depolarization and Adenylate Cyclase by 5-Hydroxytryptamine (Serotonin) in Neuroblastoma Hybrid Cells - 1979
Mace S - LSD - 1979
Mahony JB, Brown IR - Fate of mRNA followng disaggregation of brain polysomes after administration of (+)-lysergic acid diethylamide in vivo - 1979
Maj J, Lewandowska A, Rawlow A - Central Antiserotonin Action of Amitriptyline - 1979
Maj J, Palider W, Rawlow A - Trazadone, a Central Serotonin Antagonist and Agonist - 1979
Mandel JL - Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy: a Phenomenological Study - 1979
Mansour TE - Biochemical Effects of Psychopharmacological Agents - 1979
Marin J, Salaices M, Marco EJ, Gomez B, Lluch S - Analysis of the Contractile Effect of 5-Hydroxytryptamine on the Isolated Posterior Communicating Artery of the Cat - 1979
Marrazzi AS, Huang CC - Qualitative Identity of Cerebral Neuronal Membrane Actions of 5HT LSD, and CPZ - 1979
Marsh A - Visual Hallucinations During Hallucinogenic Experience and Schizophrenia - 1979
Miskiewicz M, Rokosz-Pelc A, Vetulani J - The Effect of Quipazine and LSD on Monoamines in the Rat Striatum - 1979
Natale M, Dahlberg CC, Jaffe J - The Effect of Psychotomimetics On Therapist-patient Matching Of Speech "Rhythms" - 1979
Natale M, Dahlberg CC, Jaffe J - The Effects Of LSD-25 And Dextroamphetamine On The Use Of Defensive Language - 1979
Nelson DL, Herbet A, Pichat L, Glowinski J. Hamon M - In vitro and in vivo Disposition of 3H-Methiothepin in Brain Tissues. Relationship to the Effects of Acute Treatment with Methiothepin on Central Serotoninergic Receptors - 1979
Niehoff DL, Palacios JM, Kuhar MJ - In Vivo Receptor Binding: Attempts To Improve Specific/ Non-specific Ratios - 1979
Poklis A, Mackell MA, Drake WK - Fatal intoxication from 3,4-methylenedioxyamphetamine - 1979
Polc P, Schneeberger J, Haefely W - Effects of Several Centrally Active Drugs on the Sleep-Wakefulness Cycle of Cats - 1979
Poling AD, White FJ, Appel JB - Discriminative Stimulus Properties of Phencyclidine - 1979
Prozialeck WC, Vogel WH - MAO Inhibition and the Effects of Centrally Administered LSD Serotonin, and 5-Methoxytryptamine on the Conditioned Avoidance Response in Rats - 1979
Przegalinski E, Baran L, Palider W, Siwanowicz J - The Central Action of Pizotifen - 1979
Rogawski MA, Aghajanian GK - Response of Central Monoaminergic Neurons to Lisuride: Comparison with LSD - 1979
Ruffing D, Kovacic B, Demetriou S, Domino EF - Naloxone Enhancement of DMT and LSD-25 Induced Suppression of Food-rewarded Bar Pressing Behavior in the Rat - 1979
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S - m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful Anorexia in Rats - 1979
Sbordone RJ, Wingard JA, Gorelick DA, Elliott ML - Severe Aggression in Rats Induced by Mescaline But Not Other Hallucinogens - 1979
Schild HO - L'ergot de seigle: des conceptions de dale aux rйcepteurs - 1979
Schlemmer RF, Heinze WJ, Davis JM - Evidence For Serotonin Mediation Of LSD-Induced Abnormal Behavior In Monkeys - 1979
Siddik ZH, Barnes RD, Dring LG, Smith RL, Williams RT - The Fate of Lysergic Acid Di[14C]ethylamide ([14C]LSD) in the Rat, Guinea Pig and Rhesus Monkey and of [14C]iso-LSD in Rat - 1979
Siddik ZH, Barnes RD, Dring LG, Smith RL, Williams RT - The Metabolism of Lysergic Acid Diethylamide (LSD) in the Isolated Perfused Rat Liver - 1979
Silbergeld EK, Hruska RE - Lisuride and LSD: Dopaminergic and Serotonergic Interactions in the "Serotonin Syndrome" - 1979
Sissors DL - Comparison of Mescaline and Lysergic Acid Diethyamide Effects on Lymphocyte Function In Vitro - 1979
Skett P, Mode A, Eneroth P, Gustafsson JA - The Effect Of Various Centrally-acting Drugs On Hepatic Steroid Metabolism In Male And Female Rats - 1979
Sloviter RS - Serotonin Neuropharmacology: Behavior and Hippocampal Electrophysiology - 1979
Sovilla JY, Magistretti P, Schorderet M - Potentiation of Apomorphine-Induced Climbing Behaviour in Mice by d-LSD - 1979
Sovilla JY, Schorderet M - Potentiation of Apomorphine-Induced Climbing in Mice by d-LSD - 1979
Stoney DA, Thornton JI - Solvent-Dependent Photolysis for Identification of Lysergic Acid Diethylamide and Other Indolamines - 1979
Sypniewska M - The Effect of Baclofen on the Hind Limb Flexor Reflex of the Spinal Rat - 1979
Torre E, Pavesi M, Torre C - Azione Dell'LSD-25 Sulle Colinesterasi Del Cervello Di Ratto - 1979
Trulson ME, Jacobs BL - Alterations of Serotonin and LSD Receptor Binding Following Repeated Administration of LSD - 1979
Trulson ME, Jacobs BL - Dissociations Between the Effects of LSD on Behavior and Raphe Unit Activity in Freely Moving Cats - 1979
Uebelhack R, Belkner J, Seidel K - Einfluss von LSD un 5-Methoxy-N, N-Dimethyltryptamin auf die RNS-Synthese in Zelkernen aus Rattenhirn - 1979
Vaupel DB, Nozaki M, Martin WR, Bright LD, Morton EC - The Inhibition of Food Intake in the Dog by LSD, Mescaline, Psilocin, d-Amphetamine and Phenyl-isopropylamine Derivatives - 1979
Vetulani J, Byrska B, Reichenberg K - Head twitches produced by serotonergic drugs and opiates after lesion of the mesotriatal serotonergic system of the rat - 1979
Walters JR, Baring MD, Lakoski JM - Effects of ergolines on dopaminergic and serotonergic single unit activity - 1979
Wang RY, de Montigny C, Gold BI, Roth RH, Aghajanian GK - Denervation Supersensitivity to Serotonin in the Rat Forebrain: Single Cell Studies - 1979
Whitaker PM, Seeman P - Selective Labeling of Apomorphine Receptors by 3H-LSD - 1979
White FJ, Appel JB, Kuhn DM - Discriminative Stimulus Properties of Quipazine: Direct Serotonergic Mediation - 1979
Williams JM, Yarbrough GG - Enhancement of in Vitro Binding and Some of the Pharmacological Properties of Diazepam by a Novel Anthelmintic Agent, Avermectic B1a - 1979
Winter JC - Quipazine-Induced Stimulus Control in the Rat - 1979
Wong YW, Chiu S, Mishra RK - Effect of d-Lysergic Acid Diethylamide on Striatal Choline Acetyltransferase Activity in the Rat - 1979
Ogren SO - The Effects of Chronic Treatment with Nomifensine and Zimelidine on 3H-d-LSD Binding in the Rat Cerebral Cortex - 1980
Uarens H, Zenk MH - Radioimmuntests fur die Bestimmung von Lysergsaure und einfachen Lysergsaurederivaten - 1980
Ogren SO - The Effects of Chronic Treatment with Nomifensine and Zimelidine on 3H-d-LSD Binding in the Rat Cerebral Cortex - 1980
Abraham HD - Psychiatric Illness in Drug Abusers - 1980
Blevins RD, Damie MR - The Effect of delta-9-THC on Herpes Simplex Virus Replication - 1980
Braun U, Shulgin AT, Braun G - Centrally Active N-Substituted Analogs of 3,4-Methylenedioxyphenylisopropylamine (3,4-Methylenedioxyamphetamine) - 1980
Braun U, Shulgin AT, Braun G - Prufung auf Aktivitat und Analgesia von N-substituierten Analogen des Amphetamin Derivates 3,4-Methylendioxyphenylisopropylamin - 1980
Braun U, Shulgin AT, Braun G - Centrally Active N- Substituted Analogs of 3,4-Methylenedioxyphenylisopropylamine (3,4-Methylenedioxyamphetamine) - 1980
Braun U, Shulgin AT, Braun G - Prufung auf zentral Aktivitat und Analgesie von N-substituierten Analogen des Amphetamin-Derivates 3,4-Methylenedioxyphenylisopropylamin - 1980
Ceccarelli P, Ortolani E, Zapponi GA, Loizzo A - Applications of Multivariate Analysis in the Classification of Psychotropic Drugs: Effects of LSD-25 on the EEG of the Rabbit - 1980
Colpaert FC - In Vivo Evidence Of Mixed Agonist/antagonist Activity Exerted By The Purported 5-hydroxytryptamine Antagonists Mianserin, Methysergide, And Cyproheptadine: A Drug Discrimination Analysis - 1980
Commissaris RL, Lyness WH, Moore KE, Rech RH - Antagonism of the Behavioral Effects of Hallucinogens by the 5-Hydroxytryptamine (5 HT) Antagonist Methergoline (MTG) - 1980
Crow TJ, Bourne R, Cross AJ, Ferrier IN, Owen F, Johnstone EC, Owens DGC, Whitaker PM - Neurotransmitter Enzymes and Receptors In Postmortem Brain in Schizophrenia - 1980
Dray A, Fox PC, Hilmy M, Somjen GG - The Effects of LSD and Some Analogues on the Responses of Single Cortical Neurons of the Cat to Optical Stimulation - 1980
Fink H, Morgenstern R - Scopolamine-Induced Hypermotility in Rats is Mediated via a Dopaminergic System - 1980
Geyer M A - Both lndoleamine and Phenylethylamine Hallucinogens Increase Serotonin in Both Dorsal and Median Raphe Neurons - 1980
Gold, R; Morgenstern, R.; Fink, H. - Einflub Verschiedener Serotoninantagonisten auf die LSD-Potenzierte Apomorphin-Lokomotion der Ratte - 1980
Gold R, Morgenstern R, Fink H - Effects of Atypical Antidepressants on LSD Potentiated Apomorphine Hypermotility in Rats - 1980
Green JP, Maayani S, Weinstein H, Hough LB - Histamine and Psychotropic Drugs - 1980
Grof, Stanislov - Emotional Distress and Physical Pain of Dying Individuals - 1980
Hartung J, Skorka D - The HIT Clinical Profile of Psychedelic Drug Users - 1980
Hetey L, Quiring K, Misselwitz HJ, Oelssner W - Bestimmung Unterschiedlicher Parameter des Cerebralen Dopamin- und Serotonin-Umsatzes nach Psychoharmaka - 1980
Jasinski DR - Interdisciplinary Studies on Phencyclidine at the Addiction Research Center, Lexington, Kentucky. - 1980
Kafkalides, Athanassios - The Knowledge of the Womb. Autopsychognosia with Psychedelic Drugs. - 1980
Kantor RE, Dudlettes SD, Shulgin AT - 5-Methoxy-alpha-Methyltryptamine (alpha-O-Dimethylserotonine) a Hallucinogenic Homolog of Serotonin - 1980
Kenyon CN, Melera A - Use of the Direct Liquid Inlet LC/MS System for the Analysis of Complex Mixtures of Biological Origin - 1980
Ksir CJ - Rate-Dependent and Stimulus Control Effects of Drugs - 1980
Kubos KL - Drugs and Seizure Identification by Audio Spectrometry - 1980
Kuhn DM, O'Callaghan JP, Juskevich J, Lovenberg W - Activation of Brain Tryptophan Hydroxylase by ATP-Mg2+: Dependence on Calmodulin - 1980
Laubscher A, Pletscher A - Increase of Cyclic GMP in Blood Platelets by Biogenic Amines - a Receptor-Mediated Effect - 1980
Laubscher A, Pletscher A, Honegger CG - Blood Platelets as Models for Neurons: Receptor- and Nonreceptor-Mediated Membrane Effects - 1980
Minnema DJ, Rosecrans JA - Discriminative Stimulus Interactions of LSD and d-Amphetamine - 1980
Morgenstern R, Strutz G, Gold R, Fink H - Zur Beziehung zwischen Neuroleptika-induzierter Hemmung von Spontan-Lokomotion (pD2) and LSD-potenzierter Apomorphin-Lokomotion (pA2) an der Ratte. Einfluss verschiedener Serotoninantagonisten auf die LSD-potenzierte Apomorphin-Lokomotion der Ratte. - 1980
Peroutka SJ, Moskowitz MA, Reinhard JF, Snyder SH - Neurotransmitter Receptor Binding in Bovine Cerebral Microvessels - 1980
Peroutka SJ, Snyder SH - Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding - 1980
Ramabadran K, Jacon J - Systemes serotoninergiques et nociception - 1980
Rech RH, Lyness WH, Moore KE, Commissaris RL - Behavioral Tolerance To The Effects Of LSD In Rats - 1980
Sachanska T, Haralanov H, Boaidgieva M, Koicheva V, Genova, Pektova K, Todorov V, Shmarov A - Complex Clinical, Biochemical and Electrophysiological Investigations After The Application Of LSD-25 - 1980
Schorderet M, Sovilla JY, Magistretti PJ - New Findings Related To A Possible Interaction Of Ergolines And Ergopeptines With Pre-synaptic Dopmine Receptors - 1980
Shulgin AT - Profiles of Psychedelic Drugs. 8. Psilocybin - 1980
Shulgin AT - Profiles of Psychedelic Drugs. 9. LSD - 1980
Shulgin AT, Carter MF - N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-Diisopropyltryptamine (5-MeO-DIPT). Two Orally Active Tryptamine Analogs with CNS Activity - 1980
Sloviter RS, Drust EG, Damiono BP, Connor JB - Serotonergic Mediation Of Behavioral Effects In Rats Of Indoles And Phenethylamine Hallucinogens - 1980
Standridge RT, Howell HG, Tilson HA, Chamberlain JH, Holava HM, Gylys JA, Partyka RA, Shulgin AT - Phenylalkylamines With Potential Psychotherapeutic Utility. 2. Nuclear Substituted 2-Amino-1-phenylbutanes - 1980
Abraham HD - Psychiatric Illness in Drug Abusers - 1980
Angus JA, Black JW - Pharmacological assay of cardiac H2-receptor blockade by amitriptyline and lysergic acid diethylamide - 1980
Baraban JM, Aghanjanian GK - Suppression of Firing Activity of 5-HT Neurons in the Dorsal raphe by alpha-Adrenoceptor Antagonists - 1980
Baumann PA - Presynaptic serotonin autoreceptors in rat cortex slices - 1980
Bonetti EP, Bondiolotti G - Backward locomotion in rats, a specific stereotyped behavior - 1980
Braun U, Shulgin AT, Braun G - Centrally Active N-Substituted Analogs of 3,4- Methylenedioxyphenylisopropylamine (3,4-Methylenedioxyamphetamine) - 1980
Ceccarelli P, Ortolani E, Zapponi GA, Loizzo A - Applications of Multivariate Analysis in the Classification of Psychotropic Drugs: Effects of LSD-25 on the EEG of the Rabbit - 1980
Chiu S, Mishra RK - Effects of Dopaminergic and Cholinergic Drugs. Naloxone and l-Prolyl-leucyl-glycinamide on LSD-Induced Catalepsy - 1980
Commissaris RL, Lyness WH, Moore KE, Rech RH - Antagonism of the Behavioral Effects of Hallucinogens by the 5-Hydroxytryptamine (5 HT) Antagonist Methergoline (MTG) - 1980
Connell DJ, Middlemiss DN, Stone MA - Further Evidence for an Interaction of Propranolol with the Central 5-Hydroxytryptamine (5-HT) Receptor - 1980
Dray A, Fox PC, Hilmy M, Somjen GG - The Effects of LSD and Some Analogues on the Responses of Single Cortical Neurons of the Cat to Optical Stimulation - 1980
Drummon AH, Benson JA, Levitan IB - Serotonin-induced hyperpolarization of an identified aplysia neuron is mediated by cyclic AMP - 1980
Drummond AH, Bucher F, Levitan IB - d-[3H]Lysergic Acid Diethylamide Binding to Serotonin Receptors in the Molluscan Nervous System - 1980
Editorial - Arguments Heard for Psychedelics Probe - 1980
Editorial - How is the differential diagnosis made between (a) acute alcohol poisoining, (b) acute lysergide poisoning and (c) acute schizophrenia when there is no history of any previous illness and a patient presents with symptoms of hallucinosis and amnesia? - 1980
Editorial - Wie evoziert das LSD: Halluzinationen und Traume? - 1980
Editorial - Tod-geweihte: LSD hilft sterben - 1980
Fairchild MD, Jenden DJ, Mickey MR, Yale C - EEG Effects of Hallucinogens and Cannabinoids Using Sleep-Waking Behavior as Baseline - 1980
Frischknecht HR, Waser PG - Actions of Hallucinogens on Ants (Formica Pratensis)-III. Social Behaviour Under the Influence of LSD and Tetrahydrocannabinol - 1980
Gallager DW, Mallorga P, Tallman JF - Interaction Of Diphenylhydantoin And Benzodiazepines In The CNS - 1980
Geyer M A - Both lndoleamine and Phenylethylamine Hallucinogens Increase Serotonin in Both Dorsal and Median Raphe Neurons - 1980
Gillespie JS - The physiology and pharmacology of the anococcygeus muscle - 1980
Gormezano I, Harvey JA - Sensory and Associative Effects of LSD on Classical Appetitive Conditioning of the Rabbit Jaw Movement Response - 1980
Gormezano I, Harvey JA - Sensory and Associative Effects of LSD in Classical Conditioning of Rabbit (Oryctolagus cuniculus) Nictitating Membrane Response - 1980
Green JP, Maayani S, Weinstein H, Hough LB - Histamine and Psychotropic Drugs - 1980
Hartung J, Skorka D - The HIT Clinical Profile of Psychedelic Drug Users - 1980
Hetey L, Quiring K, Misselwitz HJ, Oelssner W - Bestimmung Unterschiedlicher Parameter des Cerebralen Dopamin- und Serotonin-Umsatzes nach Psychoharmaka - 1980
Hetey L, Quiring K - Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats - 1980
Inoue T, Niwaguchi T - Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes - 1980
Ishidate M, Yoshikawa K - Chromosome Aberration Tests with Chinese Hamster Cells in vitro with and without Metabolic Activation - A Comparative study on Mutagens and Carcinogens - 1980
Ishii H, Niwaguchi T, Nakahara Y, Hayashi M - Studies on Lysergic Acid Diethylamide and Related Compounds. Part 8. Structural Identification of New Metabolites of Lysergic Acid Diethylamide Obtained by Microbial Transformation Using Streptomyces Roseochromogenes - 1980
Jarbe TUC - LSD-25 as a Discriminative Stimulus for Response Selection by Pigeons - 1980
Jasinski DR - Interdisciplinary Studies on Phencyclidine at the Addiction Research Center, Lexington, Kentucky. - 1980
Kemali M, Kemali D - Lysergic Acid Diethylamide: Morphological Study of its Effect on Synapses - 1980
Kenyon CN, Melera A - Use of the Direct Liquid Inlet LC/MS System for the Analysis of Complex Mixtures of Biological Origin - 1980
Krдuchi K, Feer H - In vivo 3H-d-LSD binding in small punched out rat brain regions - 1980
Kraus L, Stahl E, Thies W - Quantitative in situ fluorimetry of LSD by HPTLC - 1980
Ksir CJ - Rate-Dependent and Stimulus Control Effects of Drugs - 1980
Kuhn DM, O'Callaghan JP, Juskevich J, Lovenberg W - Activation of Brain Tryptophan Hydroxylase by ATP-Mg2+: Dependence on Calmodulin - 1980
Laubscher A, Pletscher A, Honegger CG - Blood Platelets as Models for Neurons: Receptor- and Nonreceptor-Mediated Membrane Effects - 1980
Laubscher A, Pletscher A - Increase of Cyclic GMP in Blood Platelets by Biogenic Amines - a Receptor-Mediated Effect - 1980
Lee EHY, Geyer MA - Persistent Effects Of Chronic Administration Of LSD On Intracellular Serotonin Content In Rat Midbrain - 1980
Maayani S, Weinstein H - "Specific Binding" of 3H-Phencyclidine: Artifacts of the Rapid Filtration Method - 1980
Makman MH, Dvorkin B, Horowitz SG, Thal LJ - Properties Of Dopamine Agonist And Antagonist Binding Sites In Mammalian Retina - 1980
Markу M, Flьeckiger E - Role of Serotonin in the Regulation of Ovulation. Evidence from Pharmacological Studies - 1980
Mccall RB, Aghajanian GK - Hallucinogens Potentiate Responses To Serotonin And Norepinephrine In The Facial Motor Nucleus - 1980
McLellan, AT, Woody GE, O'Brien CP - Psychiatric Illness in Drug Abusers - 1980
Meibach RC, Maayni S, Green JP - Characterization And Radioautography Of [3H] LSD Binding By Rat Brain Slices In Vitro: The Effect Of 6-hydroxytryptamine - 1980
Mellett P - Hypnosis. Current views on the psychophysiology of hypnosis - 1980
Minnema DJ, Rosecrans JA - Discriminative Stimulus Interactions of LSD and d-Amphetamine - 1980
Morgenstern R, Strutz G, Gold R, Fink H - Zur Beziehung zwischen Neuroleptika-induzierter Hemmung von Spontan-Lokomotion (pD2) and LSD-potenzierter Apomorphin-Lokomotion (pA2) an der Ratte. Einfluss verschiedener Serotoninantagonisten auf die LSD-potenzierte Apomorphin-Lokomotion der Ratte. - 1980
Murakami N, Sakata Y - A Possible Role of the Serotonergic System in Thermoregulation in the Rabbit - 1980
Nielsen EB, Nielsen M, Ellison G, Braestrup C - Decreased Spiroperidol And LSD Binding In Rat Brain After Continuous Amphetamine - 1980
Nielsen EB, Lee TH, Ellison G - Following Several Days of Continuous Administration d-Amphetamine Acquires Hallucinogenlike Properties - 1980
North RA, Henderson G, Katayama Y, Johnson SM - Electrophysiological Evidence For Presynaptic Inhibition Of Acetycholine Release By 5-hydroxytryptamine In The Enteric Nervous System - 1980
Oelszner W - Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug - 1980
PARKER RJ, HIROM PC, MILLBURN P - Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat: Hydrolysis of glucuronic acid conjugates in the gut lumen - 1980
Peroutka SJ, Snyder SH - Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding - 1980
Peroutka SJ, Moskowitz MA, Reinhard JF, Snyder SH - Neurotransmitter Receptor Binding in Bovine Cerebral Microvessels - 1980
Pesce VS - L'uso della droga ed i suoi riflessi sull'apparato genitale femminile - 1980
Ramabadran K, Jacon J - Systemes serotoninergiques et nociception - 1980
Rech RH, Lyness WH, Moore KE, Commissaris RL - Behavioral Tolerance To The Effects Of LSD In Rats - 1980
Ruffing DM, Domino EF - First Dose Behavioral Tolerance to Phencyclidine on Food-Rewarded Bar Pressing Behavior in the Rat - 1980
Sachanska T, Haralanov H, Boaidgieva M, Koicheva V, Genova, Pektova K, Todorov V, Shmarov A - Complex Clinical, Biochemical and Electrophysiological Investigations After The Application Of LSD-25 - 1980
Seeman P, Westman K, Coscena D, Warsh J - Serotonin Receptors in Hippocampus and Frontal Cortex - 1980
Shannon HE - MDA and DOM: Substituted Amphetamines that do not Produce Amphetamine-Like Discriminative Stimuli in the Rat - 1980
Sietnieks A, Meyerson BJ - Enhancement By Progesterone Of Lysergic Acid Diethylamide Inhibition Of The Copulatory Response In The Female Rat - 1980
Sloviter RS, Drust EG, Damiono BP, Connor JB - Serotonergic Mediation Of Behavioral Effects In Rats Of Indoles And Phenethylamine Hallucinogens - 1980
Sloviter RS, Drust EG, Damiano BP, Connor JD - A Common Mechanism for Lysergic Acid, Indolealkylamine and Phenethylamine Hallucinogens: Serotonergic Mediation of Behavioral Effects in Rats - 1980
Smith JA, Walters G, Johnston D - LSD "flashback" as a cause of diagnostic error - 1980
Strahlendorf JCR - Mechanism of Lysergic Acid Diethylamide Influence Upon Optically Evoked Potentials - 1980
Svensson TH - Effect of Chronic Treatment with Tricyclic Antidepressant Drugs on Identified Brain Noradrenergic and Serotonergic Neurons - 1980
Swann AC, Heninger GR, Marini JL, Sheard MH, Maas JW - Lithium Effects on High-Affinity Tryptophan Uptake: Evidence Against a Stabilization Mechanism - 1980
Tang SW, Seeman P - Effect of Antidepressant Drugs on Serotonergic and Adrenergic Receptors - 1980
Teal JJ, Holtzman SG - Discriminative Stimulus Effects of Cyclazocine in the Rat - 1980
Trevor-Roper P - The psychopathic eye - 1980
Vanderwolf CH, Robinson TE, Pappas BA - Monamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity - 1980
Vetulani J, Bednarczyk B, Reichenberg K, Rokosz A - Head twitches induced by LSD and quipazine: similarities and differences - 1980
Wallis DL, Nash HL - The Action Of Methylated Derivatives Of 5-hydroxytryptamine At Ganglionic Receptors - 1980
Wang RY, Aghajanian GK - Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment - 1980
Whitaker PM - Brain receptors for LSD and serotonin - 1980
White FJ, Simmons MA, West KB, Holohean AM, Appel JB - The Effect of Serotonin Depletion on the Discriminability of LSD - 1980
Winter JC - Effects of the Phenethylamine Derivatives, BL-3912, Fenfluramine, and Sch-12679, in Rats Trained with LSD as a Discriminative Stimulus - 1980
Young WS, Kuhar MJ - Serotonin Receptor Localization in Rat Brain by Light Microscopic Autoradiography - 1980
Ardrey RE, Moffat AC - Gas-Liquid Chromatographic Retention Indices of 1318 Substances of Toxicological Interest on SE-30 or OV-1 Stationary Phase. - 1981
Commissaris RL, Lyness WH, Rech RH - Effects of d-Lysergic Acid Diethylamide (LSD), 2,5-Dimethoxy-4-methylamphetamine (DOM), Pentobarbital (PB), and Methaqualone (MQ) on Conflict Behavior in Control and 5,7-Dihydroxytryptamine (5,7-DHT)-Treated Rats - 1981
Domelsmith LN, Eaton TA, Houk KN, Anderson GM, Glennon RA, Shulgin AT, Castagnoli N, Kollman PA - Photoelectron Spectra of Psychotropic Drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogues - 1981
Feltner EJ, Meibach RC, Maayani S, Green JP - Radioautographic Localization of H-5-HT and [2]H-D-LSD Binding Sites on Dopaminergic Nigral-Striatal Neurons - 1981
Fink H, Oelssner W - LSD, Mescaline and Serotonin Injected Into Medial Raphe Nucleus Potentiate Apomorphine Hypermotility - 1981
Freedman MS, Clark BD, Cruz TF, Gurd JW, Brown IR - Selective Effects of LSD and Hyperthermia on the Synthesis of Synaptic Proteins and Glycoproteins - 1981
Grillo SA - Effect of dl-Amphetamine and d-Lysergic Acid Diethylamide on the Slow Potentials Evoked in the Reticular Formation - 1981
Heinze WJ, Schlemner RF, Javaid JI, Davis JM - The Comparative Effects of d-LSD & d-Amphetamine on Stereotyped Behavior in Rats - 1981
Ingrasci, Rick - Review of Grof's LSD Psychotherapy - 1981 July
Jacob P, Shulgin AT - Sulfur Analogues of Psychotomimetic Agents. Monothio Analogues of Mescaline and Isomescaline - 1981
Maayani S, Meibach RC, Green JP - Heterogeneity of [3H]-5-HT and [3H]-LSD Binding in Rat Brain and Calf Hippocampus Slices - 1981
McKenna DJ, Towers GHN - Ultra-Violet Mediated Cytotoxic Activity of B-Carboline Alkaloids - 1981
McNall SJ, Mansour TE - H-LSD Binding to a Serotonin Receptor Coupled to Adenylate Cyclase Activity in the Liver Fluke Fasciola hepatica - 1981
Oelsner W, Fink H, Hetey L, Drescher K - Action of Antipsychotics on LSD-Induced Neurochemical and Behavioral Effects in Rats - 1981
Schlemmer RF, Davis JM - LSD-induced Behavioral Changes In Selected Members Of A Primate Social Colony - 1981
Shulgin AT - Hallucinogens - 1981
Shulgin AT - Profiles of Psychedelic Drugs. 10. DOB - 1981
Shulgin AT - Chemistry of Psychotomimetics - 1981
Shulgin AT - Profiles of Psychedelic Drugs. 11. Bufotenine - 1981
Smith, Dewey H., Jr. - Method of Using N-substituted dihydro-2-Oxazolamines as Analgesics - Mar 17,1981
Trulson ME, Brandstetter JW, Jacobs BL - Similarity of the Behavioral Effects of Quipazine and LSD in Cats - 1981
Weiss S, Drummond GI - Dopamine- And Serotonin-Sensitive Adenylate Cyclase In The Gill Of Aplysia - 1981
Commissaris RL, Lyness WH, Rech RH - Effects of d-Lysergic Acid Diethylamide (LSD), 2,5-Dimethoxy-4-methylamphetamine (DOM), Pentobarbital (PB), and Methaqualone (MQ) on Conflict Behavior in Control and 5,7-Dihydroxytryptamine (5,7-DHT)-Treated Rats - 1981
Grillo SA - Effect of dl-Amphetamine and d-Lysergic Acid Diethylamide on the Slow Potentials Evoked in the Reticular Formation - 1981
Grinspoon L - LSD Reconsidered: Should clinical research be resumed? - 1981
Gupta SP, Singh P, Bindal MC - Correlation of Inhibitory Activity of Tryptamine Derivatives on Serotonin Uptake in Thrombocyte with van der Waals Volume - 1981
Heikkila JJ, Brown IR - Comparison of the Effect of Intravenous Administration of d-Lysergic Acid Diethylamide on Free and Membrane-Bound Polysomes in the Rabbit Brain - 1981
Heinze WJ, Schlemner RF, Javaid JI, Davis JM - The Comparative Effects of d-LSD & d-Amphetamine on Stereotyped Behavior in Rats - 1981
Hirsch JD - Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol - 1981
Keseberg A - Drogenabhangigkeit Heranwachsender - 1981
Konzett H - Halluzinogene: LSD, Psilocybin und Mescalin - 1981
Lake CR, Stirba AL, Kinneman RE, Carlson B, Holloway HR - Mania Associated with LSD Ingestion - 1981
Larson AA, Chinn C, Proudfit HK, Anderson EG - Dual Actions of Lysergic Acid Diethylamide Tartrate (LSD), 2-Bromo-D-Lysergic Acid Diethylamide Bitartrate (BOL) and Methysergide on Dorsal Root Potentials Evoked by Stimulation of Raphe Nuclei - 1981
Stoff DM, Gillin JC, Wyatt RJ - Animal Models Of Drug-induced Hallucinations - 1978
Leysen JE - Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro - 1981
Loew DM - Die Wirkung von Mutterkorn-Dervaten auf das Zentralnerensystem: Synaptischetibertragungsmechansmen - 1981
Marini JL, Jacobs BL, Sheard MH, Trulson ME - Activity of a Non-Hallucinogenic Ergoline Derivative, Lisuride, in an Animal Behavior Model for Hallucinogens - 1981
McNall SJ, Mansour TE - H-LSD Binding to a Serotonin Receptor Coupled to Adenylate Cyclase Activity in the Liver Fluke Fasciola hepatica - 1981
Menon MK, Vivonia CA - Modification Of Apomorphine Hypothermia By Drugs Affecting Brain 5-hydroxytryptamine Function - 1981
Muggler-Bickel J, Maag F - Drogen und Fџhrertauglichkeit - 1981
Nahas GG - A pharmacological classification of drugs of abuse - 1981
Neuninger H - Die Biotransformation der Suchtgifte - 1981
Oelsner W, Fink H, Hetey L, Drescher K - Action of Antipsychotics on LSD-Induced Neurochemical and Behavioral Effects in Rats - 1981
Patel AJ, Barochovsky O, Lewis PD - Psychotropic Drugs And Brain Development: Effects On Cell Replication In Vivo And In Vitro - 1981
Peroutka SJ, Snyder SH - [3H]Mianserin: Differential Labeling of Serotonin2 and Histamine1 Receptors in Rat Brain - 1981
Poller D, Carroll JA, Middlemiss DN - The [3h]5-ht And [3h]spiroperidol Binding Sites In The Rat Frontal Cortex Are Thermally Inactivated At Different Rates - 1981
Pope HG Jr, Ionescu-Pioggia M, Cole JO - Drug Use and Life-style Among College Undergraduates: Nine years later - 1981
Rosenfeld MR, Makman MH - The Interaction of Lisuride, an Ergot Derivative, with Serotonergic and Dopaminergic Receptors in Rabbit Brain - 1981
Ruffig DM, Domino EF - Effects of Selected Opioid Agonists and Antagonists on DMT- and LSD-25-Induced Disruption of Food-Rewarded Bar Pressing Behavior in the Rat - 1981
Stern L - In Vivo Assessment of the Teratogenic Potential of Drugs in Humans - 1981
Trulson ME, Brandstetter JW, Jacobs BL - Similarity of the Behavioral Effects of Quipazine and LSD in Cats - 1981
Wallis D, Nash H - Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells - 1981
Weinreich P, Seeman P - Binding Of Adrenergic Ligands ([3h]clonidine And [3H]WB-4101) To Multiple Sites In Human Brain - 1981
Weiss S, Drummond GI - Dopamine- And Serotonin-Sensitive Adenylate Cyclase In The Gill Of Aplysia - 1981
Whitaker PM, Crow TJ, Ferrier IN - Tritiated LSD Binding in Frontal Cortex in Schizophrenia - 1981
White FJ, Holohean AM, Appel JB - Lack of Specificity of an Animal Behavior Model for Hallucinogenic Drug Action - 1981
White FJ, Appel JB - A Neuropharmacological Analysis of the Discriminative Stimulus Properties of Fenfluramine - 1981
Winter JC - Drug-induced stimulus control and the concept of breaking point: LSD and quipazine - 1981
Domino EF, Ruffing DM - Evidence for Opioids as Partial Antagonists for Indole Hallucinogens - 1982
Glennon R A, Young R, Rosecrans J A, Anderson G M - Discriminative Stimulus Properties of MDA Analogs - 1982
Kemali M, Milici N, Kemali D - The Pigment Screening (PS) of The Frog Retina After Administration of Psychoactive Drugs - 1982
Kleven MS, Dwoskin LP, Sparber SB - Lysergic Acid Diethylamide (LSD) attenuates 5-hydroxytryptophan (5-HTP) induced increases in 5-hydroxyindoleacetic acid (5-HIAA) in ventricular perfusate collected during operant behavior - 1982
Knight, Edward H. - The Deformed Leg in Pre-Columbian Mexican Mythology - 1982
Langer SZ, Moret C - Citalopram Antagonizes the Effects of LSD on the Presynaptic Serotonin Autoreceptors In Slices of the Rat Hypothalamus - 1982
Minnema D, Rosecrans JA - Alterations Of The Discriminative Stimulus Produced By D-amphetamine Or LSD In Rats Neonatally Depleted Of Serotonin Or Dopamine - 1982
Mokler DJ, Commissaris RL, Rech RH - Drugs that Influence Dopamine Function Do Not Alter the Disruption of Operant Behavior by Lisuride (LIS), Lysergic Acid Diethylamide (LSD) or d-Amphetamine (d-A) - 1982
Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW - Effects of Certain Hallucinogenic Amphetamine Analogues on the Release of [3H] Serotonin from Rat Brain Synaptosomes. - 1982
O'Brien BA, Bonicamp JM, Jones DW - Differentiation of Amphetamine and Its Major Hallucinogenic Derivatives Using Thin-Lager Chromatography - 1982
Sargent T, Shulgin AT, Mathis CA - New Iodinated Amphetamines by Rapid Synthesis for Use as Brain Blood Flow Indicators - 1982
Shulgin AT, Jacob P - Potential Misrepresentation of 3,4-Methylenedioxyamphetamine (MDA). A Toxicological Warning - 1982
Shulgin AT, Jacob P - 1-(3,4-Methylenedioxyphenyl)-3-aminobutane: A Potential Toxicological Problem - 1982
Shulgin AT, Jacob P III - Potential Misrepresentation of 3,4-Methylenedioxyamphetamine (MDA). A Toxicological Warning - 1982
Shulgin AT, Jacob P III - 1-(3,4-Methylenedioxyphenyl)-3-aminobutane: A Potential Toxicological Problem - 1982
Wilkison DM, Hosko MJ - Interactions of Cyproheptadine and Methysergide with LSD on Sensory Evoked Activity. - 1982
Williams M, Martin GE - Selectivity of Cyproheptadine as Assessed by Radioligand Binding - 1982
Gough TA, Baker PB - Identification of Major Drugs of Abuse Using Chromatography - 1982
Halaris AE, Rosenthal M, DeMet EM, Freedman DX - The Raphe Neuronal System And Serotonergic Effects Of LSD - 1982
Harvey JA, Gormezano I, Cool VA - Effects of d-Lysergic Acid Diethylamide, d-2-Bromolysergic Acid Diethylamide, dl-2,5-Dimethoxy-4-Methylamphetamine and d-Amphetamine on Classical Conditioning of the Rabbit Nictitating Membrane Response - 1982
Heym J, Steinfels GF, Jacobs BL - Medullary serotonergic neurons are insensitive to 5-MeoDMT and LSD - 1982
Hjorthl S, Carlssoni A, Lindberg P, Sanchez D, Wikstrцm H, Arvidsson LE, Hacksell U, Nilsson JLG - 8-Hydroxy-2-(Di-n-Propylamino)Tetralin, 8-OH-DPAT, a Potent and Selective Simplified Ergot Congener with Central 5-HT-Receptor Stimulating Activity - 1982
Holohean AM, White FJ, Appel JB - Dopaminergic and Serotonergic Mediation of the Discriminable Effects of Ergot Alkaloids - 1982
Jacobs BI, Heym J, Rasmussen K - Action of Hallucinogenic Drugs at Postsynaptic Serotonergic Receptors - 1982
Jarbe TUC - Discriminative Stimulus Properties of d-Amphetamine in Pigeons - 1982
Kemali M, Kemali D - Lysergic Acid Diethylamide (LSD)-Induced Reversible Structural Modifications, Endogenous Psychosis-Like Experience and CEEG Finding. A study in frog and man - 1982
Kemali M, Milici N, Kemali D - The Pigment Screening (PS) of The Frog Retina After Administration of Psychoactive Drugs - 1982
Kleven MS, Dwoskin LP, Sparber SB - Lysergic Acid Diethylamide (LSD) attenuates 5-hydroxytryptophan (5-HTP) induced increases in 5-hydroxyindoleacetic acid (5-HIAA) in ventricular perfusate collected during operant behavior - 1982
Koernerl J, Appel JB - Psilocybin as a Discriminative Stimulus: Lack of Specificity in an Animal Behavior Model for 'Hallucinogens' - 1982
Ksir C, Slifer B - Drug Effects on Discrimination Performance at Two Levels of Stimulus Control - 1982
Langer SZ, Moret C - Citalopram Antagonizes the Effects of LSD on the Presynaptic Serotonin Autoreceptors In Slices of the Rat Hypothalamus - 1982
Langer SZ, Moret C - Citalopram Antagonizes the Stimulation by Lysergic Acid Diethylamide of Presynaptic Inhibitory Serotonin Autoreceptors in the Rat Hypothalamus - 1982
Lucki I, Frazer A - Prevention of the Serotonin Syndrome in Rats by Repeated Administration of Monoamine Oxidase Inhibitors but not Tricyclic Antidepressants - 1982
Luscombe G, Jenner P, Marsden CD - Myoclonus in Guinea Pigs is Induced by Indole-containing but Not Piperazine-Containing 5HT Agonists - 1982
Maj J, Vetulani J, Michaluk J, Rogoz Z, Skuza G - Central Action of Amitriptyline N-oxide - 1982
McCall RB, Humphrey SJ - Involvement of Serotonin in the Central Regulation of Blood Pressure: Evidence for a Facilitating Effect on Sympathetic Nerve Activity - 1982
McCall MA, Tieman DG, Hirsch HVB - Chronic Intraventricular Administration of Lysergic Acid Diethylamide (LSD) Affects the Sensitivity of Cortical Cells to Monocular Deprivation - 1982
Minnema D, Rosecrans JA - Alterations Of The Discriminative Stimulus Produced By D-amphetamine Or LSD In Rats Neonatally Depleted Of Serotonin Or Dopamine - 1982
Mishra SK, Raviprakash V - Alpha-Thioglycerol sensitive excitatory oxytocin receptors in fowl rectum - 1982
Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW - Effects of Certain Hallucinogenic Amphetamine Analogues on the Release of [3H]Serotonin from Rat Brain Synaptosomes - 1982
Nielsen EB, White FJ, Holohean AM, Callahan PM, Appel JB - Behavioral and Biochemical Evidence for Serotonergic Actions of Tetrahydro-beta-carbolines - 1982
Peden NR, Pringle SD - Hallucinogenic Fungi - 1982
Sakharov DA, Salanki J - Effects of dopamine antagonists on snail locomotion - 1982
Shearman GT, Herz A - Non-opioid Psychotomimetic-like Discriminative Stimulus Properties Of N-allylnormetazocine (skf 10,047) In The Rat - 1982
Simon, AM - A Study of Drug Abuse in a Group of South African University Students - 1982
Snyder SH, Peroutka SJ - A Possible Role of Serotonin Receptors in Antidepressant Drug Action - 1982
Stadler PA - Neuere Ergebnisse der Mutterkornalkaloid-Forschung [New Results of Ergot Alkaloid Research] - 1982
Stadler PA, Stuetz P - Quelques Aspects Nouveaux De La Chime Des Derives De L'acide Lysergique - 1982
Stoff DM, Jeste DV, Moja EA, Stauderman KA, Wyatt RJ - Interaction of Monoamine Blocking Agents with Behavioral Effects of N, N Dimethyltryptamine - 1982
Trulson ME, Howell GA - Dissociations Between The Behavioral Effects Of LSD And Tolerance Development During Ontogeny In Cats: A Novel Approach To The Study Of Tolerance Mechanisms - 1982
Trulson ME, Crisp T - Lack of Synergism and Cross Tolerance Between Tactile Stimulus- and LSD-Induced Limb Flicking in the Cat - 1982
Vaupel DB, Morton EC - Anorexia and Hyperphagia Produced by Five Pharmacologic Classes of Hallucinogens - 1982
West KB, Hernandez LL, Appel JB - Drugs and Visual Perception: Effects of LSD, Morphine and Chlorpromazine on Accuracy, Bias and Speed - 1982
White FJ, Appel JB - Lysergic Acid Diethylarnide (LSD) and Lisuride: Differentiation of Their Neuropharmacological Actions - 1982
White FJ, Appel JB - Training Dose as a Factor in LSD-Saline Discrimination - 1982
Wilkison DM, Hosko MJ - Interactions of Cyproheptadine and Methysergide with LSD on Sensory Evoked Activity. - 1982
Williams M, Martin GE - Selectivity of Cyproheptadine as Assessed by Radioligand Binding - 1982
Young, Richard E.; Milroy, R, Hutchison S, Kesson CM - The Rising Price Of Mushrooms - Jan 23,1982
Bastiaans, Jan - Mental Liberation Facilitated by the Use of Hallucinogenic Drugs - 1983
Buckman, John - LSD - Psychiatric Therapy and Research - 1983
Engel G, v. Amsterdan F, Palacios JM - 125I-LSD, A New Useful Ligand For The Characterization And Localization Of 5HT2-Receptors - 1983
Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA - DOM-Stimulus Generalization to LSD and Other Hallucinogenic Indolealkylamines - 1983
Grinspoon, Lester; Bakalar, James B. - Psychedelic Drugs in Psychiatry - 1983
Grof, Stanislav - New Perspectives in Psychotherapy: Observations from LSD Research - 1983
Jacob P, Shulgin AT - Sulfur Analogues of Psychotomimetic Agents. 2. Analogues of (2,5-Dimethoxy-4-methylphenyl)- and (2,5-Dimethoxy-4-ethylphenyl)-isopropylamine - 1983
Jenner P, Luscombe G, Marsden CD - Interaction Of 5-HT Agonists with Guinea-Pig Brain Stem 5-HT - 1983
Kemali M, Milici N, Kemali D - Modification of the Pigment Screening of the Frog Retina Following Administration of Neuroactive Drugs - 1983
Leuner, Hanscarl - Psycholytic Therapy. Hallucinogenics as an Aid in Psychodynamically Oriented Psychotherapy - 1983
McNall SJ, Mansour TE - A Novel Serotonin Receptor In The Liver Fluke Fasciola Hepatica - 1983
Shulgin AT - Twenty Years On an Ever-Changing Quest - 1983
Shulgin AT - Twenty Years on an Ever-Changing Quest - 1983
Hofmann A, Goodwin DW - LSD: My Problem Child-- Reflections on Sacred Drugs, Mysticism, and Science - 1983
Hartig PR, Kadan MJ, Evans MJ, Krohn AM - 125-i-LSD: A High Sensitivity Ligand For Serotonin Receptors - 1983
Hetey L, Schwitzkowsky R, Oelssner W - Influence Of Psychotomimetics And Lisuride On Synaptosomal Dopamine Release In The Nucleus Accumbens Of Rats - 1983
Horowski R - Pharmacological Effects of Lisuride and Their Potential Role in Further Research - 1983
Kalkman HO, Harms YM, Van Gelderen EM, Batink HD, Timmermans WM, Van Zwieten PA - Hypotensive Activity of Serotonin Antagoinists; Correlation with - 1983
Keller HH, Bonetti EP, Pieri L, Da Prada M - Lisuride-Induced Mounting Behavior and Effects on the Monoaminergic System in Rat Brain - 1983
Kleven MS, Dwoskin LP, Sparber SB - Pharmacological Evidence for the Existence of Multiple Functional Pools of Brain Serotonin: Analysis Of Brain Perfusate From Conscious Rats - 1983
Larsson B - Demonstration of alpha-Adrenoceptors in the Rabbit Bladder Base and Urethra with 3H-Dihydroergocryptine Ligand Binding - 1983
Muller-Schweinitzer E , Engel G - Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery - 1983
Mccall RB, Schuette MR, Humphrey SJ, Lahti RA, Barsuhn C - Evidence for a Central Sympathoexcitatory Action of Alpha-2 Adrenergic Antagonists - 1983
McNall SJ, Mansour TE - A Novel Serotonin Receptor In The Liver Fluke Fasciola Hepatica - 1983
Monroe PJ, Smith DJ - Characterization of Multiple [3H]5-Hydroxytryptamine Binding Sites in Rat Spinal Cord Tissue - 1983
Morgenstern R, Fink H, Oelssner W - LSD-Potentiated Apomorphine Hypermotility: A Model for Differentiating Antipsychotic Drugs - 1983
Nielsen EB, Appel JB - The Effects of Drugs on the Discrimination of Color Following a Variable Delay Period: A Signal Detection Analysis - 1983
Palacios JM - Quantitative Receptor Autoradiography: Application to the Study of Multiple Serotonin Receptors in Rat Cortex - 1983
Palacios JM, Probst A, Cortes R - The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem - 1983
Pieri L, Keller HH, Laurent JP, Burkard WP, Pieri M, Bonetti EP, Da Prada M - Behavioral, Neurochemical, and Electrophysiological Effects of Lisuride and LSD in Animals - 1983
Potthoff AD, Ellison G, Nelson L - Ethanol Intake Increases during Continuous Administration of Amphetamine and Nicotine, but not Several Other Drugs - 1983
Ruffing DM, Domino EF - Interaction of Synthetic Opioid Metenkephalin Peptide Analogs, Lilly 127623 and FK 33-824 with Indole Hallucinogens: Antagonism of N,N-Dimethyltryptamine- and LSD-Induced Disruption of Food Rewarded Bar Pressing Behavior in the Rat - 1983
Schmidt MJ, Root MA, Hall JL - Dopamine Agonist Induced Hyperglycemia In Rats: Structure-activity;sRelationships And Mechanisms Of Action . - 1983
Schneider V, Klug E - Unklares Krankheitsbild durch LSD (Beibringung?) - 1983
Schotte A, Maloteaux JM, Laduron PM - Characterization and Regional Distribution of Serotonin S2-Receptors in Human Brain - 1983
T.A.-Gounh. and P.B. Baker - Identification of Major Drugs of Abuse Using Chromatography:-An Update - 1983
Tran MA, Montastruc JL, Montastruc P - Bases pharmacologiques de l'utilisation therapeutique des alcaloides de l'ergot de seigle - 1983
Trulson ME, Crisp T - Tolerance Develops To LSD While The Drug Is Exerting Its Maximal Behavioral Effects: Implications For The Neural Bases Of Tolerance - 1983
Vandermaelen CP, Aghajanian GK - Electrophysiological and Pharmacological Characterization of Serotonergic Dorsal Raphe Neurons Recorded Extracellularly and Intracellularly in Rat Brain Slices - 1983
Waehtel H, Dorow R - Dual Action On Central Dopamine Function Of Transdihydrolisuride, A 9, 10-dihydrogenated Analogue Of The Ergot Dopamine Agonist Lisuride - 1983
Walker EB, McNall SJ, Mansour TE - Photoreactivity Of Lysergic Acids Diethylamide And Its Possible Utility As A Photoaffinity Labeling Reagent - 1983
Whipple MR, Reinecke MG, Gage FH - Short Communication: Inhibition of Synaptosomal Neurotransmitter Uptake by Hallucinogens - 1983
White FJ, Wang RY - Comparison Of The Effects-of LSD And Lisuride On A10 Dopamine Neurons In The Rat - 1983
White FJ, Holohean AM, Appel JB - Antagonism of a Behavioral Effect of LSD and Lisuride in the Cat - 1983
White FJ, Wang RY - Comparison Of The Effects Of LSD And Lisuride On A10 Dopamine Neurons In The Rat - 1983
Young R, Rosecrans JA, Glennon RA - Behavioral Effects of 5-Methoxy-N,N-Dimethyltryptamine and Dose-Dependent Antagonism by BC-105 - 1983
Burstein, Sumner; Hunter, Sheila A.; Renzulli, Lori - Stimulation of Sphingomyelin Hydrolysis by Cannabidiol in Fibroblasts from a Niemann-Pick Patient - 1984
Davis WM, Borne RF - Pharmacologic Investigation of Compounds Related to 3,4-Methylenedioxyamphetamine (MDA) - 1984
Engel G, Hoyer D, Kalkman HO, Wick MB - Identification of 5HT-2 Receptors on Longitudinal Muscle of the Guinea Pig Ileum - 1984
Engel G, Mьller-Schweinitzer E, Palacios JM - 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors - 1984
Engel G, Muller-Schweinitzer, Gothert M - 5-HT Receptor Subtypes in Periphery and in CNS - 1984
Geaney DP, Schachter M, Elliot JM, Grahame-Smith DG - Characterisation of [3H]Lysergic Acid Diethylamide Binding to a 5-Hydroxytryptamine Receptor on Human Platelet Membranes - 1984
Glennon RA, Young R - Further Investigation of the Discriminative Stimulus Properties of MDA. - 1984
Glennon RA, Titeler M, McKenney JD - Evidence for 5HT-2 Involvement in the Mechanism of Action in Hallucinogenic Agents - 1984
Glennon RA, Young R - MDA: An Agent That Produces Stimulus Effects Similar to Those of 3,4-DMA, LSD and Cocaine - 1984
Jacob P, Shulgin AT - Sulfur Analogues of Psychotomimetic Agents. 3. The Ethyl Homologues of Mescaline and Their Monothio Analogues - 1984
Leysen JE, Gommeren W - Characterization and Quantification of Serotonin-S2 Receptor Sites on Human Blood Platelet Membranes - 1984
McKenna DJ, Towers GHN - Biochemistry and pharmacology of tryptamine and B-carboline derivatives: - 1984
McKenna DJ, Towers GHN, Abbott FS - Monoamine Oxidase Inhibitors in South American Hallucinogenic Plants: Tryptamine and B-Carboline Constituents of Ayahuasca - 1984
McKenna DJ, Towers GHN, Abbott FS - Monoamine Oxidase Inhibitors in South American Hallucinogenic Plants Pt. II: Constituents of Orally Active Myristicaceous Hallucinogens - 1984
McNall SJ, Mansour TE - Novel Serotonin Receptors In Fasciola: Characterization By Studies On Adenylate Cyclase Activation And [3H]LSD Binding - 1984
Nichols DE, Glennon RA - Medicinal Chemistry and Structure-Activity Relationships of Hallucinogens - 1984
Sargent T, Shulgin AT, Mathis CA - Radiohalogen-Labeled Imaging Agents. 3. Compounds for Measurement of Brain Blood Flow by Emission Tomography - 1984
Snider SR, Consroe P - Treatment of Meige Syndrome with Cannabidiol - 1984
Strassman RJ - Adverse reactions to psychedelic drugs. A review of the literature - 1984
Davis WM, Borne RF - Pharmacologic Investigation of Compounds Related to 3,4-Methylenedioxyamphetamine (MDA) - 1984
de Montigny C, Blier P, Chaput Y - Electrophysiologically-identified Serotonin Receptors In The Rat CNS - 1984
Hadorn DC, Anistranski JA, Connor JD - Influence Of Naloxone On The Effects Of LSD In Monkeys - 1984
Hoffman JA - LSD Flashbacks - 1984
Jarbe TUC - Discriminative Stimulus Properties of Cocaine - 1984
Kadan MJ, Krohn AM, Evans MJ, Waltz RL, Hartig PR - Characterization of 125I-Lysergic Acid Diethylamide Binding to Serotonin Receptors in Rat Frontal Cortex - 1984
Larson AA - Acute And Chronic Effects Of Lsd And 5-MeODMT On Raphe-Evoked Dorsal Root Potentials In The Cat - 1984
Leysen JE, Gommeren W - Characterization and Quantification of Serotonin-S2 Receptor Sites on Human Blood Platelet Membranes - 1984
Leysen JE, De Chaffoy De Courcelles D, De Clerck F, Niemegeers CJE, Van Nueten JM - Serotonin-s2 Receptor Binding Sites And Functional Correlates - 1984
Luscombe G, Jenner P, Marsden CD - Correlation Of [3H]5-Hydroxytryptamine (5ht) Binding to Brain Stem Preparations and the Production and Prevention of Myoclonus in Guinea Pig by 5HT Agonists and Antagonists - 1984
McNall SJ, Mansour TE - Novel Serotonin Receptors In Fasciola: Characterization By Studies On Adenylate Cyclase Activation And [3H]LSD Binding - 1984
McNall SJ, Mansour TE - Desensitization Of Serotonin-stimulated Adenylate Cyclase In The Liver Fluke Fasciola Hepatica - 1984
Meibach RC, Beck SG, Maayani S, Green JP - Regional [Differences in Binding of [3H]LSD and [3H]5-HT in Calf Hippocampal Slices Revealed by Radioautography and Rapid Filtration Studies - 1984
Minnema DJ, Rosecrans JA - Amphetamine and LSD as Discriminative Stimuli: Alterations Following Neonatal Monoamine Reductions - 1984
Mokler DJ, Commissaris RL, Henck JW, Rech RH - Naloxone Alters the Effects of LSD, DOM and Quipazine on Operant Behavior of Rats - 1984
Mokler DJ, Rech RH - Behavioral Effects of Intracerebroventricular Administration of LSD, DOM, Mescaline or Lisurde - 1984
Morgenstern R, Mende T, Gold R, Lemme P, Oelssner W - Drug-Induced Modulation of Locomotor Hyperactivity; Induced by Picrotoxin in Nucleus Accumbens - 1984
Nielsen EB, Rolandi W, Appel JB - Drug effects on the repeated generalization of a visual discrimination acquired under one trial per day conditions - 1984
Peroutka SJ, Kuhar MJ - Autoradiographic localization of 5-HT1 receptors to human and canine basilar arteries - 1984
Pietzcker A - Rauschdrogenmissbrauch und -abhangigkeit - 1984
Poser W - Tranquilizer Missbrauch und -Abhangigkeit - 1984
Raiteri M, Bonanno G, Marchi M, Maura G - Is There a Functional Linkage Between Neurotransmitter Uptake Mechanisms and Presynaptic Receptors? - 1984
Richardson BP, Engel G, Donatsch P - In Vitro Pharmacology of Neuronal 5-HT Receptor antagonists - 1984
Sethy VH, Mccall JM - High-Affinity (3H)-Dexoxadrol Binding to Rat Brain Membranes - 1984
Smith LAC, Meyerson BJ - Influence of Long-term Zimeldine Treatment on LSD-induced Behavioural Effects - 1984
Tegeler J - Der akute Drogen-Patient - 1984
Weaver KEC - Letters to the Editor: LSD and Schizophrenia - 1984
Winter JC - The stimulus properties of para-methoxyamphetamine: A nonessential serotonergic component. - 1984
Yarbrouch GG, Singh DK, Pettibone DJ - A Comparative Electrophysiological And Biochemical Assessment Of Serotonin (5-ht) And A Novel 5-ht Agonist (mk-212) On Central Serotonergic Receptors - 1984
Abramson D M - Ecstasy: The New Drug Underground. - 1985 October
Adamson, Sophia (ed.) - Through the Gateway of the Heart: Accounts of Experiences with MDMA and other Empathogenic Substances - 1985
Adamson, Sophia (ed.) - Through the Gateway of the Heart. Accounts of Experiences with MDMA and Other Empathogenic Substances - 1985
Adler, Jerry - Getting High on 'Ecstasy' - Apr 15,1985
Cohen S, Krippner S - (LSD Issue) Editors Introduction - 1985 Oct.-Dec.
Cohen S - They Call It Ecstasy. - 1985 September
Dowling CG - The Trouble with Ecstasy - August 1985
Fink H, Morgenstern R - Locomotor Effects of Lisuride: A Consequence of Dopaminergic and Serotonergic Actions - 1985
Fleming SW, Brown IR - Characterization of a Translational Inhibitor Isolated from Rabbit Brain Following Intravenous Administration of d-Lysergic Acid Diethylamide - 1985
Gehlert DR, Schmidt CJ, Wu L, Lovenberg W - Evidence for Specific Methylenedioxymethamphetamine (Ecstasy) Binding Sites in the Rat - 1985
Geyer MA, Gordon J, Adams LM - Behavioral Effects of Xylamine-Induced Depletions of Brain Norepinephrine - 1985
Gillet G, Ammor S, Fillion G - Serotonin Inhibits Acetylcholine Release from Rat Striatum Slices: Evidence for a Presynaptic Receptor-Mediated Effect - 1985
Gold MS - Ecstasy, Etc. - Sep/Oct 1985
Greer G - Using MDMA in Psychotherapy - 1985 Spring
Greer G - Using MDMA in Psychotherapy - 1985
Greer, George - Using MDMA in Psychotherapy. - 1985
Kalkman HO - Characterization of Serotonin (5-HT) Receptors in the Isolated Guinea-pig Ileum - 1985
Kurland A A - LSD in the Supportive Care of the Terminally Ill Patient - 1985
Kurland, Albert A. - LSD in the Supportive Care of the Terminally Ill Cancer Patient - 1985

Lemaire D, Jacob P, Shulgin AT - Ring Substituted beta-Methoxyphenethylamines: A New Class of Psychotomimetic Agents Active in Man - 1985
Mathis CA, Sargent T, Shulgin AT - Iodine-122-Labeled Amphetamine Derivatives with Potential for PET Brain Blood-Flow Studies - 1985
McKenna DJ, Towers GHN - On the Comparative Ethnopharmacology of the Malpighiaceous and Myristicaceous Hallucinogens - 1985
Pazos A, Cortes R, Palacios M - Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. II. Serotonin-2-Receptors - 1985
Pazos A, Palacios JM - Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. I. Serotonin-l Receptors - 1985
Repke DB, Grotjahn DB, Shulgin AT - Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of Variation of Aromatic Oxygen Substituents - 1985
Ricaurte GA, Bryan G, Strauss L, Seiden L, Schuster C - Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals - 1985
Riedlinger J E - The Scheduling of MDMA: A Pharmacist's Perspective - 1985
Snider SR, Consroe P - Beneficial and Adverse Effects of Cannabidiol in a Parkinson Patient with Sinemet-Induced Dystonic Dyskinesia - 1985
Trulson ME, Crisp T, Henderson LJ - Ascorbic Acid Antagonizes the Behavioural Effects of LSD in Cats - 1985
Weithers S, Larson AA - Desensitization To Intratbecal Substance P-induced Biting And Scratching: Effect Of LSD And Chronic Pain - 1985
Gehlert DR, Schmidt CJ, Wu L, Lovenberg W - Evidence for specific methylenedioxymethamphetamine (ecstasy) binding sites in the rat brain - 1985
Hartig PR, Scheffel U, Frost JJ, Wagner HN Jr - In Vivo Binding Of 125-i-LSD To Serotonin 5-ht2 Receptors In Mouse Brain - 1985
Hoffman BJ, Karpa MD, Lever JR, Hartig PR - N1-Methyl-2-|125|LSD(|128|)MIL), A Preferrred Ligand for Serotonin 5-HT2 Receptors - 1985
Kalkman HO - Characterization of Serotonin (5-HT) Receptors in the Isolated Guinea-pig Ileum - 1985
Mack RB - A bit on the Wilde side: MDMA abuse - 1985
McNall SJ, Mansour TE - Forskolin Activation Of Serotonin-Stimulated Adenylate-Cyclase In The Liver Fluke Fasciola Hepatica - 1985
Monroe PJ, Smith DJ - Demonstration of an Autoreceptor Modulating the Release of [3h]5-hydroxytrptamine from a Synaptosomal-Rich Spinal Cord Tissue Preparation - 1985
Morrow AL, Norman AB, Battaglia G, Loy R, Creese I - Up-Regulatlon of Serotonergic Binding Sites Labeled By [3H]WB4101 Following Fimbrial Transection And 5,7-Dihydroxytryptamine-Induced Lesions - 1985
Nathanson JA - Phenyliminoimidazolidines: Characterization of a Class of Potent Agonists of Octopamine-Sensitive Adenylate Cyclase and Their Use in Understanding the Pharmacology of Octopamine Receptors - 1985
Nielsen EB - Discriminative Stimulus Properties of Lysergic Acid Diethylamide in the Monkey - 1985
Norman AB, Battaglia G, Creese I - [3H]WB4101 Labels the 5-HT1A Serotonin Receptor Subtype in Rat Brain: Guanine Nucleotide and Divalent Cation Sensitivity - 1985
Pawlowski L, Nowak G, Gуrka Z, Mazela H - Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities - 1985
Pazos A, Hoyer D, Palacios JM - The Binding Of Serotonergic Ligands To The Porcine Choroid Plexus: Characterization Of A New Type Of Serotonin Recognition Site - 1985
Pazos A, Palacios JM - Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. I. Serotonin-l Receptors - 1985
Pazos A, Cortes R, Palacios M - Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. II. Serotonin-2-Receptors - 1985
Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C - Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals - 1985
Riedlinger JE - The Scheduling of MDMA: A Pharmacist's Perspective - 1985
Robaut C, Fillion MP, Dufois S, Fayole-Bauguen C, Rousselle J-C, Gillet G, Benkirane S, Fillion G - Multiple High Affinity Binding Sites for 5-Hydroxytryptamine: a New Class of Sites Distinct from 5-HT1 and S2 - 1985
Schachter M, Geaney DP, Grahame-Smith DG, Cowen PJ, Elliott JM - Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment - 1985
Schachter M, Godfrey PP, Minchin MCW, McClue SJ, Young MM - Serotonergic Agonists Stimulate Inositol Lipid Metabolism In Rabbit Platelets - 1985
Schindler CW, Harvey JA - Effects of Morphine and LSD on the Classically Conditioned-Nictitating Membrane- Response - 1985
Soblosky JS, Jeng I - Influence on 5-3H]Hydroxytryptamine Binding Site Development in Chick Embryo by Serotonergic Compounds - 1985
Stolerman IP, Shine PJ - Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983 - 1985
Trulson ME - Separation of Tolerance to the Behavioral Effects of LSD from Changes in Seroronin Receptor Binding in Cats - 1985
Weithers S, Larson AA - Desensitization To Intratbecal Substance P-induced Biting And Scratching: Effect Of LSD And Chronic Pain - 1985
Beardsley PM, Balster RL, Harris LS - Self-Administration of Methylenedioxymethamphetamine (MDMA) by Rhesus Monkeys - 1986
Bird M, Kornetsky C - Naloxone Antagonism of the Effects of MDMA "Ecstasy" on Rewarding Brain Stimulation - 1986
Brady JF, Di Stephano EW, Cho AK - Spectral and Inhibitory Interactions of (+/-)-3,4-Methylenedioxyamphetamine (MDA) and (+/-)-3,4-Methylenedioxymethamphetamine (MDMA) with Rat Hepatic Microsomes - 1986
Brown CR, McKinney H, Osterloh JD, Shulgin AT, Jacob III P, Olson KR - Severe Adverse Reaction to 3,4-Methylenedioxymethamphetamine (MDMA) - 1986
Champney TH, Golden PT, Matthews RT - Reduction of Hypothalamic Serotonin Levels after Acute MDMA Administration - 1986
Colasanti, Brenda K. - Review: Ocular Hypotensive Effect of Marihuana Cannabinoids: Correlate of Central Action or Separate Phenomenon - 1986
Consroe P, Sandyk R, Snyder SR - Open Label Evaluation of Cannabidiol in Dystonic Movement Disorders - 1986
Nichols DE, Hoffman AJ, Oberlender RA, Jacobs P, Shulgin AT - Derivatives of 1-(1,3-Benzodioxol-5-yl)-2-butanamine: Representatives of a Novel Therapeutic Class - 1986
Evans SM, Johanson CE - Discriminative Stimulus Properties of (+/-)-3,4-Methylenedioxymethamphetamine and (+/-)-Methylenedioxyamphetamine in Pigeons - 1986
Frye G, Matthews R - Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Contractive Responses in the G. Pig Ileum - 1986
Gibb JW, Hanson GR, Johnson M - Effects of (+)-3,4-Methylenedioxymethamphetamine [(+)MDMA] and (-)-3,4-Methylenedioxymethamphetamine [(-)MDMA] on Brain Dopamine, Serotonin, and their Biosynthetic Enzymes. - 1986
Glennon RA, Titeler M, Lyon RA, Youssif M - MDMA ("Ecstasy"): Drug Discrimination and Brain Binding Properties - 1986
Glennon RA - Discriminative Stimulus Properties of Phenylisopropylamine Derivatives - 1986
Greer G, Tolbert R - Subjective Reports of the Effects of MDMA in a Clinical Setting - 1986
Greer G, Tolbert R - Subjective Reports of the Effects of MDMA in a Clinical Setting. - 1986
Greer, George; Tolbert, Requa - Subjective Reports of the Effects of MDMA in a Clinical Setting. - 1986
Harris LS - The Stimulants and Hallucinogens Under Consideration: A Brief Overview of Their Chemistry and Pharmacology - 1986
Hollister L E - Clinical Aspects of Use of Phenylalkylamine and Indolealkylamine Hallucinogens. - 1986
Holsten DW, Schieser DW - Controls Over the Manufacture of MDMA - 1986
Johnson MP, Hoffman AJ, Nichols DE - Effects of the Enantiomers of MDA, MDMA, and Related Analogues on [3H]Serotonin and [3H]Dopamine Release from Superfused Rat Brain Slices. - 1986
Kalix P - A Comparison of the Effects of Some Phenethylamines on the Release of Radioactivity from Isolated Rat Caudate Nucleus Prelabelled with 3H-Dopamine. - 1986
Kamien JB, Johanson CE, Schuster CR, Woolverton WL - The Effects of (+/-)-Methylenedioxymethamphetamine in Monkeys Trained to Discriminate (+)-Amphetamine from Saline - 1986
Kemali M, Milici N, Kemali D. - Melatonin and LSD Induce Similar Retinal Changes in the Frog - 1986
Letter AA, Merchant K, Gibb JW, Hanson GR - Roles of D2 and 5-HT2 Receptors in Mediating the Effects of Methamphetamine, 3,4-Methylenedioxymethamphetamine, and 3,4-Methylenedioxyamphetamine on Striato-Nigral Neurotensin Systems - 1986
Levin JA, Schmidt CJ, Lovenberg W - Release of [3H]-Monoamines from Superfused Rat Striatal Slices by Methylenedioxymethamphetamine (MDMA) - 1986
Lyon R A, Glennon R A, Titeler M - 3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective Interactions at Brain 5-HT1 and 5-HT2 Receptors. - 1986
Mathis CA, Sargent T, Shulgin AT - Synthesis of 122-I and 125-I-Labeled-meta-dimethoxy-N,N-dimethyliodophenylisopropylamines - 1986
Mathis CA, Shulgin AT, Yano Y, Sargent T - (18)F-labelled N,N-dimethylamphetamine analogues for brain imaging studies - 1986
McKenna DJ, Luna LE, Towers GHN - Biodynamic Constituents in Ayahuasca Admixture Plants: an Uninvestigated Folk Pharmacopoeia - 1986
Merchant K, Letter AA, Stone DM, Gibb JW, Hanson GR - Responses of Brain Neurotensin-like Immunoreactivity to 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA). - 1986
Newmeyer J A - Some Considerations on the Prevalence of MDMA Use. - 1986
Nichols D E, Hoffman A J, Oberlender R A, Jacob III P, Shulgin A T - Derivatives of 1-(1,3-Benzodioxol-5-yl-2-butanamine: Representatives of a Novel Therapeutic Class. - 1986
Schlemmer RF Jr., Montell SE, Davis JM - MDMA Induced Behavioral Changes in Members of Primate Social Colonies - 1986
Seymour RB, Wesson DR, Smith DE - Editor's Introduction - 1986
Shulgin, Alexander T.; Shulgin, L. Ann; Jacob, Peyton III - A Protocol for the Evaluation of New Psychoactive Drugs - 1986
Slikker W Jr., Ali SF, Scallet AC, Frith CH - Methylenedioxymethamphetamine (MDMA) Produces Long Lasting Alterations in the Serotonergic System of Rat Brain - 1986
Smilkstein MJ, Smolinske SC, Kulig KW, Rumack BH - MAO Inhibitor/MDMA Interaction: Agony after Ecstasy - 1986
Smith DE, Seymour RB - Abuse Folio: MDMA - May 1986
Steele TP, Nichols DE, Yim GKW - Stereoselective Effects of MDMA on Inhibition of Monoamine Uptake - 1986
Stone DM, Stahl DC, Hanson GR, Gibb JW - Effects of 3,4-Methylenedioxyamphetamine (MDA) and 3,4-Methylenedioxymethamphetamine (MDMA) on Tyrosine Hydroxylase and Tryptophane Hydroxylase Activity in the Rat Brain. - 1986
Stone DM, Hanson GR, Gibb JW - Does Dopamine Play a Role in the Serotonergic "Neurotoxicity" Induced by 3,4-Methylenedioxymethamphetamine (MDMA)? - 1986
Stone DM, Stahl DC, Hanson GR, Gibb JW - The Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA) on Monoaminergic Systems in the Rat Brain. - 1986
Takeda H, Gazzara RA, Howard SG, Cho AK - Effects of Methylenedioxymethamphetamine (MDMA) on Dopamine (DA) and Serotonin (5-HT) Efflux in the Rat Neostriatum - 1986
Turkington, Carol - Brain Damage Found with Designer Drugs - Mar 1986
Beardsley PM, Balster RL, Harris LS - Self-Administration of Methylenedioxymethamphetamine (MDMA) by Rhesus Monkeys - 1986
Beck J, Morgan PA - Designer drug confusion: a focus on MDMA - 1986
Brady JF, Di Stefano EW, Cho AK - Spectral and Inhibitory Interactions of (+/-)-3,4-Methylenedioxyamphetamine (MDA) and (+/-)-3,4-Methylenedioxymethamphetamine (MDMA) with Rat Hepatic Microsomes - 1986
Buffum J, Moser C - MDMA and human sexual function - 1986
Callaway E - The Biology of Human Information Processing - 1986
Climko RP, Roehrich H, Sweeney DR, Al-Razi J - Ecstacy: a review of MDMA and MDA - 1986
Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS - Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain - 1986
Davis WM, Catravas JD, Waters IW - Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) in the dog and antagonism by chlorpromazine - 1986
Downing J - The Psychological and Physiological Effects of MDMA on Normal Volunteers - 1986
Evans SM, Johanson CE - Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons - 1986
Greer G, Tolbert R - Subjective Reports of the Effects of MDMA in a Clinical Setting - 1986
Grinspoon L, Bakalar JB - Can Drugs be Used to Enhance the Psychotherapeutic Process? - 1986
Grome JJ, Harper AM - Local Cerebral Glucose Utilisation Following Indoleamine- and Piperazine-Containing 5-Hydroxytryptamine Agents - 1986
Hayner GN, McKinney H - MDMA. The dark side of ecstasy - 1986
Holsten DW, Schieser DW - Controls Over the Manufacture of MDMA - 1986
Johnson MP, Hoffman AJ, Nichols DE - Effects of the Enantiomers of MDA, MDMA and Related Analogues on [3H]Serotonin and [3H]Dopamine Release from Superfused Rat Brain Slices - 1986
Kamien JB, Johanson CE, Schuster CR, Woolverton WL - The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline - 1986
Leverant R - MDMA reconsidered - 1986
Lyon RA, Glennon RA, Titeler M - 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors - 1986
McKenney JD, Glennon RA - TFMPP May Produce its Stimulus Effects Via a 5-HT1B Mechanism - 1986
Morgan DG, Finch CE - [3H]Fluphenazine Binding to Brain Membranes: Simultaneous Measurement of D- 1 and D-2 Receptor Sites - 1986
Nichols, David E. - Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens - 1986
Noggle FT Jr, DeRuiter J, Long MJ - Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs - 1986
Ransom RW, Asarch KB, Shih JC - [3H] 1-[2-(4-Aminophenyl)Ethyl]-4-(3-Trifluoromethylphenyl)Piperazine: A Selective Radioligand for 5-HT1A Receptors in Rat Brain - 1986
Renfroe CL - MDMA on the street: Analysis Anonymous - 1986
Schechter MD - Discriminative profile of MDMA - 1986
Schlemmer RF Jr, Nawara C, Heinze WJ, Davis JM, Advokat C - Influence of Environmental Context on Tolerance to LSD-Induced Behavior in Primates - 1986
Schmidt CJ, Wu L, Lovenberg W - Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue - 1986
Seymour RB, Wesson DR, Smith DE - Editor's Introduction - 1986
Shulgin AT - The Background and Chemistry of MDMA - 1986
Siegel RK - MDMA-Nonmedical use and intoxication - 1986
Stone DM, Stahl DC, Hanson GR, Gibb JW - The Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA) on Monoaminergic Systems in the Rat Brain - 1986
Wolfson PE - Meetings at the edge with Adam: A man for all seasons? - 1986
Ziporyn T - A growing industry and menace: makeshift laboratory's designer drugs - 1986
Ali SF, Scallet AC, Holson RR, Newport GD, Slikker W Jr. - Acute Administration of MDMA (Ecstasy): Neurochemical Changes Persist up to 120 Days in Rat Brain. - 1987
Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB - 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxyamphetamine Destroy Serotonin Terminals in Rat Brain: Quantification of Neurodegeneration by Measurements of [3H] Paroxetine-Labelled Serotonin Uptake Sites - 1987
Bird MP, Svendsen CN, Knapp C, Hrbek CC, Bird ED, Kornetsky C - Evidence for Dopaminergic and Not Serotonergic Mediation of the Threshold Lowering Effects of MDMA on Rewarding Brain Stimulation - 1987
Brown C, Osterloh J - Multiple Severe Complications from Recreational Ingestion of MDMA (Ecstasy) - 1987
Callahan PM, Appel JB - Differences in the Stimulus Properties of 3,4-Methylenedioxyamphetamine (MDA) and N-Methyl-3,4-methylenedioxmethamphetamine (MDMA) in Animals Trained to Discriminate Hallucinogens from Saline. - 1987
Evans, A. Tudor; Formukong, Evelyn A.; Evans, Fred J. - Actions of Cannabis Constituents on Enzymes or Arachidonate Metabolism: Anti-Inflammatory Potential - 1987
Frith C H, Chang L W, Lattin D L, Walls R C, Hamm J, Doblin R - Toxicity of Methylenedioxy-methamphetamine (MDMA) in the Dog and the Rat. - 1987
Frith CH, Chang LW, Lattin DL, Walls RC, Hamm J, Doblin R - Toxicity of Methylenedioxymethamphetamine (MDMA) in the Dog and the Rat - 1987
Glennon R A, Little P J, Rosecrans J A, Yousif M - The Effects of MDMA ("Ecstasy") and its Optical Isomers on Schedule-Controlled Responding in Mice. Pharmacol. - 1987
Gold LH, Hubner CB, Koob GF - The Role of Mesolimbic Dopamine in the Stimulant Action of MDMA - 1987
Johnson M, Bush LG, Stone DM, Hanson GR, Gibb JW - Effects of Adrenalectomy on the 3,4-Methylenedioxymethamphetamine (MDMA)-induced Decrease of Tryptophan Hydroxylase Activity in the Frontal Cortex and Hippocampus - 1987
Lamb RJ, Griffiths RR - Self-Injection of dl-3,4-Methylenedioxymethamphetamine in the Baboon - 1987
McKenna DJ, Mathis CA, Shulgin AT, Sargent T, Saavedra JM - Autoradiographic Localization of Binding Sites for 125-I-DOI, a New Psychotomimetic Radioligand, in the Rat Brain - 1987
McKenna DJ, Saavedra JM - Autoradiography of LSD and 2,5-Dimethoxyphenylisopropylamine Psychotomimetics Demonstrates Regional, Specific Cross-Displacement in the Rat Brain - 1987
McKenna DJ, Mathis CA, Shulgin AT, Saavedra JM - Hallucinogens Bind to Common Receptors in the Rat Forebrain: a Comparative Study Using 125I-LSD and 125I-DOI, a New Psychotomimetic Radioligand - 1987
McKenna DJ, Mathis CA, Shulgin AT, Sargent T III, Saavedra JM - Autoradiographic Localization of Binding Sites for 125I-(-)DOI, a New Psychotomimetic Radioligand, in the Rat Brain - 1987
Mokler DJ, Robinson SE, Rosecrans JA - Differential Depletion of Brain 5-Hydroxytryptamine (5-HT) by (+/-) 3,4-Methylenedioxymethamphetamine (MDMA). - 1987
Mokler DJ, Robinson SE, Rosecrans JA - (+/-) 3,4-Methylenedioxymethamphetamine (MDMA) Produces Long-term Reductions in Brain 5-Hydroxytryptamine in Rats. - 1987
Mokler DJ, Robinson SE, Rosecrans JA - A Comparison of the Effects of Repeated Doses of MDMA ("Ecstasy") on Biogenic Amine Levels in Adult and Neonate Rats. - 1987
Nakai, Mamoru; Enomiya, Takugi - Process for Producing Phenylacetones - Jan 20,1987
Neill, John R. - "More Than Medical Significance": LSD and American Psychiatry 1953 to 1966. - 1987
Peroutka SJ, Pascoe N, Faull KF - Monoamine Metabolites in the Cerebrospinal Fluid of Recreational Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") - 1987
Ricaurte GA, Finnegan KF, Nichols DE, DeLanney LE, Irwin I, Langston JW - 3,4-Methylenedioxymethamphetamine (MDE), a Novel Analogue of MDMA, Produces Long-lasting Depletion of Serotonin in the Rat - 1987
Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW - (+/-) Methylenedioxymethamphetamine (MDMA) Exerts Toxic Effects on Central Serotonergic Neurons in Primates - 1987
Rosecrans J A, Glennon R A - The Effect of MDA and MDMA ("Ecstasy") Isomers in Combination with Pirenpirone on Operant Responding in Mice. - 1987
Sargent TW, Shulgin AT, Mathis CA - Rapid Brain Scanning Pharmaceutical - 1987
Scallet AC, Ali SF, Holson RR, Lipe GW, Slikker Jr. W - Neurohistological Effects 120 Days after Oral Ecstasy (MDMA): Multiple Antigen Immunohistochemistry and Silver Degeneration Staining. - 1987
Shulgin AT - The 'Social-Chemistry' of Pharmacological Discovery - 1987
Stone DM, Hanson GR, Gibb JW - GABA-Transaminase Inhibitor Protects Against Methylenedioxymethamphetamine (MDMA)-induced Neurotoxicity. - 1987
Stone DM, Johnson M, Hanson GR, Gibb JW - A Comparison of the Neurotoxic Potential of Methylenedioxyamphetamine (MDA) and its N-Methylated and N-Ethylated Derivatives. - 1987
Stone DM, Hanson GR, Gibb JW - Differences in the Central Serotonergic Effects of Methylenedioxymethamphetamine (MDMA) in Mice and Rats. - 1987
Stone DM, Merchant KM, Hanson GR, Gibb JW - Immediate and Long Term Effects of 3,4-Methylenedioxymethamphetamine on Serotonin Pathways in Brain of Rat. - 1987
Trulson TJ, Trulson ME - 3,4-Methylenedioxymethamphetamine (MDMA) Suppresses Serotonergic Dorsal Raphe Neuronal Activity in Freely Moving Cats and in Midbrain Slices in vitro - 1987
Ungerleider JT, Andyrsiac T, Fairbanks L, Ellison GW, Myers LW - Delta-9-Tetrahydrocannabinol in the Treatment of Spasticity Associated with Multiple Sclerosis - 1987
Wang S S, Ricaurte G A, Peroutka S J - [3H]3,4 Methylenedioxymethamphetamine (MDMA) Interactions with Brain Membranes and Glass Fiber Filter Paper - 1987
Wilson MA, Ricaurte GA, Molliver ME - The Psychotropic Drug 3,4-Methylenedioxymethamphetamine (MDMA) Destroys Serotonergic Axons in Primate Forebrain: Regional and Laminar Differences in Vulnerability. - 1987
Yeh SY, Hsu F-L - Neurotoxicity of Metabolites of MDA and MDMA (Ecstasy) in the Rat - 1987
Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB - 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxyamphetamine Destroy Serotonin Terminals in Rat Brain: Quantification of Neurodegeneration by Measurement of [3H]Paroxetine-Labeled Serotonin Uptake Sites - 1987
Boja JW, Schechter MD - Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; 'EVE') - 1987
Brown C, Osterloh J - Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') [letter] - 1987
Davis WM, Hatoum HT, Waters IW - Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse - 1987
Dowling GP, McDonough ET 3rd, Bost RO - 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA - 1987
Frith CH, Chang LW, Lattin DL, Walls RC, Hamm J, Doblin R - Toxicity of Methylenedioxymethamphetamine (MDMA) in the Dog and the Rat - 1987
Gibb JW, Stone DM, Stahl DC, Hanson GR - The Effects of Amphetamine-Like Designer Drugs on Monoaminergic Systems in Rat Brain - 1987
Glennon RA, Little PJ, Rosecrans JA, Yousif M - The effect of MDMA ('Ecstasy') and its optical isomers on schedule-controlled responding in mice - 1987
Kulmala HK, Boja JW, Schechter MD - Behavioral suppression following 3,4-methylenenedioxymethamphetamine - 1987
Lamb RJ, Griffiths RR - Self-Injection of d,1-3,4-Methylenedioxymethamphetamine (MDMA) in the Baboon - 1987
Mokler DJ, Robinson SE, Rosecrans JA - (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats - 1987
Peroutka SJ - Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, 'Ecstasy') on an Undergraduate Campus - 1987
Peroutka SJ, Pascoe N, Faull KF - Monoamine Metabolites in the Cerebralspinal Fluid of Recreational Users of 3,4-Methylenedioxymethamphetamine (MDMA; 'Ecstasy') - 1987
Ricaurte GA, Finnegan KF, Nichols DE, DeLanney LE, Irwin I, Langston JW - 3,4-Methylenedioxyethylamphetamine (MDE), a Novel Analogue of MDMA, Produces Long-Lasting Depletion of Serotonin in the Rat Brain - 1987
Rosecrans JA, Glennon RA - The effect of MDA and MDMA ('Ecstasy') isomers in combination with pirenpirone on operant responding in mice - 1987
Schechter MD - MDMA as a discriminative stimulus: isomeric comparisons - 1987
Schmidt CJ - Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine - 1987
Smilkstein MJ, Smolinske SC, Rumack BH - A case of MAO inhibitor/MDMA interaction: agony after ecstasy - 1987
Steele TD, Nichols DE, Yim GK - Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain - 1987
Stone DM, Hanson GR, Gibb JW - Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats - 1987
Stone DM, Johnson M, Hanson GR, Gibb JW - A Comparison of the Neurotoxic Potential of Methylenedioxyamphetamine (MDA) and its N-Methylated and N-Ethylated Derivatives - 1987
Stone DM, Merchant KM, Hanson GR, Gibb JW - Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat - 1987
Thompson DM, Winsauer PJ, Mastropaolo J - Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys - 1987
Wang SS, Ricaurte GA, Peroutka SJ - [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paper - 1987
Adamson, Sophia; Metzner, Ralph - The Nature of the MDMA Experience and its Role in Healing, Psychotherapy, and Spiritual Practice. - 1988
Barnes DM - New Data Intensifies the Agony over Ecstasy. - 1988
Battaglia G, Brooks BP, Kulsakdinum C, De Souza EB - Pharmacologic Profile of MDMA 3,4-Methylenedioxymeth-amphetamine at Various Brain Recognition Sites - 1988
Battaglia G, Yeh SY, De Souza EB - MDMA-Induced Neurotoxicity: Parameters of Degeneration and Recovery of Brain Serotonin Neurons - 1988
Bost RO - 3,4-Methylenedioxymethamphetamine (MDMA) and Other Amphetamine Derivatives - 1988
Callahan PM, Appel JB - Differences in the Stimulus Properties of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxmethamphetamine in Animals Trained to Discriminate Hallucinogens from Saline. - 1988
Finnigan KT, Ricaurte GA, Ritchie LD, Irwin I, Peroutka SJ, Langston JW - Orally Administered MDMA Causes a Long-term Depletion of Serotonin in Rat Brain. - 1988
Fitzgerald RL, Blanke R, Narasimhachari N, Glennon R, Rosecrans J - Identification of 3,4-Methylenedioxyamphetamine (MDA) as a Major Urinary Metabolite of 3,4-Methylenedioxymethamphetamine (MDMA) - 1988
Glennon RA, Yousif M, Patrick G - Stimulus Properties of 1-(3,4-Methylenedioxy)-2-Aminopropane (MDA) Analogs - 1988
Gold LH, Koob GF - Methysergide Potentialtes the Hyperactivity Produced by MDMA in Rats - 1988
Grof, Stanislav - Theoretical and Empirical Foundations of Transpersonal Psychotherapy - 1988
Hansen, Gustav; Jensen, Sven Boel; Chandresh, Lars; Hilden, Thomas - The Psychotropic Effects of Ketamine - 1988
Himeno A, McKenna DJ, Nazarali AJ, Saavedra JM - (±)DOI, a Hallucinogenic Phenylalkylamine, Downregulates 5HT2 Receptors in Rat Brain - 1988
Hubner CB, Bird M, Rassnick S, Lornetsky C - The Threshold Lowering Effects of MDMA (Ecstasy) on Brain-Stimulating Reward. - 1988
Johnson M, Hanson GR, Gibb JW - Effects of Dopaminergic and Serotonergic Receptor Blockade on Neurochemical Changes Induced by Acute Administration of Methamphetamine and 3,4-Methylenedioxymethamphetamine - 1988
Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW - Effects of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Isomers on Central Serotonergic, Dopaminergic and Nigral Neurotensin Systems of the Rat - 1988
Lim HK, Foltz RL - In Vivo and In Vitro Metabolism of 3,4-Methylenedioxymethamphetamine in the Rat: Identification of Metabolites using an Ion Trap Detecor - 1988
Logan B J, Laverty R, Sanderson W D, Yee Y B - Differences Between Rats and Mice in MDMA (Methylenedioxmethamphetamine) Neurotoxicity. - 1988
O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME - Methylenedioxyamphetamine (MDA) and Methylenedioxymethamphetamine (MDMA) Cause Selective Ablation of the Serotoninergic Axon Terminals in Forebrain: Immunocytochemical Evidence for Neurotoxicity - 1988
O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME - Methylenedioxyamphetamine (MDA) and Methylenedioxymethamphetamine (MDMA) Cause Selective Ablation of Serotonergic Axon Terminals in Forebrain: Immunocytochemical Evidence for Neurotoxicity - 1988
Oberlender R, Nichols D E - Drug Discrimination Studies with MDMA and Amphetamine. - 1988
Peroutka SJ, Newman H, Harris H - Subjective Effects of 3,4-Methylenedioxymethamphetamine in Recreational Users - 1988
Pierce PA, Peroutka SJ - Ring-Substituted Amphetamine Interactions with Neurotransmitter Receptor Binding Sites in Human Cortex - 1988
Ramos JM, Johnson S, Poklis A - MDMA and MDA Cross Reactivity Observed with Abbott TDx Amphetamine/Methamphetamine Reagents - 1988
Ricaurte GA, DeLanney LE, Irwin I, Langston JW - Toxic Effects of MDMA on Central Serotonergic Neurons in the Primate: Importance of Route and Frequency of Drug Application. - 1988
Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW - 5-Hydroxyindoleacetic acid in Cerebrospinal Fluid Reflects Serotonergic Damage Induced by 3,4-Methylenedioxymethamphetamine in CNS of Non-human Primates. - 1988
Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Moliver ME, Langston JW - (+/-) 3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates. - 1988
Ruchman MC - Role of Cannabidiol in the Medical Treatment of Meige's Syndrome - 1988
Scallet AC, Lipe GW, Ali SF, Holson RR, Frith CH, Slikker W Jr. - Neuropathological Evaluation by Combined Immunohistochemistry and Degeneration-Specific Methods: Application to Methylenedioxymethamphetamine - 1988
Schechter MD - Advantages and Disadvantages of a Rapid Method to Train Drug Discrimination. - 1988
Shulgin AT - DIPT: The Distortion of Music - Winter 1988
Slikker W, Ali SF, Scallet AC, Firth CH, Newport GD, Bailey JR - Neurochemical and Neurohistological Alterations in the Rat and Monkey Produced by Orally Administered Methylenedioxmethamphetamine (MDMA). - 1988
Stone DM, Johnson M, Hanson GR, Gibb JW - Role of Endogenous Dopamine in the Central Serotonergic Deficits Induced by 3,4-Methylenedioxymethamphetamine - 1988
Verebey K, Alrazi J, Jaffe J H - The Complications of "Ecstasy" (MDMA). - 1988
Yensen, Richard - Helping at the Edge of Life. Perspectives of a Psychedelic Therapist - 1988
Yensen, Richard - From Mysteries to Paradigms: Humanity's Journey From Sacred Plants to Psychedelic Drugs. - 1988
Barnes DM - Ecstasy returns to Schedule I - 1988
Battaglia G, Brooks BP, Kulsakdinun C, De Souza EB - Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites - 1988
Battaglia G, Yeh SY, de Souza EB - MDMA-Induced Neurotoxicity: Parameters of Degeneration and Recovery of Brain Serotonin Neurons - 1988
Bost RO - 3,4-Methylenedioxymethamphetamine (MDMA) and Other Amphetamine Derivatives - 1988
Buchanan JF, Brown CR - 'Designer drugs'. A problem in clinical toxicology - 1988
Callahan PM, Appel JB - Differences in the Stimulus Properties of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine in Animals Trained to Discriminate Hallucinogens from Saline - 1988
Finnegan KT, Ricaurte GA, Ritchie LD, Irwin I, Peroutka SJ, Langston JW - Orally Administered MDMA Causes a Long-Term Depletion of Serotonin in Rat Brain - 1988
Glennon RA, Yousif M, Patrick G - Stimulus Properties of 1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDA) Analogs - 1988
Gold LH, Koob GF - Methysergide potentiates the hyperactivity produced by MDMA in rats - 1988
Hubner CB, Bird M, Rassnick S, Kornetsky C - The Threshold Lowering Effects of MDMA (Ecstasy) on Brain-Stimulation Reward - 1988
Johnson M, Hanson GR, Gibb JW - Effects of Dopaminergic and Serotonergic Receptor Blockade on Neurochemical Changes Induced by Acute Administration of Methamphetamine and 3,4-Methylenedioxymethamphetamine - 1988
Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW - Effects of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Isomers on Central Serotonergic, Dopaminergic and Nigral Neurotensin Systems of the Rat - 1988
Lim HK, Foltz RL - In Vivo and In Vitro Metabolism of 3,4-(Methylenedioxy)methamphetamine in the Rat: Identification of Metabolites Using an Ion Trap Detector - 1988
Logan BJ, Laverty R, Sanderson WD, Yee YB - Differences Between Rats and Mice in MDMA (Methylenedioxymethylamphetamine) Neurotoxicity - 1988
Mamounas LA, Molliver ME - Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA) - 1988
Nash JF Jr, Meltzer HY, Gudelsky GA - Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine - 1988
Nencini P, Woolverton WL, Seiden LS - Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine - 1988
Oberlender R, Nichols DE - Drug Discrimination Studies with MDMA and Amphetamine - 1988
Peroutka SJ, Newman H, Harris H - Subjective Effects of 3,4-Methylenedioxymethamphetamine in Recreational Users - 1988
Pierce PA, Peroutka SJ - Ring-Substituted Amphetamine Interactions with Neurotransmitter Receptor Binding Sites in Human Cortex - 1988
Ricaurte GA, DeLanney LE, Irwin I, Langston JW - Toxic Effects of MDMA on Central Serotonergic Neurons in the Primate: Importance of Route and Frequency of Drug Administration - 1988
Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW - 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid Reflects Serotonergic Damage Induced by 3,4-Methylenedioxymethamphetamine in CNS of Non-Human Primates - 1988
Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW - (+/-)3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates - 1988
Ruangyuttikarn W, Moody DE - Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine - 1988
Scallet AC, Lipe GW, Ali SF, Holson RR, Frith CH, Slikker W Jr - Neuropathological Evaluation by Combined Immunohistochemistry and Degeneration-Specific Methods: Application to Methylenedioxymethamphetamine - 1988
Schechter MD - Use of TFMPP Stimulus Properties as a Model of 5-HT1B Receptor Activation - 1988
Schechter MD - Advantages and Disadvantages of a Rapid Method to Train Drug Discrimination - 1988
Schmidt CJ, Taylor VL - Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons - 1988
Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR - Neurochemical and Neurohistological Alterations in the Rat and Monkey Produced by Orally Administered Methylenedioxymethamphetamine (MDMA) - 1988
Stone DM, Johnson M, Hanson GR, Gibb JW - Role of Endogenous Dopamine in the Central Serotonergic Deficits Induced by 3,4-Methylenedioxymethamphetamine - 1988
Suarez RV, Riemersma R - 'Ecstasy' and sudden cardiac death - 1988
Verebey K, Alrazi J, Jaffe JH - The Complications of 'Ecstasy' (MDMA) - 1988
Yamamoto BK, Spanos LJ - The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat - 1988
Beebe, Diane K.; Walley, Elizabeth - Update on Street Drugs in Mississippi - 1989
Burstein SH, Audette CA, Doyle SA, Hull K, Hunter SA, Latham V - Antagonism to the Actions of Platelet Activating Factor by a Nonpsychoactive Cannabinoid - 1989
Crisp T, Stafinsky JL, Boja JW, Schechter MD - The Antinociceptive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in the Rat - 1989
Edwards G - Blasted with Ennui - 1989
Fitzgerald R L, Blamke R V, Glennon R A, Yousif M Y, Rosecrans J A, Poklis A - Determination of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Enantiomers in Whole Blood. - 1989
Glennon R A, Misenheimer B R - Stimulus Effects of N-Monoethyl-1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDE) and N-Hydroxy-1-(3,4-Methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in Rats Trained to Discriminate MDMA from Saline. - 1989
Gold LH, Hubner CB, Koob GF - A Role for the Mesolimbic Dopamine System in the Psychostimulant Actions of MDMA - 1989
Gold LH, Koob GF - MDMA Produces Stimulant-like Conditioned Locomotor Activity - 1989
Gold LH, Geyer MA, Koob GF - Psychostimulant Properties of MDMA - 1989
Gold LH, Geyer MA, Koob GF - Neurochemical Mechanisms Involved in Behavioural Effects of Amphetamines and Related Designer Drugs - 1989
Goldstein, Richard - The Facts about 'Ecstasy' A Talk with Andrew Weil - Feb 7, 1989
Gollamudi R, Ali SF, Lipe G, Newport G, Webb P, Lopez M, Leakey JEA, Kolta M, Slikker W Jr. - Influence of Inducers and Inhibitors on the Metabolism in Vitro and Neurochemical Effects in Vivo of MDMA - 1989
Hanson GR, Sonsalla P, Letter A, Merchant KM, Johnson M, Bush L, Gibb JW - Effects of Amphetamine Analogs on Central Nervous System Neuropeptide Systems - 1989
Hekmatpanah C R, McKenna D J, Peroutka S J - Reserpine Does Not Prevent 3,4-Methylenedioxyamphetamine-Induced Neurotoxicity in the Rat. - 1989
Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB - 3,4-Methylenedioxymethamphetamine ("Ecstasy") Selectively Destroys Brain Serotonin Terminals in Rhesus Monkeys - 1989
Johnson M, Hanson GR, Gibb JW - Effect of MK-801 on the Decrease in Tryptophan Hydroxylase Induced by Methamphetamine and its Methylenedioxy Analog. - 1989
Johnson M P, Nichols D E - Neurotoxin Effects of the alpha-ethyl Homologue of MDMA Following Subacute Administration. - 1989
Johnson M, Stone D M, Bush L G, Hanson G R, Gibb J W - Glucocorticoid and 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Neurotoxicity - 1989
Johnson M, Hanson GR, Gibb JW - Effect of MK-801 on the Decrease in Tryptophan Hydroxylase Induced by Methamphetamine and Its Methylenedioxy Analog - 1989
Klein RFX, Sperling AR, Cooper DA, Kram TC - The Stereoisomers of 4-Methylaminorex - 1989
Kleven MS, Woolverton WL, Seiden LS - Evidence that Both Intragastric and Subcutaneous Administration of Methylenedioxmethamphetamine (MDMA) Produce Serotonin Neurotoxicity in Rhesus Monkeys - 1989
Lowy MT, Nash JF Jr., Meltzer HY - Selective Reduction of Striatal Type-II Glucocorticoid Receptors in Rats by 3,4-Methylenedioxymethamphetamine (MDMA) - 1989
Mansbach RS, Braff DL, Geyer MA - Prepulse Inhibition of the Acoustic Startle Response is Disrupted by N-Ethyl-3,4-methylenedioxyam-phetamine (MDEA) in the Rat - 1989
Molliver ME, Mamounas LA, Wilson MA - Effects of Neurotoxic Amphetamines on Serotonergic Neurons: Immunocytochemical Studies - 1989
Nader MA, Hoffmann SM, Barrett JE - Behavioural Effects of (+/-) 3,4-Methylenedioxyamphetamine (MDA) and (+/-) 3,4-Methylenedioxymethamphetamine (MDMA) in the Pigeon: Interactions with Noradrenergic and Serotoninergic Systems. - 1989
Price LH, Ricaurte GA, Krystal JH, Heninger GR - Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users - 1989
Ricaurte GA - Studies of MDMA-Induced Neurotoxicity in Nonhuman Primates: A Basis for Evaluating Long-Term Effects in Humans - 1989
Slikker W Jr, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM - Behavioural and Neurochemical Effects of Orally Administered MDMA in the Rodent and Nonhuman Primate - 1989
Steele TD, Nichols DE, Yim GK - MDMA Transiently Alters Biogenic Amines and Metabolites in Mouse Brain and Heart. - 1989
Stone D M, Johnson M, Hanson G R, Gibb J W - Acute Inactivation of Tryptophan Hydroxylase by Amphetamine Analogs Involves the Oxidation of Sulfhydryl Sites. - 1989
Whitaker-Azmitia PM, Aronson TA - "Ecstasy" (MDMA)-Induced Panic - 1989
Whitaker-Azmitia PM - Depression to Ecstasy. - 1989
Whitaker-Azmitia PM - Depression to Ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989 - 1989
Wilson MA, Ricaurte GA, Molliver ME - Distinct Morphologic Classes of Serotoninergic Axons in Primates Exhibit Differential Vulnerability to the Psychotropic Drug 3,4-Methylenedioxymethamphetamine - 1989
anonymous - Mind-bending Drug Could Leave Brains Permanently Warped - Jan 1989
anonymous - Deal mit Cadillac - Sep 4,1989
anonymous - Cadillac und Ecstasy - Feb 27,1989
Beebe, Diane K.; Walley, Elizabeth - Update on Street Drugs in Mississippi - 1989
Crisp T, Stafinsky JL, Boja JW, Schechter MD - The Antinociceptive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in the Rat - 1989
Dimpfel W, Spuler M, Nichols DE - Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG) - 1989
Farrell M - Ecstasy and the oxygen of publicity - 1989
Fitzgerald RL, Blanke RV, Glennon RA, Yousif MY, Rosecrans JA, Poklis A - Determination of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Enantiomers in Whole Blood - 1989
Fitzgerald RL, Blanke RV, Rosecrans JA, Glennon RA - Stereochemistry of the Metabolism of MDMA to MDA - 1989
Gazzara RA, Takeda H, Cho AK, Howard SG - Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin - 1989
Gibb JW, Stone DM, Johnson M, Hanson GR - Role of Dopamine in the Neurotoxicity Induced by Amphetamines and Related Designer Drugs - 1989
Glennon RA, Misenheimer BR - Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline - 1989
Gold LH, Geyer MA, Koob GF - Psychostimulant Properties of MDMA - 1989
Gold LH, Geyer MA, Koob GF - Neurochemical Mechanisms Involved in Behavioral Effects of Amphetamines and Related Designer Drugs - 1989
Gold LH, Hubner CB, Koob GF - A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA - 1989
Gold LH, Koob GF - MDMA produces stimulant-like conditioned locomotor activity - 1989
Gollamudi R, Ali SF, Lipe G, Newport G, Webb P, Lopez M, Leakey JEA, Kolta M, Slicker W Jr - Influence of Inducers and Inhibitors on the Metabolism in Vitro and Neurochemical Effects in Vivo of MDMA - 1989
Hanson GR, Sonsalla P, Letter A, Merchant KM, Johnson M, Bush L, Gibb JW - Effects of Amphetamine Analogs on Central Nervous System Neuropeptide Systems - 1989
Hekmatpanah CR, McKenna DJ, Peroutka SJ - Reserpine Does Not Prevent 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in the Rat - 1989
Hiramatsu M, Nabeshima T, Kameyama T, Maeda Y, Cho AK - The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats - 1989
Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB - 3,4-Methylenedioxymethamphetamine ('Ecstasy') Selectively Destroys Brain Serotonin Terminals in Rhesus Monkeys - 1989
Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW - Glucocorticoids and 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Neurotoxicity - 1989
Johnson MP, Nichols DE - Neurotoxic Effects of the alpha-ethyl Homologue of MDMA Following Subacute Administration - 1989
Kelland MD, Freeman AS, Chiodo LA - (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons - 1989
Kleven MS, Seiden LS - Toxicity of Amphetamine-Related Drugs and Resulting Behavioural Changes - 1989
Kleven MS, Woolverton WL, Seiden LS - Evidence that Both Intragastric and Subcutaneous Administration of Methylenedioxymethylamphetamine (MDMA) Produce Serotonin Neurotoxicity in Rhesus Monkeys - 1989
Laverty R, Logan BJ - Ecstasy abuse - 1989
Li AA, Marek GJ, Vosmer G, Seiden LS - Long-Term Central 5-HT Depletions Resulting from Repeated Administration of MDMA Enhances the Effects of Single Administration of MDMA on Schedule-Controlled Behavior of Rats - 1989
Lim HK, Foltz RL - Identification of metabolites of 3,4-(methylenedioxy)methamphetamine in human urine - 1989
Lorens SA, Hata N, Cabrera T, Hamilton ME - Comparison of the Behavioral and Neurochemical Effects of 5,7-DHT, MDMA and D,L-Fenfluramine - 1989
Lowy MT, Nash JF Jr, Meltzer HY - Selective Reduction of Striatal Type II Glucocorticoid Receptors in Rats by 3,4-Methylenedioxymethamphetamine (MDMA) - 1989
Mansbach RS, Braff DL, Geyer MA - Prepulse Inhibition of the Acoustic Startle Response is Disrupted by N-ethyl-3,4-Methylenedioxyamphetamine (MDEA) in the Rat - 1989
Matthews RT, Champney TH, Frye GD - Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats - 1989
Miczek KA, Tidey JW - Amphetamines: Aggressive and Social Behavior - 1989
Molliver ME, Mamounas LA, Wilson MA - Effects of Neurotoxic Amphetamines on Serotonergic Neurons: Immunocytochemical Studies - 1989
Nader MA, Hoffmann SM, Barrett JE - Behavioral Effects of (+-) 3,4-Methylenedioxyamphetamine (MDA) and (+-) 3,4-Methylenedioxymethamphetamine (MDMA) in the Pigeon: Interactions with Noradrenergic and Serotonergic Systems - 1989
Nichols DE, Oberlender R - Structure-Activity Relationships of MDMA-Like Substances - 1989
Nichols DE, Oberlender R, Burris K, Hoffman AJ, Johnson MP - Studies of Dioxole Ring Substituted 3,4-Methylenedioxyamphetamine (MDA) Analogues - 1989
Peroutka SJ - 'Ecstasy': a human neurotoxin? - 1989
Price LH, Ricaurte GA, Krystal JH, Heninger GR - Responses to I.V. L-Tryptophan in MDMA Users - 1989
Price LH, Ricaurte GA, Krystal JH, Heninger GR - Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users. Preliminary Observations - 1989
Ricaurte GA - Studies of MDMA-Induced Neurotoxicity in Nonhuman Primates: A Basis for Evaluating Long-Term Effects in Humans - 1989
Sadzot B, Baraban JM, Glennon RA, Lyon RA, Leonhardt S, Jan CR, Titeler M - Hallucinogenic Drug Interactions at Human Brain 5-HT2 Receptors: Implications for Treating LSD-induced Hallucinogenesis - 1989
Schechter MD - Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, ''ecstasy'') - 1989
Schmidt CJ - Acute and Long-Term Neurochemical Effects of Methylenedioxymethamphetamine in the Rat - 1989
Seiden LS, Kleven MS - Methamphetamine and Related Drugs: Toxicity and Resulting Behavioral Changes in Response to Pharmacological Probes - 1989
Slikker W Jr, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM - Behavioral and Neurochemical Effects of Orally Administered MDMA in the Rodent and Nonhuman Primate - 1989
Spanos LJ, Yamamoto BK - Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat [published erratum appears in Pharmacol Biochem Behav 1989 Nov;34(3):679] - 1989
Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK - MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin - 1989
Steele TD, Nichols DE, Yim GK - MDMA Transiently Alters Biogenic Amines and Metabolites in Mouse Brain and Heart - 1989
Stone DM, Hanson GR, Gibb JW - In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine - 1989
Stone DM, Johnson M, Hanson GR, Gibb JW - Acute Inactivation of Tryptophan Hydroxylase by Amphetamine Analogs Involves the Oxidation of Sulfhydryl Sites - 1989
Whitaker-Azmitia PM, Aronson TA - 'Ecstasy' (MDMA)-induced panic - 1989
Wilkerson G, London ED - Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat - 1989
Wilson MA, Ricaurte GA, Molliver ME - Distinct Morphologic Classes of Serotonergic xons in priPmates Exhibit Differential Vulnerability to the Psychotropic Drug 3,4-Methylenedioxymethamphetamine - 1989
Zaczek R, Hurt S, Culp S, De Souza EB - Characterization of Brain Interactions With Methylenedioxyamphetamine and Methylenedioxymethamphetamine - 1989
Azmitia EC, Murphy RB, Whitaker-Azmitia PM - MDMA (Ecstasy) Effects on Cultured Serotonergic Neurons: Evidence for Ca 2+ -Dependent Toxicity Linked to Release - 1990
Bakalar JB, Grinspoon L - Testing Psychotherapies and Drug Therapies: The Case of Psychedelic Drugs - 1990
Bakalar, James B.; Grinspoon, Lester - Testing Psychotherapies and Drug Therapies: The Case of Psychedelic Drugs - 1990
Bilsky EJ, Hui Y, Hubbell CL, Reid LD - Methylenedioxymethamphetamine's Capacity to Establish Place Preferences and Modify Intake of an Alcohol Beverage - 1990
Brewster WK, Nichols DE, Riggs RM, Lovenberg TW, Mottola DM, Lee RC, Lewis MH, Mailman RB - Trans-10,11-Dihydroxy-5,6,6a,7,8,12b-Hexahydrobenzo[a]phenanthridine: A Highly Potent Selective Dopamine D1 Full Agonist - 1990
Bunker CF, Johnson M, Gibb JW, Bush LG, Hanson GR - Neurochemical Effects of an Acute Treatment with 4-Methylaminorex, a New Stimulant of Abuse - 1990
Bunker CF, Johnson M, Hanson GR, Gibb JW - The Acute Effects of a Single Dose of 4-Methylaminorex on Rat Brain Neurochemistry - 1990
Callaway C W, Wing L L, Geyer M A - Serotonin Release Contributes to the Locomotor Stimulant Effects of 3,4-Methylenedioxyamphetamine in Rats. - 1990
Cho AK, Hiramatsu M, Distefano EW, Chang AS, Jenden DJ - Stereochemical Differences in the Metabolism of 3,4-Methylenedioxymethamphetamine In Vivo and In Vitro: A Pharmacokinetic Analysis - 1990
Cody JT - Cross-Reactivity of Amphetamine Analogues with Roche Abuscreen Radioimmunoassay Reagents - 1990
Cody JT - Detection of D,L-Amphetamine, D,L-Methamphetamine, and Illicit Amphetamine Analogs Using Diagnostic Products Corporation's Amphetamine and Methamphetamine Radioimmunoassay - 1990
Dowling GP - Human Deaths and Toxic Reactions Attributed to MDMA and MDEA - 1990
Finnegan KT, Skratt JJ, Irwin I, Langston JW - The N-Methyl-D-aspartate (NMDA) Receptor Antagonist, Dextrorphan, Prevents the Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in Rats. - 1990
Fitzgerald RL, Blanke RV, Poklis A - Stereoselective Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in the Rat - 1990
Gerard F - Pain, Death and LSD: A Retrospective on the work of Dr. Eric Kast - 1990
Gerard, Francis - Pain, Death and LSD: A Retrospective of the Work of Dr. Eric Kast. - 1990
Gibb JW, Johnson M, Hanson GR - Neurochemical Basis of Neurotoxicity. - 1990
Gibb JW, Johnson M, Stone D, Hanson GR - MDMA: Historical Perspectives. - 1990
Gibb JW, Stone D, Johnson M, Hanson GR - Neurochemical Effects of MDMA - 1990
Glennon RA, Misenheimer B - Stimulus Properties of a New Designer Drug: 4-Methylaminorex (U4Euh) - 1990
Goodman, Robert M. - Method of Decongesting the Nose Without Adverse Stimulant Effects - Dec 25,1990
Greer G, Tolbert R - The Therapeutic Use of MDMA. - 1990
Greer, George R.; Tolbert, Requa - The Therapeutic Use of MDMA - 1990
Hanson GR, Merchant KM, Johnson M, Letter AA, Bush L, Gibb JW - Effect of MDMA-like Drugs on CNS Neuropeptide Systems - 1990
Hiramatsu M, Kumagai Y, Unger SE, Cho AK - Metabolism of Methylenedioxymethamphetamine: Formation of Dihydroxymethamphetamine and a Quinone Identified as its Glutathione Adduct - 1990
Hiramatsu M, Cho AK - Enantiomeric Differences in the Effects of 3,4-Methylenedioxymethamphetamine on Extracellular Monoamines and Metabolites in the Striatum of Freely-Moving Rats: An In Vivo Microdialysis Study - 1990
Johnson MP, Huang X, Oberlender R, Nash JF, Nichols DE - Behavioral, Biochemical, and Neurotoxicological Actions of the alpha-ethyl Homologue of p-Chloroamphetamine - 1990
Johnson MP, Huang X, Oberlender R, Nash JF, Nichols DE - Behavioural, Biochemical and Neurotoxicological Actions of the alpha-ethyl Homologue of p-Chloroamphetamine - 1990
Mansbach RS, Sannerud CA, Griffiths RR, Balster RL, Harris LS - Intravenous Self-Administration of 4-Methylaminorex in Primates - 1990
Mayer JP, Cassady JM, Nichols DE - An Improved Synthesis of 6-Hydroxy-4-[2-(di-n-propylamino)ethyl]indole - 1990
McKenna DJ, Peroutka SJ - The Neurochemistry and Neurotoxicity of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") - 1990
McKenna DJ, Repke DB, Lo L, Peroutka SJ - Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. - 1990 Mar
Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA - Neurotoxocity of MDMA and Related Compounds: Anatomical Studies. - 1990
Nash JF, Meltzer HY, Gudelsky GA - Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbers - 1990
Nash JF - Ketanserin Pretreatment Attenuates MDMA-induced Dopamine Release in the Striatum as Measured by in vivo Microdialysis - 1990
Nichols DE, Johnson MP, Oberlender R - 5-Iodo-2-aminoindan, a Non-Neurotoxic Analogue of para-Iodoamphetamine - 1990
Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM - Nonneurotoxic Tetralin and Indan Analogues of 3,4-Methylenedioxyamphetamine (MDA) - 1990
Nichols DE, Oberlender R - Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs - 1990
Nichols DE, Oberlender R - Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents? - 1990
Oberlender R, Nichols DE - (+)-N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-Methyenedioxymethamphetamine-like Behavioral Activity - 1990
Oberlender R, Nichols DE - (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-methylenedioxymethamphetamine-Like Behavioural Activity - 1990
Paulus, Martin P.; Geyer, Mark A.; Gold, Lisa H.; Mandell, Arnold J. - Application of Entropy Measurements Derived from the Ergodic Theory of Dynamical Systems to Rat Locomotor Behaviour - 1990
Peroutka SJ - Recreational Use of MDMA - 1990
Piercey MF, Lum JT, Palmer JR - Effects of MDMA ("ecstasy") on Firing Rates of Seroronergic, Dopaminergic, and Noradrenergic Neurons in the Rat. - 1990
Price LH, Krystal JH, Heninger GR, Ricaurte GA - In Reply - 1990
Scheffel U, Ricaurte GA - Paroxetine as an in vivo Indicator of 3,4-Methylenedioxymethamphetamine Neurotoxicity: A Presynaptic Serotonergic Positron Emission Tomography Ligand? - 1990
Shulgin AT - How Similar is Substantially Similar? - 1990
Shulgin AT - History of MDMA - 1990
Wagner J, Peroutka SJ - Neurochemistry and Neurotoxicity of Substituted Amphetamines - 1990
Whitaker-Azmitia PM, Azmitia EC - A Tissue Culture Model of MDMA Toxicity - 1990
White HS, Bunker CF, Gibb JW, Hanson GR - Characterization of Seizures Induced by I.C.V. Administration of Cocaine, Methamphetamine and 4-Methylaminorex (4-MAX) - 1990
Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA - Identification of Metabolites of 3,4-Methylenedioxymethamphetamine in Rats - 1990
anonymous - Ecstasy und Cadillac - Nov 12,1990
anonymous - Anedridi Asit Asitik - Sep 3,1990
Azmitia EC, Murphy RB, Whitaker-Azmitia PM - MDMA (Ecstasy) Effects on Cultured Serotonergic Neurons: Evidence for Ca2(+)-Dependent Toxicity Linked to Release - 1990
Beck J, Rosenbaum M - The Scheduling of MDMA ('Ecstasy') - 1990
Bilsky EJ, Hui YZ, Hubbell CL, Reid LD - Methylenedioxymethamphetamine's Capacity to Establish Place Preferences and Modify Intake of an Alcoholic Beverage - 1990
Callaway CW, Wing LL, Geyer MA - Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats - 1990
Cho AK, Hiramatsu M, Distenfamo EW, Chang AS, Jenden DJ - Stereochemical Differences in the Metabolism of 3,4-Methylenedioxymethamphetamine In Vivo and In Vitro: A Pharmacokinetic Analysis - 1990
Cody JT - Detection of D,L-Amphetamine, D,L-Methamphetamine, and Illicit Amphetamine Analogs Using Diagnostic Products Corporation's Amphetamine and Methamphetamine Radioimmunoassay - 1990
Cody JT - Cross-Reactivity of Amphetamine Analogues with Roche Abuscreen Radioimmunoassay Reagents - 1990
Davies JB, Ditton J - The 1990s: decade of the stimulants? - 1990
De Souza EB, Battaglia G, Insel TR - Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies - 1990
Evans SM, Zacny JP, Johanson CE - Three-Choice Discrimination Among (+)-Amphetamine, Fenfluramine and Saline in Pigeons - 1990
Finnegan KT, Skratt JJ, Irwin I, Langston JW - The N-methyl-D-Aspartate (NMDA) Receptor Antagonist, Dextrorphan, Prevents the Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in Rats - 1990
Fitzgerald JL, Reid JJ - Effects of Methylenedioxymethamphetamine on the Release of Monoamines from Rat Brain Slices - 1990
Fitzgerald RL, Blanke RV, Poklis A - Stereoselective Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in the Rat - 1990
Gaylor DW, Slikker W Jr - Risk assessment for neurotoxic effects - 1990
Gibb JW, Johnson M, Hanson GR - Neurochemical Basis of Neurotoxicity - 1990
Gibb JW, Johnson M, Stone D, Hanson GR - MDMA: Historical Perspectives - 1990
Greer GR,Tolbert R - The Therapeutic Use of MDMA - 1990
Grob C, Bravo G, Walsh R - Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity - 1990
Hashimoto K, Goromaru T - Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine - 1990
Hashimoto K, Goromaru T - Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine - 1990
Hekmatpanah CR, Peroutka SJ - 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents - 1990
Hiramatsu M, Cho AK - Enantiomeric Differences in the Effects of 3,4-Methylenedioxymethamphetamine on Extracellular Monoamines and Metabolites in the Striatum of Freely-Moving Rats: An In Vivo Microdialysis Study - 1990
Hiramatsu M, Kumagai Y, Unger SE, Cho AK - Metabolism of Methylenedioxymethamphetamine: Formation of Dihydroxymethamphetamine and a Quinone Identified as Its Glutathione Adduct - 1990
Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE - Behavioral, Biochemical and Neurotoxicological Actions of the alpha-ethyl Homologue of p-Chloroamphetamine - 1990
Kosten TR - Neurobiology of abused drugs. Opioids and stimulants - 1990
Kunsman GW, Manno JE, Cockerham KR, Manno BR - Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine - 1990
McKenna DJ, Peroutka SJ - Neurochemistry and Neurotoxicity of 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') - 1990
Meilman PW, Gaylor MS, Turco JH, Stone JE - Drug use among college undergraduates: current use and 10-year trends - 1990
Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA - Neurotoxicity of MDMA and Related Compounds: Anatomic Studies - 1990
Nash JF - Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis - 1990
Nash JF, Meltzer HY, Gudelsky GA - Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens - 1990
Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM - Nonneurotoxic Tetralin and Indan Analogues of 3,4-(Methylenedioxy)amphetamine (MDA) - 1990
Nichols DE, Oberlender R - Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs? - 1990
Oberlender R, Nichols DE - (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-Methylenedioxy-methamphetamine-like Behavioral Activity - 1990
Paulus MP, Geyer MA, Gold LH, Mandell AJ - Application of Entropy Measures Derived from the Ergodic Theory of Dynamical Systems to Rat Locomotor Behavior - 1990
Piercey MF, Lum JT, Palmer JR - Effects of MDMA ('Ecstasy') on Firing Rates of Serotonergic, Dopaminergic, and Noradrenergic Neurons in the Rat - 1990
Poland RE - Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats - 1990
Ricaurte GA, Finnegan KT, Irwin I, Langston JW - Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations - 1990
Scheffel U, Ricaurte GA - Paroxetine as an In Vivo Indicator of 3,4-Methylenedioxymethamphetamine Neurotoxicity: A Presynaptic Serotonergic Positron Emission Tomography Ligand? - 1990
Schmidt CJ, Abbate GM, Black CK, Taylor VL - Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats - 1990
Schmidt CJ, Black CK, Abbate GM, Taylor VL - Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine - 1990
Schmidt CJ, Black CK, Taylor VL - Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine - 1990
Schmidt CJ, Kehne JH - Neurotoxicity of MDMA: neurochemical effects - 1990
Schmidt CJ, Taylor VL - Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors - 1990
Seiden LS - MDMA and Related Compounds: Session Summary - 1990
Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK - 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan - 1990
Teitler M, Leonhardt S, Appel NM, De Souza EB, Glennon RA - Receptor Pharmacology of MDMA and Related Hallucinogens - 1990
Verweij AM - Clandestine manufacture of 3,4-methylenedioxymethylamphetamine (MDMA) by low pressure reductive amination. A mass spectrometric study of some reaction mixtures - 1990
Winslow JT, Insel TR - Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine - 1990
Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA - Identification of Metabolites of 3,4-Methylenedioxymethamphetamine in Rats - 1990
Zacny JP, Virus RM, Woolverton WL - Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine - 1990
Beebe, Diane K.; Walley, Elizabeth - Substance Abuse: The Designer Drugs - May 1991
Bilsky EJ, Reid LD - MDL-72222, A Serotonin 5-HT3 Receptor Antagonist, Blocks MDMA's Ability to Establish a Conditioned Place Preference - 1991
Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA - Amphetamine Derivatives Induce Locomotor Hyperactivity by Acting as Indirect Serotonin Agonists - 1991
Callaway CW, Nichols DE, Paulus MP, Geyer MA - Serotonin Release is Responsible for the Locomotor Hyperactivity in Rats Induced by Derivatives of Amphetamine Related to MDMA - 1991
Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, Kennedy K, Schram K - Controlled Clinical Trial of Cannabidiol in Huntington's Disease - 1991
Darney KJ, Lewis MH, Brewster WK, Nichols DE, Mailman RB - Behavioral Effects in the Rat of Dihydrexidine, A High Potency Full Efficacy D1 Dopamine Receptor Agonist - 1991
Dornan WA, Katz JL, Ricaurte GA - The Effects of Repeated Administration of MDMA on the Expression of Sexual Behaviour in the Male Rat - 1991
Elsworth JD, Lawrence MS, Roth RH, Taylor JR, Mailman RB, Nichols DE, Lewis MH, Redmond DE Jr. - D1 and D2 Dopamine Receptors Independently Regulate Spontaneous Blink Rate in the Vervet Monkey - 1991
Gan, Ber K.; Baugh, Diane; Liu, Ray H.; Walia, Amrik S. - Simultaneous Analysis of Amphetamine, Methamphetamine, and 3,4-Methylenedioxymethamphetamine (MDMA) in Urine Samples by Solid-phase Extraction, Derivatization, and Gas Chromatography/Mass Spectrometry - 1991
Glennon RA - Phenylalkylamine Stimulants, Hallucinogens, and Designer Drugs - 1991
Gordon CJ, Watkinson WP, O'Callaghan JP, Miller BD - Effects of 3,4-Methylenedioxymethamphetamine on Autonomic Thermoregulatory Responses of the Rat - 1991
Gough B, Ali SF, Slikker W, Holson RR - Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Monoamines in Rat Caudate - 1991
Hoffman BJ, Mezey E, Brownstein MJ - Cloning of a Serotonin Transporter Affected by Antidepressants - 1991
Huang X, Johnson, MP Nichols DE - Reduction in Brain Serotonin Markers by alpha-Ethyltryptamine (Monase) - 1991
Johnson MP Huang X, Nichols DE - Serotonin Neurotoxicity in Rats After Combined Treatment With a Dopaminergic Agent Followed by a Non-Neurotoxic 3,4-Methylenedioxymethamphetamine (MDMA) Analogue - 1991
Johnson MP, Conarty PF, Nichols DE - [3H]-Monoamine Releasing and Uptake Inhibition Properties of 3,4-Methylene-dioxymethamphetamine and p-Chloroamphetamine Analogues - 1991
Johnson MP, Nichols DE - Combined Administration of a Non-Neurotoxic 3,4-Methylenedioxymethamphetamine Analogue with Amphetamine Produces Serotonin Neurotoxicity in Rats - 1991
Johnson MP, Conarty PF, Nichols DE - [3H]Monoamine Releasing and Uptake Inhibition Properties of 3,4-Methylenedioxymethamphetamine and p-Chloroamphetamine Analogues. - 1991
Johnson MP, Huang X, Nichols DE - Serotonin Neurotoxicity in Rats After Combined Treatment with a Dopaminergic Agent Followed by a Nonneurotoxic 3,4-Methylenedioxymethamphetamine (MDMA) Analogue. - 1991
Johnson M, Bush LG, Gibb JW, Hanson GR - Blockade of the 3,4-Methylenedioxymethamphetamine-Induced Changes in Neurotensin and Dynorphin A Systems. - 1991
Johnson MP, Frescas SP, Oberlender R, Nichols DE - Synthesis and Pharmacological Examination of 1-(3-Methoxy-4-methylphenyl)-2-aminopropane and 5-Methoxy-6-methyl-2-aminoindane: Similarities to 3,4-Methylenedioxymeth-amphetamine (MDMA). - 1991
Kumagai Y, Wickham KA, Schmitz DA, Cho AK - Metabolism of Methylenedioxyphenyl Compounds by Rabbit Liver Preparations. Participation of Different Cytochrome P450 Isozymes in the Demethylenation Reaction - 1991
Lovenberg TW, Roth RH, Nichols DE, Mailman RB - D1 Dopamine Receptors of NS20Y Neuroblastoma Cells Are Functionally Similar to Rat Striatal D1 Receptors - 1991
Lovenberg TW, Nichols DE, Nestler EJ, Roth RH, Mailman RB - Guanine Nucleotide Binding Proteins and the Regulation of Cyclic AMP Synthesis in NS20Y Neuroblastoma Cells: Role of Dl Dopamine and Muscarinic Receptors - 1991
MP Johnson, DE Nichols - Combined Administration of a Non-Neurotoxic 3,4-Methylenedioxymethamphetamine Analogue with Amphetamine Produces Serotonin Neurotoxicity in Rats - 1991
MP Johnson, SP Frescas, R Oberlender, DE Nichols - Synthesis and Pharmacological Examination of 1-(3-Methoxy-4-methylphenyl)-2-aminopropane and 5-Methoxy-6-methyl-2-aminoindan: Similarities to 3,4-Methylenedioxymethamphetamine (MDMA) - 1991
Markovich RJ, Qiu XX, Invergo B, Nichols DE, Alvarez FM, Pidgeon C - Silica Subsurface Amine Effect on the Chemical Stability and - 1991
McCann UD, Ricaurte GA - Lasting Neuropsychiatric Sequelae of (+/-) Methylenedioxymethamphetamine ("Ecstasy") in Recreational Users - 1991
McKenna D J, Guan X -M, Shulgin A T - 3,4-Methylenedioxyamphetamine (MDA) Analogues Exhibit Differential Effects on Synaptosomeal Release of 3H-Dopamine and 3H-5-Hydroxytryptamine. - 1991
McKenna D J, Peroutka S J - Serotonin Neurotoxins: Focus on MDMA (3,4-Methylenedioxymethamphetamine, "Ecstasy"). - 1991
Nash JF, Nichols DE - Microdialysis Studies on 3,4-Methylenedioxyamphetamine and Structurally Related Analogues - 1991
Nash JF, Brodkin J - Microdialysis Studies on 3,4-Methylenedioxymethamphetamine-Induced Dopamine Release: Effect of Dopamine Uptake Inhibitors - 1991
Nash JF, Nichols DE - Microdialysis Studies on 3,4-Methylenedioxyamphetamine and Structurally Related Analogues - 1991
Nichols DE, Snyder SE, Oberlender R, Johnson M, Huang X - 2,3-Dihydrobenzofuran Analogues of Hallucinogenic Phenethylamines - 1991
Noggle, F. Taylor, Jr.; Clark, C. Randall; Andurkar, Shridhar; DeRuiter, Jack - Methods for the Analysis of 1-(3,4-Methylenedioxyphenyl)-2-Butanamine and N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-Propanamine (MDMA) - 1991
Oberlender R, Nichols DE - Structural Variation and (+)-Amphetamine-like Discriminative Stimulus Properties - 1991
Persons PE, Mayer JP, Nichols DE, Cassady JM, Smalstig EB, Clemens JA - Preliminary Evaluation of 4-(2-N,N-dialkylaminoethyl)indoles as Potential Dopamine Agonists - 1991
Rosenbaum M, Doblin R - Why MDMA Should Not Have Been Made Illegal - 1991
Schifano, Fabrizio - Chronic Atypical Psychosis Associated with MDMA ("Ecstasy") Abuse - 1991
Schmidt CJ, Black CK, Taylor VL - L-DOPA Potentiation of the Serotoninergic Deficits Due to a Single Administration of 3,4-Methylenedioxymethamphetamine, p-Chloroamphetamine or Methamphetamine to Rats. - 1991
Schmidt CJ, Vicki L, Taylor GM, Nieduzak TR - 5-HT-2 Antagonist Stereoselectivly Prevents the Neurotoxicity of 3,4-Methylenedioxymethamphetamine by Blocking the Acute Stimulation of Dopamine Synthesis: Reversal by L-DOPA. - 1991
Sharkey J, McBean D E, Kelly P A T - Alterations in Hippocampal Function Following Repeated Exposure to the Amphetamine Derivative Methylenedioxymethamphetamine ("Ecstasy"). - 1991
Steele TD, Brewster WK, Johnson MP, Nichols DE, Yim GKW - Assessment of the Role of alpha-Methylepinine in the Neurotoxicity of MDMA - 1991
Steele TD, Brewster WK, Johnson MP, Nichols DE, Yim GKW - Assessment of the Role of alpha-Methylepinine in the Neurotoxicity of MDMA. - 1991
Taylor JR, Lawrence MS, Redmond DE Jr., Elsworth JD, Roth RH, Nichols DE, Mailman RB - Dihydrexidine, a Full Dopamine Agonist, Reduces MPTP-Induced Parkinsonism in Monkeys - 1991
Vogel C, Ashby CR Jr., Pan H, Fishkin L, Minabe Y, Wang RY - Effect of 4-Methylaminorex on Midbrain Dopamine Cells - 1991
Witkin JM, Nichols DE, Terry P, Katz JL - Behavioral Effects of Selective Dopaminergic Compounds in Rats Discriminating Cocaine Injections - 1991
Yeh S Y, Hsu F-L - The Neurochemical and Stimulatory Effects of Putative Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine in Rats. - 1991
Ali SF, Chang LW, Slikker W Jr - Biogenic amines as biomarkers for neurotoxicity - 1991
Battaglia G, Sharkey J, Kuhar MJ, de Souza EB - Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography - 1991
Benazzi F, Mazzoli M - Psychiatric illness associated with 'ecstasy' - 1991
Bilsky EJ, Reid LD - MDL72222, a Serotonin 5-HT3 Receptor Antagonist, Blocks MDMA's Ability to Establish a Conditioned Place Preference - 1991
Bradberry CW, Sprouse JS, Sheldon PW, Aghajanian GK, Roth RH - In vitro microdialysis: a novel technique for stimulated neurotransmitter release measurements - 1991
Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA - Amphetamine Derivatives Induce Locomotor Hyperactivity by Acting as Indirect Serotonin Agonists - 1991
Chadwick IS, Curry PD, Linsey A, Freemont AJ, Doran B - Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia - 1991
Champney TH, Matthews RT - Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats - 1991
Creighton FJ, Black DL, Hyde CE - 'Ecstasy' psychosis and flashbacks - 1991
Dornan WA, Katz JL, Ricaurte GA - The Effects of Repeated Administration of MDMA on the Expression of Sexual Behavior in the Male Rat - 1991
Dragunow M, Logan B, Laverty R - 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801 - 1991
Fukuto JM, Kumagai Y, Cho AK - Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects - 1991
Gan BK, Baugh D, Liu RH, Walia AS - Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry - 1991
Garrett ER, Seyda K, Marroum P - High performance liquid chromatographic assays of the illicit designer drug 'Ecstasy', a modified amphetamine, with applications to stability, partitioning and plasma protein binding - 1991
Glennon RA - Discriminative Stimulus Properties of Hallucinogens and Related Designer Drugs - 1991
Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB - Effects of 3,4-Methylenedioxymethamphetamine on Autonomic Thermoregulatory Responses of the Rat - 1991
Gough B, Ali SF, Slikker W Jr, Holson RR - Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Monoamines in Rat Caudate - 1991
Hiramatsu M, DiStefano E, Chang AS, Cho AK - A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates - 1991
Huang XM, Johnson MP, Nichols DE - Reduction in Brain Serotonin Markers by alpha-Ethyltryptamine (Monase) - 1991
Johnson M, Bush LG, Gibb JW, Hanson GR - Blockade of the 3,4-Methylenedioxymethamphetamine-Induced Changes in Neurotensin and Dynorphin A Systems - 1991
Johnson MP, Conarty PF, Nichols DE - [3H]Monoamine Releasing and Uptake Inhibition Properties of 3,4-Methylenedioxymethamphetamine and p-Chloroamphetamine Analogues - 1991
Johnson MP, Frescas SP, Oberlender R, Nichols DE - Synthesis and Pharmacological Examination of 1-(3-Methoxy-4-methylphenyl)-2-aminopropane and 5-Methoxy-6-methyl-2-aminoindan: Similarities to 3,4-(Methylenedioxy)methamphetamine (MDMA) - 1991
Johnson MP, Huang XM, Nichols DE - Serotonin Neurotoxicity in Rats after Combined Treatment with a Dopaminergic Agent Followed by a Nonneurotoxic 3,4-Methylenedioxymethamphetamine (MDMA) Analogue - 1991
Kumagai Y, Lin LY, Schmitz DA, Cho AK - Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds - 1991
Lim HK, Foltz RL - In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques - 1991
McCann UD, Ricaurte GA - Lasting Neuropsychiatric Sequelae of (+-)Methylenedioxymethamphetamine ('Ecstasy') in Recreational users - 1991
McCann UD, Ricaurte GA - Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons - 1991
McGuire P, Fahy T - Chronic paranoid psychosis after misuse of MDMA ('ecstasy') - 1991
McKenna DJ, Guan XM, Shulgin AT - 3,4-Methylenedioxyamphetamine (MDA) Analogues Exhibit Differential Effects on Synaptosomal Release of 3H-Dopamine and 3H-5-Hydroxytryptamine - 1991
Millan MJ, Colpaert FC - Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors - 1991
Nash JF, Arora RC, Schreiber MA, Meltzer HY - Effect of 3,4-Methylenedioxymethamphetamine on [3H]Paroxetine Binding in the Frontal Cortex and Blood Platelets of Rats - 1991
Nash JF, Brodkin J - Microdialysis Studies on 3,4-Methylenedioxymethamphetamine-Induced Dopamine Release: Effect of Dopamine Uptake Inhibitors - 1991
Nash JF, Nichols DE - Microdialysis Studies on 3,4-Methylenedioxyamphetamine and Structurally Related Analogues - 1991
Nichols DE, Johnson MP, Oberlender R - 5-Iodo-2-aminoindan, a Nonneurotoxic Analogue of p-Iodoamphetamine - 1991
Noggle FT Jr, Clark CR, Andukar S, DeRuiter J - Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA) - 1991
Pan HS, Wang RY - The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system - 1991
Pan HS, Wang RY - MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system - 1991
Park WK, Azmitia EC - 5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat brain synaptosomes - 1991
Paulus MP, Geyer MA - A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants - 1991
Rattray M - Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA - 1991
Ruttenber AJ - Stalking the elusive designer drugs: Techniques for monitoring new problems in drug abuse - 1991
Schechter MD - Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination - 1991
Schechter MD - Effect of serotonin depletion by p-chlorophenylalanine upon discriminative behaviours - 1991
Schifano F - Chronic atypical psychosis associated with MDMA ('ecstasy') abuse - 1991
Schmidt CJ, Taylor VL, Abbate GM, Nieduzak TR - 5-HT2 Antagonists Stereoselectively Prevent the Neurotoxicity of 3,4-Methylenedioxymethamphetamine by Blocking the Acute Stimulation of Dopamine Synthesis: Reversal by L-dopa - 1991
Sharkey J, McBean DE, Kelly PA - Alterations in Hippocampal Function Following Repeated Exposure to the Amphetamine Derivative Methylenedioxymethamphetamine ('Ecstasy') - 1991
St Omer VEV, Ali SF, Holson RR, Duhart HM, Scalzo FM, Slikker W Jr - Behavioral and Neurochemical Effects of Prenatal Methylenedioxymethamphetamine (MDMA) Exposure in Rats - 1991
Steele TD, Brewster WK, Johnson MP, Nichols DE, Yim GK - Assessment of the Role of alpha-Methylepinine in the Neurotoxicity of MDMA - 1991
Watson L, Beck J - New age seekers: MDMA use as an adjunct to spiritual pursuit - 1991
Winslow JT, Insel TR - Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists - 1991
Winstock AR - Chronic paranoid psychosis after misuse of MDMA - 1991
Yeh SY, Hsu FL - The Neurochemical and Stimulatory Effects of Putative Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine in Rats - 1991
Broadbent JJ, Appel JB, Michael EK, Ricker JHJ - Discriminative Stimulus Effects of the Optical Isomers of 3,4-Methylenedioxyamphetamine (MDA) - 1992
Callaway C W, Rempel N, Peng R Y, Geyer M A - Serotonin 5-HT1-Like Receptors Mediate Hyperactivity in Rats Induced by 3,4-Methylenedioxymethamphetamine. - 1992
Callaway C W, Geyer M A - Stimulant Effects of 3,4-Methylenedioxymethamphetamine in the Nucleus Accumbens of Rat. - 1992
Callaway C W, Geyer M A - Tolerance and Cross-Tolerance to the Activating Effects of 3,4-Methylendioxymethamphetamine and a 5-Hydroxytryptamine1B Agonist. - 1992
de Silva RN, Harries DP - Misuse of Ecstasy - 1992
Elayan I, Gibb JW, Hanson GR, Foltz RL, Lim HK, Johnson M - Long-term Alteration in the Central Monoaminergic Systems of the Rat by 2,4,5-Trihydroxyamphetamine but not by 2-Hydroxy-4,5-Methylenedioxymethamphetamine or 2-Hydroxy-4,5-Methylenedioxyamphetamine. - 1992
Glennon RA, Higgs R - Investigation of MDMA-Related Agents in Rats Trained to Discriminate MDMA from Saline - 1992
Glennon RA, Higgs R, Young R, Issa H - Further Studies on N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane as a Discriminative Stimulus: Antagonism by 5-Hydroxytryptamine3 Antagonists. - 1992
Hanson, Glen R.; Bunker, Carolyn F.; Johnson, Michel; Bush, Lloyd; Gibb, James W. - Response of Nonoaminergic and Neuropeptide Systems to 4-Methylaminorex: A New Drug of Abuse - 1992
Harries DP, de Silva RN - 'Ecstasy' and Intracerebral Haemorrhage - 1992
Hashimoto K, Maeda H, Goromaru T - Antagonism of 3,4-Methylenedioxymethamphetamine-induced Neurotoxicity in Rat Brain by 1-Piperonylpiperazine - 1992
Helmlin, Hans-Jorg; Brenneisen, Rudolf - Determination of Psychotropic Phenylalkylamine Derivatives in Biological Matrices by High-performance Liquid Chromatography with Photodiode-array Detection - 1992
Huang X, Marona-Lewicka D, Nichols DE - Para-methylthioamphetamine is a Potent New Nonneurotoxic Serotonin-releasing Agent - 1992
Johnson M, Mitros K, Stone D M, Zobrist R, Hanson G R, Gibb J W - Effect of Flunarizine and Nimodipine on the Decrease in Tryptophan Hydroxylase Activity Induced by Methamphetamine and 3,4-Methylenedioxymethamphetamine. - 1992
Johnson M, Elayan I, Hanson G R, Foltz R L, Gibbs J W, Lim H K - Effects of 3,4-Dihydroxymethamphetamine and 2,4,5-Trihydroxymethamphetamine, Two Metabolites of 3,4-Methylenedioxymethamphetamine, on Central Serotonergic and Dopaminergic Systems. - 1992
Johnson M, Bush L G, Midgley L, Gibb J W, Hanson G R - MK-801 Blocks the Changes in Neurotensin Concentrations Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine, Cocaine, and GBR 12909. - 1992
Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ - Effects of the Serotonin Releasers 3,4-Methylenedioxymethamphetamine (MDMA), 4-Chloroamphetamine (PCA) and Fenfluramine on Acoustic and Tactile Startle Reflexes in Rats - 1992
Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR - Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function? - 1992
Leuner, Hanscarl; Schlichting, Michael - Uber den Derzeitigen Stand der Forschung auf dem Gebiet der Psychoaktiven Substanzen [About the Current Status of Research in Psychoactive Substances] - 1992
Lin L, Kumagai Y, Cho AK - Enzymatic and Chemical Demethylenation of (Methylenedioxy)amphetamine and (Methylenedioxy)methamphetamine by Rat Brain Microsomes - 1992
Marchant NC, Breen MA, Wallace D, Bass S, Taylor AR, Ings RM, Campbell DB, Williams J - Comparative Biodisposition and Metabolism of 14C-(+/-)-Fenfluramine in Mouse, Rat, Dog and Man - 1992
McCann UD, Ricaurte GA - MDMA ("Ecstasy") and Panic Disorder: Induction by a Single Dose - 1992
Mottola DM, Brewster WK, Cook LL, Nichols DE, Mailman RB - Dihydrexidine, A Novel Full Efficacy D1 Dopamine Receptor Agonist - 1992
Paulus M P, Geyer M A - The Effects of MDMA and Other Methylenedioxy-substituted Phenylalkylamines on the Structure of Rat Locomotor Activity. - 1992
Oberlender R, Pfaff, RC Johnson MP, Huang X, Nichols DE - Stereoselective LSD-Like Activity in d-Lysergic Acid Amides of R- and S2-Aminobutane - 1992
Randall T - Ecstasy-Fuelled 'Rave" Parties Become Dances of Death for English Youths. - 1992
Randall, Teri - 'Rave' Scene, Ecstasy Use, Leap Atlantic - 1992
Ricaurte GA, McCann UD - Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans - 1992
Ricaurte GA, Marletto AL, Katz JL, Marletto MB - Lasting Effects of (+/-)-3,4-Methylenedioxymethamphetamine (MDMA) on Ventral Serotonergic Neurons in Nonhuman Primates: Neurochemical Observations - 1992
Rohrig TP, Prouty RW - Tissue Distribution of Methylenedioxymethamphetamine - 1992
Rudnick, Gary; Wall, Stephen C. - The Molecular Mechanism of "Ecstasy" [3,4-Methylenedioxymethamphetamine(MDMA)]: Serotonin Transporters are Targets for MDMA-Induced Serotonin Release - 1992
Russell ARB, Schwartz RH, Dawling S - Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine) - 1992
Scheffel U, Lever JR, Stathis M, Ricaurte GA - Repeated Administration of MDMA Causes Transient Down-Regulation of Serotonin 5-HT2 Receptors - 1992
Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL - 5-HT2-Receptors Exert a State-Dependent Regulation of Dopaminergic Function - Studies with MDL-100,907 and the Amphetamine Analogue, 3,4-Methylenedioxymethamphetamine - 1992
Screaton GR, Cairns HS, Sarner M, Singer M, Thrasher A, Cohen SL - Hyperpyrexia and Rhabdomyolysis after MDMA ("Ecstasy") Abuse. - 1992
Stafford, Peter - [reference to MDMA] in Chapter 5: Nutmeg and MDA - 1992
Sternbach G L, Varon J - Designer Drugs. - 1992
Tomaszewski Z, Johnson MP, Huang X, Nichols DE - Benzofuran Bioisosteres of Hallucinogenic Tryptamines - 1992
Yensen, Richard - Vom Mysterium zum Paradigma: Die Reise des Menschen von heiligen Pflanzen zu psychedelischen Drogen [From Mysteries to Paradigms: Humanity's Journey From Sacred Plants to Psychedelic Drugs] - 1992
Zhao Z, Castagnoli Jr. N, Ricaurte G A, Steele T, Martello M - Synthesis and Neurotoxicological Evaluation of Putative Metabolites of the Serotoninergic Neurotoxin 2-(Methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(Methylenedioxy)methamphetamine] - 1992
Abbott A, Concar D - A trip into the unknown - 1992
Russell ARB, Schwartz RH, Dawling S - Accidental Ingestion of 'Ecstasy' (3,4-Methylenedioxymethylamphetamine) - 1992
Berger UV, Gu XF, Azmitia EC - The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine - 1992
Callaway CW, Geyer MA - Tolerance and Cross-tolerance to the Activating Effects of 3,4-Methylenedioxymethamphetamine and a 5-Hydroxytryptamine1B Agonist - 1992
Callaway CW, Geyer MA - Stimulant Effects of 3,4-Methylenedioxymethamphetamine in the Nucleus Accumbens of Rat - 1992
Callaway CW, Rempel N, Peng RY, Geyer MA - Serotonin 5-HT1-like Receptors Mediate Hyperactivity in Rats Induced by 3,4-Methylenedioxymethamphetamine - 1992
de Silva RN, Harries DP - Misuse of Ecstasy - 1992
Elayan I, Gibb JW, Hanson GR, Foltz RL, Lim HK, Johnson M - Long-term Alteration in the Central Monoaminergic Systems of the Rat by 2,4,5-Trihydroxyamphetamine But Not by 2-Hydroxy-4,5-methylenedioxymethamphetamine or 2-Hydroxy-4,5-methylenedioxyamphetamine - 1992
Fahal IH, Sallomi DF, Yaqoob M, Bell GM - Acute renal failure after ecstasy - 1992
Farfel GM, Vosmer GL, Seiden LS - The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine - 1992
Glennon RA, Higgs R - Investigation of MDMA-related Agents in Rats Trained to Discriminate MDMA from Saline - 1992
Glennon RA, Higgs R, Young R, Issa H - Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists - 1992
Gouzoulis E, Steiger A, Ensslin M, Kovar A, Hermle L. - Sleep EEG Effects of 3,4-Methylenedioxyethamphetamine (MDE; "Eve" in Healthy Volunteers - 1992
Grob CS, Bravo GL, Walsh RN, Liester MB - The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs - 1992
Harries DP, de Silva R - 'Ecstasy' and Intracerebral Haemorrhage - 1992
Hashimoto K, Maeda H, Goromaru T - Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain - 1992
Hashimoto K, Maeda H, Goromaru T - Antagonism of 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain by 1-Piperonylpiperazine - 1992
Helmlin, Hans-Jorg; Brenneisen, Rudolf - Determination of Psychotropic Phenylalkylamine Derivatives in Biological Matrices by High-Performance Liquid Chromatography with Photodiode-Array Detection - 1992
Henry JA - Ecstasy and the dance of death - 1992
Henry JA, Jeffreys KJ, Dawling S - Toxicity and Deaths from 3,4-Methylenedioxymethamphetamine ('Ecstasy') - 1992
Hermle L, Funfgeld M, Oepen G, Botsch H, Borchardt D, Gouzoulis E, Fehrenbach RA, Spitzer M - Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research - 1992
Herndon JL, Pierson ME, Glennon RA - Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine - 1992
Huang X, Marona-Lewicka D, Nichols DE - p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Releasing Agent - 1992
Johnson M, Elayan I, Hanson GR, Foltz RL, Gibb JW, Lim HK - Effects of 3,4-Dihydroxymethamphetamine and 2,4,5-Trihydroxymethamphetamine, Two Metabolites of 3,4-Methylenedioxymethamphetamine, On Central Serotonergic and Dopaminergic Systems - 1992
Johnson M, Mitros K, Stone DM, Zobrist R, Hanson GR, Gibb JW - Effect of Flunarizine and Nimodipine on the Decrease in Tryptophan Hydroxylase Activity Induced by Methamphetamine and 3,4-Methylenedioxymethamphetamine - 1992
Jones C, Dickinson P - Substance abuse. From ecstasy to agony - 1992
Kaskey GB - Possible interaction between an MAOI and 'ecstasy' - 1992
Kehne JH, McCloskey TC, Taylor VL, Black CK, Faydayel GM, Schmidt CJ - Effects of the Serotonin Releasers 3,4-Methylenedioxymethamphetamine (MDMA), 4-Chloroamphetamine (PCA) and Fenfluramine on Acoustic and Tactile Startle Reflexes in Rats - 1992
Kosten TR, Price LH - Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [Commentary] - 1992
Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR - Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function? - 1992
Kumagai Y, Schmitz DA, Cho AK - Aromatic hydroxylation of methylenedioxybenzene (MDB) and methylenedioxymethamphetamine (MDMA) by rabbit liver microsomes - 1992
Lehmann J, DeSouza EB, Culp S, Zaczek R - Regional distribution to recovery of 5-HT levels after administration of 'atrophins' MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine - 1992
Liester MB, Grob CS, Bravo GL, Walsh RN - Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use - 1992
Lim HK, Zeng S, Foltz RL - Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatography-mass spectrometry assay based on perfluorotributylamine-enhanced ammonia positive ion chemical ionization - 1992
Lin LY, Kumagai Y, Cho AK - Enzymatic and Chemical Demethylenation of (Methylenedioxy)amphetamine and (Methylenedioxy)methamphetamine by Rat Brain Microsomes - 1992
McCann UD, Ricaurte GA - MDMA ('Ecstasy') and Panic Disorder: Induction by a Single Dose - 1992
McGuire P, Fahy T - Flashbacks following MDMA - 1992
Nash JF, Yamamoto BK - Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine - 1992
Pallanti S, Mazzi D - MDMA (Ecstasy) precipitation of panic disorder - 1992
Paris JM, Cunningham KA - Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA) - 1992
Paulus MP, Geyer MA - The Effects of MDMA and other Methylenedioxy-substituted Phenylalkylamines on the Structure of Rat Locomotor Activity - 1992
Preston A - Pointing out the Risk - 1992
Randall, Teri - Ecstasy-Fueled 'Rave' Parties Become Dances of Death For English Youths - 1992
Randall, Teri - 'Rave' Scene, Ecstasy Use, Leap Atlantic - 1992
Rezvani AH, Garges PL, Miller DB, Gordon CJ - Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats - 1992
Ricaurte GA, Martello AL, Katz JL, Martello MB - Lasting Effects of (+-)-3,4-Methylenedioxymethamphetamine (MDMA) on Central Serotonergic Neurons in Nonhuman Primates: Neurochemical Observations - 1992
Ricaurte GA, McCann UD - Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans - 1992
Rittoo DB, Rittoo D - Complications of 'ecstasy' misuse - 1992
Rohrig TP, Prouty RW - Tissue Distribution of Methylenedioxymethamphetamine - 1992
Rudnick, Gary; Wall, Stephen C. - The Molecular Mechanism of 'Ecstasy' [3,4-Methylenedioxymethamphetamine (MDMA)]: Serotonin Transporters are Targets for MDMA-Induced Serotonin Release - 1992
Scheffel U, Lever JR, Stathis M, Ricaurte GA - Repeated Administration of MDMA Causes Transient Down-Regulation of Serotonin 5-HT2 Receptors - 1992
Schmidt CJ, Black CK, Taylor VL, Fadayel GM, Humphreys TM, Nieduzak TR, Sorensen SM - The 5-HT2 Receptor Antagonist, MDL 28,133A, Disrupts the Serotonergic-Dopaminergic Interaction Mediating the Neurochemical Effects of 3,4-Methylenedioxymethamphetamine - 1992
Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL - 5-HT2 Receptors Exert a State-Dependent Regulation of Dopaminergic Function: Studies with MDL 100,907 and the Amphetamine Analogue, 3,4-Methylenedioxymethamphetamine - 1992
Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL - Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse - 1992
Solowij N, Hall W, Lee N - Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug - 1992
Steele TD, Katz JL, Ricaurte GA - Evaluation of the Neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-Methoxymethamphetamine, PMMA) - 1992
Sternbach GL, Varon J - 'Designer Drugs'. Recognizing and Managing Their Toxic Effects - 1992
Teggin AF - Ecstasy--a dangerous drug - 1992
Thurman EM, Pedersen MJ, Stout RL, Martin T - Distinguishing Sympathomimetic Amines from Amphetamine and Methamphetamine in Urine by Gas Chromatography/Mass Spectrometry - 1992
Zhao ZY, Castagnoli N Jr, Ricaurte GA, Steele T, Martello M - Synthesis and Neurotoxicological Evaluation of Putative Metabolites of the Serotonergic Neurotoxin 2-(Methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine] - 1992
Allen RP, McCann UD, Ricaurte GA - Persistant Effects of (+/-)3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") on Human Sleep - 1993
Ames D, Wirshing WC - Ecstasy, the Serotonin Syndrome, and Neuroleptic Malignant Syndrome - A Possible Link - 1993
Callaway CW, Wing LL, Nichols DE, Geyer MA - Suppression of Behavioral Activity by Norfenfluramine and Related Drugs is Not Mediated by Serotonin Release - 1993
Cody JT, Schwartzhoff R - Fluorescence Polarizatrion Immunoassay Detection of Amphetamine, Methamphetamine, and Illicit Amphetamine Analogues - 1993
Cody JT, Schwarzhoff R - Fluorescence Polarization Immunoassay Detection of Amphetamine, Methamphetamine, and Illicit Amphetamine Analogues - 1993
Elayan I, Gibb J W, Hanson G R, Lim H K, Foltz R L, Johnson M - Short-Term Effects of 2,4,5-Trihydroxyamphetamine, 2,4,5-Trihydroxymethamphetamine and 3,4-Dihydroxymethamphetamine on Central Tryptophan Hydroxylase Acticity. - 1993
Finnegan KT, Calder L, Clikeman J, Wei S, Karler R - Effects of L-type Calcium Channel Antagonists on the Serotonin-depleting Actions of MDMA in Rats - 1993
Friedman R - Ecstasy, the Serotonin Syndrome, and Neuroleptic Malignant Syndrome - A Possible Link. Reply. - 1993
Gibb JW, Johnson M, Stone DM, Hanson GR - Mechanisms Mediating Biogenic Amine Deficits Induced by Amphetamine and Its Congeners - 1993
Glennon R A - MDMA-Like Stimulus Effects of Alpha-Ethyltryptamine and the Alpha-Ethyl Homolog of DOM. - 1993
Hashimoto K - Effects of Benzylpiperazine Derivatives on the Acute Effects of 3,4-Methylenedioxymethamphetamine in Rat Brain - 1993
Hashimoto, Kenji; Maeda, Harumi; Hirai, Katsumi; Goromaru, Tsuyoshi - Drug Effects on Distribution of [3H]3,4-Methylenedioxymethamphetamine in Mice - 1993
Huang X, Nichols DE - 5-HT2 Receptor-Mediated Potentiation of Dopamine Synthesis and Central Serotonergic Deficits - 1993
Huang X, Nichols D - 5-HT2 Receptor-Mediated Potentiation of Dopamine Synthesis and Central Serotonergic Deficits. - 1993
Hughes J C, McCabe M, Evans R J - Intracranial Haemorrhage Associated with Ingestion of 'Ecstasy.' - 1993
Jensen K F, Olin J, Haykal-Coates N, O'Callaghan J, Miller D B, de Olmos J S - Mapping Toxicant-Induced Nervous System Damage With Cupric Silver Stain: A Quantitative Analysis of Neural Degeneration Induced by 3,4-Methylenedioxymethamphetamine. - 1993
Kohli JD, Horn PT, Glock D, Brewster WK, Nichols DE - Dihydrexidine: A New Potent DA1 (Vascular) Dopamine Agonist - 1993
Krebs K M, Geyer M A - Behavioral Characterization of Alpha-Ethyltryptamine, a Tryptamine Derivative with MDMA-like Properties in Rats. - 1993
Larner AJ - Dantrolene and 'Ecstasy' Overdose - 1993
Levine AJ, Drew S, Rees GM - 'Ecstasy' Induced Pneumomediastinum - 1993
McCann UD, Ricaurte GA - Reinforcing Subjective Effects of (+/-) 3,4-Methylenedioxymethamphetamine ("Ecstasy") May Be Separable from its Neurotoxic Actions: Clinical Evidence - 1993
McCann UD, Ricaurte GA - Strategies for Detecting Subclinical Monoamine Depletions in Humans - 1993
Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE - Synthesis and Pharmacological Examination of Benzofuran, Indan, and Tetralin Analogues of 3,4-(Methylenedioxy)amphetamine (MDA) - 1993
Newmeyer J A - X at the Crossroads. - 1993
O'Neill D, Dart J K - Methylenedioxyamphetamine (Ecstasy) Associated Keratopathy. - 1993
O'Neill D, Dart JK - Methylenedioxyamphetamine ('Ecstasy') Associated Keratopathy - 1993
Rempel N L, Callaway C W, Geyer M A - Serotonin-1B Receptor Activation Mimics Behavioral Effects of Presynaptic Serotonin Release. - 1993
Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS - 3,4-Methylenedioxymethamphetamine, Serotonin, and Memory - 1993
Robinson TE, Castaneda E, Whishaw IQ - Effects of Cortical Serotonin Depletion Induced by 3,4-Methylenedioxymethamphetamine (MDMA) on Behavior, Before and After Additional Cholinergic Blockade - 1993
Rudnick G, Wall S - Non-Neurotoxic Amphetamine Derivatives Release Serotonin through Serotonin Transporters. - 1993
Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA - Serotonergic Recovery after (+/-)3,4-(Methylenedioxy)methamphetamine Injury: Observations in Rats - 1993
Schmidt CJ, Kehne JH, Carr AA, Fadayel GM, Humphreys TM, Kettler HJ, McCloskey TC, Padich RA, Taylor VL, Sorensen SM - Contribution of Serotonin Neurotoxins to Understanding Psychiatric Disorders: The Role of 5-HT2 Receptors in Schizophrenia and Antipsychotic Activity - 1993
Schuldiner S, Steiner-Mordoch S, Yelin R, Wall SC, Rudnick G - Amphetamine Derivatives Interact with Both Plasma Membrane and Secretory Vesicle Biogenic Amine Transporters - 1993
Schwartz RH - Point-Counterpoint. A Reader Writes: Speed, Ice, and Ecstasy - 1993
Watts VJ, Lawler CP, Gilmore J, Southerland SB, Nichols DE, Mailman RB - Dopamine D1 Receptors: Efficacy of Full (Dihydrexidine) vs. Partial (SKF38393) Agonists in Primates vs. Rodents - 1993
Watts VJ, Lawler CP, Knoerzer T, Mayleben MA, Neve KA, Nichols DE, Mailman RB - Hexahydrobenzo[a]phenanthridines: Novel Dopamine D3 Receptor Ligands - 1993
Webb C, Williams V - Ecstasy Intoxication: Appreciation of Complications and the Role of Dantrolene - 1993
Weil, Andrew; Rosen, Winifred - [reference to MDMA] in Chapter 8: Psychedelics, or Hallucinogens - 1993
Young R, Glennon RA - Cocaine-Stimulus Generalization to Two New Designer Drugs: Methcathinone and 4-Methylaminorex - 1993
Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR, Paule MG, Slikker W Jr - Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate - 1993
Allen RP, McCann UD, Ricaurte GA - Persistent Effects of (+/- )3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') on Human Sleep - 1993
Ames, Donna; Wirshing, William C. - Ecstasy, the Serotonin Syndrome, and Neuroleptic Malignant Syndrome--A Possible Link? - 1993
Barrett PJ - 'Ecstasy' misuse--overdose or normal dose? - 1993
Barrett PJ, Taylor GT - 'Ecstasy' ingestion: a case report of severe complications - 1993
Brodkin J, Malyala A, Nash JF - Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity - 1993
Cadier MA, Clarke JA - Ecstasy and Whizz at a rave resulting in a major burn plus complications - 1993
Colado MI, Murray TK, Green AR - 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine - 1993
Cregg MT, Tracey JA - Ecstasy abuse in Ireland - 1993
Duxbury AJ - Ecstasy--Dental Implications - 1993
Elayan I, Gibb JW, Hanson GR, Lim HK, Foltz RL, Johnson M - Short-term Effects of 2,4,5-Trihydroxyamphetamine, 2,4,5-Trihydroxymethamphetamine and 3,4-Dihydroxymethamphetamine on Central Tryptophan Hydroxylase Activity - 1993
Finnegan KT, Calder L, Clikeman J, Wei S, Karler R - Effects of L-type Calcium Channel Antagonists on the Serotonin-Depleting Actions of MDMA in Rats - 1993
Fitzgerald JL, Reid JJ - Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices - 1993
Gledhill JA, Moore DF, Bell D, Henry JA - Subarachnoid haemorrhage associated with MDMA abuse [letter] - 1993
Glennon RA - MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM - 1993
Gouzoulis E, von Bardeleben U, Rupp A, Kovar KA, Hermle L - Neuroendocrine and cardiovascular effects of MDE in healthy volunteers - 1993
Gouzoulis E, Borchardt D, Hermle L - A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam-phetamine) - 1993
Gu XF, Azmitia EC - Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons - 1993
Harvey JA, McMaster SE, Romano AG - Methylenedioxyamphetamine: Neurotoxic Effects on Serotonergic Projections to Brainstem Nuclei in the Rat - 1993
Hashimoto K - Effects of Benzylpiperazine Derivatives on the Acute Effects of 3,4-Methylenedioxymethamphetamine in Rat Brain - 1993
Hashimoto, Kenji; Maeda, Harumi; Hirai, Katsumi; Goromaru, Tsuyoshi - Drug Effects on Distribution of [3H]3,4-Methylenedioxymethamphetamine in Mice - 1993
Hornbeck CL, Czarny RJ - Retrospective analysis of some L-methamphetamine/L-amphetamine urine data - 1993
Huang X, Nichols DE - 5-HT2 Receptor-Mediated Potentiation of Dopamine Synthesis and Central Serotonergic Deficits - 1993
Hughes JC, McCabe M, Evans RJ - Intracranial Haemorrhage Associated with Ingestion of 'Ecstasy' - 1993
Jensen KF, Olin J, Haykal-Coates N, O'Callaghan J, Miller DB, Olmos JS - Mapping Toxicant-Induced Nervous System Damage With a Cupric Silver Stain: a Quantitative Analysis of Neural Degeneration Induced by 3,4-Methylenedioxymethamphetamine - 1993
Johnson M, Bush LG, Hanson GR, Gibb JW - Effects of Ritanserin on the 3,4-Methylenedioxymethamphetamine-Induced Decrease in Striatal Serotonin Concentration and on the Increase in Striatal Neurotensin and Dynorphin A Concentrations - 1993
Krebs KM, Geyer MA - Behavioral Characterization of alpha-Ethyltryptamine, a Tryptamine Derivative with MDMA-like Properties in Rats - 1993
LeSage M, Clark R, Poling A - MDMA and Memory: The Acute and Chronic Effects of MDMA in Pigeons Performing Under a Delayed-Matching-to-Sample Procedure - 1993
Lim HK, Su Z, Foltz RL - Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry - 1993
Lin HQ, Atrens DM, Christie MJ, Jackson DM, McGregor IS - Comparison of Conditioned Taste Aversions Produced by MDMA and d-Amphetamine - 1993
Logan AS, Stickle B, O'Keefe N, Hewitson H - Survival following 'Ecstasy' ingestion with a peak temperature of 42 degrees C - 1993
Manchanda S, Connolly MJ - Cerebral infarction in association with Ecstasy abuse - 1993
Maxwell DL, Polkey MI, Henry JA - Hyponatraemia and catatonic stupor after taking 'ecstasy' - 1993
McCann UD, Ricaurte GA - Reinforcing Subjective Effects of (+/-) 3,4-Methylenedioxymethamphetamine ('Ecstasy') May be Separable from Its Neurotoxic Actions: Clinical Evidence - 1993
Michel RE, Rege AB, George WJ - High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues - 1993
Miller DB, O'Callaghan JP - The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection - 1993
O'Callaghan JP, Miller DB - Quantification of Reactive Gliosis as an Approach to Neurotoxicity Assessment - 1993
Palfreyman MG, Schmidt CJ, Sorensen SM, Dudley MW, Kehne JH, Moser P, Gittos MW, Carr AA - Electrophysiological, Biochemical and Behavioral Evidence for 5-HT2 and 5-HT3 Mediated Control of Dopaminergic Function - 1993
Rempel NL, Callaway CW, Geyer MA - Serotonin1B Receptor Activation Mimics Behavioral Effects of Presynaptic Serotonin Release - 1993
Renton RJ, Cowie JS, Oon MCH - A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis - 1993
Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS - 3,4-Methylenedioxymethamphetamine, Serotonin and Memory [published erratum appears in J Pharmacol Exp Ther 1994 Jan;268(1):529] - 1993
Roberts L, Wright H - Survival following intentional massive overdose of 'Ecstasy' - 1993
Robinson TE, Castaneda E, Whishaw IQ - Effects of Cortical Serotonin Depletion Induced by 3,4-Methylenedioxymethamphetamine (MDMA) on Behavior, Before and After Additional Cholinergic Blockade - 1993
Rothwell PM, Grant R - Cerebral venous sinus thrombosis induced by 'ecstasy' - 1993
Rudnick G, Wall SC - Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serotonin Transporters - 1993
Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA - Serotonergic Recovery After (+/-)3,4-(Methylenedioxy) methamphetamine Injury: Observations in Rats - 1993
Schechter MD, Gordon TL - Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity - 1993
Schuldiner S, Steiner-Mordoch S, Yelin R, Wall SC, Rudnick G - Amphetamine Derivatives Interact with Both Plasma Membrane and Secretory Vesicle Biogenic Amine Transporters - 1993
Seiden LS, Woolverton WL, Lorens SA, Williams JEG, Corwin RL, Hata N, Olimski M - Behavioral Consequences of Partial Monoamine Depletion in the CNS After Methamphetamine-Like Drugs: The Conflict Between Pharmacology and Toxicology - 1993
Shiue CY, Shiue GG, Rysavy JA, Pleus RC, Huang H, Bai LQ, Cornish KG, Sunderland JJ, Frick MP - Fluorine-18 and Carbon-11 Labeled Amphetamine Analogs--Synthesis, Distribution, Binding Characteristics in Mice and Rats and a PET Study in Monkey - 1993
Stolaroff MJ, Wells CW - Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7 - 1993
Tirzite D, Tirzitis G, Vigante B, Duburs G - Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentrations and on the increase in stritatal neurotensin and dynorphin A concentrations - 1993
Watson JD, Ferguson C, Hinds CJ, Skinner R, Coakley JH - Exertional heat stroke induced by amphetamine analogues: Does dantrolene have a place? - 1993
Williams H, Meagher D, Galligan P - M.D.M.A. ('Ecstasy'); a Case of Possible Drug-Induced Psychosis - 1993
Batsche K, Ashby CR, Lee C, Schwartz J, Wang RY - The Behavioral Effects of the Stereoisomers of 4-Methylaminorex, a Psychostimulant, in the Rat - 1994
Huang X, Marona-Lewicka D, Pfaff RC, Nichols DE - Drug Discrimination and Receptor Binding Studies of N-Isopropyl Lysergamide Derivatives - 1994
Lader, M. - Pharmacological Standards for Evaluation of Clinical Effects of Hallucinogens. - 1994
Ladewig, Dieter - Conclusions, with Special Regard to Clinical Aspects. - 1994
Leuner, Hanscarl - Hallucinogens as an Aid in Psychotherapy: Basic Principles and Results. - 1994
Lewis MH, Gariepy JL, Gendreau P, Nichols DE, Mailman RB - Social Reactivity and D1 Dopamine Receptors: Studies in Mice Selectively Bred for High and Low Levels of Aggression - 1994
O'Brien, C. P.; Jones, R. T. - Methodological Issues in the Evaluation of a Medication for its Potential Benefits in Enhancing Psychotherapy. - 1994
O'Callaghan JP, Miller DB - Neurotoxicity Profiles of Substituted Amphetamines in the C57BL/6J Mouse - 1994
Richter, R. - Psychotherapeutic Effects. - 1994
Romano A G, Harvey J A - MDMA Enhances Associative and Nonassociative Learning in the Rabbit. - 1994
Scheffel U, Dannals RF, Suehiro M, Ricaurte GA, Carroll FI, Kuhar MJ, Wagner HN Jr - Development of PET/SPECT Ligands for the Serotonin Transporter - 1994
Schmidt C J, Sullivan C K, Fadayel G M - Blockade of Striatal 5-Hydroxytryptamine(2) Receptors Reduces the Increase in Extracellular Concentrations of Dopamine Produced by the Amphetamine Analogue 3,4-Methylenedioxymethamphetamine. - 1994
Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R - Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. - 1994
Taylor, Jon M. - MDMA Frequently Asked Questions List. - Jan 5,1994
Ward C, McNally AJ, Rusyniak D, Salamone SJ - 125I Radioimmunoassay for the Dual Detection of Amphetamine and Methamphetamine - 1994
Woolverton WL, Massey BW, Winger G, Patrick GA, Harris LS - Evaluation of the Abuse Liability of Aminorex - Dec 1,1994
Yensen, Richard - Perspectives on LSD and Psychotherapy: The Search for a New Paradigm. - 1994
Axt KJ, Mamounas LA, Molliver ME - Structural Features of Amphetamine Neurotoxicity in the Brain. Amphetamine and its analogs: psychopharmacology, toxicology, and abuse - 1994
Broening HW, Bacon L, Slikker W Jr - Age Modulates the Long-Term but not the Acute Effects of the Serotonergic Neurotoxicant 3,4-Methylenedioxymethamphetamine - 1994
Bronson ME, Barrios-Zambrano L, Jiang W, Clark CR, DeRuiter J, Newland MC - Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives - 1994
Bronson ME, Jiang W, Clark CR, DeRuiter J - Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken - 1994
Cadet JL, Ladenheim B, Baum I, Carlson E, Epstein C - CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA) - 1994
Colado MI, Green AR - A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds - 1994
Cuomo MJ, Dyment PG, Gammino VM - Increasing Use of 'Ecstasy' (MDMA) and Other Hallucinogens on a College Campus - 1994
Dafters RI - Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') in rats - 1994
Fitzgerald JL, Reid JJ - Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Rabbit Isolated Cardiovascular Tissues - 1994
Forrest ARW, Galloway JH, Marsh ID, Strachan GA, Clark JC - A Fatal Overdose with 3,4-Methylenedioxyamphetamine Derivatives - 1994
Gordon CJ, Fogelson L - Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implications for pharmacological studies - 1994
Gudelsky GA, Yamamoto BK, Nash FJ - Potentiation of 3,4-Methylenedioxymethamphetamine-Induced Dopamine Release and Serotonin Neurotoxicity by 5-HT2 Receptor Agonists - 1994
Hastings A - Some observations on MDMA experiences induced through posthypnotic suggestion - 1994
Hewitt KE, Green AR - Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats - 1994
Hooft PJ, van de Voorde HP - Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing - 1994
Kelly PA, Ritchie IM, Sangra M, Cursham MJA, Dickson EM, Kelly B, Neilson FP, Reidy MJ, Stevens MC - Hyperaemia in Rat Neocortex Produced by Acute Exposure to Methylenedioxymethamphetamine - 1994
Kramer K, Azmitia EC, Whitaker-Azmitia PM - In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse - 1994
Leonardi ETK, Azmitia EC - MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac) - 1994
Lin HQ, McGregor IS, Atrens DM, Christie MJ, Jackson DM - Contrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions - 1994
Marona-Lewicka D, Nichols DE - Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan - 1994
Marsh JCW, Abboudi ZH, Gibson FM, Scopes J, Daly S, O'Shaunnessy DF, Baughan ASJ, Gordon-Smith EC - Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy') - 1994
McCann UD, Ridenour A, Shaham Y, Ricaurte GA - Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'): a controlled study in humans - 1994
McCoy EP, Renfrew C, Johnston JR, Lavery G - Malignant hyperpyrexia in an MDMA ('Ecstasy') abuser - 1994
McDowell DM, Kleber HD - MDMA: Its history and pharmacology - 1994
McGuire PK, Cope H, Fahy TA - Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy') - 1994
Miczek KA, Haney M - Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice - 1994
Miller DB, O'Callaghan JP - Environment-, Drug- and Stress-Induced Alterations in Body Temperature Affect the Neurotoxicity of Substituted Amphetamines in the C57BL/6J Mouse - 1994
Millman RB, Beeder AB - The new psychedelic culture: LSD, ecstasy, 'rave' parties and the Grateful Dead - 1994
Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA - Effect of the R(-) and S(+) Isomers of MDA and MDMA on Phosphatidyl Inositol Turnover in Cultured Cells Expressing 5-HT2A or 5-HT2C Receptors - 1994
Padkin A - Treating MDMA ('Ecstasy') toxicity - 1994
Poole RG, Brabbins CJ - Psychopathology and 'ecstasy' - 1994
Romano AG, Harvey JA - MDMA Enhances Associative and Nonassociative Learning in the Rabbit - 1994
Satchell SC, Connaughton M - Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion - 1994
Schifano F, Magni G - MDMA ('ecstasy') abuse: psychopathological features and craving for chocolate: a case series - 1994
Schmidt CJ, Sullivan CK, Fadayel GM - Blockade of Striatal 5-Hydroxytryptamine2 Receptors Reduces the Increase in Extracellular Concentrations of Dopamine Produced by the Amphetamine Analogue 3,4-Methylenedioxymethamphetamine - 1994
Series HG, Cowen PJ, Sharp T - p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo - 1994
Snape MF, Colado MI, et al - Chlormethiazole and dizocilpine block the behavioural, but not the neurotoxic effects of 5,7-dihydroxytryptamine in mice - 1994
Sprague JE, Huang X, Kanthasamy A, Nichols DE - Attenuation of 3,4-Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity with the Serotonin Precursors Tryptophan and 5-Hydroxytryptophan - 1994
Steele TD, McCann UD, Ricaurte GA - 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and toxicology in animals and humans - 1994
Thompson WC, Dasgupta A - Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays - 1994
Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, Hiratsuka A, Schmitz DA, Chu TY - The Demethylenation of Methylenedioxymethamphetamine ('Ecstasy') by Debrisoquine Hydroxylase (CYP2D6) - 1994
Walsh T, Carmichael R, Chestnut J - A hyperthermic reaction to 'ecstasy' - 1994
White SR, Duffy P, Kalivas PW - Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo - 1994
Wotherspoon G, Savery D, Priestley JV, Rattray M - Repeated administration of MDMA down-regulates preprocholecystokinin mRNA expression but not tyrosine hydroxylase mRNA expression in neurones of the rat substantia nigra - 1994
Yau JL, Kelly PA, Sharkey J, Seckl JR - Chronic 3,4-Methylenedioxymethamphetamine Administration Decreases Glucocorticoid and Mineralocorticoid Receptor, But Increases 5-Hydroxytryptamine1C Receptor Gene Expression in the Rat Hippocampus - 1994
Cerruti C, Sheng P, Ladenheim B, Epstein CJ, Cadet JL - Involvement of Oxidative and L-Arginine-NO Pathways in the Neurotoxicity of Drugs of Abuse in Vitro - 1995
Desarnaud, Franck; Cadas, Hugues; Piomelli, Daniele - Anandamide Amidohydrolase Activity in Rat Brain Microsomes. Identification and partial characterization - Mar. 17,1995
Gasser, Peter - Die psycholytische Psychotherapie in der Schweiz (1988-1993). Eine katamnestische Erhebung. [Psycholytic Psychotherapy in Switzerland (1988-1993). A Catamnestic Evaluation.] - 1995
Grob, Charles S.; Bravo, Gary L. - Human Research with Hallucinogens: Past Lessons and Current Trends - 1995
Grof, Stanislav - Implications of Holotropic Consciousness Research for Psychiatry: Observations from Psychedelic Therapy and Holotropic Breathwork - 1995
Passie, Torsten - Die Psycholyse in den skandinavischen Landern. Ein historischer Uberblick [Psycholytic Therapy in the Scandinavian Countries. A Historical Review] - 1995
Sanchez-Ramos, Juan R.; Mash, Deborah - Pharmacotherapy of Drug-Dependence with Ibogaine - 1995
Strassman RJ - Hallucinogenic drugs in psychiatric research and treatment: Perspectives and prospects - 1995
Yensen, Richard - From Shamans and Mystics to Scientists and Psychotherapists: Interdisciplinary Perspectives on the Interaction of Psychedelic Drugs and Human Consciousness - 1995
Aguirre N, Galbete JL, Lasheras B, Del Rio J - Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats - 1995
Barrett RL, Wiley JL, Balster RL, Martin BR - Pharmacological Specificity of delta 9-Tetrahydrocannabinol Discrimination in Rats - 1995
Broening HW, Bowyer JF, Slikker W Jr - Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response - 1995
Brown ER, Jarvie DR, Simpson D - Use of drugs at 'raves' - 1995
Cadet JL, Ladenheim B, Hirata H, Rothman RB, Ali S, Carlson E, Epstein C, Moran TH - Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice - 1995
Campbell DB - The use of toxicokinetics for the safety assessment of drugs acting in the brain - 1995
Che S, Johnson M, Hanson GR, Gibb JW - Body Temperature Effect on Methylenedioxymethamphetamine-Induced Acute Decrease in Tryptophan Hydroxylase Activity - 1995
Cirimele V, Kintz P, Mangin P - Detection of amphetamines in fingernails: an alternative to hair analysis - 1995
Cohen RS - Subjective reports on the effects of the MDMA ('ecstasy') experience in humans - 1995
Colado MI, Green AR - The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones - 1995
Colado MI, Williams JL, Green AR - The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype - 1995
Cook A - Ecstasy (MDMA): alerting users to the dangers - 1995
Dafters RI - Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing - 1995
Dyzkuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith CC - Ecstasy induced hepatitis mimicking viral hepatitis - 1995
Farfel GM, Seiden LS - Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX - 1995
Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte GA - Reorganization of Ascending 5-HT Axon Projections in Animals Previously Exposed to the Recreational Drug (+/-)3,4-mMylenedioxymethamphetamine (MDMA, 'Ecstasy') - 1995
Frederick DL, Ali SF, Slikker W Jr, Gillam MP, Allen RR, Paule MG - Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys - 1995
Frederick DL, Ali SF, Slikker W Jr, Gillam MP, Allen RR, Paule MG - Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys - 1995
Galloway G, Shulgin AT, Kornfeld H, Frederick SL - Amphetamine, Not MDMA, Is Associated with Intracranial Hemorrhage - 1995
Green AR, Cross AJ, Goodwin GM - Review of the Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') - 1995
Hanyu S, Ikeguchi K, Imai H, Imai N, Yoshida M - Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse - 1995
Hardern R, Tehan B - Ecstasy toxicity - 1995

Hegadoren KM, Baker GB, Coutts RT - Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, 'Eve') and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain - 1995
Hegadoren KM, Martin-Iverson MT, Baker GB - Comparative Behavioural and Neurochemical Studies with a Psychomotor Stimulant, an Hallucinogen and 3,4-Methylenedioxy Analogues of Amphetamine - 1995
Heller A, Won L, Heller B, Hoffmann PC - Examination of Developmental Neurotoxicity by the Use of Tissue Culture Model Systems - 1995
Hiratsuka A, Chu TY, Distefano EW, Lin LY, Schmitz DA, Cho AK - Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat - 1995
House RV, Thomas PT, Bhargava HN - Selective Modulation of Immune Function Resulting from in vitro Exposure to Methylenedioxymethamphetamine (Ecstasy) - 1995
Khakoo SI, Coles CJ, Armstrong JS, Barry RE - Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ('ecstasy') usage - 1995
Kintz P, Cirimele V, Tracqui A, Mangin P - Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry - 1995
Kramer HK, Poblete JC, Azmitia EC - 3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals - 1995
Lehmann ED, Thom CH, Croft DN - Delayed severe rhabdomyolysis after taking 'ecstasy' - 1995
Lewis LA, Ross MW - The gay dance party culture in Sydney: a qualitative analysis - 1995
McCann UD, Ricaurte GA - On the neurotoxicity of MDMA and related amphetamine derivatives [letter] - 1995
McNamara MG, Kelly JP, Leonard BE - Some Behavioural and Neurochemical Aspects of Subacute (+/-)3,4-Methylenedioxymethamphetamine Administration in Rats - 1995
Meehan SM, Gordon TL, Schechter MD - MDMA (Ecstasy) substitutes for the ethanol discriminative cue in HAD but not LAD rats - 1995
Miller RT, Serrine SL, Monks TJ - Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracerebroventricular Administration to Male Sprague-Dawley Rats - 1995
Miller DB, O'Callaghan JP - The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine - 1995
Poblete JC, Azmitia EC - Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor - 1995
Premkumar LS, Ahern GP - Blockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus - 1995
Priori A, Bertolasi L, Berardelli A, Manfredi M - Acute dystonic reaction to ecstasy - 1995
Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA - Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation - 1995
Sabol KE, Richards JB, Layton K, Seiden LS - Amphetamine analogs have differential effects on DRL 36-s schedule performance - 1995
Selmi F, Davies KG, Sharma RR, Neal JW - Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations - 1995
Slikker W Jr, Gaylor DW - Biologically based dose-response model for neurotoxicity risk assessment - 1995
Sprague JE, Nichols DE - The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits - 1995
Sprague JE, Nichols DE - Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum - 1995
Squier MV, Jalloh S, Hilton-Jones D, Series H - Death after ecstasy ingestion: neuropathological findings - 1995
Wake D - Ecstasy overdose: a case study - 1995
Wall SC, Gu H, Rudnick G - Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux - 1995
White SR, Harris GC, Imel KM, Wheaton MJ - Inhibitory Effects of Dopamine and Methylenedioxymethamphetamine (MDMA) on Glutamate-Evoked fFring of Nucleus Accumbens and Caudate/Putamen Cells are Enhanced Following Cocaine self-administration - 1995
Wichems CH, Hollingsworth CK, Bennett BA - Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release - 1995
Wolff K, Hay AW, Sherlock K, Conner M - Contents of 'ecstasy' - 1995
Woodrow G, Harnden P, Turney JH - Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy') - 1995
Yamamoto BK, Nash JF, Gudelsky GA - Modulation of Methylenedioxymethamphetamine-Induced Striatal Dopamine Release by the Interaction Between Serotonin and gamma-Aminobutyric Acid in the Substantia Nigra - 1995
Bonson KR, Buckholtz JW, Murphy DL - Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. - 1996 Jun
Bonson KR, Murphy DL - Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. - 1996
Callaway JC, Raymon LP, Hearn WL, McKenna DJ, Grob CS, BritoGS, Mash DC - Quantitation of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Plasma after Oral Dosing with Ayahuasca - 1996
McKenna, Dennis J. - Plant Hallucinogens: Springboards for Psychotherapeutic Drug Discovery - 1996
Shen, Maoxing; Piser, Timothy M.; Seybold, Virginia S.; Thayer, Stanley A. - Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures - Jul 15,1996
Strassman RJ, Qualls CR, Berg LM - Differential Tolerance to Biological and Subjective Effects of Four Closely Spaced Doses of N,N-Dimethyltryptamine in Humans - 1996
Strassman RJ - Human Psychopharmacology of N,N-Dimethyltryptamine - 1996
Baker LE, Makhay MM - Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats - 1996
Bakir AA, Dunea G - Drugs of abuse and renal disease - 1996
Bitsch A, Thiel A, Rieckmann P, Prange H - Acute inflammatory CNS disease after MDMA ('ecstasy') - 1996
Bodenham AR, Mallick A - New dimensions in toxicology: hyperthermic syndrome following amphetamine derivatives - 1996
Burns N, Olverman HJ, Kelly PA, Williams BC - Effects of Ecstasy on Aldosterone Secretion in the Rat in Vivo and in Vitro - 1996
Campbell DB - Extrapolation from animals to man: the integration of pharmacokinetics, and pharmacodynamics - 1996
Centini F, Masti A, Barni Comparini I - Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by headspace/solid phase micro-extraction (SPME) and GC/MS - 1996
Chenard-Neu MP, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, Costes V, Domergue J, Durand F, Erhard J, De Hemptinne B, Gubernatis G, Hadengue A, Kemnitz J, McCarthy M, Maschek H, Mentha G, Oldhafer K, Portmann B, Praet M, Ringers J, Rogiers X, - Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study - 1996
Chu T, Kumagai Y, DiStefano EW, Cho AK - Disposition of Methylenedioxymethamphetamine and Three Metabolites in the Brains of Different Rat Strains and Their Possible Roles in Acute Serotonin Depletion - 1996
Cohen RS - Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; 'Ecstasy') - 1996
Cook TM - Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake - 1996
Coore JR - A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity - 1996
Cox DE, Williams KR - ADAM' or EVE'?--a toxicological conundrum - 1996
Crifasi J, Long C - Traffic Fatality Related to the Use of Methylenedioxymethamphetamine - 1996
Dallakian P, Budzikiewicz H, Brzezinka H - Detection and quantitation of amphetamine and methamphetamine: electron impact and chemical ionization with ammonia--comparative investigation on Shimadzu QP 5000 GC-MS system - 1996
Dar KJ, McBrien ME - MDMA induced hyperthermia: report of a fatality and review of current therapy - 1996
Day, Michael - The Bitterest Pill - 1996
Demirkiran M, Jankovic J, Dean JM - Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome - 1996
Dowsett RP - Deaths attributed to 'ecstasy' overdose - 1996
Drake WM, Broadhurst PA - QT-interval prolongation with Ecstasy - 1996
Dulawa SC, Geyer MA - Psychopharmacology of Prepulse Inhibition in Mice - 1996
Ellis AJ, Wendon JA, Portmann B, Williams R - Acute liver damage and ecstasy ingestion - 1996
Ensslin HK, Kovar KA, Maurer HH - Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, 'Eve') and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay - 1996
Fay J, Fogerson R, Schoendorfer D, Niedbala RS, Spiehler V - Detection of Methamphetamine in Sweat by EIA and GC-MS - 1996
Fidler H, Dhillon A, Gertner D, Burroughs A - Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis - 1996
Finch E, Sell L, Arnold D - Drug workers emphasise that water is not an antidote to drug - 1996
Fineschi V, Masti A - Fatal poisoning by MDMA (ecstasy) and MDEA: a case report - 1996
Finnegan KT, Taraska T - Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo - 1996
Forsyth AJ - Places and patterns of drug use in the Scottish dance scene - 1996
Gartside SE, McQuade R, Sharp T - Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo - 1996
Geyer MA - Serotonergic Functions in Arousal and Motor Activity - 1996
Gifford AN, Minabe Y, Toor A, Wang RY, Ashby CR Jr - Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons - 1996
Grob CS, Poland RE, Chang L, Ernst T - Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations - 1996
Gudelsky GA - Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin - 1996
Gudelsky GA, Nash JF - Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions - 1996
Hall AP, Lyburn ID, Spears FD, Riley B - An unusual case of Ecstasy poisoning - 1996
Helmlin HJ, Bracher K, Bourquin D, Vonlanthen D, Brenneisen R - Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS - 1996
Henry JA - Ecstasy and serotonin depletion - 1996
Holden R, Jackson MA - Near-Fatal Hyponatraemic Coma Due to Vasopressin Over-Secretion After 'Ecstasy' (3,4-MDMA) - 1996
Jagust WJ, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, Hanrahan SM, Roberts JA, Brennan KM, Mathis CA - Iodine-123-5-Iodo-6-nitroquipazine: SPECT Radiotracer to Image the Serotonin Transporter - 1996
Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ - Effects of the Selective 5-HT2A Receptor Antagonist MDL 100,907 on MDMA-induced Locomotor Stimulation in Rats - 1996
Kehne JH, Padich RA, Ketteler - 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats - 1996
Kintz P, Tracqui A, Mangin P, Edel Y - Sweat testing in opioid users with a sweat patch - 1996
Kronstrand R - Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users - 1996
Kunsman GW, Levine B, Kuhlman JJ, Jones RL, Hughes RO, Fujiyama CI, Smith ML - MDA-MDMA Concentrations in Urine Specimens - 1996
Lesch KP, Heils A, Riederer P - The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes - 1996
Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS - Methylenedioxymethamphetamine-Induced Serotonin Deficits are Followed by Partial Recovery over a 52-Week Period. Part II: Radioligand Binding and Autoradiography Studies - 1996
Lin LY, Fujimoto M, Distefano EW, Schmitz DA, Jayasinghe A, Cho AK - Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine - 1996
Malberg JE, Sabol KE, Seiden LS - Co-administration of MDMA with Drugs That Protect Against MDMA Neurotoxicity Produces Different Effects on Body Temperature in the Rat - 1996
Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE - Reinforcing Effects of Certain Serotonin-Releasing Amphetamine Derivatives - 1996
Matthai SM, Davidson DC, Sills JA, Alexandrou D - Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted intake of water - 1996
Maurer HH - On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry - 1996
McCann UD, Slate SO, Ricaurte GA - Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy') - 1996
McCauley JC - Deaths attributed to an 'ecstasy' overdose - 1996
Miller DB, O'Callaghan JP - Neurotoxicity of d-Amphetamine in the C57BL/6J and CD-1 Mouse. Interactions with Stress and the Adrenal System - 1996
Miller RT, Lau SS, Monks TJ - Effects of Intracerebroventricular Administration of 5-(glutathion-S-yl)-alpha-Methyldopamine on Brain Dopamine, Serotonin, and Norepinephrine Concentrations in Male Sprague-Dawley Rats - 1996
Milroy CM, Clark JC, Forrest AR - Pathology of deaths associated with 'ecstasy' and 'eve' misuse - 1996
Moore KA, Mozayani A, Fierro MF, Poklis A - Distribution of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA) Stereoisomers in a Fatal Poisoning - 1996
Murray TK, Williams JL, Misra A, Colado MI, Green AR - The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine - 1996
Obradovic T, Imel KM, White SR - Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine - 1996
Onwudike M - Ecstasy Induced Retropharyngeal Emphysema - 1996
Padich RA, McCloskey TC, Kehne JH - 5-HT Modulation of Auditory and Visual Sensorimotor Gating: II. Effects of the 5-HT2A Antagonist MDL 100,907 on Disruption of Sound and Light Prepulse Inhibition Produced by 5-HT Agonists in Wistar Rats - 1996
Pu C, Broening HW, Vorhees CV - Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex - 1996
Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA - Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation - 1996
Rezvani K, Kurbaan AS, Brenton D - Ecstasy induced pneumomediastinum - 1996
Robson P - A guide to non-opiate illicit drugs - 1996
Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS - Methylenedioxymethamphetamine-Induced Serotonin Deficits are Followed by Partial Recovery over a 52-Week Period. Part I: Synaptosomal Uptake and Tissue Concentrations - 1996
Seiden LS, Sabol KE - Methamphetamine and Methylenedioxymethamphetamine Neurotoxicity: Possible Mechanisms of Cell Destruction - 1996
Seymour HR, Gilman D, Quin JD - Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged exercise - 1996
Shen M, Piser TM, Seybold VS, Thayer SA - Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures - 1996
Smit AA, Wieling W, Voogel AJ, Koster RW, van Zwieten PA - Orthostatic Hypotension Due to Suppression of Vasomotor Outflow After Amphetamine Intoxication - 1996
Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F - Increased Activation of Indirect Semantic Associations Under Psilocybin - 1996
Sprague JE, Johnson MP, Schmidt CJ, Nichols DE - Studies on the Mechanism of p-Chloroamphetamine Neurotoxicity - 1996
Sultana SR, Byrne DJ - 'Raver's' haematuria - 1996
Webb E, Ashton CH, Kelly P, Kamali F - Alcohol and Drug Use in UK University Students - 1996
White SR, Obradovic T, Imel KM, Wheaton MJ - The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on monoaminergic neurotransmission in the central nervous system - 1996
Wickremasinghe M - Commentary. Ecstasy and crack cocaine - 1996
Wilkins B - Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake (response): Hyponatraemia must be treated with low water input - 1996
Wolff K, Hay AW, Vail A, Harrison K, Raistrick D - Non-Prescribed Drug Use During Methadone Treatment by Clinic- and Community-Based Patients - 1996
Gallily, Ruth; Yamin, Aviva; Waksmann, Yaakov; Ovadia, Haim; Weidenfeld, Joseph; Bar-Joseph, Avi; Biegon, Anat; Mechoulam, Rapael; Shoham, Esther - Protection Against Septic Shock and Suppression of Tumor Necrosis Factor and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid - 1997
Gibb JW, Johnson M, Elayan I, Lim HK, Matsuda L, Hanson GR - Neurotoxicity of Amphetamines and Their Metabolites - 1997
Goff ML, Miller ML, Paulson JD, Lord WD, Richards E, Omori AI - Effects of 3,4-Methylenedioxymethamphetamine in Decomposing Tissues on the Development of Parasarcophaga ruficornis (Diptera:Sarcophagidae) and Detection of the Drug in Postmortem Blood, Liver Tissue, Larvae, and Puparia - 1997
Hasler F, Bourquin D, Brenneisen R, Bar T, Vollenweider FX - Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. - 1997 Jun
Nakahara Y, Kikura R - Hair Analysis for Drugs of Abuse. XVIII. 3,4-Methylenedioxymethamphetamine (MDMA) Disposition in Hair Roots and Use in Identification of Acute MDMA Poisoning - 1997
Tsatsakis AM, Michalodimitrakis MN, Patsalis AN - MDEA Related Death in Crete: A Case Report and Literature Review - 1997
Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J - Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. - 1997
Widmer, Samuel - Listening Into the Heart of Things: The Awakening of Love. On MDMA and LSD: The undesired Psychotherapy - 1997
Aguirre N, Frechilla D, Garcia-Osta A, Lasheras B, Del Rio J - Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids - 1997
Baker LE, Taylor MM - Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination - 1997
Baker LE, Virden TB, Miller ME, Sullivan CL - Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) - 1997
Bogusz MJ, Kala M, Maier RD - Determination of phenylisothiocyanate derivatives of amphetamine and its analogues in biological fluids by HPLC-APCI-MS or DAD - 1997
Box SA, Prescott LF, Freestone S - Hyponatraemia at a rave - 1997
Boys A, Lenton S, Norcross K - Polydrug use at raves by a Western Australian sample - 1997
Brauer RB, Heidecke CD, Nathrath W, Beckurts KT, Vorwald P, Zilker TR, Schweigart U, Holscher AH, Siewert JR - Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy - 1997
Capurro A, Reyes-Paroda M, Olazabal D, Perrone R, Silveira R, Macadar O - Aggressive Behavior and Jamming Avoidance Response in Weakly Electric Fish Gymnotus carapo: Effects of Methylenedioxymethamphetamine (MDMA) - 1997
Clark AD, Butt N - Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant - 1997
Cohen RS, Cocores J - Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: 'Ecstasy') - 1997
Colado MI, O'Shea E, Granados R, Murray TK, Green AR - In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine - 1997
Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR - A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy - 1997
Cooper AJ, Egleston CV - Accidental ingestion of Ecstasy by a toddler: unusual cause for convulsion in a febrile child - 1997
Crespi D, Mennini T, Gobbi M - Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine - 1997
Cunningham M - Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure - 1997
Curran HV, Travill RA - Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low - 1997
Dal Cason TA, Young R, Glennon RA - Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs - 1997
Davison D, Parrott AC - Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological Effects - 1997
de Boer D, Tan LP, Gorter P, van de Wal RM, Kettenes-van den Bosch JJ, de Bruijn EA, Maes RA - Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry - 1997
de Groot MJ, Bijloo GJ, van Acker FA, Fonseca Guerra C, Snijders JG, Vermeulen NP - Extension of a predictive substrate model for human cytochrome P4502D6 - 1997
De Souza I, Kelly JP, Harkin AJ, Leonard BE - An Appraisal of the Pharmacological and Toxicological Effects of a Single Oral Administration of 3,4-Methylenedioxymethamphetamine (MDMA) in the Rat - 1997
Ensslin HK, Maurer HH, Gouzoulis E, Hermle L, Kovar KA - Metabolism of Racemic 3,4-Methylenedioxyethylamphetamine in Humans. Isolation, Identification, Quantification, and Synthesis of Urinary Metabolites - 1997
Forsyth AJ, Barnard M, McKeganey NP - Musical preference as an indicator of adolescent drug use - 1997
Frederick DL, Paule MG - Effects of MDMA on complex brain function in laboratory animals - 1997
Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, Shohami E - Protection Against Septic Shock and Suppression of Tumor Necrosis Factor Alpha and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid - 1997
Gartside SE, McQuade R, Sharp T - Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems - 1997
Gillman PK - Ecstasy, serotonin syndrome and the treatment of hyperpyrexia - 1997
Glennon RA, Young R, Dukat M, Cheng Y - Initial characterization of PMMA as a discriminative stimulus - 1997
Hall AP - Hyponatraemia, water intoxication and 'ecstasy' - 1997
Hall AP - Ecstasy and the Anaesthetist - 1997
Huether G, Zhou D, Ruther E - Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its congeners - 1997
Kikura R, Nakahara Y, Mieczkowski T, Tagliaro F - Hair Analysis for Drug Abuse. XV. Disposition of 3, 4-Methylenedioxymethamphetamine (MDMA) and its Related Compounds into Rat Hair and Application to Hair Analysis for MDMA Abuse - 1997
Kintz P, Cirimele V - Interlaboratory comparison of quantitative determination of amphetamine and related compounds in hair samples - 1997
Koch S, Galloway MP - MDMA Induced Dopamine Release In Vivo: Role of Endogenous Serotonin - 1997
Kramer HK, Poblete JC, Azmitia EC - Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter - 1997
Lanz M, Brenneisen R, Thormann W - Enantioselective Determination of 3,4-Methylenedioxymethamphetamine and Two of Its Metabolites in Human Urine by Cyclodextrin-Modified Capillary Zone Electrophoresis - 1997
Lenton S, Boys A, Norcross K - Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia - 1997
LeSage M, Poling A - MDMA and d-amphetamine produce comparable effects in pigeons performing under a multiple fixed-ratio interresponse-time-greater-than-t schedule of food delivery - 1997
Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK - Oxidation of Methamphetamine and Methylenedioxymethamphetamine by CYP2D6 - 1997
Lin HQ, Jackson DM, Atrens DM, Christie MJ, McGregor IS - Serotonergic Modulation of 3,4-Methylenedioxymethamphetamine (MDMA)-Elicited Reduction of Response Rate but not Rewarding Threshold in Accumbal Self-Stimulation - 1997
MacConnachie AM - Ecstasy poisoning - 1997
Mallick A, Bodenham AR - MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C - 1997
Mann H, Ladenheim B, Hirata H, Moran TH, Cadet JL - Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice - 1997
Marquet P, Lacassie E, Battu C, Faubert H, Lachatre G - Simultaneous determination of amphetamine and its analogs in human whole blood by gas chromatography-mass spectrometry - 1997
Martinez DL, Geyer MA - Characterization of the Disruptions of Prepulse Inhibition and Habituation of Startle Induced by alpha-Ethyltryptamine - 1997
Miller RT, Lau SS, Monks TJ - 2,5-bis-(Glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations - 1997
Moeller MR, Hartung M - Ecstasy and Related Substances--Serum Levels in Impaired Drivers - 1997
Montgomery H, Myerson S - 3,4-methylenedioxymethamphetamine (MDMA, or 'ecstasy') and associated hypoglycemia - 1997
Morgan AE, Horan B, Dewey SL, Ashby CR Jr - Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study - 1997
Murthy BV, Wilkes RG, Roberts NB - Creatine kinase isoform changes following Ecstasy overdose - 1997
Murthy BV, Roberts NB, Wilkes RG - Biochemical implications of ecstasy toxicity - 1997
editorial - Helping Patients Who Misuse Drugs - 1997
Nuvials X, Masclans JR, Peracaula R, de Latorre FJ - Hyponatraemic coma after ecstasy ingestion - 1997
Parr MJ, Low HM, Botterill P - Hyponatraemia and death after 'ecstasy' ingestion - 1997
Parrott AC, Stuart M - Ecstacy (MDMA), amphetamine, and LSD: Comparative mood profiles in recreational polydrug users - 1997
Pereira SP, McCarthy M, Ellis AJ, Wendon J, Portmann B, Rela M, Heaton N, Williams R - Auxiliary partial orthotopic liver transplantation for acute liver failure - 1997
Pittman JA, Pounsford JC - Spontaneous pneumomediastinum and Ecstasy abuse - 1997
Poland RE, Lutchmansingh P, McCracken JT, Zhao JP, Brammer GL, Grob CS, Boone KB, Pechnick RN - Abnormal ACTH and Prolactin Responses to Fenfluramine in Rats Exposed to Single and Multiple Doses of MDMA - 1997
Robson P, Bruce M - A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations? - 1997
Rohrich J, Kauert G - Determination of amphetamine and methylenedioxy-amphetamine-derivatives in hair - 1997
Rothe M, Pragst F, Spiegel K, Harrach T, Fischer K, Kunkel J - Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users - 1997
Rutty GN, Milroy CM - The pathology of the ring-substituted amphetamine analogue 3,4-methylenedioxymethylamphetamine - 1997
Sadeghipour F, Veuthey JL - Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection - 1997
Schechter MD - Discrete versus cumulative dosing in dose-response discrimination studies - 1997
Schechter MD - Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats - 1997
Schechter MD - Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum - 1997
Schwartz RH, Miller NS - MDMA (ecstasy) and the rave: a review - 1997
Simantov R, Tauber M - The Abused Drug MDMA (Ecstasy) Induces Programmed Death of Human Serotonergic Cells - 1997
Spatt J, Glawar B, Mamoli B - A pure amnestic syndrome after MDMA ('ecstasy') ingestion - 1997
Taraska T, Finnegan KT - Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine - 1997
Tillmann HL, van Pelt FN, Martz W, Luecke T, Welp H, Dorries F, Veuskens A, Fischer M, Manns MP - Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption - 1997
Towers S - Sorted - 1997
Uhl M - Determination of drugs in hair using GC/MS/MS - 1997
Watson ID, Serlin M, Moncur P, Tames F - Acute Hyponatraemia - 1997
White JM, Bochner F, Irvine RJ - The agony of 'ecstasy' - 1997
Williams A, Unwin R - Prolonged elevation of serum creatine kinase (CK) without renal failure after ingestion of ecstasy - 1997
Williamson S, Gossop M, Powis B, Griffiths P, Fountain J, Strang J - Adverse effects of stimulant drugs in a community sample of drug users - 1997
Wu D, Otton SV, Inaba T, Kalow W, Sellers EM - Interactions of Amphetamine Analogs with Human Liver CYP2D6 - 1997
Yau JL, Noble J, Seckl JR - Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: role of corticosterone and serotonin - 1997
Yeh SY - Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats - 1997
Zheng Y, Russell B, Schmierer D, Laverty R - The effects of aminorex and related compounds on brain monoamines and metabolites in CBA mice - 1997
Bisogno T, Melck D, De Petrocellis L, Bobrov MY, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V - Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase - Jul 1998
Callaway CJ, McKenna DJ - Neurochemistry of Psychedelic Drugs - 1998
D'Esposito M - Serotonin Neurotoxicity: Implications for Cognitive Neuroscience and Neurology - 1998
De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V - The Endogenous Cannabinoid Anandamide Inhibits Human Breast Cancer Cell Proliferation - Jul 7,1998
Doblin R - Dr. Leary's Concord Prison Experiment: a 34-year follow-up study. - 1998
Hampson AJ, Grimaldi M, Axelrod J, Wink D - Cannabidiol and (-)delta9-Tetrahydrocannabinol are Neuroprotective Antioxidants - Jul 7,1998
Klein TW, Newton C, Friedman H - Cannabinoid Receptors and the Cytokine Network - 1998
Mangini M - Treatment of alcoholism using psychedelic drugs: a review of the program of research. - 1998
Morimoto BH, Lovell S, Kahr B - Ecstasy: 3,4-Methylenedioxymethamphetamine (MDMA) - 1998
O'Donohoe A, O'Flynn K, Shields K, Hawi Z, Gill M - MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6 - 1998
O'Shea E, Granados R, Esteban B, Colado MI, Green AR - The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy') - 1998
Ropero-Miller JD, Goldberger BA - Recreational Drugs. Current Trends in the 90s - 1998
Tagliaro F, Manetto G, Bellini S, Scarcella D, Smith FP, Marigo M - Simultaneous chiral separation of 3,4-methylenedioxymethamphet- amine, 3-4-methylenedioxyamphetamine, 3,4-methylenedioxyethylam- phetamine, ephedrine, amphetamine and methamphetamine by capillary electrophoresis in uncoated and coated capillaries...hair - 1998
Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D - Psilocybin Induces Schizophrenia-Like Psychosis in Humans via a Serotonin-2 Agonist Action - 1998
Aguirre N, Ballaz S, Lasheras B, Del Rio J - MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion - 1998
Aguirre N, Barrionuevo M, Lasheras B, Del Rio J - The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats - 1998
Ahmed JM, Salame MY, Oakley GD - Chest pain in a young girl - 1998
Ajaelo I, Koenig K, Snoey E - Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use - 1998
Andreu V, Mas A, Bruguera M, Salmeron JM, Moreno V, Nogue S, Rodes J - Ecstasy: a common cause of severe acute hepatotoxicity - 1998
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP - Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3, 4-Methylenedioxymethamphetamine ('Ecstasy') in Serotonin Transporter-deficient Mice - 1998
Bhattacharya SK, Bhattacharya A, Ghosal S - Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an experimental study - 1998
Bilsky EJ, Montegut MJ, Nichols ML, Reid LD - CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences - 1998
Bingham C, Beaman M, Nicholls AJ, Anthony PP - Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine - 1998
Bolla KI, McCann UD, Ricaurte GA - Memory Impairment in Abstinent MDMA ('Ecstasy') Users - 1998
Brody S, Krause C, Veit R, Rau H - Cardiovascular autonomic dysregulation in users of MDMA ('Ecstasy') - 1998
Byard RW, Gilbert J, James R, Lokan RJ - Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the culprit? - 1998
Cadet JL, Brannock C - Free radicals and the pathobiology of brain dopamine systems - 1998
Colado MI, Granados R, O'Shea E, Esteban B, Green AR - Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR - 1998
Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, Leonard BE - Acute 3,4-Methylenedioxymethamphetamine(MDMA) Administration Produces a Rapid and Sustained Suppression of Immune Function in the Rat - 1998
Dafters RI, Lynch E - Persistent Loss of Thermoregulation in the Rat Induced by 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') But Not Fenfluramine - 1998
Davies JP, Evans RO, Newington DP - Ecstasy Related Trauma - 1998
D'Esposito M - Serotonin Neurotoxicity: Implications for Cognitive Neuroscience and Neurology - 1998
Dulawa SC, Hen R, Scearce-Levie K, Geyer MA - 5-HT1B Receptor Modulation of Prepulse Inhibition: Recent Findings in Wild-type and 5-HT1B Knockout Mice - 1998
Felgate HE, Felgate PD, James RA, Sims DN, Vozzo DC - Recent paramethoxyamphetamine deaths - 1998
Frederick DL, Ali SF, Gillam MP, Gossett J, Slikker W, Paule MG - Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment - 1998
Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R - Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans - 1998
Gervin M, Smith R, Bamford L, Keenan E - Chasing the dragon: experience in Ireland and association with 'Ecstasy' - 1998
Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H. - Methodological issues of human experimental research with hallucinogens - 1998
Gouzoulis-Mayfrank E, Thelen B, Maier S, Habermeyer E, Spitzer M, Sass H - Modulation of semantic priming effects by psilocybin, MDE (ecstasy) and d-methamphetamine; principles and applicaitons of the model psychosis strategy - 1998
Gouzoulis-Mayfrank E, Hermle L, Thelen B, Sass H. - History, rationale and potential of human experimental hallucinogenic drug research in psychiatry - 1998
Gouzoulis-Mayfrank E, Habermeyer E, Hermle L, Steinmeyer AM, Kunert HJ, Sass H - Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study - 1998
Granoff MI, Ashby CR Jr - The Effect of the Repeated Administration of the Compound 3,4-methylenedioxymethamphetamine on the Response of Rats to the 5-HT2A,C Receptor Agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) - 1998
Greer GR, Tolbert R - A Method of Conducting Therapeutic Sessions with MDMA - 1998
Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M - Low-Dose MDMA ('Ecstasy') Induces Vasopressin Secretion - 1998
Henry JA, Hill IR - Fatal interaction between ritonavir and MDMA - 1998
Jacks AS, Hykin PG - Retinal haemorrhage caused by 'ecstasy' - 1998
Kalivas PW, Duffy P, White SR - MDMA elicits behavioral and neurochemical sensitization in rats - 1998
Kankaanpaa A, Meririnne E, Lillsunde P, Seppala T - The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens - 1998
Keller T, Miki A, Regenscheit P, Dirnhofer R, Schneider A, Tsuchihashi H - Detection of designer drugs in human hair by ion mobility spectrometry (IMS) - 1998
Kramer HK, Poblete JC, Azmitia EC - Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT) - 1998
Kurova T, Shoubnikova M, Malceva A, Mardh PA - Prostitution in Riga, Latvia--a socio-medical matter of concern - 1998
Lauerma H, Wuorela M, Halme M - Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine? - 1998
Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE - Serotonergic basis of antipsychotic drug effects in schizophrenia - 1998
Lindenblatt H, Kraemer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar KA - Quantitation of Psilocin in Human Plasma by High-Performance Liquid Chromatography and Electrochemical Detection: Comparison of lLquid-Liquid Extraction with Automated On-Line Solid-Phase Extraction - 1998
Magee C, Staunton H, Tormey W, Walshe JJ - Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female - 1998
Malberg JE, Seiden LS - Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and ore Body Temperature in the Rat - 1998
Matsushima K, Nagai T, Kamiyama S - Optical Isomer Analysis of 3,4-Methylenedioxyamphetamine Analogues and Their Stereoselective Disposition in Rats - 1998
McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA - Positron Emission Tomographic Evidence of Toxic Effect of MDMA ('Ecstasy') on Brain Serotonin Neurons in Human Beings - 1998
McElhatton PR, Bateman DN, Evans C, Pughe KR, Worsley AJ - Does prenatal exposure to ecstasy cause congenital malformations? A prospective follow-up of 92 pregnancies - 1998
Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF - Serotonin in Aging, Late-Life Depression, and Alzheimer’s Disease: The Emerging Role of Functional Imaging - 1998
Metzger RR, Hanson GR, Gibb JW, Fleckenstein AE - 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function - 1998
Moeller MR, Steinmeyer S, Kraemer T - Determination of drugs of abuse in blood - 1998
Morgan MJ - Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity - 1998
Muck-Seler D, Takahashi S, Diksic M - The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT synthesis rate in the rat brain: an autoradiographic study - 1998
Mueller PD, Korey WS - Death by 'ecstasy': the serotonin syndrome? - 1998
Murray MO, Wilson NH - Ecstasy related tooth wear - 1998
Nagilla R, Newland MC, Snyder J, Bronson ME - Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats - 1998
Nakahara Y, Kikura R, Takahashi K - Hair analysis for drugs of abuse XX. Incorporation and behaviors of seven methamphetamine homologs in the rat hair root - 1998
Obradovic T, Imel KM, White SR - Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin - 1998
Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K - Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits - 1998
Parrott AC, Lasky J - Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance - 1998
Plessinger MA - Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy - 1998
Ramcharan S, Meenhorst PL, Otten JM, Koks CH, de Boer D, Maes RA, Beijnen JH - Survival After Massive Ecstasy Overdose - 1998
Ramseier A, Caslavska J, Thormann W - Screening for urinary amphetamine and analogs by capillary electrophoretic immunoassays and confirmation by capillary electrophoresis with on-column multiwavelength absorbance detection - 1998
Redfearn PJ, Agrawal N, Mair LH - An association between the regular use of 3,4 methylenedioxy-methamphetamine (ecstasy) and excessive wear of the teeth - 1998
Sabol KE, Seiden LS - Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis - 1998
Schechter MD - 'Candyflipping': synergistic discriminative effect of LSD and MDMA - 1998
Schechter MD - MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats - 1998
Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA - In Vivo Detection of Short- and Long-Term MDMA Neurotoxicity--A Positron Emission Tomography Study in the Living Baboon Brain - 1998
Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R - MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients - 1998
Schuster P, Lieb R, Lamertz C, Wittchen HU - Is the use of ecstasy and hallucinogens increasing? Results from a community study - 1998
Shankaran M, Gudelsky GA - Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin - 1998
Shen M, Thayer SA - Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity - 1998
Sprague JE, Everman SL, Nichols DE - An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine - 1998
Tagliaro F, Manetto G, Crivellente F, Scarcella D, Marigo M - Hair analysis for abused drugs by capillary zone electrophoresis with field-amplified sample stacking - 1998
Vollenweider FX, Gamma A, Liechti M, Huber T - Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA ('Ecstasy') in MDMA-Naive Healthy Volunteers - 1998
Webb E, Ashton CH, Kelly P, Kamah F - An Update on British Medical Students' Lifestyles - 1998
Weinmann W, Bohnert M - Lethal monointoxication by overdosage of MDEA - 1998
Williams H, Dratcu L, Taylor R, Roberts M, Oyefeso A - Saturday night fever: ecstasy related problems in a London accident and emergency department - 1998
Williams A, Segal O, Andrews B - Short gastric artery perforation after use of 'ecstasy' - 1998
Wollina U, Kammler HJ, Hesselbarth N, Mock B, Bosseckert H - Ecstasy pimples - a new facial dermatosis - 1998
Young R, Glennon RA - Discriminative stimulus properties of (-)ephedrine - 1998
Zheng Y, Laverty R - Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats - 1998
Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass H, Geyer MA. - Effects of the Hallucinogen Psilocybin on Habituation and Prepulse Inhibition of the Startle Reflex in Humans - 1998
Aghajanian GK, Marek GJ - Serotonin and hallucinogens. - 1999 Aug
Akram G, Galt M - A Profile of Harm-reduction Practices and Co-use of Illicit and Licit Drugs Amongst Users of Dance Drugs - 1999
Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC - Pharmacokinetics of Hoasca Alkaloids in Healthy Humans - 1999
Di Marzo, Vincenzo; Melck, Dominique; Bisogno, Tiziana; De Petrocellis, Luciano - Endocannabinoids: Endogenous Cannabinoid Receptor Ligands with Neuromodulatory Action - 1999
Halpern, John H.; Pope, Harrison G., Jr. - Do Hallucinogens Cause Residual Neuropsychological Toxicity - Feb 1,1999
Hodgkin, Jonathan - Mice That Can't Get High - 1999
O'Connell D, Heffron JJ - Rapid analysis of illicit drugs by mass spectrometry: results from seizures in Ireland - 1999
O'Connor A, Cluroe A, Couch R, Galler L, Lawrence J, Synek B - Death from hyponatraemia-induced cerebral oedema associated with MDMA ('Ecstasy') use - 1999
Perkonigg, Axel; Lieb, Roselind; Hofler, Michael; Schuster, Peter; Sonntag, Holger; Wittchen, Hans-Ulrich - Patterns of Cannabis Use, Abuse and Dependence Over Time: Incidence, Progression and Stability in a Sample of 1228 Adolescents - 1999
Rogers A, McCarthy M - Drugs and Drugs Education in the Inner City: The Views of 12-year-olds and Their Parents - 1999
Suy K, Gijsenbergh F, Baute L. - Emergency medical assistance during a mass gathering - 1999
Vollenweider FX, Vontobel P, Hell D, Leenders KL - 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride - 1999
Adolphs R - Social cognition and the human brain - 1999
Aguirre N, Barrionuevo M, Ramirez MJ, Del Rio J, Lasheras B - Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity - 1999
Alciati A, Scaramelli B, Fusi A, Butteri E, Cattaneo ML, Mellado C - Three cases of delirium after 'ecstasy' ingestion - 1999
Appel JB, West WB, Rolandi WG, Alici T, Pechersky K - Increasing the selectivity of drug discrimination procedures - 1999
Bai F, Lau SS, Monks TJ - Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity - 1999
Beijnen JH, Meenhorst PL - Follow-up of ecstasy intoxication - 1999
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E - 3,4-Methylenedioxymethamphetamine (Ecstasy)-Induced Hepatotoxicity: Effect on Cytosolic Calcium Signals in Isolated Hepatocytes - 1999
Bertram M, Egelhoff T, Schwarz S, Schwab S - Toxic leukencephalopathy following 'ecstasy' ingestion - 1999
Bogusz MJ, Maier RD, Kruger KD, Webb KS, Romeril J, Miller ML - Poor reproducibility of in-source collisional atmospheric pressure ionization mass spectra of toxicologically relevant drugs - 1999
Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J - Substance Use Among Young People: The Relationship Between Perceived Functions and Intentions - 1999
Chang L, Ernst T, Grob CS, Poland RE - Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users - 1999
Colado MI, O'Shea E, Esteban B, Granados R, Green AR - In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism - 1999
Colado MI, Granados R, O'Shea E, Esteban B, Green AR - The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, 'eve') on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ('ecstasy') - 1999
Colado MI, Esteban B, O'Shea E, Granados R, Green AR - Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration - 1999
Colado MI, O'Shea E, Granados R, Esteban B, Martin AB, Green AR - Studies on the Role of Dopamine in the Degeneration of 5-HT Nerve Endings in the Brain of Dark Agouti Rats Following 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') Administration - 1999
Connor TJ, McNamara MG, Kelly JP, Leonard BE - 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Produces Dose-Dependent Neurochemical, Endocrine, and Immune Changes in the Rat - 1999
Cozzi NV, Sievert MK, Shulgin AT, Jacob P 3rd, Ruoho AE - Inhibition of Plasma Membrane Monoamine Transporters by beta-Ketoamphetamines - 1999
Dafters RI, Duffy F, O'Donnell PJ, Bouquet C - Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence - 1999
de la Torre R, Ortuno J, Mas M, Farre M, Segura J - Fatal MDMA Intoxication - 1999
Delaforge M, Jaouen M, Bouille G - Inhibitory Metabolite Complex Formation of Methylenedioxymethamphetamine with Rat and Human Cytochrome P450. Particular Involvement of CYP 2D - 1999
Erdtmann-Vourliotis M, Mayer P, Riechert U, Hollt V - Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine) - 1999
Fallon JK, Kicman AT, Henry JA, Milligan PJ, Cowan DA, Hutt AJ - Stereospecific Analysis and Enantiomeric Disposition of 3, 4-Methylenedioxymethamphetamine (Ecstasy) in Humans - 1999
Fineschi V, Centini F, Mazzeo E, Turillazzi E - Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases - 1999
Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR - Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function - 1999
Gamma A, Frei E, Lehmann D, PascuaI-Marqui RD, Hell D, Vollenweider FX - Mood State and Brain Electric Activity in Ecstasy Users - 1999
Gijsman HJ, Verkes RJ, van Gerven JM, Cohen AF - MDMA Study - 1999
Glennon RA - Arylalkylamine drugs of abuse: an overview of drug discrimination studies - 1999
Gore SM, Drug Survey Investigator's Consortium - Effective monitoring of young people's use of illegal drugs: meta-analysis of UK trends and recommendations - 1999
Gore SM - Fatal uncertainty: death-rate from use of ecstasy or heroin - 1999
Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Bьll U, Sass H - Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers - 1999
Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H - Psychopathological, Neuroendocrine and Autonomic Effects of 3,4-Methylenedioxyethylamphetamine (MDE), Psilocybin and d-Methamphetamine in Healthy Volunteers. Results of an xperimental Double-Blind Placebo-Controlled Study - 1999
Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Bull U, Sass H. - Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG - 1999
Hamilton J, Balint P, Field M, Sturrock RD - A concealed cause of recurrent renal failure in a patient with juvenile chronic arthritis - 1999
Hammersley R, Ditton J, Smith I,Short E - Patterns of ecstasy use by drug users - 1999
Hanson GR, Jensen M, Johnson M, White HS - Distinct Features of Seizures Induced by Cocaine and Amphetamine Analogs - 1999
Harrington RD, Woodward JA, Hooton TM, Horn JR - Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate - 1999
Hatzidimitriou G, McCann UD, Ricaurte GA - Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (+/-)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery - 1999
Hegadoren KM, Baker GB, Bourin M - 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans - 1999
Hensley D, Cody JT - Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS - 1999
Holland J - Positron Emission Tomography Findings in Heavy Users of MDMA - 1999
Holmes SB, Banerjee AK, Alexander WD - Hyponatraemia and seizures after ecstasy use - 1999
Jansen KL, Forrest AR - Toxic effect of MDMA on brain serotonin neurons - 1999
Jansen KL - Ecstasy (MDMA) dependence - 1999
Jayanthi S, Ladenheim B, Andrews AM, Cadet JL - Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy) - 1999
Jones AL, Simpson KJ - Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications - 1999
Kintz P, Samyn N - Determination of 'Ecstasy' components in alternative biological specimens - 1999
Klugman A, Hardy S, Baldeweg T, Gruzelier J - Toxic effect of MDMA on brain serotonin neurons - 1999
Kramer E, Kovar KA - On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine - 1999
Krishnan A, Brown R - Plain abdominal radiography in the diagnosis of the 'body packer' - 1999
Kuikka JT, Ahonen AK - Toxic effect of MDMA on brain serotonin neurons - 1999
Lavelle A, Honner V, Docherty JR - Investigation of the Prejunctional alpha2-Adrenoceptor Mediated Actions of MDMA in Rat Atrium and Vas Deferens - 1999
Laviola G, Adriani W, Terranova ML, Gerra G - Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models - 1999
Lieberman JA, Aghajanian GK - Caveat Emptor: Researcher Beware - 1999
Lin HQ, Burden PM, Christie MJ, Johnston GA - The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine - 1999
Lind J, Oyefeso A, Pollard M, Baldacchino A, Ghodse H - Death rate from use of ecstasy or heroin - 1999
Lynskey M, White V, Hill D, Letcher T, Hall W - Prevalence of illicit drug use among youth: results from the Australian School Students' Alcohol and Drugs Survey - 1999
Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F - Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats - 1999
Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP - Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat - 1999
Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J, Cami J - Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3, 4-Methylenedioxymethamphetamine in Humans - 1999
McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA - Toxic Effect of MDMA on Brain Serotonin Neurons - 1999
McCann UD, Szabao Z, Scheffel U, Dannals RF, Ricaurte GA - Positron Emission Tomography Findings in Heavy Users of MDMA - 1999
McCann UD, Mertl M, Eligulashvili V, Ricaurte GA - Cognitive Performance in (+/-) 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') Users: A Controlled Study - 1999
McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA - Altered Neuroendocrine and Behavioral Responses to m-Chlorophenylpiperazine in 3,4-Methylenedioxymethamphetamine (MDMA) Users - 1999
McCreary AC, Bankson MG, Cunningham KA - Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors - 1999
McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH - Congenital Anomalies After Prenatal Ecstasy Exposure - 1999
Milosevic A, Agrawal N, Redfearn P, Mair L - The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine) - 1999
Milroy CM - Ten years of 'ecstasy' - 1999
Mintzer S, Hickenbottom S, Gilman S - Parkinsonism after taking ecstasy - 1999
Monks TJ, Ghersi-Egea JF, Philbert M, Cooper AJ, Lock EA - Symposium overview: the role of glutathione in neuroprotection and neurotoxicity - 1999
Morgan JF - Toxic Effect of MDMA on Brain Serotonin Neurons - 1999
Morgan, Michael John - Memory Deficits Associated with Recreational Use of 'Ecstasy' (MDMA) - 1999
Morgan JF - Ecstasy Use and Neuropathology - 1999
Mortensen OV, Kristensen AS, Rudnick G, Wiborg O - Molecular cloning, expression and characterization of a bovine serotonin transporter - 1999
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA - Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures - 1999
Navarro JF, Maldonado E - Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice - 1999
Nishisawa S, Mzengeza S, Diksic M - Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography - 1999
Ortuno J, Pizarro N, Farre M, Mas M, Segura J, Cami J, Brenneisen R, de la Torre R - Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection - 1999
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Segura J, de la Torre R - Immunomodulating Properties of MDMA Alone and in Combination with Alcohol: A Pilot Study - 1999
Pedersen W, Skrondal A - Ecstasy and New Patterns of Drug Use: A Normal Population Study - 1999
Quin GI, McCarthy GM, Harries DK - Spontaneous pneumomediastinum and ecstasy abuse - 1999
Ramseier A, Caslavska J, Thormann W - Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis - 1999
Ramsey JD, Johnston A, Holt DW - Death rate from use of ecstasy or heroin - 1999
Reed LJ, Winstock A, Cleare AJ, McGuire P - Toxic effect of MDMA on brain serotonin neurons - 1999
Regenthal R, Kruger M, Rudolph K, Trauer H, Preiss R - Survival after massive 'ecstasy' (MDMA) ingestion - 1999
Rella JG, Nelson LS - Recovery after Ecstasy intoxication - 1999
Rochester JA, Kirchner JT - Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology - 1999
Scearce-Levie K, Chen JP, Gardner E, Hen R - 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders - 1999
Scearce-Levie K, Viswanathan SS, Hen R - Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor - 1999
Schirren CA, Berghaus TM, Sackmann M - Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver failure - 1999
Schwab M, Seyringer E, Brauer RB, Hellinger A, Griese EU - Fatal MDMA Intoxication - 1999
Selim K, Kaplowitz N - Hepatotoxicity of psychotropic drugs - 1999
Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC - Reduced In Vivo Binding to the Serotonin Transporter in the Cerebral Cortex of MDMA ('Ecstasy') Users - 1999
Sexton TJ, McEvoy C, Neumaier JF - (+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain - 1999
Shankaran M, Yamamoto BK, Gudelsky GA - Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine - 1999
Shankaran M, Yamamoto BK, Gudelsky GA - Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum - 1999
Shankaran M, Gudelsky GA - A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration - 1999
Sherlock K, Wolff K, Hay AW, Conner M - Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department - 1999
Sondermann N, Kovar KA - Screening experiments of ecstasy street samples using near infrared spectroscopy - 1999
Spruit IP - Ecstasy use and policy responses in the Netherlands - 1999
Stein DJ, Rink J - Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors - 1999
Stephenson CP, Hunt GE, Topple AN, McGregor IS - The Distribution of 3,4-Methylenedioxymethamphetamine 'Ecstasy'-Induced c-fos Expression in Rat Brain - 1999
Stumm G, Schlegel J, Schafer T, Wurz C, Mennel HD, Krieg JC, Vedder H - Amphetamines Induce Apoptosis and Regulation of Bcl-x Splice Variants in Neocortical Neurons - 1999
Tagliaro F, De Battisti Z, Groppi A, Nakahara Y, Scarcella D, Valentini R, Marigo M - High sensitivity simultaneous determination in hair of the major constituents of ecstasy (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylene-dioxyethylamphetamine) by high-performance liquid chromatography with direct fluor - 1999
Talwar D, Watson ID, Stewart MJ - Routine analysis of amphetamine class drugs as their naphthaquinone derivatives in human urine by high-performance liquid chromatography - 1999
ten Berge J - Breakdown or Breakthrough? A History of European Research into Drugs and Creativity - 1999
Topp L, Hando J, Dillon P, Roche A, Solowij N - Ecstasy Use in Australia: Patterns of Use and Associated Harm - 1999
Ugland HG, Krogh M, Rasmussen KE - Automated determination of 'Ecstasy' and amphetamines in urine by SPME and capillary gas chromatography after propylchloroformate derivatisation - 1999
van de Wijngaart GF, Braam R, de Bruin D, Fris M, Maalste NJM, Verbraeck HT - Ecstasy use at large-scale dance events in the Netherlands. - 1999
van Heijst A - Ecstasy intoxication and gastric lavage - 1999
Varela-Rey M, Montiel-Duarte C, Beitia G, Cenarruzabeitia E, Iraburu MJ - 3,4-Methylenedioxymethamphetamine ('Ecstasy') Stimulates the Expression of alpha1(I) Procollagen mRNA in Hepatic Stellate Cells - 1999
Vollenweider FX, Gamma A, Liechti M, Huber T - Is a Single Dose of MDMA Harmless? - 1999
Vollenweider FX, Remensberger S, Hell D, Geyer MA - Opposite Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Sensorimotor Gating in Rats versus Healthy Humans - 1999
Walker TM, Davenport-Jones JE, Fox RM, Atterwill CK - The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture - 1999
Walubo A, Seger D - Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature - 1999
Westwood SC, Hanson GR - Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems - 1999
Woodrow G, Turney JH - Ecstasy-induced renal vasculitis - 1999
Yeh SY - N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats - 1999
Yeh SY, Dersch C, Rothman R, Cadet JL - Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats - 1999
Young R, Dukat M, Malmusi L, Glennon RA - Stimulus properties of PMMA: effect of optical isomers and conformational restriction - 1999
Cooper GA, Allen DL, Scott KS, Oliver JS, Ditton J, Smith ID - Hair Analysis: Self-reported Use of 'Speed' and 'Ecstasy' Compared with Laboratory Dindings - 2000
Ferguson, David M.; Horwood, L. John - Does Cannabis Use Encourage Other Forms of Illicit Drug Use? - 2000
Gamma A, Frei E, Lehmann D, Pascual-Marqui RD, Hell D, Vollenweider FX - Mood State and Brain Electric Activity in Ecstasy Users - 2000
Goodwin AK, Baker LE - A Three-choice Discrimination Procedure Dissociates the Discriminative Stimulus Effects of d-Amphetamine and (+/-)-MDMA in Rats - 2000
Kalia M, O'Callaghan JP, Miller DB, Kramer M - Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry - 2000
Lawston, Jodie; Borella, Alice; Robinson, John K.; Whitaker-Azmitia, Patricia M. - Changes in Hippocampal Morphology Following Chronic Treatment With the Synthetic Cannabinoid WIN 55,212-2 - 2000
O'Cain PA, Hletko SB, Ogden BA, Varner KJ - Cardiovascular and Sympathetic Responses and Reflex Changes Elicited by MDMA - 2000
Rashed AM, Anderson RA, King LA - Solid-phase Extraction for Profiling of Ecstasy Tablets - 2000
Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA - The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors. - 2000 Jan 1
Allen DL, Oliver JS - The use of supercritical fluid extraction for the determination of amphetamines in hair - 2000
Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J - Chemical Analysis of Ecstasy Pills - 2000
Barrionuevo M, Aguirre N, Del Rio JD, Lasheras B - Serotonergic Deficits and Impaired Passive-avoidance Learning in Rats by MDEA: a Comparison with MDMA - 2000
Behan WMH, Madigan M, Clark BJ, Goldberg J, McLellan DR - Muscle changes in the neuroleptic malignant syndrome - 2000
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E - Ecstasy-Induced Toxicity in Rat Liver - 2000
Bell SEJ, Burns DT, Dennis AC, Matchett LJ, Speers JS - Composition Profiling of Seized Ecstasy Tablets by Raman Spectroscopy [In Process Citation] - 2000
Bell SEJ, Burns DT, Dennis AC, Speers JS - Rapid Analysis of Ecstasy and Related Phenethylamines in Seized Tablets by Raman Spectroscopy - 2000
Bellis MA, Hale G, Bennett A, Chaudry M, Kilfoyle M. - Ibiza Uncovered: Changes in Substance use and Sexual Behaviour Amongst Young People Visiting an International Night-Life Resort - 2000
Bogusz MJ - Liquid Chromatography-Mass Spectrometry as a Routine Method in Forensic Sciences: A Proof of Maturity [In Process Citation] - 2000
Boot BP, McGregor IS, Hall W - MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks - 2000
Borth S, Hansel W, Rosner P, Junge T - Regioisomeric differentiation of 2,3- and 3,4-methylenedioxy ring-substituted phenylalkylamines by gas chromatography/tandem mass spectrometry - 2000
Burgess C, O'Donohoe A, Gill M - Agony and ecstasy: a review of MDMA effects and toxicity - 2000
Burrows KB, Gudelsky G, Yamamoto BK - Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration - 2000
Byrne T, Baker LE, Poling A - MDMA and Learning: Effects of Acute and Neurotoxic Exposure in the Rat - 2000
Cami J; Farre M; Mas M; Roset PN; Poudevida S; Mas A; San L; de la Torre R - Human Pharmacology of 3,4-Methylenedioxymethamphetamine ('Ecstasy'): Psychomotor Performance and Subjective Effects - 2000
Carter N, Rutty GN, Milroy CM, Forrest ARW - Deaths Associated with MBDB Misuse - 2000
Chang L, Grob C, Ernst T, Itti L, Mishkin F, Jose-Melchor R, Poland RE - Effect of Ecstasy [3,4-Methylenedioxymethamphetamine (MDMA)] on Cerebral Blood Flow: A Co-Registered SPECT and MRI Study - 2000
Christophersen AS - Amphetamine designer drugs - an overview and epidemiology - 2000
Clauwaert KM, Van Bocxlaer JF, De Letter EA, Van Callenbergh S, Lambert WE, De Leenheer AP - Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine - 2000
Connor TJ, Kelly JP, McGee M, Leonard BE - Methylenedioxymethamphetamine (MDMA; Ecstasy) Suppresses IL-1b and TNF-a Secretion Following an in Vivo Lipopolysaccharide Challenge - 2000
Connor TJ , Kelly JP, Leonard BE - An Assessment of the Acute Effects of the Serotonin Releasers Methylenedioxymethamphetamine, Methylenedioxyamphetamine and Fenfluramine on Immunity in Rats - 2000
Curran HV - Is MDMA (`Ecstasy') Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research - 2000
Daws EC, Irvine RJ, Callaghan PD, Toop NP, White JM, Bochner F - Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat [In Process Citation] - 2000
de la Torre R, Farre' M, Ortuno J, Mas M, Brenneisen R, Roset PN, Segura J, Cami J - Non-Linear Pharmacokinetics of MDMA (`Ecstasy') in Humans - 2000
de la Torre R, Farre M, Roset PN, Hernandez Lopez C, Mas M, Ortuno J, Menoyo E, Pizarro N, Segura J, Cami J - Pharmacology of MDMA in Humans - 2000
Dublin NN, Razack AH - Priapism: Ecstasy Related? - 2000
Dulawa SC, Geyer MA - Effects of Strain and Serotonergic Agents on Prepulse Inhibition and Habituation in Mice - 2000
Dulawa SC, Scearce-Levie KA, Hen R, Geyer MA - Serotonin Releasers Increase Prepulse Inhibition in Serotonin 1B Knockout Mice - 2000
Erdtmann-Vourliotis M, Mayer P, Riechert U, Hollt V - Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum - 2000
Ferrie R, Loveland RC - Bilateral gluteal compartment syndrome after 'ecstasy' hyperpyrexia - 2000
Fischer HS, Zernig G, Schatz DS, Humpel C, Saria A - MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum - 2000
Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX - 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H2 15 O]-PET in Healthy Humans - 2000
Gamma A, Buck A, Berthold T, Hell D, Vollenweider F - Erratum. 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H(2)(15)O]-PET in Healthy Humans - 2000
Geiser L, Cherkaoui S, Veuthey JL - Simultaneous analysis of some amphetamine derivatives in urine by nonaqueous capillary electrophoresis coupled to electrospray ionization mass spectrometry - 2000
Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi GF, Delsignore R, Brambilla F - Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans - 2000
Ghuran A, Nolan J - Recreational drug misuse: issues for the cardiologist - 2000
Girod C, Staub C - Analysis of drugs of abuse in hair by automated solid-phase extraction, GC/EI/MS and GC ion trap/CI/MS - 2000
Glennon RA, Young R - MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin - 2000
Gomez-Balaguer M, Pena H, Morillas C, Hernandez A - Syndrome of Inappropriate Antidiuretic Hormone Secretion and 'Designer Drugs' (ecstasy) - 2000
Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H - Impaired Cognitive Performance in Drug Free Users of Recreational Ecstasy (MDMA) - 2000
Graeme KA - New drugs of abuse - 2000
Grob CS - Deconstructing Ecstasy: The Politics of MDMA Research - 2000
Harris, D, Baggott, M, Jones, RT, Mendelson, J - MDMA Pharmacokinetics and Physiological and Subjective Effects in Humans - 2000
Harvey DC, Lacan G, Tanious SP, Melega WP - Recovery from Methamphetamine Induced Long-term Nigrostriatal Dopaminergic Deficits without Substantia Nigra Cell Loss - 2000
Heinz A, Jones DW - Serotonin transporters in ecstasy users - 2000
Henry JA - Metabolic Consequences of Drug Misuse - 2000
Hervнas I, Lasheras B, and Aguirre N - 2-Deoxy-D-Glucose Prevents and Nicotinamide Potentiates 3,4-Methylenedioxymethamphetamine-Induced Serotonin Neurotoxicity - 2000
Horan B, Gardner EL, Ashby CR Jr - Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA) - 2000
Iravani M, Asari D, Patel J, Wieczorek WJ, and Kruk ZL - Direct Effects of 3,4-Methylenedioxymethamphetamine(MDMA) on Serotonin or Dopamine Release and Uptake in the Caudate Putamen, Nucleus Accumbens, Substantia Nigra Pars Reticulata, and the Dorsal Raphe' Nucleus Slices - 2000
Johnson EA, Sharp DS, Miller DB - Restraint as a Stressor in Mice: Against the Dopaminergic Neurotoxicity of D-MDMA, Low Body Weight Mitigates Restraint-Induced Hypothermia and Consequent Neuroprotection - 2000
Jurado C, Gimenez MP, et al - Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS - 2000
Kelly P - Does Recreational Ecstasy Use Cause Long-Term Cognitive Problems? - 2000
Kelly PA - Impaired Cognitive Performance in Drug Free Users of Recreational Ecstasy (MDMA) - 2000
Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS - Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user - 2000
Klitzman RL, Pope HG Jr, Hudson JI - MDMA ('Ecstasy') abuse and high-risk sexual behaviors among 169 gay and bisexual men - 2000
Kreth KP,Kovar KA, Schwab M, Zanger UM - Identification of the Human Cytochromes P450 Involved in the Oxidative Metabolism of 'Ecstasy'-Related Designer Drugs - 2000
Kuhn DM, Geddes TJ - Molecular footprints of Neurotoxic Amphetamine Action - 2000
Lee GS, Taylor RC, Dawson M, Kannangara GS, Wilson MA - High-resolution solid state 13C nuclear magnetic resonance spectra of 3,4-methylenedioxyamphetamine hydrochloride and related compounds and their mixtures with lactose [In Process Citation] - 2000
Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J - Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine. A Double-Blind, Placebo-Controlled Trial - 2000
Liechti ME, Vollenweider FX - The Serotonin Uptake Inhibitor Citalopram Reduces Acute Cardiovascular and Vegetative Effects of 3,4-Methylenedioxymethamphetamine ('Ecstasy') in Healthy Volunteers - 2000
Liechti ME, Baumann C, Gamma A, Vollenweider FX - Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') are Attenuated by the Serotonin Uptake Inhibitor Citalopram - 2000
Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX - Psychological and Physiological Effects of MDMA ('Ecstasy') after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans - 2000
Liechti ME, Vollenweider FX - Acute Psychological and Physiological Effects of MDMA ('Ecstasy') after Haloperidol Pretreatment in Healthy Humans - 2000
Louw DF, Yang FW, Sutherland GR - The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat - 2000
Maldonado E, Navarro JF - Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box - 2000
Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT - Toxicokinetics and Analytical Toxicology of Amphetamine-Derived Designer Drugs ('Ecstasy') - 2000
McCann UD, Eligulashvili V, Ricaurte GA - (+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin Neurotoxicity: Clinical Studies - 2000
McFee RB, Mofenson HC, Caraccio TR - Dextromethorphan: Another 'Ecstasy'? - 2000
McGuire P - Long term psychiatric and cognitive effects of MDMA use - 2000
Mieczkowski T, Newel R - Statistical examination of hair color as a potential biasing factor in hair analysis - 2000
Morgan MJ - Ecstasy (MDMA): a review of its possible persistent psychological effects - 2000
Morland J - Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use - 2000
Morley KC, McGregor IS - (+/-)-3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats - 2000
Nakahara Y, Hanajiri R - Hair analysis for drugs of abuse XXI. Effect of para-substituents on benzene ring of methamphetamine on drug incorporation into rat hair - 2000
Nicotra AS, Parvez H - Nitric Oxide and Neuronal and Pancreatic Beta Cell Death - 2000
Nixon PJ, Youngson CC, Beese A - Tooth surface loss: does recreational drug use contribute? - 2000
O'Neal C, Crouch DJ, Fatah AA - Validation of twelve chemical spot tests for the , detection of drugs of abuse - 2000
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Hernandez Lopez C, Ortuno J, Segura J, Cami J, de la Torre R - Immunomodulating Activity of MDMA - 2000
Parrott AC, Sisk E, Turner JJD - Psychobiological problems in heavy `ecstasy' (MDMA) polydrug users - 2000
Parrott AC - Human research on MDMA (3,4-Methylene-dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change - 2000
Ramseier A, Siethoff C, Caslavska J, Thormann W - Confirmation testing of amphetamines and designer drugs in human urine by capillary electrophoresis-ion trap mass spectrometry - 2000
Rella JG, Nelson LS, Hoffman RS - 7 Years of 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity - 2000
Reneman L, Booij J, Schmand B, van den Brink W, Gunning B - Memory disturbances in 'Ecstasy' users are correlated with an altered brain serotonin neurotransmission - 2000
Reneman L, Habraken JBA, Majoie CBL, Booij J, den Heeten GJ - MDMA ('Ecstasy') and Its Association with Cerebrovascular Accidents: Preliminary Findings - 2000
Ricaurte GA, Yuan J, McCann UD - (+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin Neurotoxicity: Studies in Animals - 2000
Ricaurte GA, McCann UD, Szabo Z, Scheffel U - Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') - 2000
Rieder MJ - Some light from the heat: implications of rave parties for clinicians - 2000
Rodgers J - Cognitive Performance Amongst Recreational Users of 'Ecstasy' - 2000
Rohrich J, Zorntlein S, Potsch L, Skopp G, Becker J - Effect of the Shampoo Ultra Clean on Drug Concentrations in Human Hair - 2000
Rothman RB, Partilla JS, Baumann MH, Dersch CM, Carroll FI, Rice KC - Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse - 2000
Russell BR, Laverty R - Correlation between 5-HT content and uptake site density following (S)- MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021 [In Process Citation] - 2000
Samyn N, van Haeren C - On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users - 2000
Schatz DS, Kaufmann WA, Schuligoi R, Humpel C, Saria A - 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices - 2000
Schifano F - Potential Human Neurotoxicity of MDMA (`Ecstasy'): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies - 2000
Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Zimny M, Zeggel T, Wagenknecht G, Kaiser HJ, Sass H, Buell U - "Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study - 2000
Schroeder B, Brieden S - Bilateral sixth nerve palsy associated with MDMA ('ecstasy') abuse - 2000
Shannon M - Methylenedioxymethamphetamine (MDMA, 'Ecstasy') [In Process Citation] - 2000
Sharma R, Nelson LS - Methylenedioxymethamphetamine (MDMA) induced hyponatremia - 2000
Shewan D, Dalgarno P, Reith G - Perceived risk and risk reduction among ecstasy users; the role of drug, set and setting - 2000
Shirayama Y, Hashimoto K, Iyo M, Watanabe K, Higuchi T, Minabe Y - 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-Induced egr-1 mRNA in Rat Brain: Pharmacological Manipulation [In Process Citation] - 2000
Slotkin TA, Seidler FJ, Ali SF - Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions - 2000
Smart RG, Ogborne AC - Drug use and drinking among students in 36 countries [In Process Citation] - 2000
Tagliaro F, Valentini R, Manetto G, Crivellente F, Carli G, Marigo M - Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licences - 2000
Tuchtenhagen F, Daumann J, Norra C, Gobbelй R, Becker S, Pelz S, Sass H, Buchner H, Gouzoulis-Mayfrank E - High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users - 2000
Turner JJD, Parrott AC - 'Is MDMA a Human Neurotoxin?': Diverse Views from the Discussants - 2000
Uhl M - Tandem mass spectrometry: a helpful tool in hair analysis for the forensic expert - 2000
van Aerts LAGJM, Malleret M, Rigter H - N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks - 2000
van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB - Age-related decline in central serotonin transporter availability with [ 123 I] b-CIT SPECT - 2000
Vollenweider FX, Gucker P, Schonbachler R, Kamber E, Vollenweider-Scherpenhuyzen MFI, Schubiger G, Hell D - Effects of MDMA on 5-HT Uptake Sites Using PET and [11C]-McN5652 in Humans - 2000
Waldo CR, McFarland W, Katz MH, MacKellar D, Valleroy LA - Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II - 2000
Wareing M, Fisk JE, Murphy PN - Working Memory Deficits in Current and Previous Users of MDMA - 2000
Weinmann W, Renz M, Vogt S, Pollak S - Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS [In Process Citation] - 2000
Weir E - Raves: a review of the culture, the drugs and the prevention of harm - 2000
Winstock AR, Griffiths P, Stewart D - Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK - 2000
Wright JD, Pearl L - Experience and knowledge of young people regarding illicit drug use, 1969-99 - 2000
Zenenberg R, Goldfarb DS - Evaluation of hyponatremia associated with the use of methylenedioxymethamphetamine (MDMA) - 2000
Alper KR - Ibogaine: a review. - 2001
Clauwaert KM, Van Bocxlaer JF, De Leenheer AP - Stability study of the designer drugs "MDA, MDMA and MDEA" in water, serum, whole blood, and urine under various storage temperatures. - 2001
Di Marzo, Vincenzo - The Endocannabinoid System: Can It Contribute to Cannabis Therapeutics - 2001
Gettman, Jon - Cannabis and the U.S. Controlled Substances Act - 2001
Gold MS, Tabrah H, Frost-Pineda K - Psychopharmacology of MDMA (Ecstasy) - 2001
Golub A, Johnson BD, Sifaneck, S J, Chesluk B, Parker H - Is the U.S. Experiencing an Incipient Epidemic of Hallucinogen Use? - 2001
Gouzoulis-Mayfrank E - Differential actions of an entactogen compared to a stimulant - 2001
Hollister, Leo E. - Marijuana (Cannabis) as Medicine - 2001
Horgan J - The future of mind-science - 2001
Krupitsky EM, Burakov AM, Romanov TN, Grinenko AY, Strassman RJ - Ketamine-Assisted Psychotherapy (KPT) of Heroin Addiction: Immediate Effects and Six Months Follow-Up - 2001
Lozano, Indalecio - The Therapeutic Use of Cannabis sativa (L.) in Arabic Medicine - 2001
McPartland, John M. - Cannabis and Eicosanoids: A Review of Molecular Pharmacology - 2001
Nichols CD, Sanders-Bush E - Serotonin Receptor Signaling and Hallucinogenic Drug Action - 2001
Nichols DE - LSD and Its Lysergamide Cousins - 2001
O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM - Behavioural, Hyperthermic and Neurotoxic Effects of 3,4- - 2001
Perrine DM - Visions in the Night: Western medicine meets peyote (1887-1899) - 2001
Russo, Ethan - An Editorial Introduction - 2001
Russo, Ethan - Cognoscenti of Cannabis I: Jacques-Joseph Moreau (1804-1884) - 2001
Russo, Ethan - The Science of Marijuana, by Leslie L. Iversen [review] - 2001
Russo, Ethan - Hashish!, by Robert Connell Clarke [review] - 2001
Vollenweider FX, Geyer M, Greer G - Acute Psychological and Neurophysiological Effects - 2001
Zhao H, Brenneisen R, Scholer A, McNally AJ, ElSohly MA, Murphy TP, Salamone SJ - Profiles of Urine Samples Taken from Ecstasy Users at Rave Parties: Analysis by Immunoassays, HPLC, and GC-MS - 2001
Acquas E, Marrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, Di Chiara G - Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo - 2001
Aghajanian, George K.; Liebermann, Jeffrey A. - Response [Caveat Emptor: Editors Beware] - 2001
Al-Sahli W, Ahmad H, Kheradmand F, Connolly C, Docherty JR - Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery - 2001
Baggott M, Jerome L, Stuart R - 3,4-Methylenedioxymethamphetamine (MDMA): A Review of the English-Language Scientific and Medical Literature - 2001
Bai F, Jones DC, Lau SS, Monks TJ - Serotonergic Neurotoxicity of 3,4-(+/-)-Methylenedioxyamphetamine and 3,4-(+/-)-Methylenedioxymethamphetamine (Ecstasy) Is Potentiated by Inhibition of y-Glutamyl Transpeptidase - 2001
Bankson MB, Cunningham KA - 3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotonin Receptor Function and Serotonin-Dopamine Interactions - 2001
Bhattachary, Sarajane; Powell, Jane H. - Recreational Use of 3,4-Methylenedioxymethamphetamine (MDMA) or 'Ecstasy': Evidence for Cognitive Impairment - 2001
Biello, SM, Dafters, RI - MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro - 2001
Boyer E, Quang L, Woolf A, Shannon M, Magnani B - Dextromethorphan and Ecstasy Pills - 2001
Boys A, Marsden J, Strang J - Understanding Reasons for Drug Use Amongst Young People: A Functional Perspective - 2001
Braff, DL, Geyer, MA and Swerdlow, NR - Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies - 2001
Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV - 3,4-Methylenedioxymethamphetamine (Ecstasy)-Induced Learning and Memory Impairments Depend on the Age of Exposure during - 2001
Buchert R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L, Bohuslavizki KH, Clausen M - Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET - 2001
Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL,. Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK - Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters are Agonists of a Rat Trace Amine Receptor - 2001
Callahan BT, Cord BJ, Ricaurte GA - Long-Term Impairment of Anterograde Axonal Transport Along Fiber Projections Originating in the Rostral Raphe Nuclei After Treatment With Fenfluramine or Methylenedioxymethamphetamine - 2001
Cannon DM, Keenan AK, Guiry PJ, Buon C, Baird AW, McBean GJ - In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA - 2001
Carvalho M, Carvalho F, Bastos ML - Is Hyperthermia the Triggering Factor for the Hepatoxicity Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) ? An in vitro Study Using Freshly Isolated Mouse Hepatocytes - 2001
Colado MI, O'Shea E, Esteban B, Green AR - Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ('ecstasy')-induced neurodegeneration in rat brain. - 2001
Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR - A study of the mechanisms involved in the neurotoxic action of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain - 2001
Colfax GN, Mansergh G, Guzman R, Vittinghoff E, Marks G, Rader M, Buchbinder S - Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison - 2001
Connor TJ, Dennedy MC, Harkin A, Kelly JP - Methylenedioxymethamphetamine-Induced Suppression of Interleukin-1beta and Tumour Necrosis Factor-alpha is not Mediated by Serotonin - 2001
Connor TJ, Connelly DB, Kelly JP - Methylenedioxymethamphetamine (MDMA, 'Ecstasy') Suppresses Antigen-specific IgG2a and IFN-Gamma Production - 2001
Cottler LB, Womack SB, Compton WM, Ben-Abdallah A - Ecstasy Abuse and Dependence Among Adolescents and Young Adults: Applicability and Reliability of DSM-IV Criteria - 2001
Croft, RJ, Klugman, A, Baldeweg, T, and Gruzelier, JH - Electrophysiological evidence of serotonergic impairment in lonf-term MDMA ('ecstasy') users - 2001
Croft RC, Macay AJ, Mills ATD, Gruzelier JGH - The relative contributions of ecstasy and cannabis to cognitive impairment - 2001
Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E - Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use - 2001
Dughiero G, Schifano F, Forza G - Personality dimensions and psychopathological profiles of Ecstasy users - 2001
Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI - 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose - 2001
Fletcher PJ, Robinson SR, Slippoy DL - Pre-Exposure to (+/-)3,4-methylenedioxymethamphetamine (MDMA) Facilitates Acquisition of Intravenous Cocaine Self-Administration in Rats - 2001
Fornai F, Giorgi FS, Gesi M, Chen K, Alessandri MG, Shih JC - Biochemical Effects of the Monoamine Neurotoxins DSP-4 and MDMA in Specific Brain Regions of MAO-B-Deficient Mice - 2001
Forsling, M, Fallon, JK, Kicman, AT, Hutt, AJ, Cowan, DA, Henry, JA - Arginine Vasopressin Release in Response to the Administration of 3,4- Methylenedioxymethamphetamine ('Ecstasy'): Is Metabolism a Contributory Factor? - 2001
Fox HC, Toplis AS, Turner JJD, Parrott AC - Auditory Verbal Learning in Drug-Free Ecstasy Polydrug Users - 2001
Fox HC, Parrott AC, Turner JJD - Ecstasy Use: Cognitive Deficits Related to Dosage Rather than Self-Reported Problematic Use of the Drug - 2001
Frei E, Gamma A, Pascual-Marqui R, Lehmann D, Hell D, Vollenweider FX - Localization of MDMA-Induced Brain Activity in Healthy Volunteers Using Low Resolution Brain Electromagnetic Tomography (LORETA) - 2001
Gamma A, Buck A, Berthold T, Vollenweider FX - No Difference in Brain Activation During Cognitive Performance Between Ecstasy (MDMA) Users and Controls: A [H2(15)O]-PET Study - 2001
Gerra G, Zaimovic A, Ampollini R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F - Experimentally induced aggressive behavior in subjects with 3,4- methylenedioxy-methamphetamine ('Ecstasy') use history: psychobiological correlat - 2001
Gervin M, Hughes R, Bamford L, Smyth BP, Keenan E - Heroin smoking by 'chasing the dragon' in young opiate users in Ireland: stability and associations with use to 'come down' off 'Ecstasy' - 2001
Hansen D, Maycock B, Lower T - 'Weddings, Parties, Anything…', A Qualitative Analysis of Ecstasy Use in Perth, Western Australia - 2001
Heffernan TM, Jarvis H, Rodgers J , Scholey AB, Ling J - Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy - 2001
Ho E, Karimi-Tabesh L, Koren G - Characteristics of pregnant women who use Ecstasy (3, 4- methylenedioxymethamphetamine) - 2001
Hong SS - Discriminative stimulus properties of alpha-ethyltryptamine optical isomers - 2001
Jones GRN - Causes of Alzheimer’s disease: paracetamol (acetaminophen) today? Amphetamines tomorrow? - 2001
Kalant, H - The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs - 2001
Kavanagh P, Dunne J, Feely J, Maguire R, Corrigan D, Keating JJ, Meegan MJ, Clancy JM, Burdett J - Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland - 2001
Krupitsky EM, Burakov AM, Romanova TN, Grinenko NI, Grinenko AY, Fletcher J, Petrakis IL, Krystal JH - Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists - 2001
Liechti ME, Gamma A, Vollenweider FX - Gender Differences in the Subjective Effects of MDMA - 2001
Liechti ME, Geyer MA, Hell D, Vollenweider FX - Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin - 2001
Liechti ME, Vollenweider FX - Which Neuroreceptors Mediate the Subjective Effects of MDMA in Humans? A Summary of Mechanistic Studies - 2001
Logan BK, Couper FJ - 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment - 2001
MacInnes, N, Handley, SL and Harding, GFA - Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users report mild depressive symptoms - 2001
Maldonado E, Navarro JF - Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encounters between male mice - 2001
Mamamoorthy Y, Tyndale R, Sellers EM - Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates - 2001
Mattison, AM, Ross, MW, Wolfson, T, Franklin, D - Circuit party attendance, club drug use, and unsafe sex in gay men - 2001
Mayerhofer A, Kovar KA, Schmidt WJ - Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats - 2001
McCann UD, Ricaurte GA - Caveat Emptor: Editors Beware - 2001
McCann UD, Ricaurte GA, Molliver MD - 'Ecstasy' and Serotonin Neurotoxicity: New Findings Raise More Questions - 2001
McDaid J, Docherty JR - Vascular actions of MDMA involve alpha(1) and alpha(2)-adrenoceptors in the anaesthetized rat - 2001
McElrath K, McEvoy K. - Fact, fiction, and function: mythmaking and the social construction of ecstasy use - 2001
Mechan AO, O'Shea E, Elliott JM, Colado MI, Green AR - A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation - 2001
Mendelson J - Dextromethorphan and Ecstasy Pills (reply) - 2001
Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS - Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ('Ecstasy') - 2001
Mortensen OV, Kristensen AS, Wiborg O - Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants - 2001
Navarro M, Pichini S, Farre M, Ortuno J, Roset PN, Segura J, de la Torre R - Usefulness of Saliva for Measurement of 3,4- Methylenedioxymethamphetamine and Its Metabolites: Correlation with Plasma Drug Concentrations and Effect of Salivary pH - 2001
Nixdorf WL, Burrows KB, Gudelsky GA, Yamamoto BK - Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate - 2001
Obergriesser T, Ende G, Braus DF, Henn FA - Hippocampal [1H]-MRSI in Ecstasy Users - 2001
O'Shea E, Esteban B, Camarero J, Green AR, Colabo MI - Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain - 2001
Pacifici R, Zuccaro P, Lopez CH, Pichini S, di Carlo S, Farre M, Roset PN, Ortuno J, Segura J, de la Torre R - Acute Effects of 3,4-Methylenedioxymethamphetamine Alone and in Combination with Ethanol on the Immune System in Humans - 2001
Pacifici R, Zuccaro P,. Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R - Effects of Repeated Doses of MDMA ('Ecstasy') on Cell-Mediated Immune Response in Humans - 2001
Parrott AC - Human psychopharmacology of ecstasy; A review of 15 years of empirical research - 2001
Parrott AC, Milani RM, Parmar R, Turner JD - Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems - 2001
Pedersen NP, Blessing WW - Cutaneous Vasoconstriction Contributes to Hyperthermia Induced by 3,4- Methylenedioxymethamphetamine (Ecstasy) in Conscious Rabbits - 2001
Pentney AR - An exploration of the history and controversies surrounding MDMA and MDA - 2001
Pham JV, Puzantian T - Ecstasy: Dangers and controversies - 2001
Pope, HG Jr., Ionescu-Pioggia, M, and Pope, KW - Drug use and life style among college undergraduates: a 30-year longitudinal study - 2001
Rajamani K, Leong S, Lavelle A, Docherty JR - Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and a(2A/D)-adrenoceptor knockout mice - 2001
Ramamoorthy Y, Tyndale RF, Sellers EM - Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates - 2001
Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA - PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA - 2001
Ratzenboeck E, Saria A, Kriechbaum N, Zernig G - Reinforcing Effects of MDMA ('Ecstasy') in Drug-Naive and Cocaine-Trained Rats - 2001
Reneman L, Majoie CB, Habraken JB, den Heeten GJ - Effects of Ecstasy (MDMA) on the Brain in Abstinent Users: Initial Observations with Diffusion and Perfusion MR Imaging - 2001
Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J - Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy'): Preliminary Findings - 2001
Reneman L, Majoie CBLM, Schmand B, van den Brink W, den Heeten GJ - Pre-Frontal N-Acetylaspartate is Strongly Associated with Memory Performance in (Abstinent) Ecstasy Users: Preliminary Report - 2001
Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W - Effects of Dose, Sex and Long-Term Abstention from Use on Toxic Effects of MDMA (Ecstasy) on Brain Serotonin Neurons - 2001
Reneman L, Booij J, Majoie CBLM, van den Brink,W, den Heeten GJ - Investigating the Potential Neurotoxicity of Ecstasy (MDMA): an Imaging Approach - 2001
Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ - Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers - 2001
Ricaurte GA, McCann UD - Assessing Long-Term Effects of MDMA (Ecstasy) - 2001
Riley SCE, James C, Gregory D, Dingle H, Cadger M - Patterns of recreational drug use at dance events in Edinburgh, Scotland - 2001
Rodgers J, Buchanan T, Scholey AB, Heffernan, TM, Ling J, Parrott A - Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study - 2001
Rogers, RD & Robbins, TW - Investigating the neurocognitive deficits associated with chronic drug misuse - 2001
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS - Amphetamine-Type Central Nervous System Stimulants Release Norepinephrine More Potently Than They Release Dopamine and Serotonin - 2001
Russell BR, Laverty R - The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity - 2001
Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI - The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain - 2001
Segura M, Ortuno J, Farre M, McLure JA, Pujadas M, Pizarro N, Llebaria A Juglar, J, Roset PN, Segura J, de la Torre R - 3,4-Dihydroxymethamphetamine (HHMA). A Major in Vivo 3,4-methylenedioxymethamphetamine (MDMA) Metabolite in Humans - 2001
Shankaran M, Yamamoto BK, Gudelsky GA - Ascorbic Acid Prevents 3,4- Methylenedioxymethamphetamine (MDMA)-Induced Hydroxyl Radical Formation and the Behavioral and Neurochemical Consequences of the Depletion of Brain 5-HT - 2001
Siliquini R, Faggiano F, Geninatti S, Versino E, Mitola B, Ippolito R - Patterns of drug use among young men in Piedmont (Italy) - 2001
Soar K, Turner JJD, Parrott AC - Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history - 2001
Spitzer M, Franke B, Walter H, Buechler J, Wunderlich AP, Schwab M, Kovar KA, Hermle L, Grön G - Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans - 2001
Taffe MA, Weed MR, Davis S, Huitron-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH - Functional Consequences of Repeated (+/-)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys - 2001
Tancer, ME, Johanson, C-E - The Subjective Effects of MDMA and mCPP in Moderate MDMA Users - 2001
Taylor JR, Jentsch D - Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: differential effects of cocaine, d-amphetamine and 3,4-methylenedioxymethamphetamine ('Ecstasy') - 2001
Tossmann P, Boldt S, Tensil MD - The use of drugs within the techno party scene in European metropolitan cities. - 2001
Vaiva G, Boss V, Bailly D, Thomas P, Lestavel P, Goudemand M - An 'Accidental' Acute Psychosis with Ecstasy Use - 2001
van der Stelt M, Veldhuis WB, Bar PR, Veldink GA, Vliegenthart JF, Nicolay K - Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity - 2001
Vastag B - Ecstasy experts want realistic messages - 2001
Verkes RJ, Gijsman HJ, Pieters MSM, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJM, de Bruin D, Van de Wijngaart G, Van Gerven JMA, Cohen AF - Cognitive Performance and Serotonergic Function in Users of Ecstasy - 2001
Vollenweider FX, Jones RT, Baggott MJ - Caveat Emptor: Editors Beware (reply) - 2001
Wallace TL, Gudelsky GA, Vorhees CV - Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine - 2001
Zakzanis KK, Young DA - Memory Impairment in Abstinent MDMA (“Ecstasy”) Users: A Longitudinal Investigation - 2001
Zakzanis K, Young DA - Executive Function in Abstinent MDMA ('Ecstasy') Users - 2001
Zemishlany Z, Aizenberg D, Weizman A - Subjective effects of MDMA ('Ecstasy') on human sexual function - 2001
Cody JT, Valtier S - Differentiation of the 2,3-Methylenedioxy Regioisomer of 3,4-MDMA (ecstasy) by Gas Chromatography-Mass Spectrometry - 2002
Cole JC, Sumnall HR, Wagstaff GF - Methodological problems with Ecstasy and the SCL-90 - Jul 2002
Cole JC, Sumnall HR - The BDI of the Beholder - Mar 2002
Cole JC, Sumnall HR, Wagstaff GF - What is a Dose of Ecstasy? - Jun 2002
Hasler F, Bourquin D, Brenneisen R, Vollenweider FX - Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. - 2002
Landry MJ - MDMA: a review of epidemiologic data. - 2002
MacInnes N, Handley SL, Harding GF - The BDI of the beholder: an eye to experimental design. - 2002 Sep
Nichols DE, Frescas S, Marona-Lewicka D, Kurrasch-Orbaugh DM - Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD). - 2002
O'Shea E, Easton N, Fry JR, Green AR, Marsden CA - Protection Against 3,4-Methylenedioxymethamphetamine-Induced Neurodegeneration Produced by Glutathione Depletion in Rats is Mediated by Attenuation of Hyperthermia - 2002
Passie T, Seifert J, Schneider U, Emrich HM - The pharmacology of psilocybin. - 2002
Umbricht D, Vollenweider FX, Schmid L, Grubel C, Skrabo A, Huber T, Koller R - Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia - 2002
Umbricht D, Koller R, Vollenweider FX, Schmid L - Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. - 2002
Arnold DH - Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure - 2002
Arria AM, Yacoubian GS, Fost E, Wish ED - Ecstasy Use Among Club Rave Attendees - 2002
Badaoui R, El Kettani C, Fikri M, Ouendo M, Canova-Bartoli P, Ossart M - Spontaneous cervical and mediastinal air emphysema after ecstasy abuse - 2002
Badon LA, Hicks A, Lord K, Ogden BA, Meleg-Smith S, Varner KJ - Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited during Binge Administration of Ecstasy - 2002
Baggott, Matthew J. - Preventing Problems in Ecstasy Users; Reduce Use to Reduce Harm - 2002
Bankson MG, Cunningham KA - Pharmacological Studies of the Acute Effects of (+)-3,4- Methylenedioxymethamphetamine on Locomotor Activity. Role of 5- HT(1B/1D) and 5-HT(2) Receptors - 2002
Bellis MA, Hughes K, Lowey H - Healthy Nightclubs and Recreational Substance Use. From a Harm Minimisation to a Healthy Settings Approach - 2002
Boatto G, Faedda MV, Pau A, Asproni B, Menconi S, Cerri R - Determination of amphetamines in human whole blood by capillary electrophoresis with photodiode array detection - 2002
Bobes J, Saiz PA, Gonzalez MP, Bascaran MT, Bousono M, Ricaurte GA, McCann UD - Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain. A Five-Year Study - 2002
Boire RG - What should the public be told about the risks of Ecstasy? (2) - 2002
Boot BP, Mechan AO, McCann UD, Ricaurte GA - MDMA- and p-Chlorophenylalanine-Induced Reduction in 5-HT Concentrations: Effects on Serotonin Transporter Densities - 2002
Braida D, Pozzi M, Cavallini R, Sala M - 3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats - 2002
Braida D, Sala M - Role of the endocannabinoid system in MDMA intracerebral self- administration in rats - 2002
Brecht M-L, von Mayrhauser C - Differences between ecstasy-using and non-using methamphetamine users - 2002
Butcher J - MDMA research leaves ravers far from ecstatic - 2002
Caballero F, Lopez-Navidad A, Cotorruelo J, Txoperena G - Ecstasy-Induced Brain Death and Acute Hepatocellular Failure: Multiorgan Donor and Liver Transplantation - 2002
Camarero J, Sanchez V, O'Shea E, Green AR, Colado MI - Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum - 2002
Carvalho M, Carvalho F, Remiao F, de Lourdes Pereira M, Pires-Das-Neves R, de Lourdes Bastos M - Effect of 3,4-Methylenedioxymethamphetamine ('Ecstasy') on Body Temperature and Liver Antioxidant Status in Mice: Influence of Ambient Temperature - 2002
Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks TJ, Fernandes E, Carvalho F, Bastos ML - Role of Metabolites in MDMA (Ecstasy)-Induced Nephrotoxicity: An in vitro Study Using Rat and Human Renal Proximal Tubular Cells - 2002
Cherney DZ, Davids MR, Halperin ML - Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis - 2002
Cleary L, Buber R, Docherty JR - Effects of Amphetamine Derivatives and Cathinone on Noradrenaline-Evoked Contractions of Rat Right Ventricle - 2002
Colbron S, Jones M, Biello SM - MDMA alters the response of the circadian clock to a photic and non-photic stimulus - 2002
Cole J, Sumnall H, Grob C - Sorted: Ecstasy facts and fiction - 2002
Cole J, Sumnall H, Grob C - Where are the casualties? - 2002
Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA - The Content of Ecstasy Tablets: Implications for the Study of Their Long-Term Effects - 2002
Croft RJ - 'Danger' remains best message - 2002
Crouch DJ, Hersch RK, Cook RF, Frank JF, Walsh JM - A field evaluation of five on-site drug-testing devices - 2002
Darvesh AS, Shankaran M, Gudelsky GA - 3,4-methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain - 2002
De Letter EA, Clauwaert KM, Lambert WE, Van Bocxlaer JF, De Leenheer AP, Piette MHA - CASE REPORT: Distribution Study of 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxy-amphetamine in a Fatal Overdose - 2002
De Letter EA, Belpaire FM, Clauwaert KM, Lambert WE, Van Bocxlaer JF, Piette MH - Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') in the rabbitPart II: post-mortem infusion in trachea or stomach - 2002
De Letter EA, Clauwaert KM, Belpaire FM, Lambert WE, Van Bocxlaer JF, Piette MH - Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') in the rabbitPart I: experimental approach after in vivo intravenous infusion - 2002
Ellison G - Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry - 2002
Falk EM, Cook VJ, Nichols DE, Sprague JE - An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA - 2002
Fallon JK, Shah D, Kicman AT, Hutt AJ, Henry JA, Cowan DA, Forsling M. - Action of MDMA (Ecstasy) and Its Metabolites on Arginine Vasopressin Release - Jun 2002
Fang C, Chung YL, Liu JT, Lin CH - Rapid analysis of 3,4-methylenedioxymethamphetamine: a comparison of nonaqueous capillary electrophoresis/fluorescence detection with GC/MS - 2002
Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G - 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') and its Stereoisomers as Reinforcers in Rhesus Monkeys: Serotonergic Involvement - 2002
Fernandez F, Aguerre S, MormA?de P, Chaouloff F - Influences of the Corticotropic Axis and Sympathetic Activity on Neurochemical Consequences of 3,4-Methylenedioxymethamphetamine (MDMA) Administration in Fischer 344 Rats. - 2002
Fletcher PJ, Korth KM, Robinson SR,. Baker GB - Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement - 2002
Fone KF, Beckett SG, Topham IA, Swettenham J, Ball M, Maddocks L - Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity - 2002
Fornai F, Gesi M, Lenzi P, Ferrucci M, Pellegrini A, Ruggieri S, Casini A, Paparelli A - Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration - 2002
Forsling ML, Fallon JK Shah D, Tilbrook GS, Cowan DA, Kicman AT, Hutt AJ - The Effect of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and its Metabolites on Neurohypophysial Hormone Release from the iIolated Rat Hypothalamus - 2002
Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ - Neuropsychological Evidence of a Relatively Selective Profile of Temporal Dysfunction in Drug-Free MDMA ('Ecstasy') Polydrug Users - 2002
Freese T, Miotto K, Reback C - The Effects and Consequences of Selected Club Drugs - 2002
Gentili S, Torresi A, Marsili R, Chiarotti M, Macchia T - Simultaneous detection of amphetamine-like drugs with headspace solid-phase microextraction and gas chromatography-mass spectrometry - 2002
Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R, Laviola G, Macchia T, Brambilla F - Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans - 2002
Gesi M, Lenzi P, Soldani P, Ferrucci M, Giusiani A, Fornai F, Paparelli A - Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure - 2002
Gesi M, Soldani P, Lenzi P, Ferrucci M, Giusiani A, Fornai F, Paparelli . - Ecstasy during Loud Noise Exposure Induces Dramatic Ultrastructural Changes in the Heart - 2002
Gijsman HJ, Van Gerven JM, Verkes RJ, Schoemaker RC, Pieters MS, Pennings EJ, Hessing TJ, Cohen AF - Saccadic peak velocity and EEG as end-points for a serotonergic challenge test - 2002
Gilhooly TC, Daly AK - CYP2D6 deficiency, a factor in ecstasy related deaths? - 2002
Gill JR, Hayes JA, deSouza IS, Marker E, Stajic M - Ecstasy (MDMA) deaths in New York City: a case series and review of the literature - 2002
Glennon RA, Young R, Rangisetty JB - Further characterization of the stimulus properties of 5,6,7,8- tetrahydro-1,3-dioxolo[4,5-g]isoquinoline - 2002
Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, Mennini T - p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro - 2002
Goodwin AK, Baker LE - An Analysis of the Utility of Differential Outcome Procedures in Drug Discrimination Research - 2002
Gough B, Imam SZ, Blough B, Slikker W Jr, Ali SF - Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study - 2002
Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagen F, Daumann J - Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis? - 2002
Gouzoulis-Mayfrank E, Thelen B, Maier S, Heekeren K, Kovar KA, Sass H, Spitzer M - Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans - 2002
Green AR, McGregor IS - On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA - 2002
Gross SR, Barrett SP, Shestowsky JS, Pihl RO - Ecstasy and drug consumption patterns: a Canadian rave population study - 2002
Gudelsky GA, Yamamoto BK - Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine - 2002
Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS - Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion - 2002
Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE - Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity - 2002
Harris DS, Baggott M, Mendelson J, Mendelson JE, Jones RT - Subjective and Hormonal Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in Humans - 2002
Hartung TK, Schofield E, Short AI, Parr MJ, Henry JA - Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion - 2002
Hatzidimitriou G, Tsai EH McCann U D, Ricaurte GA - Altered Prolactin Response to m-Chlorophenylpiperazine in Monkeys Previously Treated with 3,4-Methylenedioxymethamphetamine (MDMA) or Fenfluramine - 2002
Hayner, GN - MDMA misrepresentation: An unresolved problem for ecstasy users - 2002
Heffernan TM, Ling J, Scholey AB - Subjective ratings of prospective memory deficits in MDMA ('ecstasy') users - 2002
Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de La Torre R - 3,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics - 2002
Hess D, DeBoer S - Ecstasy: This designer drug is increasing in popularity and may be coming soon to an ED near you - 2002
Holden C - Drug Find Could Give Ravers the Jitters - 2002
Indig D, Thackway S, Jorm L, Salmon A, Owen T - Illicit drug-related harm during the Sydney 2000 Olympic Games: implications for public health surveillance and action - 2002
Iwata YT, Garcia A, Kanamori T, Inoue H, Kishi T, Lurie IS - The Use of a Highly Sulfated Cyclodextrin for the Simultaneous Chiral Separation of Amphetamine-Type Stimulants by Capillary Electrophoresis - 2002
Jiang XR, Dryhurst G - Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione - 2002
Johnson EA, Shvedova AA, Kisin E, O'Callaghan JP, Kommineni C, Miller DB, - d-MDMA During Vitamin E Deficiency: Effects on Dopaminergic Neurotoxicity and Hepatotoxicity - 2002
Johnson EA, O'Callaghan JP, Miller DB. - Chronic Treatment with Supraphysiological Levels of Corticosterone Enhances D-MDMA-Induced Dopaminergic Neurotoxicity in the C57BL/6J Female Mouse - 2002
Kanthasamy A, Sprague J, Shotwell J, Nichols D - Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum - 2002
Kelly PA, Ritchie IM, Quate L, McBean DE, Olverman HJ - Functional Consequences of Perinatal Exposure to 3,4-Methylenedioxymethamphetamine in Rat Brain - 2002
Kish SJ - How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? - 2002
Klitzman RL, Greenberg JD, Pollack LM, Dolezal C - MDMA ('ecstasy') use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City - 2002
Koesters SC, Rogers PD, Rajasingham CR - MDMA ('ecstasy') and other 'club drugs'. The new epidemic - 2002
Kraemer T, Maurer HH - Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives - 2002
Kupiec T, DeCicco L, Spiehler V, Sneed G, Kemp P - Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine - 2002
Lange-Brock N, Berg T, Muller AR, Fliege H, Neuhaus P, Wiedenmann B, Klapp BF, Monnikes H - Akutes Leberversagen nach dem Konsum von Ecstasy (MDMA) [Acute Liver ailure Following the Use of Ecstasy (MDMA)] - 2002
Leshner AI - What should the public be told about the risks of Ecstasy? - 2002
Lieb R, Schuetz, CG, Pfister H, von Sydow K, Wittchen H-U - Mental Disorders in Ecstasy Users; A Prospective-Longitudinal Investigation - 2002
Masi G, Mucci M, Floriani C - Acute catatonia after a single dose of ecstasy - 2002
Matuszewich L, Filon ME, Finn DA, Yamamoto BK - Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine - 2002
McElrath K, McEvoy K - Negative experiences on ecstasy: The role of drug, set and setting - 2002
Mechan A, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR - A Study of the Effect of a Single Neurotoxic Dose of 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') on the Subsequent Long-Term Behavior in the Plus Maze and Open Field - 2002
Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR - The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats - 2002
Meyer JS, Ali SF - Serotonergic Neurotoxicity of MDMA (Ecstasy) in the Developing Rat Brain - 2002
Meyer A, Mayerhofer A, Kovar K, Schmidt W - Rewarding Effects of the Optical Isomers of 3,4-Methylenedioxymethylamphetamine ('Ecstasy') and 3,4-Methylenedioxyethylamphetamine ('Eve') Measured by Conditioned Place Preference in Rats - 2002
Meyer A, Mayerhofer A, Kovar K, Schmidt W - Enantioselective Metabolism of the Designer Drugs 3,4-Methylenedioxymethamphetamine ('Ecstasy') and 3,4-Methylenedioxyethylamphetamine ('Eve') Isomers in Rat Brain and Blood - 2002
Moeller MR, Kraemer T - Drugs of abuse monitoring in blood for control of driving under the influence of drugs - 2002

Montiel-Duarte C, Varela-Rey M, Oses-Prieto JA, Lopez-Zabalza MJ, Beitia G, Cenarruzabeitia E, Iraburu MJ - 3,4-Methylenedioxymethamphetamine ("Ecstasy") Induces Apoptosis of Cultured Rat Liver Cells - 2002
Montoya AG, Sorrentino R, Lukas SE, Price BH - Long-Term Neuropsychiatric Consequences of 'Ecstasy' (MDMA): A Review - 2002
Morgan MJ, McFie L, Flettwood LH, Robinson JA - Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? - 2002
Morgan M - Throwing the baby out with the bathwater? - 2002
Morley-Fletcher S, Bianchi M, Gerra G, Laviola G - Acute and carryover effects in mice of MDMA ('ecstasy') administration during periadolescence - 2002
Mortier K, Maudens K, Lambert W, Clauwaert K, Van Bocxlaer J, Deforce D, Van Peteghem C, De Leenheer A - Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry - 2002
Murphy J, Flynn JJ, Cannon DM, Guiry PJ, McCormack P, Baird AW, McBean GJ, Keenan AK - In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine - 2002
Navarro JF, Maldonado E - Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze - 2002
Nunez O, Banares R, Barrio J, Menchen L, Diego A, Salinero E, Clemente G - [Variability of the clinical expression of Ecstasy-induced hepatotoxicity] - 2002
Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R - Specific neurotoxicity of chronic use of ecstasy - 2002
Osterhoudt KC - Experiencing Ecstasy: Is it all the Rave? - 2002
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Palmi I, Ortuno J, Menoyo E, Segura J, de la Torre R - Cell-Mediated Immune Response in MDMA Users After Repeated Dose Administration: Studies in Controlled Versus Noncontrolled Settings - 2002
Parrott AC - Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. - 2002
Parrott A - Very real, very damaging - 2002
Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J - Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users - 2002
Parry CD, Bhana A, Pluddemann A, Myers B, Siegfried N, Morojele NK, Flisher AJ, Kozel NJ - The South African Community Epidemiology Network on Drug Use (SACENDU): description, findings (1997-99) and policy implications - 2002
Pellegrini M, Rosati F, Pacifici R, Zuccaro R, Romolo FS, Lopez A - Rapid Screening Method for Determination of Ecstasy and Amphetamines in Urine Samples Using Gas Chromatography-Chemical Ionisation Mass Spectrometry - 2002
Peng W, Premkumar A, Mossner R, Fukuda M, Lesch KP, Simantov R - Synaptotagmin I and IV are differentially regulated in the brain by the recreational drug 3,4-methylenedioxymethamphetamine (MDMA) - 2002
Pichini S, Navarro M, Farre M, Ortuno J, Roset PN, Pacifici R, Zuccaro P, Segura J, de la Torre R - On-Site Testing of 3,4-Methylenedioxymethamphetamine (Ecstasy) in Saliva with Drugwipe and Drugread: A Controlled Study in Recreational Users - 2002
Piette V, Parmentier F - Analysis of illicit amphetamine seizures by capillary zone electrophoresis - 2002
Pizarro N, Ortuno J, Farre M, Hernandez-Lopez C, Pujadas M, Llebaria A, Joglar J. Roset PN. Mas M. Segura J. Cami J, de la Torre R - Determination of MDMA and its Metabolites in Blood and Urine by Gas Chromatography-Mass Spectrometry and Analysis of Enantiomers by Capillary Electrophoresis - 2002
Pompei P, Cavazzuti E, Martarelli D, Pediconi D, Arletti R, Lucas L, Massi M - Preprotachykinin A gene expression after administration of 3,4- methylene dioxymethamphetamine (Ecstasy) - 2002
Raikos N, Tsoukali H, Psaroulis D, Vassiliadis N, Tsoungas M, Njau S - Amphetamine derivative related deaths in northern Greece - 2002
Ramamoorthy Y, Yu A, Suh N, Haining RL, Tyndale RF, Sellers EM - Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro - 2002
Reneman L, Majoie CB, Flick H, den Heeten GJ - Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4- Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results - 2002
Reneman L,, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff F, Booij J - The acute and chronic effects of MDMA (“Ecstasy”) on cortical 5-HT - 2002
Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W - Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study-- preliminary report - 2002
Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA - Validity of [123I]beta-CIT SPECT in Detecting MDMA-Induced Serotonergic Neurotoxicity - 2002
Riba J, Anderer P, Morte A, Urbano G, JanГ© F, Saletu B, Barbanoj MJ - Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers - 2002
Riba J, Rodriguez-Fornells A, Barbanoj MJ - Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively - 2002
Rothman R, Baumann M - Therapeutic and Adverse Actions of Serotonin Transporter Substrates - 2002
Samyn N, De Boeck G, Wood M, Lamers C, De Waard D, Brookhuis K, Verstraete A, Riedel W - Plasma, Oral Fluid and Sweat Wipe Ecstasy Concentrations in Controlled and Real Life Conditions - 2002
Schmidt WJ, Mayerhofer A, Meyer A, Kovar KA - Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? - 2002
Simon NG, Mattick RP - The Impact of Regular Ecstasy Use on Memory Function - 2002
Skender L,. Karacic VV, Brcic II, Bagaric A. - Quantitative determination of amphetamines, cocaine, and opiates in human hair by gas chromatography/mass spectrometry - 2002
Smith KM, Larive LL, Romanelli F - Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate - 2002
Stock SL, Goldberg E, Corbett S, Katzman DK - Substance use in female adolescents with eating disorders - 2002
Strote J - Increasing MDMA use among college students: results of a national survey - 2002
Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, Thomasius R - Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users - 2002
Sue YM, Lee YL, Huang JJ - Acute Hyponatremia, Seizure, and Rhabdomyolysis after Ecstasy Use - 2002
Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA - Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions - 2002
Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH - Cognitive Performance of MDMA-Treated Rhesus Monkeys: Sensitivity to Serotonergic Challenge - 2002
ten Berge J - Jekyll and Hyde revisited: paradoxes in the appreciation of drug experiences and their effects on creativity. - 2002
Thiriet N, Ladenheim B, McCoy MT, Cadet JL - Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex - 2002
Traub SJ, Hoffman RS, Nelson LS - The "Ecstasy" Hangover: Hyponatremia Due to 3,4-Methylenedioxymethamphetamine - 2002
Vandeputte C, Docherty JR - Vascular actions of 3,4-methylenedioxymethamphetamine in alpha(2A/D)-adrenoceptor knockout mice - 2002
Vastag B - What should the public be told about the risks of Ecstasy? (3) - 2002
Verheyden SL, Hadfield J, Calin T, Curran HV - Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, 'ecstasy') on mood: evidence of gender differences - 2002
Vollenweider FX, Liechti ME, Gamma A, Greer G, Geyer M - Acute Psychological and Neurophysiological Effects of MDMA in Humans - 2002
von Sydow K, Lieb R, Pfister H, Hofler M, Wittchen H-U - Use, Abuse and Dependence of Ecstasy and Related Drugs in Adolescents and Young Adults—A Transient Phenomenon? Results From a Longitudinal Community Study - 2002
Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H - Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans - 2002
Whitworth TL, Herndon LC, Quick MW - Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons - 2002
Winsauer PJ, McCann UD, Yuan J, Delatte MS, Stevenson MW, Ricaurte GA, Moerschbaecher JM - Effects of Fenfluramine, m-CPP and Triazolam on Repeated-Acquisition in Squirrel Monkeys Before and After Neurotoxic MDMA Administration - 2002
Won L, Bubula N, Heller A - Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three- dimensional reaggregate tissue culture - 2002
Yacoubian GS, Arria AM, Fost E, Wish ED - Estimating the Prevalence of Ecstasy Use Among Juvenile Offenders - 2002
Yacoubian GS - Assessing the temporal relationship between race and ecstasy use among high school seniors - 2002
Young R, Glennon RA - The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinoline is similar to that of cocaine but different from that of amphetamine - 2002
Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA - Effect of Depleting Vesicular and Cytoplasmic Dopamine on Methylenedioxymethamphetamine Neurotoxicity - 2002
Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA - Effect of Glucoprivation on Serotonin Neurotoxicity Induced by Substituted Amphetamines - 2002
Zagnoni PG, Albano C - Psychostimulants and epilepsy - 2002
Zakzanis KK, Young DA, Radkhoshnoud NF - Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users - 2002
Anderson KL, Itzhak Y - Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice. - 2003 Aug
Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE - Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. - 2003 Nov
Ball KT, Budreau D, Rebec GV - Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors. - 2003 Dec 24
Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS - Heat Increases 3,4-Methylenedioxymethamphetamine self-administration and social effects in rats. - 2003
Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC - Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM. - Jul 2003
Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J - Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy"). - 2003 Nov
Finsterer J, Stollberger C, Steger C, Kroiss A - Long lasting impaired cerebral blood flow after ecstasy intoxication. - 2003
Fornai F, Lazzeri G, Lenzi P, Gesi M, Ferrucci M, Soldani P, Pellegrini A, Capobianco L, De Blasi A, Ruggieri S, Paparelli A - Amphetamines induce ubiquitin-positive inclusions within striatal cells. - 2003 Oct
Garcia-Repetto R, Moreno E, Soriano T, Jurado C, Gimenez, MP, Menendez M - Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose. - 2003 Aug 12
Gonzalez-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M, Weisstaub N, Hen R, Gingrich JA, Sealfon SC - Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. - 2003
Koprich JB, Campbell NG, Lipton JW - Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. - 2003 Dec 30
Lai TI, Hwang JJ, Fang CC, Chen WJ - Methylene 3, 4 dioxymethamphetamine-induced acute myocardial infarction. - 2003 Dec
Marek GJ - Behavioral evidence for mu-opioid and 5-HT2A receptor interactions. - 2003 Aug 1
Mithoefer M, Jerome L, Doblin R - MDMA ("ecstasy") and neurotoxicity. - 2003 Jun 6
O'Suilleabhain P, Giller C - Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs. - 2003
Peters FT, Samyn N, Wahl M, Kraemer T, De Boeck G, Maurer HH - Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. - 2003
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC - Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A web-based study - Dec 2003
Schifano F, Leoni M, Martinotti G, Rawaf S, Rovetto F - Importance of Cyberspace for the Assessment of the Drug Abuse Market: Preliminary Results from the Psychonaut 2002 Project - 2003
Sprague JE, Preston AS, Leifheit M, Woodside B - Hippocampal Serotonergic Damage Induced by MDMA (Ecstasy): Effects on Spatial Learning - 2003
Vallee JN, Crozier S, Guillevin R, Obadia M, Lo D, Barragan-Campos HM, Samson Y, Chiras J - Acute Basilar Artery Occlusion Treated by Thromboaspiration in a Cocaine and Ecstasy Abuser - 2003
Wakonigg G, Sturm K, Saria A, Zernig G - Methylenedioxymethamphetamine (MDMA, 'Ecstasy') Serves as a Robust Positive Reinforcer in a Rat Runway Procedure - Dec 2003
Yin Foo Lee G, Wooi Kee Gong G, Vrodos N, Patrick Brophy B - 'Ecstasy'-induced subarachnoid haemorrhage: an under-reported neurological complication? - 2003 Nov
Zghoul T, Blier P - Enhancing Action of LSD on Neuronal Responsiveness to Serotonin in a Brain Structure Involved in Obsessive-Compulsive Disorder - 2003
Achat-Mendes C, Anderson KL, Itzhak Y - Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood - 2003
Arrue A, Ruiz-Ortega JA, Ugedo L, Giralt MT - Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat - 2003
Auer J, Berent R, Weber T, Lassnig E, Eber B - Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult - 2003
Banjaw MY, Mayerhofer A, Schmidt WJ - Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat - 2003
Blessing WW, Seaman B, Pedersen NP, Ootsuka Y - Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats - 2003
Bogen IL, Haug KH, Myhre O, Fonnum F - Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo - 2003
Bond AJ, Verheyden SL, Wingrove J, Curran HV - Angry cognitive bias, trait aggression and impulsivity in substance users - 2003
Borg J, AndrГ©e B, Soderstrom H, Farde L - The serotonin system and spiritual experiences - 2003
Bowyer JF, Young JF, Slikker W, Itzak Y, Mayorga AJ, Newport GD, Ali SF, Frederick DL, Paule MG - Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations - 2003
Boyd CJ, McCabe SE, d'Arcy H - Ecstasy Use Among College Undergraduates: Gender, Race and Sexual Identity - 2003
Boys A, Marsden J - Perceived Functions Predict Intensity of Use and Problems in Young Polysubstance Users - 2003
Brazier WJ, Dhariwal DK, Patton DW, Bishop K - Ecstasy related periodontitis and mucosal ulceration - a case report - 2003
Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M - Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET - 2003
Budisavljevic MN, Stewart L, Sahn SA, Ploth DW - Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ('Ecstasy') abuse - 2003
Bull EJ, Hutson PH, Fone KC - Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT(2C) receptor responsivity - 2003
Carter JF, Sleeman R, Parry J - The distribution of controlled drugs on banknotes via counting machines - 2003
Cleary L, Docherty JR - Actions of Amphetamine Derivatives and Cathinone at the Noradrenaline Transporter - 2003
Cole JC, Sumnall HR - Altered States: The Clinical Effects of Ecstasy - 2003
Cole JC, Sumnall HR - The Pre-Clinical Behavioural Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA) - 2003
Compan V, Scearce-Levie K, Crosson C, Daszuta A, Hen R - Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine - 2003
Cowan RL, Lyooa IK,Sunga SM, Ahna KH, Kima MJ, Hwangc J, Hagaa E, Vimala RLP, Lukasb SE, Renshawa PF - Reduced Cortical Gray Matter Density in Human MDMA (Ecstasy) Users: A Voxel-Based Morphometry Study - 2003
Dafters RI, Hoshi R, Talbot AC - Contribution of Cannabis and MDMA ('Ecstasy') to Cognitive Changes in Long-Term Polydrug Users - 2004
Dafters RI, Biello SM - The effect of 3,4-methylenedioxymethamphetamine (\'Ecstasy\') on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia - 2003
Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van Calenbergh S, De Leenheer AP - Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study - 2003
Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E - Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study - 2003
Daumann J, Schnitker R, Weidemann J, Schnell K, Thron A, Gouzoulis-Mayfrank E - Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users - 2003
de Almeida SP, Silva MT - Ecstasy (MDMA): effects and patterns of use reported by users in SГЈo Paulo - 2003
De Letter EA, Espeel MF, Craeymeersch ME, Lambert WE, Clauwaert KM, Dams R, Mortier KA, Piette MH - Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland - 2003
Descroix S, Varenne A, Geiser L, Cherkaoui S, Veuthey JL, Gareil P. - Influence of electrolyte nature on the separation selectivity of amphetamines in nonaqueous capillary electrophoresis: protonation degree versus ion pairing effects - 2003
Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JR, Robertson MD, Swann P - The incidence of drugs in drivers killed in Australian road traffic crashes - 2003
Dundes L - DanceSafe and ecstasy: protection or promotion? - 2003
Easton N, Fry J, O'Shea E, Watkins A, Kingston S, Marsden CA - Synthesis, in Vitro Formation, and Behavioural Effects of Glutathione Regioisomers of alpha-Methyldopamine with Relevance to MDA and MDMA (Ecstasy) - 2003
Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH - Pharmacological Characterization of the Effects of 3,4-Methylenedioxymethamphetamine ("Ecstasy") and its Enantiomers on Lethality, Core Temperature, and Locomotor Activity in Singly Housed and Crowded Mice - 2003
Fernandez F, Porras G, MormA?de P, Spampinato U, Chaouloff F - Effects of 3,4-Methylenedioxymethamphetamine on Locomotor Activity and Extracellular Dopamine in the Nucleus Accumbens of Fischer 344 and Lewis Rats - 2003
Ferrucci M, Gesi M, Lenzi P, Soldani P, Ruffoli R, Pellegrini A, Ruggieri S, Paparelli A, Fornai F - Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls - 2003
Fornai F, Lenzi P, Frenzilli G, Gesi M, Ferrucci M, Lazzeri G, Biagioni F, Nigro M, Falleni A, Giusiani M, Pellegrini A, Blandini F, Ruggieri S, Paparelli A - DNA Damage and Ubiquitinated Neuronal Inclusions in the Substantia Nigra and Striatum of Mice Following MDMA (Ecstasy) - 2004
Forrest AR - Dataset on deaths related to taking ecstasy looks incomplete - 2003
Frishman WH, Del Vecchio A, Sanal S, Ismail A - Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine - 2003
Fucci N, De Giovanni N, Chiarotti M - Simultaneous detection of some drugs of abuse in saliva samples by SPME technique - 2003
Gerra G, Bassignana S, Zaimovic A, Moi G, Bussandri M, Caccavari R, Brambilla F, Molina E - Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (\'ecstasy\') use history: correlation with dopamine receptor sensitivity - 2003
Gimeno P, Besacier F, Chaudron-Thozet H - Optimization of extraction parameters for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets - 2003
Goodwin AK, Pynnonen DM, Baker LE - Serotonergic-dopaminergic Mediation of MDMA's Discriminative Stimulus Effects in a Three-choice Discrimination - 2003
Gordon J, Barnes NM - Lymphocytes Transport Serotonin and Dopamine: Agony or Ecstasy? - 2003
Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J - Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users - 2003
Grant I, Gonzalez R, Cary C, Natarajan L, Wolfson T - Non-acute (residual) neurocognitive effects of cannabis use: A meta-analysis study - 2003
Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI - The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") - 2003
Greene SL, Dargan PI, O\'connor N, Jones AL, Kerins M - Multiple toxicity from 3,4-methylenedioxymethamphetamine (\"ecstasy\") - 2003
Halpern JH - Hallucinogens: an Update - 2003
Hasler F , Grimberg U, Benz MA, Huber T, Vollenweider FX - Acute Psychological and Physiological Effects of Psilocybin in Healthy Humans: A Double-Blind, Placebo-Controlled Dose-Effect Dtudy - 2004
Huang YS, Liu JT, Lin LC, Lin CH - Chiral Separation of 3,4-Methylenedioxymeth-amphetamine and Related Compounds in Clandestine Tablets and Urine Samples by Capillary Electrophoresis/fluorescence Spectroscopy - 2003
Huang Z, Zhang S - Confirmation of Amphetamine, Methamphetamine, MDA and MDMA in Urine Samples Using Disk Solid-Phase Extraction and Gas Chromatography-Mass Spectrometry After Immunoassay Screening - 2003
Inman DS, Greene D - The agony and the ecstasy: acute urinary retention after MDMA abuse - 2003
Iravani MM, Jackson MJ, Kuoppamaki M, Smith LA, Jenner P - 3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates - 2003
Itzhak Y, Ali SF, Achat CN, Anderson KL - Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice - 2003
Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH - Preliminary evidence of hippocampal dysfunction in adolescent MDMA ('ecstasy') users: possible relationship to neurotoxic effects - 2003
Jorm LR, Thackway SV, Churches TR, Hills MW - Watching the Games: public health surveillance for the Sydney 2000 Olympic Games - 2003
Jovanovski D, Zakzanis KK - Donepezil in a chronic drug user--a potential treatment? - 2003
Kish SJ - What Is the Evidence That Ecstasy (MDMA) Can Cause Parkinson’s Disease? - 2003
Koprich JB, Chen EY, Kanaan NM, Campbell NG, Kordower JH, Lipton JW - Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats - 2003
Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R - Successful Treatment of Refractory Cerebral Oedema in Ecstasy/Cocaine-Induced Fulminant Hepatic Failure Using a New High-Efficacy Liver Detoxification Device (FPSA-Prometheus) - 2003
Kuniyoshi SM, Jankovic J - MDMA and Parkinsonism - 2003
Kwon C, Zaritsky A, Dharnidharka VR - Transient proximal tubular renal injury following Ecstasy ingestion - 2003
Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ - Dissociable Effects of a Single Dose of Ecstasy (MDMA) on Psychomotor Skills and Attentional Performance - 2003
Lebsanft HB, Mayerhofer A, Kovar KA, Schmidt WJ - Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent? - 2003
Lingford-Hughes A, Nutt D - Neurobiology of Addiction and Implications for Treatment - 2003
Lua AC, Lin HR, Tseng YT, Hu AR, Yeh PC - Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse - 2003
Lyles J, Cadet JL - Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms - 2003
Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, GutiГ©rrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schatz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B - CB1 cannabinoid receptors and on-demand defense against excitotoxicity - 2003
McCabe SE, Boyd C, Hughes TL, d'Arcy H - Sexual Identity and Substance Use Among Undergraduate Students - 2003
McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM, Cornish JL, Hunt GE - Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes - 2003
McGregor IS, Clemens KJ, Van Der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ - Increased Anxiety 3 Months after Brief Exposure to MDMA ('Ecstasy') in Rats: Association with Altered 5-HT Transporter and Receptor Density - 2003
Michael JC, Pak J, Pulido J, de Venecia G - Central serous chorioretinopathy associated with administration of sympathomimetic agents - 2003
Mills EM, Banks ML, Sprague JE, Finkel T - Pharmacology: Uncoupling the Agony from Ecstasy - 2003
Mlinar B, Corradetti R - Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons - 2003
Nordgren HK, Beck O - Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry - 2003
Oliveri M, Calvo G - Increased visual cortical excitability in ecstasy users: a transcranial magnetic stimulation study - 2003
Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J - Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users - 2003
Passie T, Karst M, Borsutzky M, Wiese B, Emrich HM, Schneider U - Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man - 2003
Peng W, Simantov R - Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: Differential regulation of GABA transporter subtypes - 2003
Peters FT, Maurer HH, Hellstern P - Prevalence of illicit drug use in plasmapheresis donors - 2003
Pichini S, Navarro M, Pacifici R, Zuccaro P, Ortuno J, Farre M, Roset PN, Segura J, de la Torre R - Usefulness of Sweat Testing for the Detection of MDMA After a Single-Dose Administration - 2003
Pizarro N, Llebaria A, Cano S, Joglar J, Farre M, Segura J, Torre Rd Rde L - Stereochemical Analysis of 3,4-Methylenedioxymethamphetamine and Its Main Metabolites by Gas Chromatography/mass Spectrometry - 2003
Preston NJ, Stirling ML, Perera K, Bell RJ, Harrison TJ, Whitworth L, Castle DJ - A Statewide Evaluation System for Early Psychosis - 2003
Pubill D, Canudas AM, Pallаs M, Camins A, Camarasa J, Escubedo E - Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity - 2003
Raikos N, Christopoulou K, Theodoridis G, Tsoukali H, Psaroulis D - Determination of amphetamines in human urine by headspace solid-phase microextraction and gas chromatography - 2003
Reijneveld SA, Crone MR, Verhulst FC, Verloove-Vanhorick SP - The effect of a severe disaster on the mental health of adolescents: a controlled study - 2003
Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ - Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics - 2003
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott A.C. - Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A Web-Based Study - 2003
Roiser JP, Sahakian BJ - Relationship between ecstasy use and depression: a study controlling for poly-drug use - 2004
Romanelli F, Smith KM, Pomeroy C - Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men - 2003
Ross MW, Mattison AM, Franklin DR - Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men - 2003
Saadat KS, Elliott JM, Colado MI, Green AR - Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs - 2003
Salzmann J, Marie-Claire C, Le Guen S, Roques BP, Noble F - Importance of ERK Activation in Behavioral and Biochemical Effects Induced by MDMA in Mice - 2003
Sanchez V, Camarero J, O\'Shea E, Green AR, Colado MI - Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats - 2003
Schifano F, Oyefeso A, Webb L, Pollard M, Corkery J, Ghodse AH - Review of Deaths Related to Taking Ecstasy, England and Wales, 1997-2000 - 2003
Schifano F, Oyefeso A, Corkery J, Cobain K, Jambert-Gray R, Martinotti G, Ghodse AH - Death Rates from Ecstasy (MDMA, MDA) and Polydrug Use in England and Wales 1996-2002 - 2003
Schmued LC - Demonstration and Localization of Neuronal Degeneration in the Rat Forebrain Following a Single Exposure to MDMA - 2003
Schneider RC, Kovar KA - Analysis of ecstasy tablets: comparison of reflectance and transmittance near infrared spectroscopy - 2003
Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL - 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro - 2003
Simonsen KW, Kaa E, Nielsen E, Rollmann D - Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000 - 2003
Stout PR, Klette KL, Wiegand R - Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine - 2003
Stuerenburg HJ, Petersen K, Buhmann C, Rosenkranz M, Baeumer T, Thomasius R - Plasma Amino Acids in Ecstasy Users - 2003
Swanston HY, Plunkett AM, O\'Toole BI, Shrimpton S, Parkinson PN, Oates RK - Nine years after child sexual abuse - 2003
Taffe MA, Huitron-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH - MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys - 2003
Tancer M, Johanson C-E - Reinforcing, Subjective, and Physiological Effects of MDMA in Humans: A Comparison with d-Amphetamine and mCPP - 2003
Timбr J, Gyarmati S, Szabу A, Fьrst S - Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives - 2003
Turner C, Russell A, Brown W - Prevalence of illicit drug use in young Australian women, patterns of use and associated risk factors - 2003
Underwood B, Fox K, Nixon PJ - Alcohol and Drug Use Among Vocational Dental Practitioners - 2003
Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bar PR, Nicolay K, Di Marzo V - Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases - 2003
Verbaten MN - Specific memory deficits in ecstasy users? The results of a meta-analysis - 2003
Verheyden SL, Henry JA, Curran HV - Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users - 2003
Verheyden SL, Maidment R, Curran HV - Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health - 2003
Vuori E, Henry JA, Ojanperä I, Nieminen R, Savolainen T, Wahlsten P, Jäntti M - Death following ingestion of MDMA (ecstasy) and moclobemide - 2003
Walters ST, Foy BD, Castro RJ - The agony of ecstasy: responding to growing MDMA use among college students - 2003
Weinbroum AA - Importance of early identification of methylenedioxymethamphetamine (\'ecstasy\') ingestion in victims of motor vehicle accidents - 2003
Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV - Developmental 3,4-Methylenedioxymethamphetamine (MDMA) Impairs Sequential and Spatial but not Cued Learning Independent of Growth, Litter Effects or Injection Stress - 2003
Won M, Minabe Y, Tani K, Suzuki K, Kawai M, Sekine Y, Ashby CR, Takei N, Mori N - The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats - 2003
Yacoubian GS, Boyle C, Harding CA, Loftus EA - It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees - 2003
Zhou W, Cunningham KA, Thomas ML - Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats - 2003
Zhou JF, Zhou YH, Zhang L, Chen HH, Cai D - 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage - 2003
Zhou JF, Chen P, Zhou YH, Zhang L, Chen HH - 3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage - 2003
Alting Von Geusau N, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof KR/Niels Alting von Geusau1, Pieter Stalenhoef1, Mariette Huizinga1, Jan Snel1 and K. Richard Ridderinkhof - Impaired Executive Function in Male MDMA ("Ecstasy") Users - Mar 18,2004
Armstrong BD, Noguchi KK - The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats. - 2004
Arrue A, GуҐє FM, Giralt MT - Effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') on the jaw-opening reflex and on the alpha-adrenoceptors which regulate this reflex in the anesthetized rat. - 2004
Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G - Effects of a Single Dose of 3,4-Methylenedioxymethamphetamine on Circadian Patterns, Motor Activity and Sleep in Drug-Naive Rats and Rats Previously Exposed to MDMA - May 2004
Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O'Keeffe M, Thomas SH - A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. - 2004
Beveridge TJ, Mechan AO, Sprakes M, Pei Q, Zetterstrom TS, Green AR, Elliott JM - Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain. - 2004 May
Bexis S, Phillis BD, Ong J, White JM, Irvine RJ - Baclofen prevents MDMA-induced rise in core body temperature in rats. - 2004 Apr 9
Blessing WW - Clozapine and olanzapine, but not haloperidol, reverse cold-induced and lipopolysaccharide-induced cutaneous vasoconstriction. - 2004 Oct
Bordo DJ, Dorfman MA - Ecstasy overdose: rapid cooling leads to successful outcome. - 2004 Jul
Brown PL, Kiyatkin EA - Brain Hyperthermia Induced by MDMA (Ecstasy): Modulation by Environmental Conditions. - 2004
Bubar MJ, Pack KM, Frankel PS, Cunningham KA - Effects of dopamine D(1)- or D(2)-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA. - 2004 May
Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M - A Voxel-Based PET Investigation of the Long-Term Effects of "Ecstasy" Consumption on Brain Serotonin Transporters - 2004
Bull EJ, Hutson PH, Fone KC - Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. - 2004 Feb
Butler GK, Montgomery AM - Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. - 2004 Oct 5
Carlson RG, Falck RS, McCaughan JA, Siegal HA - MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention. - 2004
Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX - Psilocybin impairs high-level but not low-level motion perception. - 2004
Carvalho M, Milhazes N, Remiao F, Borges F, Fernandes E, Amado F, Monks TJ, Carvalho F, Bastos ML - Hepatotoxicity of 3,4-Methylenedioxyamphetamine and alpha-Methyldopamine in Isolated Rat Hepatocytes: Formation of Glutathione Conjugates - 2004
Carvalho M, Remiao F, Milhazes N, Borges F, Fernandes E, Carvalho F, Bastos ML - The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. - 2004
Caslavska J, Thormann W - Monitoring of drugs and metabolites in body fluids by capillary electrophoresis with XeHg lamp-based and laser-induced fluorescence detection. - 2004
Clemens KJ, Van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS - MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. - 2004 May
Colado MI, O'Shea E, Green AR - Acute and Long-Term Effects of MDMA on Cerebral Dopamine Biochemistry and Function. - 2004 May
Connor TJ - Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system. - 2004
Connor TJ, Harkin A, Kelly JP - Methylenedioxymethamphetamine (MDMA; "Ecstasy") Suppresses Production of the Pro-Inflammatory Cytokine Tumor Necrosis Factor-{alpha} Independent of a {beta}-Adrenoceptor-Mediated Increase in Interleukin-10. - Aug 26,2004
Cosentino C - Ecstasy and Acute Dystonia - Sept 14 2004
Curran HV, Rees H, Hoare T, Hoshi R, Bond A - Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. - 2004 May
Daniela E, Brennan K, Gittings D, Hely L, Schenk S - Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. - 2004
Darvesh AS, Gudelsky GA - The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats. - 2004
Daumann J, Fischermann T, Pilatus U, Thron A, Moeller-Hartmann W, Gouzoulis-Mayfrank E - Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. - 2004
Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E - Neural Mechanisms of Working Memory in Ecstasy (MDMA) Users Who Continue or Discontinue Ecstasy and Amphetamine Use: Evidence from an 18-Month Longitudinal functional magnetic resonance imaging Study - 2004
Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E - Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. - 2004
Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E - Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. - 2004 Sep 15
De Win MM, Reneman L, Reitsma JB, Den Heeten GJ, Booij J, Van Den Brink W - Mood Disorders and Serotonin Transporter Density in Ecstasy Users-The Influence of Long-Term Abstention, Dose, and Gender - 2004
De Micheli D, Formigoni ML - Drug use by Brazilian students: associations with family, psychosocial, health, demographic and behavioral characteristics. - 2004 May
Delgado JH, Caruso MJ, Waksman JC, Honigman B, Stillman D - Acute, transient urinary retention from combined ecstasy and methamphetamine use. - 2004 Feb
Fantegrossi WE, Kiessel CL, Leach PT, Martin CV, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH - Nantenine: an Antagonist of the Behavioral and Physiological Effects of MDMA in Mice - May 2004
Fantegrossi WE, Woods JH, Winger G - Transient Reinforcing Effects of Phenylisopropylamine and Indolealkylamine Hallucinogens in Rhesus Monkeys - Mar 2004
Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA - Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004). - 2004 Oct
Farre M, De La Torre R, O Mathuna B, Roset PN, Peiro AM, Torrens M, Ortuna J, Pujadas M, Cami J - Repeated Doses Administration of MDMA in Humans: Pharmacological Effects and Pharmacokinetics - May 2004
Fisk JE, Montgomery C, Murphy P, Wareing M - Evidence for executive deficits among users of MDMA (Ecstasy). - 2004
Frecska E, White KD, Luna LE - Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation. - 2004 Apr
Gamma A - Keeping a clear head on effects of illicit drugs. - 2004
Gamma A, Lehmann D, Frei E, Iwata K, Pascual-Marqui RD, Vollenweider FX - Comparison of Simultaneously Recorded [H2(15)O]-PET and LORETA During Cognitive and Pharmacological Activation - 2004
Garcia-Osta A, Del RнЇ J, Frechilla D - Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus. - 2004
Gesi M, Ferrucci M, Giusiani M, Lenzi P, Lazzeri G, Alessandri MG, Salvadorini A, Fulceri F, Pellegrini A, Fornai F, Paparelli A - Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice. - 2004
Green AR, Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI - Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. - 2004 May
Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd DA - Reply to Lyvers and Hasking (2004). - 2004
Hanson KL, Luciana M - Neurocognitive Function in Users of MDMA: The Importance of Clinically Significant Patterns of Use - Feb 2004
Hasler F , Grimberg U, Benz MA, Huber T, Vollenweider FX - Acute Psychological and Physiological Effects of Psilocybin in Healthy Humans: A Double-Blind, Placebo-Controlled Dose-Effect Dtudy - 2004
Heekeren K, Daumann J, Geyer MA, Gouzoulis-Mayfrank E - Plasticity of the Acoustic Startle Reflex in Currently Abstinent Ecstasy (MDMA) Users - May 2004
Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA - Role of the serotonin 5-HT(2A) receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. - 2004 10 23
Heydari A, Rowland Yeo K, Lennard M, Ellis SW, Tucker G, Rostami-Hodjegan A - The Mechanism-Based Inactivation of CYP2D6 by Methylenedioxymethamphetamine (MDMA) - 2004
Ho YJ, Pawlak CR, Guo L, Schwarting RK - Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. - 2004
Hoshi R, Bisla J, Curran HV - The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings. - 2004
Hrometz SL, Brown AW, Nichols DE, Sprague JE - 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Mediated Production of Hydrogen Peroxide in an in vitro Model: The Role of Dopamine, the Serotonin-Reuptake Transporter, and Monoamine Oxidase-B - Aug 26,2004
Jerome L, Doblin R, MIthoefer M - Ecstasy use-Parkinson's disease link tenuous - 2004
Johnson EA, O'Callaghan JP, Miller DB - Brain Concentrations of d-MDMA are Increased After Stress. - 2004 May
Jones DC, Lau SS, Monks TJ - THIOETHER METABOLITES OF MDA AND MDMA INHIBIT hSERT FUNCTION AND SIMULTANEOUSLY STIMULATE DOPAMINE UPTAKE INTO hSERT-EXPRESSING SK-N-MC CELLS. - 2004 May 28: Published on-line
Kalasinsky KS, Hugel J, Kish SJ - Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). - 2004
Keizers PH, Lussenburg BM, de Graaf C, Mentink LM, Vermeulen NP, Commandeur JN - Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism. - 2004
Khorana N, Pullagurla MR, Young R, Glennon RA - Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization. - 2004
Lora-Tamayo C, Tena T, Rodriguez A, Moreno D, Sancho JR, Ensenat P, Muela F - The designer drug situation in Ibiza. - 2004 Mar 10
Lyvers M, Hasking P - Have Halpern et al. (2004) Detected 'Residual Neuropsychological Effects' of MDMA? Not Likely. - 2004
Maurer HH, Kraemer T, Springer D, Staack RF - Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. - 2004 Apr
McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C - Chronic MDMA (ecstasy) use, cognition and mood. - 2004 May
Meyer JS, Grande M, Johnson K, Ali SF - Neurotoxic Effects of MDMA ("Ecstasy") Administration to Neonatal Rats. - 2004
Milani RM, Parrott AC, Turner JJ, Fox HC - Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. - 2004
Mills EM, Rusyniak DE, Sprague JE - The Role of the Sympathetic Nervous System and Uncoupling Proteins in the Thermogenesis Induced by 3,4-Methylenedioxymethamphetamine. - 2004
Moeller FG, Steinberg JL, Dougherty DM, Narayana PA, Kramer LA, Renshaw PF - Functional MRI study of working memory in MDMA users. - 2004
Montiel-Duarte C, Ansorena E, Lopez-Zabalza MJ, Cenarruzabeitia E, Iraburu MJ - Role of Reactive Oxygen Species, Glutathione and NF-kappaB in Apoptosis Induced by 3,4-Methylenedioxymethamphetamine ("Ecstasy") on Hepatic Stellate Cells - 2004
Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS - Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats. - 2004 Jun
Moyano S, Frechilla D, Del RнЇ J - NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment. - 2004 May
Nair SG, Gudelsky GA - Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat. - 2004
Navarro JF, Rivera A, Maldonado E, Cavas M, de la Calle A - Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala. - 2004 Mar
Nichols DE - Hallucinogens. - 2004
O'Regan MC, Clow A - Decreased pain tolerance and mood in recreational users of MDMA. - 2004 May
O'Suilleabhain P, Giller C - Ecstasy Use-Parkinson's Disease Link Tenuous - Sept 14 2004
Ootsuka Y, Nalivaiko E, Blessing WW - Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine. - 2004
Orio L, O'Shea E, Sanchez V, Pradillo JM, Escobedo I, Camarero J, Moro MA, Green AR, Colado MI - 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. - 2004
Pacifici R, Pichini S, Zuccaro P, Farre M, Segura M, Ortuno J, Di Carlo S, Bacosi A, Roset P, Segura J, De La Torre R - Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Humans - 2004
Parrott AC - Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. - 2004 May
Parrott AC - MDMA and the Loss of Reinforcement in Fantegrossi et al (2004). - 2004 Oct
Parrott AC, Gouzoulis-Meyfrank E, Rodgers J, Solowij N - Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects. - 2004 Dec
Parrott AC - MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves. - 2004
Parry CD, Myers B, Morojele NK, Flisher AJ, Bhana A, Donson H, Pl?nn A - Trends in adolescent alcohol and other drug use: findings from three sentinel sites in South Africa (1997-2001). - 2004
Piper BJ, Meyer JS - Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. - 2004
Pizarro N, Farre M, Pujadas M, Peiro AM, Roset PN, Joglar J, De La Torre R - Stereochemical Analysis of 3,4-Methylenedioxymethamphetamine and Its Main Metabolites in Human Samples Including the Catechol-Type Metabolite (3,4-Dihydroxymethamphetamine). - 2004
Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA - MDMA "Ecstasy" Alters Hyperactive and Perseverative Behaviors in Dopamine Transporter Knockout Mice - May 2004
Quate L, McBean DE, Ritchie IM, Olverman HJ, Kelly PA - Acute Methylenedioxymethamphetamine Administration: Effects on Local Cerebral Blood Flow and Glucose Utilisation in the Dark Agouti Rat - May 2004
Ricaurte GA - MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities. Brendon P. Boot, Annis O. Mechan, Una D. McCann, George A. Ricaurte [Eur. J. Pharmacol. 453 (2002) 239-244]. - 2004
Robledo P, Balerio G, Berrendero F, Maldonado R - Study of the Behavioural Responses Related to the Potential Addictive Properties of MDMA in Mice - 2004
Robledo P, Mendizabal V, Ortun? S, de la Torre R, Kieffer BL, Maldonado R - The Rewarding Properties of MDMA are Preserved in Mice Lacking mu-Opioid Receptors - Aug 2004
Roiser JP, Sahakian BJ - Relationship between ecstasy use and depression: a study controlling for poly-drug use - 2004
Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P - MDMA-evoked changes in cerebral blood flow in living porcine brain: Correlation with hyperthermia. - 2004
Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P - MDMA-evoked changes in [(11)C]raclopride and [(11)C]NMSP binding in living pig brain. - 2004
Rusch M, Lampinen TM, Schilder A, Hogg RS - Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role. - 2004
Rusyniak DE, Tandy SL, Kamendulis LM, Sprague JE, Klaunig JE - The Effects of Ecstasy (MDMA) on Rat Liver Bioenergetics. - 2004
Saldana SN, Barker EL - Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake. - 2004 Jan 16
Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR - Effect of Repeated ('Binge') Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-HT and Dopamine Neurones. - 2004
Schifano F - A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. - 2004 May
Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J - Increased Intensity of Ecstasy and Polydrug Usage in the More Experienced Recreational Ecstasy/MDMA Users: A WWW Study - Jun 2004
Simantov R, Peng W - MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission. - 2004 Apr 9
Singer LT, Linares TJ, Ntiri S, Henry R, Minnes S - Psychosocial profiles of older adolescent MDMA users. - 2004
Sprague JE, Brutcher RE, Mills EM, Caden D, Rusyniak DE - Attenuation of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Induced Rhabdomyolysis with alpha1- plus beta3-Adrenoreceptor Antagonists. - Jun 2004
Sumnall HR, O'Shea E, Marsden CA, Cole JC - The Effects of MDMA Pretreatment on the Behavioural Effects of Other Drugs of Abuse in the Rat Elevated Plus-Maze Test - Apr 2004
Sumnall HR, Wagstaff GF, Cole JC - Self-Reported Psychopathology in Polydrug Users - 2004
Sveen ML, Knudsen GM, Aznar S - No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures. - 2004 May 13
Tan B, Foley P - Guttate psoriasis following Ecstasy ingestion. - 2004 Aug
Thomas DM, Dowgiert J, Geddes TJ, Francescutti-Verbeem D, Liu X, Kuhn DM - Microglial Activation is a Pharmacologically Specific Marker for the Neurotoxic Amphetamines - 2004
Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, McGregor IS - Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. - 2004 Apr
Vorhees CV, Reed TM, Skelton MR, Williams MT - Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning. - 2004
Wang X, Baumann MH, Xu H, Rothman RB - 3,4-Methylenedioxymethamphetamine (MDMA) Administration to Rats Decreases Brain Tissue Serotonin but not Serotonin Transporter Protein and Glial Fibrillary Acidic Protein - 2004
Wareing M, Fisk JE, Murphy P, Montgomery C - Verbal working memory deficits in current and previous users of MDMA. - 2004
Winsauer PJ, Quinton MS, Porter JR, Corll CB, Moerschbaecher JM, Delatte MS, Leonard ST, Stroble SB - Effects of MDMA Administration on Scopolamine-Induced Disruptions of Learning and Performance in Rats - 2004
Xie T, Tong L, McCann UD, Yuan J, Becker KG, Mechan AO, Cheadle C, Donovan DM, Ricaurte GA - Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons. - 2004 Aug 11
Yacoubian GS, Miller S, Pianim S, Kunz M, Orrick E, Link T, Palacios WR, Peters RJ - Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees. - 2004
Brookhuis KA, De Waard D, Samyn N - Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety - 2004
de la Torre R, Farrй M - Neurotoxicity of MDMA (ecstasy): the limitations of - 2004
De Win MM, Reneman L, Reitsma JB, Den Heeten GJ, Booij J, Van Den Brink W - Mood Disorders and Serotonin Transporter Density in Ecstasy Users-The Influence of Long-Term Abstention, Dose, and Gender - 2004
Falck RS, Carlson RG, Wang J, Siegal HA - Sources of Information About MDMA (3,4-Methylenedioxymethamphetamine): Perceived Accuracy, Importance, and Implications for Prevention Among Young Adult Users - 2004
Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G - Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys. - 2004
Pacifici R, Pichini S, Zuccaro P, Farre M, Segura M, Ortuno J, Di Carlo S, Bacosi A, Roset P, Segura J, De La Torre R - Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Humans - 2004
Parrott AC, Rodgers J, Buchanan T, Scholey AB, Heffernan T, Ling J - The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003) - 2004
Sumnall HR, Jerome L, Doblin R, Mithoefer MC - Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's Disorder, Psychomotor Problems and Dopaminergic Neurotoxicity in Recreational Ecstasy/MDMA Users. Psychopharmacology 167(4):449-450 - 2004
Wareing M, Murphy PN, Fisk JE - Visuospatial memory impairments in users of MDMA ('ecstasy') - 2004
Achat-Mendes C, Ali SF, Itzhak Y - Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. - 2005 Jun
Adams DH, Hanson GR, Keefe KA - 3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum. - 2005
Ball KT, Rebec GV - Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. - 2005 Oct
Banta-Green C, Goldbaum G, Kingston S, Golden M, Harruff R, Logan BK - Epidemiology of MDMA and Associated Club Drugs in the Seattle Area - 2005
Barbosa PC, Giglio JS, Dalgalarrondo P - Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. - 2005
Barrett SP, Gross SR, Garand I, Pihl RO - Patterns of simultaneous polysubstance use in Canadian rave attendees. - 2005
Bexis S, Docherty JR - Role of alpha(2A)-adrenoceptors in the effects of MDMA on body temperature in the mouse. - 2005
Bubenikova V, Votava M, Horacek J, Palenicek T - Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA). - 2005 Mar
Cadoni C, Solinas M, Pisanu A, Zernig G, Acquas E, Di Chiara G - Effect of 3,4-methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core. - 2005
Callaghan PD, Irvine RJ, Daws LC - Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. - 2005
Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX - Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT(2A) and 5-HT(1A) Agonist Psilocybin - 2005
Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX - Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors - 2005
Casco C, Forcella M, Beretta G, Grieco A, Campana G - Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials. - 2005
Clatts MC, Goldsamt LA, Yi H - Club Drug Use Among Young Men Who Have Sex With Men in NYC: A Preliminary Epidemiological Profile - 2005
Clemens KJ, Cornish JL, Li KM, Hunt GE, McGregor IS - MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. - 2005
Cohen MA, Skelton MR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT - Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood. - 2005 Sep 1
Cole JC, Michailidou K, Jerome L, Sumnall HR - The effects of stereotype threat on cognitive function in ecstasy users. - 2006
Cole JC, Sumnall HR, Smith GW, Rostami-Hodjegan A - Preliminary Evidence of the Cardiovascular Effects of Polysubstance Misuse in Nightclubs - 2005
Conductier G, Crosson C, Hen R, Bockaert J, Compan V - 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221. - 2005
Connor TJ, Harkin A, Kelly JP - Methylenedioxymethamphetamine Suppresses Production of the Proinflammatory Cytokine Tumor Necrosis Factor-alpha Independent of a beta-Adrenoceptor-Mediated Increase in Interleukin-10. - 2005
Crowley N - A role for psychedelics in psychiatry? - 2005 Nov
Dafters RI - Impulsivity, inhibition and negative priming in ecstasy users. - 2006
Darvesh AS, Yamamoto BK, Gudelsky GA - Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. - 2005
Darvesh AS, Gudelsky GA - Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT. - 2005
De Almeida SP, Silva MT - Characteristics of ecstasy users in Saio Paulo, Brazil. - 2005
De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W - The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. - 2005
Degenhardt L, Copeland J, Dillon P - Recent trends in the use of "club drugs": an Australian review. - 2005
Duarte JA, Leao A, Magalhaes J, Ascensao A, Bastos ML, Amado FL, Vilarinho L, Quelhas D, Appell HJ, Carvalho F - Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice. - 2005
Dyck E - Flashback: Psychiatric Experimentation With LSD in - 2005
Dyck E - Flashback: psychiatric experimentation with LSD in historical perspective. - 2005 Jun
Edwards G - A role for psychedelics in psychiatry? - 2005 Nov
Escobedo I, O'shea E, Orio L, Sanchez V, Segura M, de la Torre R, Farre M, Green AR, Colado MI - A Comparative Study on the Acute and Long-Term Effects of MDMA and 3,4-Dihydroxymethamphetamine (HHMA) on Brain Monoamine Levels After I.P. or Striatal Administration in Mice - 2005
Falck RS, Wang J, Carlson RG, Siegal HA - Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio. - 2005 May 25
Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH - Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. - 2005 Jun 28
Fernandez MI, Bowen GS, Varga LM, Collazo JB, Hernandez N, Perrino T, Rehbein A - High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami, Florida. - 2005
Fornai F, Lenzi P, Ferrucci M, Lazzeri G, di Poggio AB, Natale G, Busceti CL, Biagioni F, Giusiani M, Ruggieri S, Paparelli A - Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice. - 2005
Freezer A, Salem A, Irvine RJ - Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide. - 2005
Galineau L, Belzung C, Kodas E, Bodard S, Guilloteau D, Chalon S - Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat. - 2005
Gamma A, Jerome L, Liechti ME, Sumnall HR - Is Ecstasy Perceived to be Safe? A Critical Survey - Feb 14,2005
Gamma A, Brandeis D, Brandeis R, Vollenweider FX - The P3 in 'Ecstasy' Polydrug Users During Response Inhibition and Execution. - 2005
Gardani M, Blance RN, Biello SM - MDMA alters the response of the mammalian circadian clock in hamsters: effects on re-entrainment and triazolam-induced phase shifts. - 2005
Giorgi FS, Pizzanelli C, Ferrucci M, Lazzeri G, Faetti M, Giusiani M, Pontarelli F, Busceti CL, Murri L, Fornai F - Previous exposure to (+/-) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility. - 2005
Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J - Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use - 2005
Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Daumann J, Obradovic M, Kovar KA - Inhibition of Return in the Human 5HT(2A) Agonist and NMDA Antagonist Model of Psychosis. - 2006
Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA - Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers - 2005
Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E - Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex. - 2005 Sep
Guillot C - A clinical crossroads for MDMA. - 2005 Dec
Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG - Psychological and Cognitive Effects of Long-term Peyote Use Among Native Americans - Oct .15, 2005
Hendrickson JC, Gerstein DR - Criminal Involvement Among Young Male Ecstasy Users. - 2005
Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA - Role of the serotonin 5-HT(2A) receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. - 2005 Apr
Herning RI, Better W, Tate K, Cadet JL - Neuropsychiatric Alterations in MDMA Users: Preliminary Findings. - 2005 Aug
Herzig V, Capuani EM, Kovar KA, Schmidt WJ - Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats. - 2005
Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S, Singer EA, Sitte HH - Serotonin-Transporter Mediated Efflux: A Pharmacological Analysis of Amphetamines and Non-Amphetamines - 2005
Isbister GK, Buckley NA - The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. - 2005
Jaehne EJ, Salem A, Irvine RJ - Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation. - 2005
Jayanthi LD, Ramamoorthy S - Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. - 2005
Joe Laidler KA - The rise of club drugs in a heroin society: the case of Hong Kong. - 2005
Johanson CE, Kilbey M, Gatchalian K, Tancer M - Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. - 2006
Keizers PH, de Graaf C, de Kanter FJ, Oostenbrink C, Feenstra KA, Commandeur JN, Vermeulen NP - Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation. - 2005
Kelly BC - Conceptions of Risk in the Lives of Club Drug-Using Youth - 2005
Klingler W, Heffron JJ, Jurkat-Rott K, O'sullivan G, Alt A, Schlesinger F, Bufler J, Lehmann-Horn F - 3,4-Methylenedioxymethamphetamine (ecstasy) activates skeletal muscle nicotinic acetylcholine receptors - 2005
Koenig J, Lazarus C, Jeltsch H, Ben Hamida S, Riegert C, Kelche C, Jones BC, Cassel JC - MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females. - 2005 Jul
Kuypers KP, Ramaekers JG - Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine. - 2005
Lebsanft HB, Kohles T, Kovar KA, Schmidt WJ - 3,4-Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy. - 2005 Mar 1
Lebsanft HB, Kovar KA, Schmidt WJ - 3,4-Methylenedioxymethamphetamine and naloxone in rat rotational behaviour and open field. - 2005 May 23
Levy KB, O'Grady KE, Wish ED, Arria AM - An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students. - 2005
Liechti ME, Kunz I, Kupferschmidt H - Acute medical problems due to Ecstasy use. Case-series of emergency department visits. - 2005
Liechti ME, Kunz I, Kupferschmidt H - Acute medical problems due to Ecstasy use. Case-series of emergency department visits. - 2005 Oct 29
Lile JA, Ross JT, Nader MA - A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. - 2005
ter Bogt MTF, Engels RC - "Partying" Hard: Party Style, Motives for and Effects of MDMA Use at Rave Parties. - 2005
Marona-Lewicka D, Thisted RA, Nichols DE - Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. - 2005
Maxwell JC - Party drugs: properties, prevalence, patterns, and problems. - 2005
Maxwell JC, Spence RT - Profiles of club drug users in treatment. - 2005
McCaughan JA, Carlson RG, Falck RS, Siegal HA - From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States. - 2005
McElrath K - MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk. - 2005
Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA - Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons. - 2006
Medina KL, Shear PK, Corcoran K - Ecstasy (MDMA) Exposure and Neuropsychological Functioning: A Polydrug Perspective. - 2005
Mejias S, Rossignol M, Debatisse D, Streel E, Servais L, Guerit JM, Philippot P, Campanella S - Event-related potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task. - 2005
Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK - Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter. - 2005
Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN - Syllogistic reasoning performance in MDMA (Ecstasy) users. - 2005
Montgomery C, Fisk JE, Newcombe R, Murphy PN - The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. - 2005
Montgomery C, Fisk JE, Newcombe R - The nature of ecstasy-group related deficits in associative learning. - 2005
Morgan MJ, Impallomeni LC, Pirona A, Rogers RD - Elevated Impulsivity and Impaired Decision-Making in Abstinent Ecstasy (MDMA) Users Compared to Polydrug and Drug-Naive Controls. - 2005 Nov 9
Morley KC, Arnold JC, McGregor IS - Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. - 2005
Moyano S, Del Rio J, Frechilla D - Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits. - 2005
Nair SG, Gudelsky GA - 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. - 2005
O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI - Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. - 2005 Jul
O'Shea E, Sanchez V, Orio L, Escobedo I, Green AR, Colado MI - 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity. - 2005
Ompad DC, Galea S, Fuller CM, Edwards V, Vlahov D - Ecstasy Use Among Hispanic and Black Substance Users in New York City. - 2005
Palenicek T, Votava M, Bubenikova V, Horacek J - Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. - 2005
Parrott AC - Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. - 2005 Jan
Passie T, Hartmann U, Schneider U, Emrich, HM,Kruger, THC (2005) - Ecstasy (MDMA) mimics the post-orgasmic state: Impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion - 2005
Passie T, Karst M, Wiese B, Emrich HM, Schneider U - Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. - 2005
Patel MM, Belson MG, Wright D, Lu H, Heninger M, Miller MA - Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: An autopsy study. - 2005 Aug
Patel MM, Belson MG, Longwater AB, Olson KR, Miller MA - Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. - 2005 Nov
Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, de Boeck G, Maurer HH - Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs 3,4-Methylenedioxyamphetamine, 3,4-Methylenedioxymethamphetamine (MDMA), and 3,4-Methylenedioxyethylamphetamine and Its Application to Samples from a Controlled Study with MDMA - 2005
Pichini S, Abanades S, Farre M, Pellegrini M, Marchei E, Pacifici R, Torre Rde L, Zuccaro P - Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking. - 2005
Piper BJ, Fraiman JB, Meyer JS - Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. - 2005
Ramaekers JG, Kuypers KP - Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol - 2006
Ramos M, Goni-Allo B, Aguirre N - Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats. - 2005 May 28
Ramos M, Goni-Allo B, Aguirre N - Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. - 2005
Read T - A role for psychedelics in psychiatry? - 2005 Nov
Reveron ME, Monks TJ, Duvauchelle CL - Age-dependent (+)MDMA-mediated neurotoxicity in mice. - 2005
Rizzo M, Lamers CT, Sauer CG, Ramaekers JG, Bechara A, Andersen GJ - Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users. - 2005
Roiser JP, Cook LJ, Cooper JD, Rubinsztein DC, Sahakian BJ - Association of a Functional Polymorphism in the Serotonin Transporter Gene With Abnormal Emotional Processing in Ecstasy Users. - Mar 2005
Roiser JP, Rogers RD, Sahakian BJ - Neuropsychological Function in Ecstasy Users: A Study Controlling for Polydrug Use - 2005
Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA - Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. - 2006
Rusyniak DE, Tandy SL, Hekmatyar SK, Mills E, Smith DJ, Bansal N, MacLellan D, Harper ME, Sprague JE - The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis. - 2005
Saadat KS, O'shea E, Colado MI, Elliott JM, Green AR - The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature. - 2005
Sandison R - A role for psychedelics in psychiatry? - 2005 Nov
Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L - SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist. - 2005
Segura M, Farre M, Pichini S, Peiro AM, Roset PN, Ramirez A, Ortuno J, Pacifici R, Zuccaro P, Segura J, de la Torre R - Contribution of Cytochrome P450 2D6 to 3,4-Methylenedioxymethamphetamine Disposition in Humans : Use of Paroxetine as a Metabolic Inhibitor Probe - 2005
Seidel S, Singer EA, Just H, Farhan H, Scholze P, Kudlacek O, Holy M, Koppatz K, Krivanek P, Freissmuth M, Sitte HH - Amphetamines Take Two to Tango: an Oligomer-Based Counter-Transport Model of Neurotransmitter Transport Explores the Amphetamine Action. - 2005
Sessa B - Can Psychedelics Have a Role in Psychiatry Once Again? - 2005
Sessa B - Author's Reply - 2005
Sheridan RD, Turner SR, Cooper GJ, Tattersall JE - Effects of seven drugs of abuse on action potential repolarisation in sheep cardiac Purkinje fibres. - 2005
Shlosberg A, Strous RD - Long-term follow-up (32 Years) of PTSD in Israeli Yom Kippur War veterans. - 2005
Soellner R - Club drug use in Germany. - 2005
Sprague JE, Moze P, Caden D, Rusyniak DE, Holmes C, Goldstein DS, Mills EM - Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model. - 2005 Jun
Strous RD, Weiss M, Felsen I, Finkel B, Melamed Y, Bleich A, Kotler M, Laub D - Video Testimony of Long-Term Hospitalized Psychiatrically Ill Holocaust Survivors. - 2005 Dec
Stuckey DE, Lawson R, Luna LE - EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences. - 2005
Sumnall HR, Cole JC - Self-Reported Depressive Symptomatology in Community Samples of Polysubstance Misusers Who Report Ecstasy Use: A Meta-Analysis - 2005
Taffe MA, Lay CC, Von Huben SN, Davis SA, Crean RD, Katner SN - Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. - 2006
Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A - Mental Disorders in Current and Former Heavy Ecstasy (MDMA) Users - 2005
Tiangco DA, Lattanzio FA, Osgood CJ, Beebe SJ, Kerry JA, Hargrave BY - 3,4-Methylenedioxymethamphetamine Activates Nuclear Factor-kappaB, Increases Intracellular Calcium, and Modulates Gene Transcription in Rat Heart Cells - 2005
Verdejo-Garcia AJ, Lopez-Torrecillas F, Aguilar de Arcos F, Perez-Garcia M - Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. - 2005
Verrico CD, Miller GM, Madras BK - MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. - 2007
Vollenweider FX, Liechti ME, Paulus MP - MDMA Affects Both Error-Rate Dependent and Independent Aspects of Decision-Making in a Two-Choice Prediction Task - Dec 2005
Wang X, Baumann MH, Xu H, Morales M, Rothman RB - ({+/-})-3,4-Methylenedioxymethamphetamine (MDMA) Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter its Distribution Between Endosomes and the Plasma Membrane. - 2005
Wareing M, Fisk JE, Murphy P, Montgomery C - Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). - 2005
Williams MT, Schaefer TL, Ehrman LA, Able JA, Gudelsky GA, Sah R, Vorhees CV - 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. - 2005
Yip JT, Lee TM - Effect of ecstasy use on neuropsychological function: a study in Hong Kong. - 2005 May
de la Torre R, Farre M, O Mathuna B, Roset PN, Pizarro N, Segura M, Torrens M, Ortuno J, Pujadas M, Cami J - MDMA (Ecstasy) Pharmacokinetics in a CYP2D6 Poor Metaboliser and in Nine CYP2D6 Extensive Metabolisers - 2005
Able JA, Gudelsky GA, Vorhees CV, Williams MT - 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. - 2006 Jun 15
Ando RD, Benko A, Ferrington L, Kirilly E, Kelly PA, Bagdy G - Partial Lesion of the Serotonergic System by a Single Dose of MDMA Results in Behavioural Disinhibition and Enhances Acute MDMA-Induced Social Behaviour on the Social Interaction Test. - 2006
Baumann MH, Wang X, Rothman RB - 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. - 2007
Bexis S, Docherty JR - Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors. - 2006
Bishop C, Taylor JL, Kuhn DM, Eskow KL, Park JY, Walker PD - MDMA and Fenfluramine Reduce L-DOPA-Induced Dvia Indirect 5-HT1A Receptor Stimulation. - 2006
Blessing WW, Zilm A, Ootsuka Y - Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats. - 2006
Brennan KA, Schenk S - Initial deficit and recovery of function after MDMA preexposure in rats. - 2006
Brevard ME, Meyer JS, Harder JA, Ferris CF - Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy"). - 2006
Buchert R, Thomasius R, Petersen K, Wilke F, Obrocki J, Nebeling B, Wartberg L, Zapletalova P, Clausen M - Reversibility of Ecstasy-Induced Reduction in Serotonin Transporter Availability in Polydrug Ecstasy Users - 2006
Bull EJ, Porkess V, Rigby M, Hutson PH, Fone KC - Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain. - 2006 Mar
Callaghan PD, Farrand K, Salem A, Hughes P, Daws LC, Irvine RJ - Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. - 2006 Sep 28
Camarasa J, Pubill D, Escubedo E - Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. - 2006 Sep 21
Capela JP, Meisel A, Abreu AR, Branco PS, Ferreira LM, Lobo AM, Remiao F, Bastos ML, Carvalho F - Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. - 2006
Carlezon WA, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM - Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. - 2006 Jan
Chipana C, Camarasa J, Pubill D, Escubedo E - Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: Involvement of nicotinic receptors. - 2006 Sep
Clemens KJ, Cornish JL, Hunt GE, McGregor IS - Repeated weekly exposure to MDMA, methamphetamine or their combination: Long-term behavioural and neurochemical effects in rats. - 2006 Jul 31
Clemens KJ, Cornish JL, Hunt GE, McGregor IS - Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration. - 2006
Cole JC, Michailidou K, Jerome L, Sumnall HR - The effects of stereotype threat on cognitive function in ecstasy users. - 2006
Copeland J, Dillon P, Gascoigne M - Ecstasy and the concomitant use of pharmaceuticals. - 2006
Cowan RL - Neuroimaging research in human MDMA users: a review. - 2007
Cowan RL, Haga E, Frederick BD, Dietrich MS, Vimal RL, Lukas SE, Renshaw PF - MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users. - 2006
Dafters RI - Impulsivity, inhibition and negative priming in ecstasy users. - 2006
Dafters RI - Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions. - 2006 Jun 28
Daumann J, Till B, Fischermann T, Rezk M, Gouzoulis-Mayfrank E - Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study. - 2006 Mar
De La Garza R, Fabrizio KR, Gupta A - Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. - 2006 Feb 10
Di Benedetto M, D'addario C, Candeletti S, Romualdi P - Chronic and acute effects of 3,4-methylenedioxy-N-methylamphetamine ('Ecstasy') administration on the dynorphinergic system in the rat brain. - 2006
Dumont GJ, Verkes RJ - A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. - 2006
Fisk JE, Montgomery C, Wareing M, Murphy PN - The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? - 2006
Fletcher PJ, Sinyard J, Higgins GA - The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. - 2006
Freudenmann RW, Oxler F, Bernschneider-Reif S - The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents*. - 2006
Gonzalez D, Riba J, Bouso JC, Gomez-Jarabo G, Barbanoj MJ - Pattern of use and subjective effects of Salvia divinorum among recreational users. - 2006
Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Daumann J, Obradovic M, Kovar KA - Inhibition of Return in the Human 5HT(2A) Agonist and NMDA Antagonist Model of Psychosis. - 2006
Gouzoulis-Mayfrank E, Daumann J - The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. - 2006 Mar
Guillot C, Greenway D - Recreational ecstasy use and depression. - 2006 May
Guillot CR, Berman ME - MDMA (Ecstasy) use and psychiatric problems. - 2006 Oct 24
Hall AP, Henry JA - Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. - 2006
Han DD, Gu HH - Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. - 2006
Hopper JW, Su Z, Looby AR, Ryan ET, Penetar DM, Palmer CM, Lukas SE - Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: An ecological momentary assessment study. - 2006
Hoshi R, Pratt H, Mehta S, Bond AJ, Curran HV - An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences? - 2006 Mar
Huizink AC, Ferdinand RF, van der Ende J, Verhulst FC - Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study. - 2006 Feb 24
Huxster JK, Pirona A, Morgan MJ - The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. - 2006 Mar
Huxster JK, Pirona A, Morgan MJ - The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. - 2006
Irvine RJ, Keane M, Felgate P, McCann UD, Callaghan PD, White JM - Plasma drug concentrations and physiological measures in 'dance party' participants. - 2006
Johanson CE, Kilbey M, Gatchalian K, Tancer M - Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. - 2006
Kindlundh-Hogberg AM, Svenningsson P, Schioth HB - Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain. - 2006 Jun 30
Krebs-Thomson, Kirsten; Ruiz, Erbert M.; Masten, Virginia; Buell, Mahalah; Geyer, Mark A. - The Roles of 5-HT1A and 5-HT2 Receptors in the Effects of 5-MeO-DMT on Locomotor Activity and Prepulse Inhibition in Rats - Dec 2006
Lamers CT, Bechara A, Rizzo M, Ramaekers JG - Cognitive Function and Mood in MDMA/THC Users, THC Users and Non-Drug Using Controls - Mar 2006
Lerner M, Lyvers M - Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study - 2006
McNamara R, Kerans A, O'neill B, Harkin A - Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). - 2006
Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA - Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons. - 2006
Meyer JS, Brevard ME, Piper BJ, Ali SF, Ferris CF - Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys. - 2006
Moreno FA, Wiegand CB, Taitano EK, Delgado PL - Safety, tolerability and efficacy of psilocybin in 9 patients with Obsessive-Compulsive Disorder - 2006
Murphy PN, Wareing M, Fisk J - Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study. - 2006 May
Nair SG, Gudelsky GA - 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat. - 2006
Nutt DJ - A tale of two Es. - 2006 May
Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB - Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users - 2006
Parrott AC - MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. - 2006
Partilla JS, Dempsey AG, Nagpal AS, Blough BE, Baumann MH, Rothman RB - Interaction of amphetamines and related compounds at the vesicular monoamine transporter. - 2006
Pavarin RM - Substance use and related problems: a study on the abuse of recreational and not recreational drugs in Northern Italy. - 2006
Piper BJ, Meyer JS - Increased responsiveness to MDMA in adult rats treated neonatally with MDMA. - 2006
Piper BJ, Vu HL, Safain MG, Oliver AJ, Meyer JS - Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. - 2006
Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M - Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). - 2006 Jan 20
Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M - Memory Deficits in Abstinent MDMA (Ecstasy) Users: Neuropsychological Evidence of Frontal Dysfunction - May 2006
Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M - Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). - 2006 Jan 20
Ramaekers JG, Kuypers KP - Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol - 2006
Ramaekers JG, Kuypers KP, Samyn N - Stimulant Effects of 3,4-Methylenedioxymethamphetamine (MDMA) 75 mg and Methylphenidate 20 mg on Actual Driving During Intoxication and Withdrawal - 2006
Reay JL, Hamilton C, Kennedy D, Scholey AB - MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. - 2006 May
Reinhard C, Wolffgramm J - Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors. - 2006
Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O - Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. - 2006 May
Reveron ME, Maier EY, Duvauchelle CL - Experience-dependent changes in temperature and behavioral activity induced by MDMA. - 2006 Jul 26
Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA - Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-induced Effects on Locomotor Behavior Patterns in Mice - Nov 2006
Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Hefferman TM, Scholey AB - Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study - 2006
Roiser JP, Rogers RD, Cook LJ, Sahakian BJ - The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. - 2006
Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA - Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. - 2006
Saadat KS, Elliott JM, Colado MI, Green AR - The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice. - 2006 Mar
Saadat KS, Elliott JM, Green AR, Moran PM - High-dose MDMA does not result in long-term changes in impulsivity in the rat. - 2006
Schifano F, Corkery J, Deluca P, Oyefeso A, Ghodse AH - Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). - 2006 May
Sessa B - From Sacred Plants to Psychotherapy: The History and Re-Emergence of - 2006
Sewell RA, Halpern JH, Pope HG - Response of cluster headache to psilocybin and LSD. - 2006
Smith RM, Tivarus M, Campbell HL, Hillier A, Beversdorf DQ - Apparent transient effects of recent "ecstasy" use on cognitive performance and extrapyramidal signs in human subjects. - 2006 Sep
Soar K, Turner JJ, Parrott AC - Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors. - 2006 May
Sumnall HR, Cole JC, Jerome L - The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. - 2006 Jan 9
Taffe MA, Lay CC, Von Huben SN, Davis SA, Crean RD, Katner SN - Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. - 2006
Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A - Mood, Cognition and Serotonin Transporter Availability in Current and Former Ecstasy (MDMA) Users: The Longitudinal Perspective - Mar 2006
Trachsel D, Hadorn M, Baumberger F - Synthesis of fluoro analogues of 3,4-(methylenedioxy)amphetamine (MDA) and its derivatives - 2006
Trigo JM, Panayi F, Soria G, Maldonado R, Robledo P - A reliable model of intravenous MDMA self-administration in naive mice. - 2006
Valdes IH, Steinberg JL, Narayana PA, Kramer LA, Dougherty DM, Swann AC, Barratt ES, Moeller FG - Impulsivity and BOLD fMRI activation in MDMA users and healthy control subjects. - 2006
Van LM, Heydari A, Yang J, Hargreaves J, Rowland-Yeo K, Lennard MS, Tucker GT, Rostami-Hodjegan A - The Impact of Experimental Design on Assessing Mechanism-Based Activation of CYP2D6 by MDMA (Ecstasy). - Mar 10, 2006
Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA - Impact of Ambient Temperature on Hyperthermia Induced by (+/-)3,4-Methylenedioxymethamphetamine in Rhesus Macaques. - 2006 Apr 12
Warren MW, Zheng W, Kobeissy FH, Cheng Liu M, Hayes RL, Gold MS, Larner SF, Wang KK - Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. - 2006 Aug 2
White B, Degenhardt L, Breen C, Bruno R, Newman J, Proudfoot P - Risk and benefit perceptions of party drug use. - 2006
Wolff K, Tsapakis EM, Winstock AR, Hartley D, Holt D, Forsling ML, Aitchison KJ - Vasopressin and Oxytocin Secretion in Response to the Consumption of Ecstasy in a Clubbing Population - May 2006
Yang J, Jamei M, Heydari A, Yeo K, De La Torre R, Farre M, Tucker GT, Rostami-Hodjegan A - Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. - 2006 May 19
Yip JT, Lee TM - Selective impairment of sadness and disgust recognition in abstinent ecstasy users. - 2006
Zakzanis KK, Campbell Z - Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. - 2006 Mar 14
Zolkowska D, Rothman RB, Baumann MH - Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. - 2006
de Wit H - Towards a Science of Spiritual Experience - Jul 7, 2006
de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W - A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users - 2007
de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W - Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. - 2006 Mar
ter Bogt TF, Engels RC, Dubas JS - Party People: Personality and MDMA Use of House Party Visitors. - 2006 Jul
Acquas E, Pisanu A, Spiga S, Plumitallo A, Zernig G, Di Chiara G - Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core. - 2007 Jul
Alati R, Kinner SA, Hayatbakhsh MR, Mamun AA, Najman JM, Williams GM - Pathways to ecstasy use in young adults: Anxiety, depression or behavioural deviance? - 2007 Sep 10
Allott K, Redman J - Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? - 2007
Alves E, Summavielle T, Alves CJ, Gomes-da-Silva J, Barata JC, Fernandes E, Bastos Mde L, Tavares MA, Carvalho F - Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. - 2007
Ball KT, Walsh KM, Rebec GV - Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues. - 2007
Barbanoj MJ, Riba J, Clos S, Gimenez S, Grasa E, Romero S - Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers. - 2007
Brown J, Edwards M, McKone E, Ward J - A long-term ecstasy-related change in visual perception. - 2007 Apr 25
Callaghan PD, Owens WA, Javors MA, Sanchez TA, Jones DJ, Irvine RJ, Daws LC - In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function. - 2007
Chen HI, Kuo YM, Liao CH, Jen CJ, Huang AM, Cherng CG, Su SW, Yu L - Long-term Compulsive Exercise Reduces the Rewarding Efficacy of 3,4-Methylenedioxymethamphetamine. - 2008
Cho KO, Kim SK, Rhee GS, Kwack SJ, Cho DH, Sung KW, Kim SY - Chronic 3,4-methylenedioxymethamphetamine treatment suppresses cell proliferation in the adult mouse dentate gyrus. - 2007
Cowan RL - Neuroimaging research in human MDMA users: a review. - 2007
Cowan RL, Bolo NR, Dietrich M, Haga E, Lukas SE, Renshaw PF - Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users. - 2007 Aug 15
Crean RD, Davis SA, Taffe MA - Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques. - 2007 May
Droogmans S, Cosyns B, D'haenen H, Creeten E, Weytjens C, Franken PR, Scott B, Schoors D, Kemdem A, Close L, Vandenbossche JL, Bechet S, Van Camp G - Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease. - 2007
Escobedo I, Peraile I, Orio L, Colado MI, O'Shea E - Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain. - 2007 Jun
Fantegrossi WE - Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity? - 2007 Jan
Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC - Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT(1A) and 5-HT(2A) receptors in rodents. - 2007
Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC - Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT(1A) and 5-HT(2A) receptors in rodents. - 2008
Fantegrossi WE, Murnane KS, Reissig CJ - The behavioral pharmacology of hallucinogens. - 2007 Jul 20
Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza Ii R, Traynor JR, Woods JH - A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. - 2007
Frenzilli G, Ferrucci M, Giorgi FS, Blandini F, Nigro M, Ruggieri S, Murri L, Paparelli A, Fornai F - DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations. - 2007 Sep
Giannaccini, Gino; Betti, Laura; Pirone, Andrea; Palego, Lionella; Fabiani, Ortenzio; Fabbrini, Laura; Mascia, Giovanni; Giusti, Laura; Macchia, Marco; Giusiani, Mario; Martini, Claudia; Lucacchini, Antonio - Short-term Effects of 3,4-Methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) Receptors in the Rat Hippocampus - Dec 2007
Glennon RA, Young R, Dukat M, Chang-Fong J, El-Zahabi M - N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) Produce Non-Identical Discriminative Stimuli in Rats - Mar 2007
Golding JF, Groome DH, Rycroft N, Denton Z - Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls. - 2007
Goni-Allo B, O Mathuna B, Segura M, Puerta E, Lasheras B, de la Torre R, Aguirre N - The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity. - 2007
Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic, L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou G, Sealfon SG, Gingrich JA - Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior - 2007
Gordon CJ - Thermophysiological responses to hyperthermic drugs: extrapolating from rodent to human. - 2007
Gramsbergen JB, Cumming P - Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats. - 2007
Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL - 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. - 2007
Groth-Marnat G, Howchar H, Marsh A - Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users. - 2007
Guillot C - Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms - 2007
Guillot C, Berman ME, Abadie BR - The role of MDMA neurotoxicity in anxiety - 2007
Hamida SB, Plute E, Cosquer B, Kelche C, Jones BC, Cassel JC - Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects. - 2007
Heekeren K, Neukirch A, Daumann J, Stoll M, Obradovic M, Kovar KA, Geyer MA, Gouzoulis-Mayfrank E - Prepulse Inhibition of the Startle Reflex and its Attentional Modulation in the Human S-ketamine and N,N-dimethyltryptamine (DMT) Models of Psychosis. - 2007
Hewton R, Salem A, Irvine RJ - Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. - 2007
Hoshi R, Cohen L, Lemanski L, Piccini P, Bond A, Curran HV - Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls. - 2007
Izco M, Marchant I, Escobedo I, Peraile I, Delgado M, Higuera-Matas A, Olias O, Ambrosio E, O'Shea E, Colado MI - Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") exhibit increased ethanol consumption and preference. - 2007 Sep
Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V - Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. - 2007
Kalechstein AD, De La Garza R, Mahoney JJ, Fantegrossi WE, Newton TF - MDMA use and neurocognition: a meta-analytic review. - 2007
Kovacs GG, Ando RD, Adori C, Kirilly E, Benedek A, Palkovits M, Bagdy G - Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord. - 2007
Krupitsky, EM, Burakof AM, Dunaevsky IV, Romanova TN, Slavina TY, Grinenko AY - Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence - 2007
Kuypers KP, Wingen M, Samyn N, Limbert N, Ramaekers JG - Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. - 2007
Laws KR, Kokkalis J - Ecstasy (MDMA) and memory function: - 2007
Ludwig V, Mihov Y, Schwarting RK - Behavioral and Neurochemical Consequences of Multiple MDMA Administrations in the Rat: Role of Individual Differences in Anxiety-Related Behavior - Dec 23,2007
Martin TL, Chiasson DA, Kish SJ - Does Hyperthyroidism Increase Risk of Death Due to the Ingestion of Ecstasy - Jul 2007
Martins, Liliane Ferreira; Yegles, Michel; Samyn, Nele; Ramaekers, Johannes G.; Wennig R, Robert Wennig - Time-Resolved Hair Analysis of MDMA Enantiomers by GC/MS-NCI - Feb 12,2007
Moeller FG, Steinberg JL, Lane SD, Buzby M, Swann AC, Hasan KM, Kramer LA, Narayana PA - Diffusion tensor imaging in MDMA users and controls: association with decision making. - 2007
Montgomery C, Fisk J - Everyday memory deficits in ecstasy-polydrug users. - 2007
Montgomery T, Buon C, Eibauer S, Guiry PJ, Keenan AK, McBean GJ - Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [(3)H]noradrenaline and [(3)H]5-HT transport in mammalian cell lines. - 2007
Montgomery C, Fisk JE, Wareing M, Murphy P - Self reported sleep quality and cognitive performance in ecstasy users. - 2007
Nutt D - A reply from the editor - 2007
Nutt D, King LA, Saulsbury W, Blakemore C - Development of a Rational Scale to Assess the Harm of Drugs of Potential Misuse - 24 Mar 2007
Parrott AC - Ecstasy versus alcohol: Tolstoy and the variations of unhappiness. - 2007 Jan
Parrott AC - Alcohol, ecstasy, Aldous Huxley's 'soma'. - 2007 Jan
Parrott AC, Milani RM, Gouzoulis-Mayfrank E, Daumann J - Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. - 2007
Parrott AC - The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. - 2007
Peters FT, Samyn N, Kraemer T, Riedel WJ, Maurer HH - Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. - 2007
Rendell PG, Gray TJ, Henry JD, Tolan A - Prospective memory impairment in "ecstasy" (MDMA) users. - 2007
Rhinewine JP, Williams OJ - Holotropic Breathwork: the potential role of a prolonged, voluntary hyperventilation procedure as an adjunct to psychotherapy. - 2007
Rodriguez-Alarcon G, Canales JJ, Salvador A - Rewarding effects of 3,4-methylenedioxymethamphetamine ("Ecstasy") in dominant and subordinate OF-1 mice in the place preference conditioning paradigm. - 2007
Santos RG, Landeira-Fernandez J, Strassman RJ, Motta V, Cruz AP - Effects of Ayahuasca on Psychometric Measures of Anxiety, Panic-like and Hopelessness in Santo Daime Members. - 2007
Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC - MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. - 2007 Dec
Schilt T, de Win ML, Koeter M, Jager G, Korf DJ, Van den Brink W, Schmand B. - Cognition in novice ecstasy users with minimal exposure to other drugs; A prospective cohort study. - 2007
Schilt T, Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W - Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. - 2008
Sessa B, Nutt DJ - MDMA, politics and medical research: Have we thrown the baby out with the bathwater? - 2007
Sigafoos J, Green VA, Edrisinha C, Lancioni GE - Flashback to the 1960s: LSD in the treatment of autism. - 2007
Silins E, Copeland J, Dillon P - Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. - 2007
Soto-Montenegro ML, Vaquero JJ, Arango C, Ricaurte G, Garcia-Barreno P, Desco M - Effects of MDMA on blood glucose levels and brain glucose metabolism. - 2007 Jun
Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS - A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). - 2007
Tourino C, Ledent C, Maldonado R, Valverde O - CB(1)Cannabinoid Receptor Modulates 3,4-Methylenedioxymethamphetamine Acute Responses and Reinforcement. - 2007
Trigo JM, Renoir T, Lanfumey L, Hamon M, Lesch KP, Robledo P, Maldonado R - 3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice. - 2007
Valtier S, Phelix CF, Cody JT - Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA. - 2007 Apr
Verrico CD, Miller GM, Madras BK - MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. - 2007
Wang X, Baumann MH, Dersch CM, Rothman RB - Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of l-5-hydroxytryptophan. - 2007 Published Online Jul 11
Winter JC, Rice KC, Amorosi DJ, Rabin RA - Psilocybin-induced stimulus control in the rat. - 2007
Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G - Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines. - 2007 May 2
Yarosh HL, Katz EB, Coop A, Fantegrossi WE - MDMA-like behavioral effects of N-substituted piperazines in the mouse. - 2007 Nov
Yen CF, Hsu SY - Symptoms of Ecstasy Dependence and Correlation with Psychopathology in Taiwanese Adolescents. - Oct 2007
Young R, Glennon RA - MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice. - 2007
Young R, Glennon RA - MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice. - 2008
Zakzanis KK, Campbell Z, Jovanovski D - The neuropsychology of ecstasy (MDMA) use: a quantitative review. - 2007
de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W - A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users - 2007
Allott K, Canny BJ, Broadbear JH, Stepto NK, Murphy B, Redman J - Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users. - 2008 Jun 18
Banks ML, Czoty PW, Sprague JE, Nader MA - Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys. - 2008 Mar
Baumann MH, Clark RD, Franken FH, Rutter JJ, Rothman RB - Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. - 2008
Baumann MH, Clark RD, Rothman RB - Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. - 2008
Bedi G, Redman J - Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean? - 2010
Bedi G, Van Dam N, Redman J - Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use. - 2008
Bouso JC, Doblin R, Farre M, Alcazar MA, Gomez-Jarabo G - MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. - 2008
Busceti CL, Biagioni F, Riozzi B, Battaglia G, Storto M, Cinque C, Molinaro G, Gradini R, Caricasole A, Canudas AM, Bruno V, Nicoletti F, Fornai F - Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine ("Ecstasy"). - 2008 Mar 19
Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ - Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. - 2008 Jun 18
Chen HI, Kuo YM, Liao CH, Jen CJ, Huang AM, Cherng CG, Su SW, Yu L - Long-term Compulsive Exercise Reduces the Rewarding Efficacy of 3,4-Methylenedioxymethamphetamine. - 2008
Chipana C, Camarasa J, Pubill D, Escubedo E - Memantine prevents MDMA-induced neurotoxicity. - 2008
Chipana C, Garcia-Rates S, Camarasa J, Pubill D, Escubedo E - Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine. - 2008
Clark L, Roiser JP, Robbins TW, Sahakian BJ - Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users. - 2008
Craig L, Fisk J, Montgomery C, Murphy P, Wareing M - Is emotional intelligence impaired in ecstasy-polydrug users? - 2008
Daumann J, Heekeren K, Neukirch A, Thiel CM, Moller-Hartmann W, Gouzoulis-Mayfrank E - Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT(2A) agonist and NMDA antagonist model of psychosis. - 2008
Dickerson SM, Walker DM, Reveron ME, Duvauchelle CL, Gore AC - The Recreational Drug Ecstasy Disrupts the Hypothalamic-Pituitary-Gonadal Reproductive Axis in Adult Male Rats. - 2008
Dumont G, Kramers C, Sweep F, Willemsen J, Touw D, Schoemaker R, van Gerven J, Buitelaar J, Verkes R - Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology. - 2008
Falck RS, Jichuan Wang, Carlson RG - Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis. - 2008 Jan
Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC - Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT(1A) and 5-HT(2A) receptors in rodents. - 2008
Fantegrossi WE, Murnane KS, Reissig CJ - The behavioral pharmacology of hallucinogens. - 2008
Fantegrossi WE - In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. - 2008
Feduccia AA, Duvauchelle CL - Auditory stimuli enhances MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses. - 2008
Fisk JE, Montgomery C - Evidence for selective executive function deficits in ecstasy/polydrug users. - 2008
Fonsart J, Menet MC, Decleves X, Galons H, Crete D, Debray M, Scherrmann JM, Noble F - Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). - 2008
Geyer MA, Vollenweider FX - Serotonin Research: Contributions to Understanding Psychoses. - 2008
Goni-Allo B, Puerta E, Mathuna BO, Hervias I, Lasheras B, de la Torre R, Aguirre N - On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats. - 2008 Feb 3
Goni-Allo B, Puerta E, Ramos M, Lasheras B, Jordan J, Aguirre N - Minoxidil prevents 3,4-methylenedioxymethamphetamine-induced serotonin depletions: role of mitochondrial ATP-sensitive potassium channels, Akt and ERK. - 2008 Feb
Granado N, Escobedo I, O'Shea E, Colado MI, Moratalla R - Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. - 2008 Jan
Guillot, CR - MDMA and impulsivity: A review - 2008
Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ - Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. - 2008
Hanson KL, Luciana M, Sullwold K - Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. - 2008
Hasler F, Studerus E, Lindner K, Ludewig S, Vollenweider F - Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. - 2009
Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E - Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis. - 2008
Kirilly E, Molnar E, Balogh B, Kantor S, Hansson SR, Palkovits M, Bagdy G - Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days. - 2008
Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA - Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults. - 2008
Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA - Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration. - 2008
Krall CM, Richards JB, Rabin RA, Winter JC - Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice. - 2008 Jan
Krebs, TS, Johansen, PO - No evidence of decrease in cognitive function in users of low-dose ecstsay - 2008
Kurling S, Kankaanpaa A, Seppala T - Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats - Jan 5,2008
Kuypers KP, Wingen M, Ramaekers JG - Memory and mood during the night and in the morning after repeated evening doses of MDMA. - 2009
Li JX, Rice KC, France CP - Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. - 2008 Feb
Loxton NJ, Wan VL, Ho AM, Cheung BK, Tam N, Leung FY, Stadlin A - Impulsivity in Hong Kong-Chinese club-drug users. - 2008
McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA - Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. - 2008 Oct
Meyer JS, Piper BJ, Vancollie VE - Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence. - 2008
Mlinar B, Mascalchi S, Morini R, Giachi F, Corradetti R - MDMA Induces EPSP-Spike Potentiation in Rat Ventral Hippocampus In Vitro Via Serotonin and Noradrenaline Release and Coactivation of 5-HT(4) and beta(1) Receptors. - 2008
Montgomery C, Fisk JE - Ecstasy-related deficits in the updating component of executive processes. - 2008
Mueller M, Peters FT, Maurer HH, McCann UD, Ricaurte GA - Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. - 2008
Nichols DE, Nichols CD - Serotonin Receptors. - 2008 May 14
O'Mathuna B, Farre M, Rostami-Hodjegan A, Yang J, Cuyas E, Torrens M, Pardo R, Abanades S, Maluf S, Tucker GT, de la Torre R - The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. - 2008
Parrott AC, Lock J, Conner AC, Kissling C, Thome J - Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes - 2008
Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A - The Pharmacology of Lysergic Acid Diethylamide: a Review. - 2008

Ramaekers JG, Kuypers KP, Wingen M, Heinecke A, Formisano E - Involvement of Inferior Parietal Lobules in Prospective Memory Impairment during Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study. - 2008
Reissig CJ, Eckler JR, Rabin RA, Rice KC, Winter JC - The stimulus effects of 8-OH-DPAT: Evidence for a 5-HT(2A) receptor-mediated component. - 2008 Jan
Reissig CJ, Rabin RA, Winter JC, Dlugos CA - d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex. - 2008
Renoir T, Paizanis E, Yacoubi ME, Saurini F, Hanoun N, Melfort M, Lesch KP, Hamon M, Lanfumey L - Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. - 2008 Jul 9
Riegert C, Wedekind F, Hamida SB, Rutz S, Rothmaier AK, Jones BC, Cassel JC, Jackisch R - Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain. - 2008
Riley SC, Blackman G - Between prohibitions: patterns and meanings of magic mushroom use in the UK. - 2008
Rusyniak DE, Ootsuka Y, Blessing WW - When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: Effects of pretreatment with 5-HT(1A) and dopamine D(2) antagonists. - 2008 May 2
Schilt T, Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W - Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. - 2008
Schilt, T, de Win, MM, Koeter M, Jager G, Korf D, van den Brink W, Schmand B - Reply - 2008
Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B - Decision making as a predictor of first ecstasy use: a prospective study. - 2009
Skelton MR, Williams MT, Vorhees CV - Developmental effects of 3,4-methylenedioxymethamphetamine: a review. - 2008 Mar
Soar K, Parrott A, Turner J - Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users. - 2008
Starr MA, Page ME, Waterhouse BD - MDMA (3,4-methylenedioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posterior medial thalamus. - 2008
Verrico CD, Lynch L, Fahey MA, Fryer AK, Miller GM, Madras BK - MDMA-Induced Impairment in Primates: Antagonism by a Selective Norepinephrine or Serotonin, But Not by a Dopamine/Norepinephrine Transport Inhibitor - Feb 28, 2008
Wackermann J, Wittmann M, Hasler F, Vollenweider FX - Effects of varied doses of psilocybin on time interval reproduction in human subjects. - 2008
Young R, Glennon RA - MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice. - 2008
Yu B, Becnel J, Zerfaoui M, Rohatgi R, Boulares AH, Nichols CD - Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency. - 2008
de Sola Llopis S, Miguelez-Pan M, Pena-Casanova J, Poudevida S, Farre M, Pacifici R, Bohm P, Abanades S, Garcia AV, Zuccaro P, de la Torre R - Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. - 2008 Jan 21
de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W - Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. - 2008
de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W - Neurotoxic effects of ecstasy on the thalamus. - 2008 Oct
Biezonski DK, Courtemanche AB, Hong SB, Piper BJ, Meyer JS - Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist. - 2009
Boland B, Mitcheson L, Wolff K - Lhermitte's sign, Electric shock sensations and high dose ecstasy consumption: preliminary findings. - 2009
Carhart-Harris RL, Nutt DJ, Munafo MR, Christmas DM, Wilson SJ - Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. - 2009
Cowan RL, Joers JM, Dietrich MS - N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: A 3 T magnetic resonance spectroscopy study. - 2009
Dumont GJ, Sweep FC, van der Steen R, Hermsen R, Donders AR, Touw DJ, van Gerven JM, Buitelaar JK, Verkes RJ - Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. - 2009
McCann UD, Wilson MJ, Sgambati FP, Ricaurte GA - Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users. - 2009
Piper BJ, Farelli JD, Meyer JS - Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats. - 2009
Pirona A, Morgan M - An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users. - 2010
Randall S, Johanson CE, Tancer M, Roehrs T - Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study. - 2009
Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M - The harmful health effects of recreational ecstasy: a systematic review of observational evidence. - 2009 Jan
Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B - Decision making as a predictor of first ecstasy use: a prospective study. - 2009
Schilt T, Koeter MW, de Win MM, Zinkstok JR, van Amelsvoort TA, Schmand B, den Brink W - The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene. - 2009
Selvaraj S, Hoshi R, Bhagwagar Z, Murthy NV, Hinz R, Cowen P, Curran HV, Grasby P - Brain serotonin transporter binding in former users of MDMA ('ecstasy'). - 2009 Apr
Trachsel D, Nichols DE, Kidd S, Hadorn M, Baumberger F - 4-aryl-substituted 2,5-dimethoxyphenethylamines: synthesis and serotonin 5-HT(2A) receptor affinities. - 2009
Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ - Content of ecstasy in the Netherlands: 1993-2008. - 2009
Adori C, Ando RD, Ferrington L, Szekeres M, Vas S, Kelly PA, Hunyady L, Bagdy G - Elevated BDNF Protein Level in Cortex But Not in Hippocampus of MDMA-Treated Dark Agouti rats: A Potential Link to the Long-Term Recovery of Serotonergic Axons. - 2010
Angelucci F, Ricci V, Martinotti G, Palladino I, Spalletta G, Caltagirone C, Bria P - Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. - Jul 2010
Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE - Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans - 2010
Bedi G, Redman J - Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean? - 2010
Bedi G, Hyman D, de Wit H - Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional States in others. - 2010
Benzenhofer U, Passie T. - Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. - 2010
Biezonski DK, Meyer JS - Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. - 2010
Brown J, McKone E, Ward J - Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task. - 2010
Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ - The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. - 2010 Apr 15
George J, Kinner SA, Bruno R, Degenhardt L, Dunn M - Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use. - 2010 May
Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. - Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer - Sep 6, 2010
Hanson KL, Luciana M - Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor. - 2010 Apr
Hirt D, Fonsart J, Menet MC, Debray M, Noble F, Decleves X, Scherrmann JM - Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats. - 2010 Mar
Hysek CM, Vollenweider FX, Liechti ME - Effects of a {beta}-blocker on the cardiovascular response to MDMA (Ecstasy). - 2010
Johnson, Matthew W.; Maclean, Katherine A.; Reissig, Chad R.; Prisinzano, Thomas E.; Griffiths, Roland R. - Human Psychopharmacology and Dose-Effects of Salvinorin A, a Kappa Opioid Agonist Hallucinogen Present in the Plant Salvia divinorum - Dec 3, 2010
Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. - The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations. - 2011
Lansbergen MM, Dumont GJ, van Gerven JM, Buitelaar JK, Verkes RJ - Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol). - 2010
Marrone GF, Pardo JS, Krauss RM, Hart CL - Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech. - 2010
Martin-Santos R, Torrens M, Poudevida S, Langohr K, Cuyas E, Pacifici R, Farre M, Pichini S, de la Torre R - 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study. - 2010
Matthews AJ, Bruno R - An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers. - 2010
McClung J, Fantegrossi W, Howell LL - Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys. - 2010 May
Mendelson JE, Coyle JR, Lopez JC, Baggott MJ, Flower K, Everhart ET, Munro TA, Galloway GP, Cohen BM - Lack of Effect of Sublingual Salvinorin A, A Naturally Occurring Kappa Opioid, in Humans: A Placebo-Controlled Trial - Dec 8, 2010
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R - The safety and efficacy of (+/-)-3,4-methylenedioxymethamphetamine-assisted - 2011
Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, Howell LL - Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and its jStereoisomers in Rhesus Monkeys. - 2010
Piper BJ, Ali SF, Daniels LG, Meyer JS - Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats. - 2010
Roberts GM, Garavan H - Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. - 2010
Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H - Overview of Amphetamine-Type Stimulant Mortality Data - UK, 1997-2007. - 2010 Jan 29
Schilt T, Koeter MW, Smal JP, Gouwetor MN, van den Brink W, Schmand B - Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. - 2010
Scott RM, Hides L, Allen JS, Burke R, Lubman DI - Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use. - 2010
Studerus E, Gamma A, Vollenweider FX. - Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV). - 2010
Swartz R - Medical marijuana users in substance abuse treatment. - 2010
Verbaten MD - Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects. - 2010
Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL - Human Ecstasy Use is Associated with Increased Cortical Excitability: An fMRI Study. - 2011
Bosker WM, Kuypers KP, Conen S, Kauert GF, Toennes SW, Skopp G, Ramaekers JG - MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid. - 2011
Brunt TM, Koeter MW, Niesink RJ, van den Brink W - Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. - 2011
Burgess AP, Venables L, Jones H, Edwards R, Parrott AC - Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users. - 2011
Corlett PR, Honey GD, Krystal JH, Fletcher PC - Glutamatergic model psychoses: prediction error, learning, and inference. - 2011
Dos Santos RG, Grasa E, Valle M, Ballester MR, Bouso JC, Nomdedeu JF, Homs R, Barbanoj MJ, Riba J - Pharmacology of ayahuasca administered in two repeated doses. - 2011
Dumont G, van Hasselt J, de Kam M, van Gerven J, Touw Dj, Buitelaar J, Verkes R - Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers. - 2011
Erritzoe D, Frokjaer VG, Holst KK, Christoffersen M, Johansen SS, Svarer C, Madsen J, Rasmussen PM, Ramsoy T, Jernigan TL, Knudsen GM - In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") and Hallucinogen Users. - 2011
Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R - Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. - 2011 Jun
Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N - Everyday and prospective memory deficits in ecstasy/polydrug users. - 2011
Huot P, Johnston TH, Lewis KD, Koprich JB, Reyes MG, Fox SH, Piggott MJ, Brotchie JM - Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time. - 2011
Kirkpatrick MG, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL - A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. - 2011
Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. - The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations. - 2011
Liao Y, Tang J, Corlett PR, Wang X, Yang M, Chen H, Liu T, Chen X, Hao W, Fletcher PC - Reduced dorsal prefrontal gray matter after chronic ketamine use. - 2011
Light, Donald W.; Warburton, Rebecca - Demythologizing the high costs of pharmaceutical research - 7 Feb 2011
Maclean KA, Johnson MW, Griffiths RR - Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness. - 2011
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R - The safety and efficacy of (+/-)-3,4-methylenedioxymethamphetamine-assisted - 2011
Morgan HL, Turner DC, Corlett PR, Absalom AR, Adapa R, Arana FS, Pigott J, Gardner J, Everitt J, Haggard P, Fletcher PC - Exploring the impact of ketamine on the experience of illusory body ownership. - 2011
Mueller M, Goodwin AK, Ator NA, McCann UD, Ricaurte GA - Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences. - 2011
Parrott AC, Gibbs A, Scholey AB, King R, Owens K, Swann P, Ogden E, Stough C - MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. - 2011
Quednow BB, Kometer M, Geyer MA, Vollenweider FX - Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers. - 2011
Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX - Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments. - 2011 Oct 26
Simmler LD, Hysek CM, Liechti ME - Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects. - 2011
Slater, Lauren - That Lovin' Feeling - 2011
Stough C, King R, Papafotiou K, Swann P, Ogden E, Wesnes K, Downey LA - The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning. - 2011 Oct 22
Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, Aitchison KJ - Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. - 2011
Yubero-Lahoz S, Pardo R, Farre M, O'Mahony B, Torrens M, Mustata C, Perez-Mana C, Carbo ML, de la Torre R - Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans. - 2011 May 1
de Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, de Martinis BS, Crippa JA, Hallak JE, Santos AC - Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion. - 2011
den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L - Preliminary evidence of hippocampal damage in chronic users of ecstasy. - 2011
Sempere AP, Berenguer-Ruiz L, Almazan F - [Chronic cluster headache: response to psilocybin.] - Not available
Jeng I, Harnacker B, Klemm BN, Rieser C - Relationship between 5-hydroxytryptamine and Lysergic Acid Diethylamid - 1981
Newman B, Dihrberg A, Sullivan V - Thin layer chromatography of lysergic acid diethylamide (LSD_, N,N dimethyl tryptamine (DMT), methylenedioxyphenyl isopropylamine (STP, DOM) and ibogaine. - 1968
Newmeyer JA - Some Considerations on the Prevalence of MDMA Use - 1986
Okey AB et.al. - Is Delta-9-tetrahydrocannabinol Estrogenic? - Mar 4 1977
Petitet, Francois; Jeantaud, Bernadette; Bertrand, Philippe; Imperato, Assunta - Cannabinoid Penetration Into Mouse Brain as Determined by Ex Vivo Binding - 1999
Adams, R - Marihuana - Aug 9 1940
Ashton, CH - Pharmacology and effects of cannabis: a brief review - 2001
Bessey, Ernst A. - Sex Problems in Hemp - Jun 1933
Borthwick HA, Scully NJ - Photoperiodic Responses of Hemp - Sep 1954
Dayanandan P, Kaufman PB - Trichomes of Cannabis Sativa L. (Cannabaccae) - 1976
French CN, Moore PD - Deforestation, Cannabis Cultivation and Schwingmoor Formation at Cors Llyn (Llyn Mire), Central Wales - Mar 1996
Hammond, Charles T.; Mahlberg, Paul G. - Morphology of Glandular Hairs of Cannabis Sativa from Scanning Electron Microscopy - Jul 1973
Hammond CT, Mahlberg PG - Morphogenesis of Capitate Glandular Hairs of Cannabis Sativa (Cannabacceae) - Sep 1977
Hammond, Charles T.; Mahlberg, Paul G. - Ultrastructural Development of Capitate Glandular Hairs of Cannabis Sativa L. (Cannabaceae) - Feb 1978
Haney, Alan; Kutscheid, Benjamin B. - An Ecological Study of Naturalized Hemp (Cannabis sativa L.) in East-Central Illinois - Jan 1975
Heslop-Harrison, J. - Suppressive Effects of 2-Thiouracil on Differentiation and Flowering in Cannabis sativa - Dec 30,1960
Kim ES, Mahlberg PG - Glandular Cuticle Formation in Cannabis (Cannabcceae) - Oct 1995
Kojoma M et.al. - DNA Fingerprinting of Cannabis sativa using intersimple sequence repeat (ISSR) amplification - 2002
Lanyon VS, Turner JC, Mahlberg PG - Quantitative Analysis of Cannabinoids in the Secretory Product from Capitate-Stalked Glands of Cannabis sativa L. (Cannabaceae) - Sep 1981
Lichtman, Aron H.; Poklis, Justin L.; Poklis, Alphonse; Wilson, David M.; Martin, Billy R. - The Pharmacological Activity of Inhalation Exposure to Marijuana Smoke in Mice - 2001
Mackay, Elizabeth L. - Sex Chromosomes of Cannabis sativa - Nov 1939
Mahlberg, Paul G.; Hemphill, John K. - Effect of Light on Cannabinoid Content of Cannabis sativa L. (Cannabacceae) - Mar 1983
Mahlberg, Paul G.; Kim, Eun-Soo - Secretory Visicle Formation in Glandular Trichomes of Cannabis sativa (Cannabacceae) - Feb 1992
McPhee, Hugh C. - Meiotic Cytokinesis of Cannabis - Nov 1924
Mechoulam, Raphael - Marihuana Chemistry - Jun 5,1970
Menzel, Margaret Y. - Meiotic Chromosomes of Monoecious Kentucky Hemp (Cannabis sativa) - May 1964
Miller, Fred A. - The Propagation of Medicinal Plants - Feb 1914
Robson P - Therapeutic aspects of cannabis and cannabinoids - 2001
Schaffner, John H. - Influence of Environment on Sexual Expression in Hemp - Mar 1921
Schaffner, John H. - The Fluctuation Curve of Sex Reversal in Staminate Hemp Plants Induced by Photoperiodicity - Jan 1931
Scripture, E.W. - Consciousness Under the Influence of Cannabis Indica - Oct. 27, 1893
Sharma GK - Altitudinal Variation in Leaf Epidermal Patterns of Cannabis sativa - Jul/Aug 1975
Small, Ernest; Jui, Perry Y.; Lefkovitch, L.P. - A Numerical Taxonomic Analysis of Cannabis with Special Reference to Species Delimitation - Spring 1976
Stefanis, Costas N.; Issidorides, Marietta R. - Marihuana Effects - Mar 1976
Turner, Jocelyn C.; Hemphill, John; Mahlberg, Paul G. - Gland Distribution and Cannabinoid Content in Clones of Cannabis sativa L - Jul 1977
Turner, Jocelyn C.; Hemphill, John K.; Mahlberg, Paul G. - Quantitative Determination of Cannabinoids in Individual Glandular Trichomes of Cannabis sativa L. (Cannabaceae) - Nov 1978
Turner, Jocelyn C.; Hemphill, John K.; Mahlberg, Paul G. - Trichomes and Cannabinoid Content of Developing Leaves and Bracts of Cannabis sativa L. (Cannabaceae) - Nov 1980
Turner, Jocelyn C.; Mahlberg, Paul G.; Lanyon, Vicki S.; Pleszczynska, Joanna - A Temporal Study of Cannabinoid Composition in Continual Clones of Cannabis sativa L. (Cannabacceae), - Mar 1985
Vogelmann, Ann F.; turner, Jocelyn C.; Mahlberg, Paul G. - Cannabinoid Occurence in Seedlings of Cannabis sativa L.: Quantitation in Seedlings of Known Age and Primary Leaf Length - Dec 1987
Wilson, D. Gay - Plant Remains from the Gravency Boat and the Early History of Humulus lupulus L. in W. Europe - Nov 1975
Michele Arnone, Jeanne Maruani, Frederique Chaperon, Marie-Helene Thiebot, M. Poncelet, Philippe Soubrie, Gerard Le Fur - Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors - 1997
Berger, Alvin; Crozier, Gayle; Bisogno, Tiziana; Cavaliere, Paolo; Innis, Sheila; Di Marzo, Vincenzo - Anandamide and Diet: Inclusion of Dietary Arachidonate and Docosahexaenoate Leads to Increased Brain Levels of the Corresponding N-Acylethanolamines in Piglets - May 2001
Cui, Shu-Sen; Bowen, Rudy C.; Gu, Gui-Bao; Hannesson, Darren K.; Yu, Peter H.; Zhang, Xia - Prevention of Cannabinoid Withdrawal Syndrome by Lithium: Involvement of Oxytocinergic Neuronal Activation - Dec 2001
De Vries, Taco J.; Shaham, Yavin; Homberg, Judith R.; Crombag, Hans; Schuurman, Karianne; Dieben, Jeanine; Vanderschuren, Louk J.M.J.; Schoffelmeer, Anton N.M. - A Cannabinoid Mechanism in Relapse to Cocaine Seeking - October 2001
Vincenzo Di Marzo et.al. - Trick or treat from food endocannabinoids? - 1998
Liana Fattore, M. Cristina Martellotta, Gregorio Cossu, M. Stefania Mascia, Walter Fratta - CB1 Cannabinoid Receptor Agonist WIN 55, 212-2 Decreases Intravenous Cocaine Self-Administration in Rats - October 1999
Fowler CJ, Tiger G, Stenstrom A - Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship - 1997 Nov
Jason E. Gallate, I. S. McGregor - original investigation: The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716 - 1999
Sara Gonzalez, Javier Fernandez-Ruiz, Valentina Sparpaglione, Daniela Parolaro, Jose A. Ramos - Chronic Exposure to Morphine, Cocaine or Ethanol in Rats Produced Different Effects in Brain Cannabinoid CB1 Receptor Binding and mRNA Levels - 2002
Gorsky J - Marijuana Test: No Ibuprofen Interference - Aug 1988
Hine B, Freidman E, Torrelio M, Gershon S - Morphine-Dependent Rats: Blockage of Precipitated Abstinence by THC - 7 Feb 1975
Hoffman AF, Lupica CR - Direct Ations of Cannabinoids on Synaptic Transmission in the Nucleus Accumbens: A Comparrison With Opioids - 2001
B. L. Hungund, B. S. Basavarajappa - ARE ANANDAMIDE AND CANNABINOID RECEPTORS INVOLVED IN ETHANOL TOLERANCE? A REVIEW OF THE EVIDENCE - 2000
S. Lamarque, K. Taghzouti, H. Simon - Chronic treatment with 9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction - 2001
Lichtman AH, Sheikh SM, Loh HH, Martin BR - Opioid and Cannabinoid Modulation of Precipitated Withdrawal in 9-Tetrahydrocannabinol and Morphine-Dependent Mice - 2001
Scott E. Lukas, Sara Orozco - Ethanol increases plasma 9-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers - 2001
DT Malone, DA Taylor - Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat - 1998
Daniel T. Malone, David A. Taylor - Modulation by fluoxetine of striatal dopamine release following 9-tetrahydrocannabinol: a microdialysis study in conscious rats - 1999
Jorge Manzanares, Javier Corchero, Julian Romero, Javier J. Fernandez-Ruiz, Jose A. Ramos Jose A. Fuentes - Pharmacological and biochemical interactions between opioids and cannabinoids - 1999
Justin P. Meschler, Francis A. Clarkson, Patricia J. Mathews, Allyn C. Howlett, Bertha K. Madras - D2, but Not D1 Dopamine Receptor Agonists Potentiate Cannabinoid-Induced Sedation in Nonhuman Primates - 2000
Ng, E. Orenz K.Y.; Lamprecht, Friedhelm; Edford, R.; Williams, B.; Kopin, Irwin J. - Delta-9-tetrahydrocannabinol and Ethanol: Differential Effects on Sympathetic Activity in Differing Environmental Settings - Jun 1973
Piomelli, Daniele - Cannabinoid Activity Curtails Cocaine Craving - October 2001
Francesco E. Pontieri, Paola Monnazzi, Alessandra Scontrini, Francesca R. Buttarelli, Francesca R. Patacchioli - Behavioral sensitization to heroin by cannabinoid pretreatment in the rat - 2001
Lutz G. Schmidt, Jerzy Samochowiec, Ulrich Finckh, Ewa Fiszer-Piosik, Jan Horodnicki, B. Wendel, Hans Rommelspacher, Margret R. Hoehe - Association of a CB1 Cannabinoid Receptor Gene (CNR 1) polymorphism with severe alcohol dependence - 2002
Sepe N, De Petrocellis L, Montanaro F, Cimino G, Di Marzo V - Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry - 1998 Jan 15
Salvatore Serra, Mauro A.M. Carai, Giuliana Brunetti, Raquel Gomez, Samuele Melis, Giovanni Vacca, Giancarlo Colombo, Gian Luigi Gessa - The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats - 2001
Smith FL, Cichewicz D, Martin ZL, Welch SP - The Enhancement of Morphine Antinociception in Mice by delta9-Tetrahydrocannabinol - Jun 1998
Vaccarino, Anthony L.; Olson, Gayle A.; Olson, Richard D.; Kastin, Abba J. - Endogenous Opiates: 1998 - 1999
Vaccarino, Anthony L,; Kastin, Abba J. - Endogenous Opiates: 1999 - 2000
Stephen R. Wachtel, Harriet de Wit - Naltrexone does not block the subjective effects of oral 9-tetrahydrocannabinol in humans - 2000
Welch, Sandra P.; Eads, Micah - Synergistic Interactions of Endogenous Opioids and Cannabinoid Systems - Nov1999
Welch, Sandra P.; Stevens, David L. - Antinociceptive Activity of Intrathecally Administered Cannabinoids Alone, and in Combination with Morphine, in Mice - Jul 1999
Welch SP, Thomas C. Patrick GS - Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine - 1995 Jan
Wiley, Jenny L.; Martin, Billy R. - Effects of SR141716A on Diazepam Substitution for 9-Tetrahydrocannabinol in Rat Drug Discrimination. - Nov 1999
Yamaguchi, Taku; Hagiwara, Yumi; Tanaka, Hiroyuki; Sugiura, Takayuki; Waku, Keizo; Shoyama, Yukihiro; Watanabe, Shigenori; Yamamoto, Tsuneyuki - Endogenous Cannabinoid, 2-Arachidonoylglycerol, Attenuates Naloxone-Precipitated Withdrawal Signs in Morphine-Dependent Mice - 2001
Diana L. Cichewicz, Victoria L. Haller, Sandra P. Welch - Changes in Opioid and Cannabinoid Receptor Protein following Short-Term Combination Treatment with delta-9 Tetrahydrocannabinol and Morphine; - Not available
George E. da Silva, Gina S. Morato, Reinaldo N. Takahashi - Rapid tolerance to D 9-tetrahydrocannabinol and cross-tolerance between ethanol and D 9 - tetrahydrocannabinol in mice - 2001
Baron JA, Folan RD, Kelley ML Jr - Ulcerative colitis and marijuana [letter] - 1990 Mar 15
Malcolm Begg, Areles Molleman, Mike Parsons - Modulation of the release of endogenous g-aminobutyric acid by cannabinoids in the guinea pig ileum - 2002
T Croci, L Manara, G Aureggi, F Guagnini, M Rinaldi-Carmona, JP Maffrand, G Le Fur, S Mukenge, G Ferla - In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum - 1998
Nissar A. Darmani - Delta-9-tetrahydrocannabinol differently suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew - 2001
Nissar A. Darmani - The Potent Emetogenic Effects of the Endocannabinoid, 2-AG (2-Arachidonoylglycerol) Are Blocked by 9 -Tetrahydrocannabinol and Other Cannnabinoids - 2002
Nissar A. Darmani - The cannabinoid CB receptor antagonist SR 141716A reverses the 1 antiemetic and motor depressant actions of WIN 55, 212-2 - 2001
Nissar A. Darmani, Ph.D - D 9 -Tetrahydrocannabinol and Synthetic Cannabinoids Prevent Emesis Produced by the Cannabinoid CB1 Receptor Antagonist/ Inverse Agonist SR 141716A - 2001
Di Marzo, Vincenzo; Goparaju, Sravan K.; Wang, Lei; Liu, Jie; Batkai, Sandor; Jarai, Zolta; Fezza, Filomena; Miura, Grant I.; Palmiter, Richard D.; Sugiurak, Takayuki; Kunos, George - Leptin-Regulated Endocannabinoids are Involved in Maintaining Food Intake - 12 Apr 2001
Daniela Giuliani, Alessandra Ottani, Francesca Ferrari - Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats - 2000
Holzer, Peter - Gastrointestinal Afferents as Targets of Novel Drugs for the Treatment of Functional Bowel Disorders and Visceral Pain - 2001
AA Izzo, N Mascolo, F Borrelli, F Capasso - Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors - 1998
Izzo, Angelo A.; Mascolob, Nicola; Pinto, Luisa; Capasso, Raffaele; Capasso, Francesco - The Role of Cannabinoid Receptors in Intestinal Motility, Defaecation and Diarrhoea in Rats - 1999
Katayama K, Ueda N, Kurahashi Y, Suzuki H, Yamamoto S, Kato I - Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine - 1997 Aug 16
F Lopez-Redondo, GM Lees, RG Pertwee - Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum - 1997
R G Pertwee - Cannabinoids and the gastrointestinal tract - Not available
RA Ross, HC Brockie, SR Fernando, B Saha, RK Razdan, RG Pertwee - Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine - 1998
Sallan SE, Zinberg NE, Frei E 3d - Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy - 1975 Oct 16
Anna H.V. Soderpalm, Alyson Schuster, Harriet de Wit - Antiemetic efficacy of smoked marijuana Subjective and behavioral effects on nausea induced by syrup of ipecac - 2001
Van Sickle, Marja D.; Oland, Lorraine D.; Ho, Winnie; Hillard, Cecilia J.; Mackie, Ken; Davison, Joseph S.; Sharkey, Keith A. - Cannabinoids Inhibit Emesis Through CB1 Receptors in the Brainstem of the Ferret - 2001
Claire M. Williams, Tim C. Kirkham - Reversal of D-9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine - 2002
Krowicki, Zbigniew K.; Moerschbaecher, Joseph M.; Winsauer, Peter J.; Digavalli, Sivarao V.; Hornby, Pamela J. - 9-Tetrahydrocannabinol Inhibits Gastric Motility in the Rat Through Cannabinoid CB1 Receptors - 1999
Bisogno T, Delton-Vandenbroucke I, Milone A, Lagarde M, Di Marzo V - Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N- Docosahexaenoylethanolamine in Bovine Retina - Oct 1999
Elsohly MA, Harland E, Murphy JC, Wirth P, Waller CW - Cannabinoids in Glaucoma: A Primary Screening Procedure - Aug 1981
Fried PA, Watkinson B - Visuoperceptial functioning differs in 9- to 12- year olds prenatally exposed to cigarettes and marijuana - 2000
Green, Keith - Marijuana Smoking vs Cannabinoids for Glaucoma Therapy - Nov 1998
Hepler RS, Frank IR - Marihuana smoking and intraocular pressure - 1971 Sep 6
Kaufman, Paul L. - Marijuana and Glaucoma [editorial; comment] - Nov 1998
F. Markus Leweke, Udo Schneider, Maren Radwan, Eike Schmidt, Hinderk M. Emrich - Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man - 2000
Jose Melena, Neville N. Osborne - Voltage-dependent Calcium Channels in the Rat Retina: Involvement in NMDA-stimulated Influx of Calcium - 2001
Porcella A, Casellas P, Gessa GL, Pani L - Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana - 1998 Jul
Song, Zhao-Hui; Slowey, Carole-Anne - Involvement of Cannabinoid Receptors in the Intraocular Pressure-Lowering Effects of WIN55212-21 - Jan 2000
W.D. Stamer, S.F. Golightly, Y. Hosohata, E.P. Ryan, A.C. Porter, E. Varga, R.J. Noecker, C.C. Felder, H.I. Yamamura - Cannabinoid CB receptor expression, activation and detection of 1endogenous ligand in trabecular meshwork and ciliary process tissues - 2001
Straiker, Alex; Stella, Nephi; Piomelli, Daniele; Mackie, Ken; Karten, Harvey J.; Maguire, Greg - Vertebrate Retina: Localization and Function of an Endogenous Signaling System - 1999
National Academy of Sciences, Institute of Medicine - Marijuana and Medicine: Assessing the Science Base; Executive Summary; recommendation 5 - 1999
Chevannes, Barry; Edwards, Webster; Freckleton, Anthony; Linton, Norma; McDowell, DiMario; Standard-Goldson, Aileen; Smith, Barbara - A Report of the National Commission on Ganja. To Rt. Hon. P.J. Patterson, Q.C., M.P. Prime Minister of Jamaica - Aug 7,2001
Institute of Medice, Division of Heath Sciences Policy - Marijuana and Health: Report of a Study by a committee of the Institute of Medicine, Division of Health Sciences Policy - 1982
Michael Bayewitch, Man-Hee Rhee, Tomer Avidor-Reiss, Aviva Breuer, Raphael Mechoulam, Zvi Vogel - Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase - April 26 1996
E.V. Berdyshev - Cannabinoid receptors and the regulation of immune response - 2000
Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P - Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression - 1996 May 1
Buckley NE et.al. - Immunomodulation by cannabinoids is absent in mice deficient for cannabinoid CB2 receptor - 2000
Burstein, Sumner; Hunter, Sheila A.; Ozman, Kent - Prostaglandins and Cannabis. XII. The Effect of Cannabinoid Structure on the Synthesis of Prostaglandins by Human Lung Fibroblasts - 1983
Veronica A. Campbell - Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation - 2001
R. Cesa, A. Guastalla, E. Cottone, K. Mackie, M. Beltramo, M. F. Franzoni - Relationships between CB1 Cannabinoid Receptors and Pituitary Endocrine Cells in Xenopus laevis: An Immunohistochemical Study. General and Comparative - 2002
Childers SR, Deadwyler SA - Role of cyclic AMP in the actions of cannabinoid receptors. [Review] [68 refs] - 1996 Sep 27
Condie, Robin; Herring, Amy; Koh, Woo S.; Lee, Michael; Kaminski, Norbert E. - Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2 - May 1996
Daaka Y, Zhu W, Friedman H, Klein TW - Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor - 1997 Mar
Dax EM, Pilotte NS, Adler WH, Nagel JE, Lange WR - The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function - 1989
Fischer-Stenger K; Dove Pettit DA; Cabral GA - Delta 9-Tetrahydrocannabinol Inhibition of Tumor Necrosis Factor-Alpha: Suppression of Post-Translational Events - Dec 1993
M. A. Garcia, G. Weigert, S. Duk, M. Alarcon - Chromosome Aberrations Study in Human Lymphocytes from Marijuana Smokers - 1999
Brian Gardner, Li X. Zu, Sherven Sharma, Qian Liu, Alexandros Makriyannis, Donald P. Tashkin, Steven M. Dubinett - Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-b - 2002
Greenberg JH, Mellors A - Specific Inhibition of an Acyltransferase by delta9-Tetrahydrocannabinol - Feb 1,1978
Gurwitz, David; Kloog, Yoel - Do Endogenous Cannabinoids Contribute to HIV-Mediated Immune Failure? - May 1998
Herring, Amy C.; Kaminski, Norbert E. - Cannabinol-Mediated Inhibition of Nuclear Factor-B, cAMP Response Element-Binding Protein, and Interleukin-2 Secretion by Activated Thymocytes - Dec 1999
Herring AC, Koh WS, Kaminski NE - Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid - 1998 Apr 1
Omar Jbilo - Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60 - Not available
YJ Jeon, KH Yang, JT Pulaski, NE Kaminski, - Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation - Aug 1996
Kaminski NE - Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors. [Review] [61 refs] - 1998 Mar 15
Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR - Identification of a Functionally Relevant Cannabinoid Receptor on Mouse Spleen Cells that is Involved in Cannabinoid-Mediated Immune Modulation - 1992
Kaminski NE, Koh WS, Yang KH, Lee M. Kessler - Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism - 1994 Nov 16
Klein TW et.al. - The cannabinoid system and cytokine network - 2000
Klein, Thomas W.; Newton, Cathy; Friedman, Herman - Cannabinoid Receptors and Immunity [Review article] - 1998
Thomas W. Klein, Catherine A. Newton, Noryia Nakachi, Herman Friedman - 9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-, IL-12, and IL-12 Receptor 2 Responses to Legionella pneumophila Infection - June 2000
Lau, R. Jane; Tubergen, David G.; Barr, Mason, Jr.; Domino, Edward F.; Benowitz, N.; Jones, Reese T. - Phytohemagglutinin-Induced Lynphocyte Transformation in Humans Receiving Delta-9-Tetrahydrocannabinol - May 21,1976
Massi P et.al. - Relative involvement of cannabinoid CB1 and CB2 receptors in the delta-9-tetrahydrocannabinol-induced inhibition of natural killer activity - 2000
McCoy, Kathleen L.; Matveyeva, Marina; Carlisle, Steven J.; Cabral, Guy A. - Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation - Jun 1999
Molina-Holgado F, Lledo A, Guaza C - Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes - 1997 May 27
Francisco Molina-Holgado, Eduardo Molina-Holgado, Carmen Guaza - The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway - 1998 August 14
Murphy LL, Munoz RM, Adrian BA, Villanua MA - Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion - 1998 Dec
Nahas, Gabriel G.; Suciu-Foca, Nicole; Armand, Jean-Pierre; Morishtma, Akira - Inhibition of Cellular Mediated Immunity in Marihuana Smokers - Feb 1974
Newton C et.al. - The role of macrophages in THC-induced alteration of the cytokine network - 1998
Noe SN et.al. - Cannabinoid receptor agonists enhance synctia formation in MT-2 cells infected with cell free HIV-1 MN - 1998
Ouyang Y, Hwang SG, Han SH, Kaminski NE - Suppression of Interleukin-2 by the Putative Endogenous Cannabinoid 2-Arachidonyl-Glycerol is Mediated Through Down-Regulation of the Nuclear Factor of Activated T Cells - 1998
Patel NA, Moldow RL, Patel JA, Wu G, Chang SL - Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. - 1998 Jun 29
Pestonjamasp VK, Burstein SH - Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system - 1998 Nov 2
Poinot-Chazel C, Portier M, Bouaboula M, Vita N, Pecceu F, Gully D, Monroe JG, Maffrand JP, Le Fur G, Casellas P - Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24 - 1996 Nov 15
Kaminski NE - Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. [Review] [61 refs] - 1996 Oct
Lynn AB, Herkenham M - Localization of Cannabinoid Receptors and Nonsaturable High-Density Cannabinoid Binding Sites in Peripheral Tissues of the Rat: Implications for receptor-mediated immune modulation by cannabinoids - Mar 1994
Michel Salzet - Invertebrate molecular neuroimmune processes - 2000
Ruth A. Ross, Heather C. Brockie, Roger G. Pertwee - Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide - 2000
Paola Sacerdote, Paola Massi, Alberto E. Panerai, Daniela Parolaro - In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors - 2000
Salzet M. et.al. - Comparative biology of the endocannabinoid system, Possible role in the immune response - 2000
Sanchez, Cristina; Galve-Roperh, Ismael; Rueda, Daniel; Guzman, Manuel - Involvement of Sphingomyelin Hydrolysis and the Mitogen-Activated Protein Kinase Cascade in the 9-Tetrahydrocannabinol-Induced Stimulation of Glucose Metabolism in Primary Astrocytes - 1998
Silverstein MJ, Lessin PJ - Normal skin test responses in chronic marijuana users - 1974 Nov 22
Smith, Sidney R.; Terminelli, Carol; Denhardt, Georgetta - Modulation of Cytokine Responses in Corynebacterium Parvum-Primed Endotoxemic Mice by Centrally Administered Cannabinoid Ligands - 2001
Sidney R. Smith, Carol Terminelli, Georgetta Denhardt - Effects of Cannabinoid Receptor Agonist and Antagonist Ligands on Production of Inflammatory Cytokines and Anti-Inflammatory Interleukin-10 in Endotoxemic Mice. - 2000
Specter SC, Klein TW, Newton C, Mondragon M, Widen R, Friedman H - Marijuana Effects on Immunity: Suppression of Human Natural Killer Cell Activity of delta-9-Tetrahydrocannabinol - 1986
Srivastava MD, Srivastava BI, Brouhard B - Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. - 1998 Nov
George B. Stefano, Yannick Goumon, Thomas V. Bilinger, Ingeborg D. Welters, Patrick Cadet - Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor - 2000
George B. Stefano, Enzo Ottaviani - The biochemical substrate of nitric oxide signaling is present in primitive non-cognitive organisms - 2002
George B. Stefano, Yu Liu, Michael S. Goligorsky - Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes, - Aug 1996
Stephen E. Straus - Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents - Aug 2000
Waksman, Yaakov; Olson, John M.; Carlisle, Steven J.; Cabral, Guy A. - The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells - Mar 1999
Zheng ZM, Specter S, Friedman H - Inhibition by delta-9-Tetrahydrocannabinol of Tumor Necrosis Factor Alpha Production by Mouse and Human Macrophages - Nov 1992
Zhu W, Igarashi T, Qi ZT, Newton C, Widen RE, Friedman H, Klein TW - Delta-9-Tetrahydrocannabinol (THC) Decreases the Number of High and Intermediate Affinity IL-2 Receptors of the IL-2 Dependent Cell Line NKB61A2 - 1993
Zhu W, Newton C, Daaka Y, Friedman H, Klein TW - Delta 9-Tetrahydrocannabinol Enhances the Secretion of Interleukin 1 from Endotoxin-Stimulated Macrophages - Sep 1994
Russo, Ethan - An Editorial Introduction - 2001
R. Alonso, B. Voutsinos, M. Fournier, C. Labie, R. Steinberg, J. Souilhac, G. Le Fur, P. Soubrie - Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function - 1999
Cristina Arevalo, Rosario de Miguel, Rafael Hernandez-Tristan - Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. - 2001
Bovaso GB - Cannabis Abuse as a Risk Factor for Depressive Symptoms - 2001
Carlson ET - Cannabis indica in 19th-century psychiatry - 1974 Sep
Cousens K, DiMascio A - (-) Delta 9 THC as an hypnotic. An experimental study of three dose levels - 1973 Dec 20
Dean B, Sundram S, Bradbury R, Scarr E, Copolov D - Studies on [3 H]CP-55940 Binding in the Human Central Nervous System: Regional Specific Changes in Density of Cannabinoid-1 Receptors Associated with Schizophrenia and Cannabis Use - 2001
Patrick Dumas, Mohamed Aoud, Ebastien Bouafia, Christel Gutknecht, Rene Ecochard, Jean Dalery, Thierry Rochet, Thierry d'Amato - Cannabis use correlates with schizotypal personality traits in healthy students - 2002
Emrich HM, Leweke FM, Schneider U - Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due To Dysregulation of the Endogenous Cannabinoid System - Apr 1997
Fritzsche M - Are cannabinoid receptor knockout mice animal models for schizophrenia? - 2000
G. Grammatikopoulos, M. Pignatelli, F. D'Amico, C. Fiorillo, A. Fresiello, A.G. Sadile - Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples High-Excitability rat - 2002
Green, Brian E.; Ritter, Christian - Marijuana Use and Depression - Mar 2002
David Gurwitz - Emerging molecular targets - 1998
Harrigan, Peter - Are Cannabis and Psychosis Linked? - Feb 27,1999
Imade AG, Ebie JC - A retrospective study of symptom patterns of cannabis- induced psychosis - 1991 Feb
Johns A - Psychiatric effects of cannabis - 2001
Kotin J, Post RM, Goodwin FK - 9-Tetrahydrocannabinol in Depressed Patients - Mar 1973
Leweke FM et.al. - Elevated endogenous cannabinoids in schizophrenia - 1999
Giovanni Marsicano, Carsten T. Wotjakq, Shahnaz C. Azad, Tiziana Bisogno, Gerhard Rammes, Maria Grazia Cascio, Heike Hermann, Jianrong Tang, Clementine Hofmann, Walter Zieglgansberger, Vincenzo Di Marzo, Beat Lutz - The endogenous cannabinoid system controls extinction of aversive memories - 1 August 2002
Rob McGee, Sheila Williams, Richie Poulton, Terrie Moffitt - A longitudinal study of cannabis use and mental health from adolescence to early adulthood. - 2000
Miczek KA - Delta-9-Tetrahydrocannabinol: Antiaggressive Effects in Mice, Rats, and Squirrel Monkeys - Mar.31,1978
Muller-Vahl KR et.al. - Treatment of Tourette's syndrome with delta-9-THC): A Randomized Crossover Trial - 2002
Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F - Acute Administration of the CB1 Cannabinoid Receptor Antagonist SR 141716A Induces Anxiety-Like Responses in the Rat - 1997 Jan 20
Alessandra Ottani, Francesca Ferrari, Daniela Giuliani* - Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models - 2002
D. Peckys and Y. L. Hurd - Prodynorphin and k opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders - 2001
Polli G - Haschish in melancholia. 1874 - 1972 Jul
Rey et.al - Mental Health of Teenagers who use cannabis - 2002
Scher J - Marijuana as an agent in rehabilitating alcoholics - 1971 Jan
Stockings GT - A New Euphoriant for Depressive Mental States - 28 Jun 1947
Subramanian, Natarajan; Kalkman, Hans O. - Receptor Profile of P88-8991 and P95-12113, Metabolites of the Novel Antipsychotic Iloperidone - 2002
Swartz, James A.; Lurigio, Arthur J. - Psychotic Illness and Comorbidity Among Adult Male Detainess in Drug Treatment - Dec 1999
Alfonso Troisi, Augusto Pasini, Michele Saracco, Gianfranco Spalletta - Psychiatric symptoms in male cannabis users not using other illicit drugs - 1998
Volicer L et.al. - Effects of Dronabinol on Anorexia and Disturbed Behavior in Patients with Alzheimer's Disease - 1997
Lakshmi N.P. Voruganti, Piotr Slomka, Pamela Zabel, Adel Mattar, A. George Awad - Cannabis induced dopamine release: an in-vivo SPECT study - 2001
Warner, Richard; Taylor, Dawn; Wright, Joy; Sloat, Alison; Springette, Gwynette; Arnold, Sandy; Weinberg, Heather - Substance Use Among the Mentally Ill: Prevalence, Reasons for Use, and Effects on Illness - Jan 1994
Weil, Andrew T.; Zinberg, Norman E.; Nelsen, Judith M. - Clinical and Psychological Effects of Marihuana in Man - Dec 13,1968
J. H. Williams, N. A. Wellman, J. N. P. Rawlins - Cannabis use correlates with schizotypy in healthy people - 1996
Wood MD, Reavill C, Trail B, Wilson A, Stean T, Kennett GA, Lightowler S, Blackburn TP,Thomas D, Gager TL, Riley G, Holland V, Bromidge SM, Forbes IT, Middlemiss DN - SB-243213; a Selective 5-HT2C Receptor Inverse Agonist with Improved Anxiolytic Profile: Lack of Tolerance and Withdrawal Anxiety - 2001
Zablocki, Benjamin; Aidala, Angela; Hansell, Stephen; White, Helene Raskin - Marijuana Use, Introspectiveness, and Mental Health - Mar 1991
Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG - Action of Cannabidiol on the Anxiety and Other Effects Produced by delta-9-THC in Normal Subjects. - 1982
Zuardi AW, Morais SL, Guimaraes FS, Mechoulam R - Antipsychotic effect of cannabidiol [letter] - 1995 Oct
Berrendero F. Romero J. Garcia-Gil L. Suarez I. De la Cruz P. Ramos JA. Fernandez-Ruiz JJ - Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats - 1998 Sep 30
Elwan O. Hassan AA. Abdel Naseer M. Elwan F. Deif R. El Serafy O. El Banhawy E. El Fatatry M - Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking - 1997 May 1
Lyketsos CG. Garrett E. Liang KY. Anthony JC - Cannabis use and cognitive decline in persons under 65 years of age - 1999 May 1
Sidney S. Beck JE. Tekawa IS. Quesenberry CP. Friedman GD - Marijuana Use and Mortality - Apr 1997
Andreas Zimmer, Anne M. Zimmer*, Andrea G. Hohmann, Miles Herkenham, and Tom I. Bonner* - Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice - 1999 May 11
Bifulco, Maurizio; Laezza, Chiara; Portella, Giuseppe; Vitale, Mario; Orlando, Pierangelo; De Petrocellis, Luciano; Di Marzo, Vincenzo - Control by the Endogenous Cannabinoid System of Ras Oncogene-Dependent Tumor Growth - October 29, 2001
Bisogno T, Katayama K, Melck D, Ueda N, De Petrocellis L, Yamamoto S, Di Marzo V - Biosynthesis and Degradation of Bioactive Fatty Acid Amides in Human Breast Cancer and Rat Pheochromocytoma Cells--Implications for Cell Proliferation and Differentiation - Jun 15,1998
Luciano De Petrocellis, Dominique Melck, Tiziana Bisogno, Vincenzo Di Marzo - Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders - 2000
Vincenzo Di Marzo, Tiziana Bisogno, Luciano De Petrocellis, Dominique Melck, Pierangelo Orlando, Jens A. Wagner, and George Kunos - Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages - 1999
Galve-Roperh, Ismael; Sanchez, Cristina; Cortes, Maria Luisa; del Pulgar, Teresa Gomez; Izquierdo, Marta; Guzman, Manuel - Anti-Tumoral Action of Cannabinoids: Involvement of Sustained Ceramide Accumulation and Extracellular Signal-Regulated Kinase Activation - 2000 March
David Gurwitz - Emerging molecular targets - 1998
Stig O. P. Jacobsson, Thomas Wallin, Christopher J. Fowler - Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors - 2001
Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, Picard C, Rahier A, Taton M, Loison G, Caput D, Ferrara P, Lupker J - Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step - 1998 Sep 1
Maccarrone M, et.al - Anandamide induces Apoptosis in Human Cells via Vanilloid Receptors: evidence for a protective role of cannabinoid receptors - 2000 Oct 13
Mackie K, Hille B - Cannabinoids Inhibit N-Type Calcium Channels in Neuroblastoma-Glioma Cells - 1992 May 1
Mao, Li; Oh,Yun - Does Marijuana or Crack Cocaine Case Cancer? - Aug 19,1998
Murison G, et.al - Cannabinoids Induce Incomplete Maturation of Cultured Human Leukemia Cells - 1987 Aug. 1
Piomelli, Daniele - Pot of Gold for Glioma Therapy - March 2000
Rueda, Daniel; Galve-Roperh, Ismael; Haro, Amador; Guzman, Manuel - The CB1 Cannabinoid Receptor is Coupled to the Activation of c-Jun N-Terminal Kinase - 2000
Cristina Sanchez, Ismael Galve-Roperh, Cecile Canova, Philippe Brachet, Manuel Guzman - Delta 9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells - Not available
Theodore A. Sarafian, Donald P. Tashkin, and Michael D. Roth - Marijuana Smoke and D9-Tetrahydrocannabinol Promote Necrotic Cell Death but Inhibit Fas-Mediated Apoptosis - 2001
Weigang Zhu, Herman Friedman and Thomas W. Klein - Delta 9-Tetrahydrocannabinol Induces Apoptosis in Macrophages and Lymphocytes: Involvement of Bcl-2 and Caspase-11 - August 1998
Zhu, Li X.; Sharma, Sherven; Stolina, Marina; Gardner, Brian; Roth, Michael D.; Tashkin, Donald P.; Dubinett, Steven M. - Delta-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway - Jul 2000
Aceto MD, Scates SM, Razdan RK, Martin BR - Anandamide, an Endogenous Cannabinoid, Has a Very Low Physical Dependence Potential - Nov 1998
Patrick M. Beardsley, Mario E. Dance, Robert L. Balster, Patrik Munzar - Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys - 2002
Beautrais, Annette L.; Joyce, Peter R.; Mulder, Roger T. - Cannabis Abuse and Serious Suicide Attempts - 1999
Beinfeld, Margery C.; Connolly, Kelly - Activation of CB1 Cannabinoid Receptors in Rat Hippocampal Slices Inhibits Potassium-Evoked Cholecystokinin Release, a Possible Mechanism Contributing to the Spatial Memory Defects Produced by Cannabinoids - 2001
Boyle MH et.al - Familial Influences on Substance Use by Adolescents and Young Adults - 2001
Brodkin J. Moerschbaecher JM - SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats - 1997 Sep
Brook JS et.al - Risk Factors for Adolescent Marijuana Use Across Cultures and Across Time - 2001
Budney, Alan J.; Novy, Pamela L.; Hughes, John R. - Marijuana Withdrawal Among Adults Seeking Treatment for Marijuana Dependence - 1999
Budney, Alan J.; Bickel, Warren K.; Amass, Leslie - Marijuana Use and Treatment Outcome Among Opioid-Dependent Patients - 1988
D. Carriero, J. Aberman, S. Y. Lin, A. Hill, A. Makriyannis, J. D. Salamone - original investigation: A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing - 1998
Casswell, Sally; Marks, David F. - Cannabis and Temporal Disintegration in Experienced and Naive Subjects - Feb 1973
Chaperon, Frederique; Soubrie, Philippe; Puech, Alain J.; Thiebot, Marie-Helene - Involvement of Central Cannabinoid (CB1) Receptors in the Establishment of Place Conditioning in Rats - Feb 1998
Arthur Christopoulos, Kathryn Wilson - Interaction of anandamide with the M1 and M4 muscarinic acetylcholine receptors - 2001
Cook, Stacie A.; Lowe, John A.; Martin, Billy R. - CB1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to 9-Tetrahydrocannabinol - Jun 1998
George E. Da Silva, Reinaldo N. Takahashi - SR 141716A prevents 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice - 2002
Ehrenreich, Hannelore; Rinn, Thomas; Kunert, Hanns J.; Moeller, Manfred R.; Poser, Wolfgang; Schilling, Lothar; Gigerenzer, Gerd; Margret, R - Hoehe Original Investigation: Specific Attentional Dysfunction in Adults Following Early Start of Cannabis Use - 1999
Fendrich, Michael; Vaughn, Connie M. - Diminished Lifetime Substance Use Over Time: An Inquiry Into Differential Underreporting - Spring 1994
David M. Fergusson, L. John Horwood - Does cannabis use encourage other forms of illicit drug use? - 2000
F. Ferrari, A. Ottani, D. Giuliani - Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour - 2000
Fowler FJ, Stringfellow VL - Learning from experience: estimating teen use of alcohol, cigarettes, and marijuana from three survey protocols - 2001
French, Eegar D.; Dillon, Kathryn; Wu, Xiaofang - Cannabinoids Excite Dopamine Neurons in the Ventral Tegmentum and Substantia Nigra - Feb 10,1997
Peter Fried, Barbara Watkinson, Deborah James, Robert Gray - Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults - Apr 2 2002
Gardner, Eliot L.; Vorel, S. Robert - Cannabinoid Transmission and Reward-Related Events - Dec 1998
Ghozland, Sandy; Matthes, Hans W.D.; Simonin, Frederic; Filliol, Dominique; Kieffer, Brigitte L.; Maldonado, Rafael - Motivational Effects of Cannabinoids Are Mediated by u-Opioid and k-Opioid Receptors - Feb 1,2002
Ginsberg, Irving J.; Greenly, James R. - Competing Theories of Marijuana Use: A Longitudinal Study - Mar 1978
Giuliani D. et.al - the cannabinoid receptor agonist HU 210 modifies rat behavioral responses to novelty and stress - 2000
Golub AL, Johnson BD - Alcohol is Not the Gateway to Hard Drug Abuse - 1998
Golub A et.al.; - Response Reliablity and the Study of Adolescent Substance Use Progression - 2000
Mark K. Greenwald, Maxine L. Stitzer - Antinociceptive, subjective and behavioral effects of smoked marijuana in humans - 2000
M. Haney, Amie S. Ward, Sandra D. Comer, Richard W. Foltin, Marian W. Fischman - Original investigation: Abstinence symptoms following smoked marijuana in humans - 1999
Shuzhen Hao, Yosefa Avraham, Raphael Mechoulam & Elliot M. Berry - Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice - 2000
Salvador Huitron-Resendiz, Lhys Gombart, Benjamin F. Cravatt, and Steven J. Henriksen - Effect of Oleamide on Sleep and Its Relationship to Blood Pressure, Body Temperature, and Locomotor Activity in Rats - 2001
Hutcheson, Daniel M.; Tzavara, Eleni Th.; Smadja, Claire; Valjent, Emmanuel; Roques, Bernard P.; Hanoune, Jacques; Maldonado, Rafael - Behavioural and Biochemical Evidence for Signs of Abstinence in Mice Chronically Treated with delta-9-Tetrahydrocannabinol - Dec 1998
Jano J. Janoyan, Jennifer L. Crim, Nissar A. Darmani - Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by 9-THC and other cannabinoids - 2002
T. U. C. Jarbe, R. J. Lamb, A. Makriyannis, S. Lin, A. Goutopoulos - original investigation: 9-THC training dose as a determinant for (R)- methanandamide generalization in rats - 1998
Jentsch JD, Wise A, Katz Z, Roth RH - Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex - 1998 Jan
Jones RT, Benowitz NL, Herning RI - Clinical Relevance of Cannabis Tolerance and Dependence - Aug 1981
Klonoff H - Marijuana and Driving in Real-Life Situations - 1974
Elena M. Kouri, Harrison G. Pope Jr, Scott E. Lukas - original investigation: Changes in aggressive behavior during withdrawal from long-term marijuana use - 1999
Aron H. Lichtman - SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats - 2000
Lynsky M, Hall W - The Effects of adolescent cannabis use on educational attainment: a review - 2000
Maldonado, Rafael; Rodriguez de Fonseca, Fernando - Cannabinoid Addiction: Behavioral Models and Neural Correlates - May 1, 2002
Mallet PE, Beninger RJ - The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide - 1998 Nov
Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W - Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice - 1998 Jul
Martin P, Consroe P - Cannabinoid Induced Behavioral Convulsions in Rabbits - Nov. 26, 1976
Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z - Anandamide may mediate sleep induction - 1997 Sep 4
Jan K Melichar, Mark RC Daglish, David J Nutt - Addiction and withdrawal - current views - 2001
Murillo-Rodriguez, Eric; Giordano, Magda; Cabeza, Rafael; Henriksen, Steve J.; Mendez Diaz, Monica; Navarro, Luz; Prospero-Garcia, Oscar - Oleamide Modulates Memory in Rats - 2001
Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D - Anandamide Modulates Sleep and Memory in Rats - 23 Nov 1998
F. Nava, G. Carta, G. Colombo, G.L. Gessa - Effects of chronic 9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze - 2001
Navarro M, Carrera MRA, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F - Functional Interaction Between Opioid and Cannabinoid Receptors in Drug Self-Administration - Jul 15,2001
Douglas K. Novins, Christina M. Mitchell - Factors associated with marijuana use among American Indian adolescents - 1998
Hofler, Michael; Lieb, Roselind; Perkonigg, Axel; Schuster, Peter; Sonntag, Holger; Wittchen, Hans-Ulrich - Covariates of Cannabis Use Progression in a Representative Population Sample of Adolescents: A Prospective Examination of Vulnerability and Risk Factors - 1999
Poncelet M, Barnouin MC, Breliere JC, Le Fur G, Soubrie P - Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils - 1999 May
Rafaelsen, Ole J.; Bech, Per; Christiansen, Johannes; Christrup, Henriette; Nyboe, Jorgen; Rafaelsen, Ltse - Cannabis and Alcohol: Effects on Simulated Car Driving - Mar 2,1973
Reibaud M. et.al - Enhancement of memory in cannabinoid CB 1 receptor knockout mice - 1999
David Reilly, Peter Didcott, Wendy Swift, Wayne Hall - Long-term cannabis use: characteristics of users in an Australian rural area - 1998
F. Rodriguez de Fonseca, M. Navarro, R. Gomez, L. Escuredo, F. Nava, J. Fu, E. Murillo-Rodriguez, A. Giuffrida, J. LoVerme, S. Gaetani, S. Kathuria, C. Gallk & D. Piomelli - An Anorexic Lipid Mediator Regulated by Feeding - 8 Nov 2001
Rodriguez de Fonseca, Fernando; Rocio, M.; Carrera, A.; Navarro, Miguel; Koob, George F.; Weiss, Friedbert - Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal - 1997 27 June
Rubino T, Patrini G, Massi P, Fuzio D, Vigano D, Giagnoni G, Parolaro D - Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression - 1998 May
Sanudo-Pena MC, Walker JM - Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system - 1998 Jan
Sanudo-Pena MC, Force M, Tsou K, Miller AS, Walker JM - Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system - 1998 Oct
Zoltan Sarnyai, Yavin Shaham, Stephen C. Heinrichs - The Role of Corticotropin-Releasing Factor in Drug Addiction - 2001
Schaeffer J; Andrysiak T; Ungerleider JT - Cognition and Long-Term Use of Ganja (Cannabis) - 1981
Schuckit, Marc A.; Daeppen, Jean-Bernard; Danko, George P.; Tripp, Megan L. ; Smith, Tom L.; Li, Ti.-K.; Hesselbrock, Victor M.; Bucholz, Kathleen K. - Clinical Implications for Four Drugs of the DSM-IV Distinction Between Substance Dependence With and Without a Physiological Component - Jan 1999
Sheldon T - Cannabis Use Falls Among Dutch Youth - 16 Sep 2000
Soderstrom, Ken; Johnson, Frank - CB1 Cannabinoid Receptor Expression in Brain Regions Associated with Zebra Finch Song Control - 2000
L.P. Spear - The adolescent brain and age-related behavioral manifestations - 2000
Swaim RC, Bates SC, Chavez EL - Structural equation socialization model of substance use among Mexican-American and white non-Hispanic school dropouts - 1998 Sep
Wendy Swift, Wayne Hall, Maree Teesson - Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing - 2001
Wendy Swift, Wayne Hall, Peter Didcott, David Reilly - Patterns and correlates of cannabis dependence among long-term users in an Australian rural area - 1998
Wendy Swift, Jan Copeland, Wayne Hall - Choosing a diagnostic cut-off for cannabis dependence - 1998
Tanda G, Loddo P, Di Chiara G - Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol - 1999 Jul 2
Tanda, Gianluigi; Pontieri, Francesco E.; Di Chiara, Gaetano - Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ1 Opioid Receptor Mechanism - Jun 1997
Lars Terenius - Rational treatment of addiction - 1998
Valverde, Olga; Maldonado, Rafael; Valjent, Emmanuel; Zimmer, Anne M.; Zimmer, Andreas - Cannabinoid Withdrawl Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice - Dec 15,2000
S. A. Varvel, A. H. Lichtman - Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze - 2002
Walsh, Gordon W.; Mann, Robert E. - On the High Road: Driving Under the Influence of Cannabis in Ontario - Jul 1999
Gerhard A. Wiesbeck, Marc A. Schuckit, Jelger A. Kalmijn, Jayson E. Tipp, Kathleen K. Bucholz, Tom L. Smith - An Evaluation of the History of a Marijuana Withdrawal Syndrome in a Large Population - 1996
Claire M. Williams, T. C. Kirkham - rapid communication: Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors - 1999
Wu X, French ED - Effects of chronic delta-9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment - 2000
Kirsten von Sydow, Roselind Lieb, Hildegard Pfister, Michael Hofler, Holger Sonntag, Hans-Ulrich Wittchen - The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults - 2001
Acquas, Elio; Pisanu, Augusta; Marrocu, Paola; Goldberg, Steven R.; Di Chiara, Gaetano - D 9 -Tetrahydrocannabinol Enhances Cortical and Hippocampal Acetylcholine Release in Vivo: A Microdialysis Study - 2001
Jonathon C. Arnold, Ann N. Topple, Paul E. Mallet, Glenn E. Hunt, Iain S. McGregor - The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain - 2001
Michael Bayewitch, Man-Hee Rhee, Tomer Avidor-Reiss, Aviva Breuer, Raphael Mechoulam, Zvi Vogel - Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase - April 26 1996
Ben-Zvi Z, Mechoulam R - 6 beta-Hydroxy-Delta (1)- Tetrahydrocannabinol Synthesis and biological activity - Nov. 26, 1971
Bonhaus DW, Chang LK, Kwan J, Martin GR - Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses - Dec 1998
Bouaboula M. Dussossoy D. Casellas P - Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses - 1999 Jul 16
Christopher S. Breivogel, Steven R. Childers - Cannabinoid Agonist Signal Transduction in Rat Brain: Comparison of Cannabinoid Agonists in Receptor Binding, G-Protein Activation, and Adenylyl Cyclase Inhibition - 2000
Barbara Costa, Mariapia Colleoni - Changes in rat brain energetic metabolism after exposure to anandamide or 9-tetrahydrocannabinol - 2000
DePetrocellis D et.al. - The activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and is Limited by Intracellular Metabolism - Apr 20 2001
Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulamt, Raphael - Isolation and Structure of a Brain Constituent that Binds to the Cannabinoid Receptor - Dec 18,1992
Edgemond, William S.; Greenberg, Marcie J.; Mcginley, P.J.; Muthian, Shanmugam; Campbell, William B.; Hillard, Cecilia J. - Synthesis and Characterization of Diazomethylarachidonyl Ketone: An Irreversible Inhibitor of N- Arachidonylethanolamine Amidohydrolase - Jul 1998
Felder CC et.al - Cannabinoid Agonists Stimulate Both Receptor- and Non-Receptor-Mediated Signal Transduction Pathways in Cells Transfected with and Expressing Cannabinoid Receptor Clones - 1992
Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M - LY320135, a Novel Cannabinoid CB1 Receptor Antagonist, Unmasks Coupling of the CB1 Receptor to Stimulation of cAMP Accumulation - 1998 Jan
Fellermeier M et.al. - Biosynthesis of Cannabinoids: Incorporation experiments with 13 C-labeled glucoses - 2001
Fellermeier, Monika; Zenk, Meinhart H. - Prenylation of Olivetolate by a Hemp Transferase Yields Cannabigerolic Acid, the Precursor of Tetrahydrocannabinol - May 8,1998
Galanter, Mark; Wyatt, Richard J.; Lemberger, Louis; Weingartner, Herbert; Vaughan, Tom B.; Roth, Walton T. - Effects on Humans of Delta-9-Tetrathydrocannabinol Administration by Smoking - May 26,1972
Paul Gouldson, Bernard Calandra, Pascale Legoux, Aimee Kerneis, Murielle Rinaldi-Carmona, Francis Barth, Gerard Le Fur, Pascual Ferrara, David Shire, - Mutational Analysis and Molecular Modelling of the Antagonist SR 144528 Binding Site on the Human Cannabinoid CB Receptor 2 - 2000
Griffin, Graeme; Wray, Emma J.; Martin, Billy R.;Abood, Mary E. - Cannabinoid Agonists and Antagonists Discriminated by Receptor Binding in Rat Cerebellum - 1999
Griffin G. et.al. - Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5-0-(3-{35S}thio)-trihosphate Binding Assay in Rat Cerebellar Membranes - 1998
Anderson GM, Braun G, Braun U, Nichols DE, Shulgin AT - Absolute Configuration and Psychotomimetic Activity - 1978
Haagen-Smit AJ, Wawra CZ, Koepfli JB, Allen GA, Feigen GA, Pratcer AN - A Physiologically Active Principle from Cannabis Sativa (Marijuana) - Jan 21,1940
Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E - HU-308: A Specific Agonist for CB2, a Peripheral Cannabinoid Receptor - Dec 7,1999
Hawkins BL, Roberts JD - Nuclear Magnetic Resonance Spectroscopy: fourier Transform Spectra of Delta-8 and Delta-9 tetrahydrocannabinol - Apr 1973
Hillard, Cecilia J.; Manna, Sukumar; Greenberg, Marcie J.; DiCamelli, Ralph; Ross, Ruth A.; Stevenson, Lesley A.; Murphy, Vicki; Pertwee, Roger G.;Campbell, William B. - Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1) - June 1999
Hockman CH et.al. - Electroencephalographic and Behavioral Alterations Produced by Delta-1-Tetrahydrocannabinol - Not available
Howlett, Allyn C.; Wilken, Gerald H.; Pigg, J.Jill; Houston, Devin B.; Lan, Ruoxi; Liu, Qian; Makriyannis,Alexandros - Azido- and Isothiocyanato-Substituted Aryl Pyrazoles Bind Covalently to the CB 1 Cannabinoid Receptor and Impair Signal Transduction - 2000
Iwamura H et.al. - In Vitro and in Vivo Pharmacological Characterization of JTE- 907, a Novel Selective Ligand for Cannabinoid CB2 Receptor - 2001
Marcel A.K. Jansen, Victor Gaba and Bruce M. Greenberg - Higher plants and UV-B radiation: balancing damage, repair and acclimation [Review article] - 3:4:131-135
Kim E-S - Imunnochemical Localization of tetrahydrocannabinol (THC) in cryofixed Glandular trichomes of cannabis (Cannabaceae) - 1997
Kirk, J.M.; De Wit, Harriet - Responses to Oral 9-Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users - 1999
Kittler, Josef T.; Grigorenko, Elena V.; Clayton, Chris; Zhuang, Shou-yuan; Bundey, Sarah C.; Trower, Michael M.;Wallace, Don; Hampson, Robert; Deadwyler, Sam - Large-Scale Analysis of Gene Expression Changes During Acute and Chronic Exposure to delta- 9 -THC in Rats - 2000
Lemberger, Louis; Silberstein, Stephen D.; Axelrod, Julius; Kopin, Irwin J. - Marihuana: Studies on the Disposition and Metabolism of Delta-9-Tetrahydrocannabinol in Man - Dec 18,1970
Lemberger, Louis; Tamarkin, Norman; Axelrod, Julius; Kopin, Irwin J. - Delta-9-Tetrahydrocannabinol: Metabolism and Disposition in Long-Term Marihuana Smokers - Jul 2,1971
MacLennan SJ, Reynen PH, Kwan J, Bonhaus DW - Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors - 1998 Jun
Daniel T. Malone, David A. Taylor - Involvement of somatodendritic 5-HT1A receptors in D-9-tetrahydrocannabinol-induced hypothermia in the rat - 2001
Martin, Billy R.; Beletskaya, Irina; Patrick, Gray; Jefferson, Rene E.; Winckler, Ramona; Deutsch, Dale G.; Di Marzo, Vincenzo; Dasse, Olivier; Mahadevan, Ann; Razdan, Raj K. - Cannabinoid Properties of Methylfluorophosphonate Analogs - 2000
Martin, Billy R.; Jefferson, Renee G.; Winckler, Ramona; Wiley, Jenny L.; Thomas, Brian F.; Crocker, Peter J.; Williams, William; Razdan, Raj K. - Assessment of Structural Commonality Between Tetrahydrocannabinol and Anandamide - 2002
Martin BR, Jefferson R, Winckler R, Wiley JL, Huffman JW, Crocker PJ, Saha B,Razda RK - Manipulation of the Tetrahydrocannabinol Side Chain Delineates Agonists, Partial Agonists, and Antagonists - Sep 1999
Mechoulam, Rafael; Shani, Arnon; Edery, Habib; Grunfeld, Yona - Chemical Basis of Hashish Activity - Aug 7,1970
Felice Nava, Giovanna Carta, Gian Luigi Gessa - Permissive Role of Dopamine D2 Receptors in the Hypothermia Induced by D 9 -Tetrahydrocannabinol in Rats - 2000
Nilsson IM, Agurell S, Nilsson JLG, Ohlsson A, Sandberg F, Wahlquist M - Delta-9-tetrahydrocannabinol: Sructure of a Major Metabolite - Jun 5,1970
Petcoff, Darrell G.; Strain, S. Michael; Brown, William R.; Ribi, Edgar - Marihuana: Idnetification of Cannabinoids by Centrifugal Chromatography - Aug 27,1971
Petitet, Francois; Jeantaud, Bernadette; Bertrand, Philippe; Imperato, Assunta - Cannabinoid Penetration Into Mouse Brain as Determined by Ex Vivo Binding - 1999
Emil Pop - Cannabinoids, endogenous ligands and synthetic analogs [Review article] - 1999
Pop E, Brewster ME - Dimerization of dexabinol by hydrogen bonding accounts for its hydrophobic character - 1997
Porcella A et.al - Delta 9-Tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain - 1998
Marielle Portier, Murielle Rinaldi-Carmona, Florence Pecceu, Therese Combes, Caroline Poinot-Chazel, Bernard Calandra, Francis Barth, Gerard Le Fur and Pierre Casellas - SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist - February 1999
Vera Ralevic, David A. Kendall, Jeffrey C. Jerman, Derek N. Middlemiss, Darren Smart - Cannabinoid activation of recombinant and endogenous vanilloid receptors - 2001
Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL - SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor - 1998 Feb
Ruth A, Ross, T, Michael Gibson, Lesley A, Stevenson, Bijali Saha, Peter Crocker, Raj K, Razdan and Roger G, Pertwee - Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-8-tetrahydrocannabinol at cannabinoid receptors - 1999
RA Ross, HC Brockie, LA Stevenson, VL Murphy, F Templeton, A Makriyannis, RG Pertwee - Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630 - 1999
Tiziana Rubino, Daniela Vigano, Paola Massi, Maurizio Spinello, Elisabetta Zagato, Gabriella Giagnoni, Daniela Parolaro - Chronic -9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions - Not available
Sagan S et.al - Anandamide and WIN 55212-2 inhibkt cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes - 1999
Scheckel, Carl L.; Boff, Edward; Dahlen, Philip; Stamp, Terrence - Behavioral Effects in Monkeys of Racemates of Two Biologically Active Marijuana Constituents - Jun 28,1968
Taura, Futoshi; Morimoto, Satoshi; Shoyama, Yukihiro - Purification and Characterization of Cannabidiolic-acid Synthase from Cannabis sativa L. Biochemical analysis of a novel enzyme that catalyzes the oxidocyclization of cannabigerolic acid to cannabidiolic acid - Jul 19,1996
Brian F. Thomas, Anne F. Gilliam, David F. Burch, Michael J. Roche Herbert H. Seltzman - Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists - April 1998
Tognetto, Michele; Amadesi, Silvia; Harrison, Selena; Creminon, Christophe; Trevisani, Marcello; Carreras, Mirko; Matera, Mario; Geppetti, Pierangelo; Bianchi, Alfredo - Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation - Feb 15,2001
Wiley JL et.al. - Novel Pyrazole Cannabinoids: Insights into CB1 Receptor Recognition and Activation - 2001
Wiley, Jenny L.; Beletskaya, Irina D.; Ng, Edward W.; Dai, Zongmin; Crocker, Peter J.; Mahadevan, Anu; Razdan, Raj K.; Martin, Billy R. - Resorcinol Derivatives: A Novel Template for the Development of Cannabinoid CB1 /CB2 and CB2 -Selective Agonists - 2002
Wiley, Jenny L.; Compton, David R.; Dai, Dong; Lainton, Julia A. H.; Phillips, Michelle; Huffman, John W.; Martin, Billy R. - Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids - Jun 1998
Xie, Xiang-Qun; Melvin, Lawrence S.; Makriyannis, Alexandros - The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940 - May 3,1996
Adams IB, Compton DR, Martin BR - Assessment of Anandamide Interaction with the Cannabinoid Brain Receptor: SR 141716A Antagonism Studies in Mice and Autoradiographic Analysis of Receptor Binding in Rat Brain - Mar 1998
A. Al-Hayani, K.N. Wease, R.A. Ross, R.G. Pertwee, S.N. Davies - The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice - 2001
M. Beltramo, N. Stella, A. Calignano, S. Y. Lin, A. Makriyannis, D. Piomelli - Functional Role of High Affinity Anandamide Transport, as Revealed by Selective Inhibition - 22 Aug 1997
Bisogno, Tiziana; Maccarrone, Mauro; De Petrocellis, Luciano; Jarrahian, Abbas; Finazzi-AgroA, Alessandro; Hillard, Cecilia; Di Marzo, Vincenzo - The Uptake by Cells of 2-Arachidonoylglycerol, an Endogenous Agonist of Cannabinoid Receptors - 2001
Tiziana Bisogno, Nunzio Sepe, Dominique Melck, Stefano Maurelli, Luciano De Petrocellis, Vincenzo Di Marzo - Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells - 1997
Boger, Dale L.; Sato, Haruhiko; Lerner, Aaron E.; Hedrick, Michael P.; Fecik, Robert A.; Miyauchi, Hiroshi; Wilkie, Gordon D.; Austin, Bryce J.; Patricelli, Matthew P.; Cravatt, Benjamin F. - Exceptionally Potent Inhibitors of Fatty Acid Amide Hydrolase: The Enzyme Responsible for Degradation of Endogenous Oleamide and Anandamide - May 9, 2000
Cadas, Hugues; Gaillet, Sylvie; Beltramo, Massimiliano; Venance, Laurent; Piomelli, Daniele - Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and Its Control by Calcium and cAMP, - Jun 15,1996
Cadas, Hugues; di Tomaso, Emmanuelle; Piomelli, Daniele - Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain - Feb 15,1997
Compton DR. Martin BR - The Effect of the Enzyme Inhibitor Phenylmethylsulfonyl Fluoride on the Pharmacological Effect of Anandamide in the Mouse Model of Cannabimimetic Activity - Dec 1997
Theresa A. Day, Fariborz Rakhshan, Dale G. Deutsch, Eric L. Barker - Role of Fatty Acid Amide Hydrolase in the Transport of theEndogenous Cannabinoid Anandamide - 2001
DePetrocellis D. et.al - Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response - 1999
Deutsch, Dale G.; Glaser, Sherrye T.; Howell, Judy M.; Kunz, Jeffrey S.; Puffenbarger, Robyn A.; Hillard, Cecilia J.; Abumradi, Nada - The Cellular Uptake of Anandamide is Coupled to its Breakdown by Fatty-acid Amide Hydrolase - Mar.19, 2001
Di Marzo, Vincenzo; Bisogno, Tiziana; De Petrocellis, Luciano - Anandamide: Some Like it Hot - Jul 2001
Vincenzo Di Marzo, Dale G. Deutsch - Biochemistry of the Endogenous Ligands of Cannabinoid Receptors - 1998
Di Marzo V, De Petrocellis L, Sepe N, Buono A - Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells - 1996 Jun 15
Fride E. Mechoulam - Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent - 1993 Feb 9
Andrea Giuffrida, Fernando Rodrguez de Fonseca, Daniele Piomelli - Quantification of Bioactive Acylethanolamides in Rat Plasma by Electrospray Mass Spectrometry - Apr 2000
Andrea Giuffrida, Massimiliano Beltramo, Daniele Piomelli - Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology - 2001
Andrea Giuffrida, Daniele Piomelli - Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma - Not available
Waldemar Gonsiorek, Charles Lunn, Xuedong Fan, Satwant Narula, Daniel Lundell, R. William Hipkin - Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide - 2000
S. Gonzlez, T. Bisogno, T. Wenger, J. Manzanares, A. Milone, F. Berrendero, V. Di Marzo, J. A. Ramos, J. J. Fernndez-Ruiz - Sex Steroid Influence on Cannabinoid CB1 Receptor mRNA and Endocannabinoid Levels in the Anterior Pituitary Gland - Apr 2000
Sravan Kumar Goparaju, Natsuo Ueda, Hiroko Yamaguchi, Shozo Yamamoto - Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand - Not available
Hanus, Lum??r; Abu-Lafi, Saleh; Fride, Ester; Breuer, Aviva; Vogel, Zvi; Shalev, Deborah E.; Kustanovich, Irina; Mechoulam, Raphael - 2-Arachidonyl Glycerol Ether, an Endogenous Agonist of the Cannabinoid CB1 Receptor - Mar 27,2001
Cecilia J. Hillard, Abbas Jarrahian - The movement of N arachidonoylethanolamine (anandamide) across cellular membranes - 2000
Abbas Jarrahian, Sukumar Manna, William S. Edgemond, William B. Campbell, Cecilia J. Hillard - Structure-Activity Relationships Among N-Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter - 2000
Kempe, Kirsten; Hsu, Fong-Fu; Bohrer, Alan; Turk, John - Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue - Jul 19,1996
Kondo S, Kondo H, Nakane S, Kodaka T, Tokumura A, Waku K, Sugiura T - 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+ -dependent and -independent mechanisms - 1998 Jun 12
Kevin R. Kozak, Jeffery J. Prusakiewicz, Scott W. Rowlinson , Claus Schneider, Lawrence J. Marnett - Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol* - Aug 10 2001
Kozak, Kevin R.; Rowlinson, Scott W.; Marnett, Lawrence J. - Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2 - Oct. 27, 2000
Kunos G - the discovery of endogenous cannabinoids - 1999
Lin S, Khanolkar AD, Fan P, Goutopoulos A, Qin C, Papahadjis D, Makriyannis A - Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability - Not available
Maingret F et.al. - The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1 - 2001
Wallace B. Mendelson, M.D., and Anthony S. Basile, Ph.D - The Hypnotic Actions of the Fatty Acid Amide, Oleamide - 2001
Victoria E. Mendizabal, Maria Luz Orliac, Edda Adler-Graschinsky - Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed - 2001
Shanmugam Muthian, Kasem Nithipatikom, William B. Campbell, Cecilia J. Hillard - Synthesis and Characterization of a Fluorescent Substrate for the N-Arachidonoylethanolamine (Anandamide) Transmembrane Carrier - 2000
Patricelli, Matthew P.; Cravatt, Benjamin F. - Clarifying the Catalytic Roles of Conserved Residues in the Amidase Signature Family - Jun 23,2000
Piomelli, Daniele; Beltramo, Massimiliano; Giuffrida, Andrea; Stella, Nephi - Endogenous Cannabinoid Signaling - Dec 1998
Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie, Xiang-Qun; Makriyannis A - Structural Determinants for Recognition and Translocation by the Anandamide Transporter - May 11,1999
Porter AC, Sauer J-M, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC - Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor - 2002
Fariborz Rakhshan, Theresa A. Day, Randy D. Blakely, Eric L. Barker - Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells - 2000
Harald H.O. Schmid - Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? - 2000
Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR - The Pharmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice - Jul 1994
Stahl SM - Getting stoned without inhaling: anandamide is the brain's natural marijuana - 1998 Nov
Nephi Stella, Daniele Piomelli - Receptor-dependent formation of endogenous cannabinoids in cortical neurons - 2001
Sugiura, Takayuki; Kondo, Sachiko; Kishimoto, Seishi; Miyashita, Tomoyuki; Nakane, Shinji; Kodaka, Tomoko; Suhara, Yoshitomo; Takayama, Hiroaki; Waku, Keizo - Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor Comparison of the Agonistic Activities of Various Cannabinoid Receptor Ligands in hl-60 Cells - Jan 7,2000
Sugiura, Takayuki; Yoshinaga, Naoki; Kondo, Sachiko; Waku, Keizo; Ishima, Yoshio - Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Picrotoxinin-Administered Rat Brain - May 2000
Sugiura, Takayuki; Waku, Keizo - 2-Arachidonoylglycerol and the Cannabinoid Receptors - 2000
Sugiura T. Kondo S. Sukagawa A. Tonegawa T. Nakane S. Yamashita A. Ishima Y, Waku K - Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine - 1996 Aug 15
Natsuo Ueda, Robyn A. Puffenbarger, Shozo Yamamoto, Dale G. Deutsch - The fatty acid amide hydrolase (FAAH) - 2000
Ueda, Natsuo; Kurahashi, Yuko; Yamamoto, Shozo; Tokunaga, Takashi - Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide - Oct. 6, 1995
Wiley, Jenny L. - Cannabis: Discrimination of ''Internal Bliss''? - October 1999
Willoughby KA. Moore SF. Martin BR. Ellis EF - The Biodisposition and Metabolism of Anandamide in Mice - Jul 1997
Rachel I. Wilson, Roger A. Nicoll - Endocannabinoid Signaling in the Brain - April 26 2000
Peter M. Zygmunt, David Julius, Vincenzo Di Marzo Edward D. Hцgestдtt - Anandamide - the other side of the coin [Comment] Trends in Pharmacological - 2000
Anat Biegon, Ilan A. Kerman - Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain - 2001
Breivogel, Christopher S.; Griffin, Graeme; Di Marzo, Vincenzo; Martin, Billy R. - Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain - 2001
Breivogel, Christopher S.; Childers, Steven R. - The Functional Neuroanatomy of Brain Cannabinoid Receptors - Dec 1998
Christopher S. Breivogel, Laura J. Sim, Steven R. Childers - Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain - 1997
Chin, Chen-ni; Murphy, James W.; Huffman, John W.; Kendall, Debra A. - The Third Transmembrane Helix of the Cannabinoid Receptor Plays a Role in the Selectivity of Aminoalkylindoles for CB2, Peripheral Cannabinoid Receptor - November 1999
Coutts AA et.al. - Agonist-Induced Internalization and Trafficking of Cannabinoid CB1 Receptors in Hippocampal Neurons - April 2001
Jean-Marie Derocq, Omar Jbilo, Monsif Bouaboula, Michel Sйgui, Christophe Clиre, Pierre Casellas - Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60. Possible involvement of the cb2 receptor in cell differentiation - 2000
Di Marzo, Vincenzo; Bisogno, Tiziana; Melck, Dominique; Ross, Ruth; Brockie, Heather; Stevenson, Lesley; Pertwee, Roger; De Petrocellis, Luciano - Interactions Between Synthetic Vanilloids and the Endogenous Cannabinoid System - 09 October 1998
Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A - Mast Cells Express a Peripheral Cannabinoid Receptor with Differential Sensitivity to Anandamide and Palmitoylethanolamide - Apr 11,1995
Gadzicki D, Muller-Vahl K, Stuhrmann M - A Frequent Polymorphism in the Coding Exon of the Human annabinoid rReceptor (CNR1) Gene - 1999
Garcia DE, Brown S, Hille B, Mackie K - Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor - 1998 Apr 15
Gifford AN, Bruneus M, Gatley SJ, Lan R, Makriyannis A, Volkow ND - Large receptor reserve for cannabinoid actions in the central nervous system - 1999 Feb
Glass, Michelle; Northup, John K. - Agonist Selective Regulation of G Proteins by Cannabinoid CB1 and CB2 Receptors - 1999
Glass M, Felder CC - Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1receptor - 1997 Jul 15
Graeme Griffin, Qing Tao, Mary E. Abood - Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor - 2000
N. Hajos, C. Ledent, T. F. Freund - A novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus - 2001
Herkenham M et.al. - Cannabinoid localization in Brain - Mar 1990
H. Hermann, G. Marsicano, B. Lutz - Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain - 2002
A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, R. Mechoulam, R. G. Pertwee - International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors - 2002
Howlett AC - The CB1 cannabinoid receptor in the brain - 1998 Dec
Howlett AC, Johnson MR, Melvin LS, Milne GM - Nonclassical Cannabinoid Analgetics Inhibit Adenylate Cyclase: Development of a Cannabinoid Receptor Model - 1988
Howlett AC, Johnson MR, Melvin LS - Classical and Nonclassical Cannabinoids: Mechanism of Action-Brain Binding - 1990
Howlett, Allyn C.; Song, Chao; Berglund, Barbara A.; Wilken, Gerald H.; Pigg, J. Jill - Characterization of CB1 Cannabinoid Receptors Using Receptor Peptide Fragments and Site-Directed Antibodies - 1998
Atmaram D. Khanolkar, Sonya L. Palmer, Alexandros Makriyannis - Molecular probes for the cannabinoid receptors - 2000
Anjali Kulkarni-Narla, David R. Brown - Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons - 2001
Lucy Lay, James A. Angus, Christine E. Wright - Pharmacological characterisation of cannabinoid CB receptors in the rat and mouse - 2000
Ledent, Catherine; Valverde, Olga; Cossu, Gregorio; Petitet, Francuois; Aubert, Francuoise; Beslot, F; Bohme, Georg A; Imperato, Assunta; Pedrazzini, Thierry; Roques, Bernard P.; Vassart, Gilbert; Fratta, Walter; Parmentier, Marc - Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB1 Receptor Knockout Mice - Jan 15, 1999
Sumi Fong Lee, Catherine Newton, Raymond Widen, Herman Friedman, Thomas W. Klein - Differential expression of cannabinoid CB receptor mRNA in mouse immune cell subpopulations and following B cell stimulation - 2001
Mariscano G, Lutz B - Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain - 1999
Marx, Jean - Marijuana Receptor Gene Cloned - Aug 10,1990
Matias, Isabel; Bisogno, Tiziana; Melck, Dominique; Vandenbulcke, Franck; Verger-Bocquet, Martine; De Petrocellis, Luciano; Sergheraert, Christian; Breton, Christophe; Di Marzo, Vincenzo; Salzet, Michel - Evidence for an Endocannabinoid System in the Central Nervous System of the Leech Hirudo medicinalis - 2001
Matsuda LA. Lolait SJ. Brownstein MJ. Young AC. Bonner TI - Structure of a cannabinoid receptor and functional expression of the cloned cDNA [see comments] - 1990 Aug 9
A. J. McDonald, F. Mascagni - Localization of the cb1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons - 2001
Mukhopadhyay, Somnath; McIntosh, Helen H.; Houston, Devin B.; Howlett, Allyn C. - The CB1 Cannabinoid Receptor Juxtamembrane C-Terminal Peptide Confers Activation to Specific G proteins in Brain - 2000
Mukhopadhyay S, Howlett AC - CB1 receptor-G protein association; Subtype selectivity is determined by distinct intracellular domains - 2001
Navarro M, Rodriguez de Fonseca F - The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease - 1998 Dec
Nie, Jingjiang; Lewis, Deborah L. - Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration - Nov. 15, 2001
J. Nie, D. L. Lewis - The proximal and distal c-terminal tail domains of the cb1 cannabinoid receptor mediate - 2001
Ong WY, Mackie K - A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain - Not available
Prather, Paul L.; Martin, Nancy A.; Breivogel, Christopher S.; Childers, Steven R. - Activation of Cannabinoid Receptors in Rat Brain by WIN 55212-2 Produces Coupling to Multiple G Protein-Subunits with Different Potencies - 2000
Rawls, S. M.; Cabassa, Jose; Geller, Ellen B.; Adlerk, Martin W. - CB1 Receptors in the Preoptic Anterior Hypothalamus Regulate WIN 55212-2 [(4,5-Dihydro-2- methyl-4(4-morpholinylmethyl)-1-(1- naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-Induced Hypothermia. - 2002
Rhee, Man-Hee; Nevo, Igal; Avidor-Reiss, Tomer; Levy, Rivka; Vogel, Zvi - Differential Superactivation of Adenylyl Cyclase Isozymes after Chronic Activation of the CB1 Cannabinoid Receptor - 2000
Roche, John P.; Bounds, Sid; Brown, Sean; Mackie, Ken - A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization - 1999
Rodriguez-Puertas R et.al - Autoradiography of receptor-activated G-proteins in post mortum human brain - 2000
Rodriguez, Jose J.; Mackie, Kenneth; Pickel, Virginia M. - Ultrastructural Localization of the CB1 Cannabinoid Receptor in m-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus - Feb 2001
Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, Fernandez-Ruiz JJ - Atypical location of cannabinoid receptors in white matter areas during rat brain development - 1997 Jul
Romero J, Berrendero F, Manzanares J, Perez A, Corchero J, Fuentes JA, Fernandez-Ruiz JJ, Ramos JA - Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol - 1998 Nov
Sanchez, Cristina; Rueda, Daniel; Segui, Bruno; Galve-Roperh, Ismael; Levade, Thierry; Guzman, Manuel - The CB1 Cannabinoid Receptor of Astrocytes Is Coupled to Sphingomyelin Hydrolysis through Adaptor Protein Fan - 2001
Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P - Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A - 1996 Mar 22
Sim, Laura J.; Hampson, Robert E.; Deadwyler, Sam A.; Childers, Steven R. - Effects of Chronic Treatment with 9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPS Autoradiography in Rat Brain - Dec 15,1996
Darren Smart, Jeffery C. Jerman - Anandamide: an endogenous activator of the vanilloid receptor [Letters] - 2000
Ken Soderstrom, Mark Leid, Frank L. Moore, Thomas F. Murray - Behavioral, Pharmacological, and Molecular Characterization of an Amphibian Cannabinoid Receptor - 2000
Soderstrom K, Johnson F, Zebra Finch - CB1 Cannabinoid Receptor: Pharmacology and in Vivo and in Vitro Effects of Activation - 2001
Zhao-Hui Song and Miao Zhong - CB1 Cannabinoid Receptor-Mediated Cell Migration - 2000
Song, Z. H.; Slowey, Carole-Anne; Hurst, Dow P.; Reggio, Patricia H. - The Difference Between the CB1 and CB2 Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2 - 1999
Steiner, Heinz; Bonner, Tom I.; Zimmer, Anne M.; Kitai, Stephen T.; Zimmer, Andreas - Altered Gene Expression in Striatal Projection Neurons in CB1 Cannabinoid Receptor Knockout Mice - May 11,1999
Olov Sterner, Arpad Szallasi - Novel natural vanilloid receptor agonists: new therapeutic targets for drug development [Review] - 1999
Sugiura,Takayuki; Kodaka, Tomoko; Nakane, Shinji; Miyashita, Tomoyuki; Kondo, Sachiko; Suhara, Yoshitomo; Takayama, Hiroaki; Waku, Keizo; Seki, Chiyo; Baba, Naomichi; Ishima, Yoshio - Evidence That the Cannabinoid CB1 Receptor Is a 2- Arachidonoylglycerol Receptor Structure-Activity Relationship of 2-Arachidonoylglycerol, Ether-Linked Analogues, and Related Compounds - Jan 29,1999
Janos Szolcsanyi - Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? [Comment] - 2000
Janos Szolcsanyi - Anandamide and the question of its functional role for activation of capsaicin receptors [Letter] - 2000
Tao, Qing; Abood, Mary E. - Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling - May 1998
Tao, Qing; McAllister, Sean D.; Andreassi, John; Nowell, Katharine W.; Cabral, Guy A.; Hurst, Dow P.; Bachtel, Kevin; Ekman, Marie C.; Reggio, Patricia H.; Abood, Mary E. - Role of a Conserved Lysine Residue in the Peripheral Cannabinoid Receptor (CB2): Evidence for Subtype Specificity - 1999
Valk PJ, Hol S, Vankan Y, Ihle JN, Askew D, Jenkins NA, Gilbert DJ, Copeland NG, de Both NJ, Lowenberg B, Delwel R - The Genes Encoding the Peripheral Cannabinoid Receptor and alpha-L-Fucosidase Are Located Near a Newly Identified Common Virus Integration Site, Evi11 - Sep 1997
Namita Varma, Gregory C. Carlson, Catherine Ledent, Bradley E. Alger - Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus - 2001
Vasquez, Clemente; Lewis, Deborah L. - The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors - Nov 1999
Timo Wittenberger, H. Chica Schaller, Susanne Hellebrand - An Expressed Sequence Tag (EST) Data Mining Strategy Succeeding in the Discovery of New G- Protein Coupled Receptors - 2001
Abood ME, Martin BR - Molecular Neurobiology of the Cannabinoid Receptor - 1996
Adams, Irma B.; Martin, Billy R. - Cannabis: Pharmacology and Toxicology in Animals and Humans - 1996
Ameri A - The effects of cannabinoids on the brain. [Review] [223 refs] - 1999 Jul
Di Marzo V - 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance - 1998 Jun 15
Christian C. Felder, Michelle Glass - Cannabinoid Receptors and Their Endogenous Agonists - 1998
Javier Fernandez-Ruiz, Fernando Berrendero, Mari Luz Hernandez and Jose A. Ramos - The endogenous cannabinoid system and brain development - 2000
Glass M, Dragunow M, Faull RL - Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain - 1997 Mar
Hollister, Leo E. - Cannabis - 1988
Hollister, Leo E. - Health Aspects of Cannabis - 1986
Allyn C. Howlett - Pharmacology of Cannabinoid Receptors - 1995
Martin, Billy R. - Identification of the Endogenous Cannabinoid System Through Integrative Pharmacological Approaches - 2002
Raphael Mechoulam, Lumir Hanusi - A historical overview of chemical research on cannabinoids - 2000
Emilia Nocerino, Marianna Amato, Angelo A. Izzo - Cannabis and cannabinoid receptors - 2000
Weissman A - On the Definition of Cannabinoids: Botanical? Chemical? Pharmacological? - 1981 Aug-Sep
Batkai, Sandor; Jarai, Zoltan; Wagner, Jens A.; Goparaju, Sravan K.; Varga, Karoly; Liu, Jie; Wang, Lei; Mirshahi, Faridoddin; Khanolkar, Atmaram D.; Makriyannis, Alexandros; Urbaschek, Renata; Garcia, Nelson, Jr; Sanyal, Arun J.; Kunos, George - Endocannabinoids Acting at Vascular CB1 Receptors Mediate the Vasodilated State in Advanced Liver Cirrhosis - Jul 2001
Rodney S. Berman, Patricia E. M. Martin, W. Howard Evans, Tudor M. Griffith - Relative Contributions of NO and Gap Junctiona Communication to Endothelium-Dependent Relaxations of Rabbit Resistance Arteries Vary with Vessel Size - 2002
Block, Robert I.; O'Leary, Daniel S.; Hichwa, Richard D.; Augustinack, Jean C.; Boles-Ponto, Laura L.; Ghoneim, M.M.; Arndt, Stephan; Hurtig, Richard R.; Watkins, G. Leonard; Hall, James A.; Nathan, Peter E.; Andreasen, Nancy C. - Effects of Frequent Marijuana Use on Memory-Related Regional Cerebral Blood Flow - 2002
Brandes, Ralf P.; Schmitz-Winnenthal, Friedrich-Hubertus; Feletou, Michel; Godecke, Axel; Huang, Paul L.; Vanhoutte, Paul M.; Fleming, Ingrid; Busse, Rudi - An Endothelium-Derived Hyperpolarizing Factor Distinct from NO and Prostacyclin is a Major Endothelium-Dependent Vasodilator in Resistance Vessels of Wild-Type and Endothelial NO Synthase Knockout Mice - Aug 15,2000
T Chataigneau, M Feletou, C Thollon, N Villeneuve, JP Vilaine, J Duhault, PM Vanhoutte - Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries - 1998
Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P - Cannabinoids enhance human B-cell growth at low nanomolar concentrations - 1995 Aug 7
J.-M. Derocq, M. Bouaboula, J. Marchand M. Rinaldi-Carmona, M. Segui, P. Casellas - The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines - Apr 1998
Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, Moore LC - Production and physiological actions of anandamide in the vasculature of the rat kidney - 1997 Sep 15
Fleming I, Schermer B, Popp R, Busse R - Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists - Not available
Fulton, David; Quilley, John - Evidence Against Anandamide as the Hyperpolarizing Factor Mediating the Nitric Oxide-Independent Coronary Vasodilator Effect of Bradykinin in the Rat - September 1998
Garcia N et.al. - Systemic and portal hemodynamic effects of anandamide - 2001
David Gurwitz - Haemorrhagic shock: endogenous cannabinoids to the rescue - 1998
Cecilia J. Hillard - Perspectives in Pharmacology, Endocannabinoids and Vascular Function - 2000
Holland, Michael; Challiss, R. A. John; Standen, Nicholas B.; Boyle, John P. - Cannabinoid CB1 Receptors Fail to Cause Relaxation, But Couple via Gi/Go to the Inhibition of Adenylyl Cyclase in Carotid Artery Smooth Muscle - 1999
Jarai, Zoltan; Wagner, Jens A.; Varga, Karoly; Lake, Kristy D.; Compton, David R.; Martin, Billy R.; Zimmer, Anne M.; Bonner, Tom I.; Buckley, Nancy E.; Mezey, Eva; Razdan, Raj K.; Zimmer, Andreas; Kunos, George - Cannabinoid-Induced Mesenteric Vasodilation Through an Endothelial Site Distinct from CB1 or CB2 Receptors - Nov 23,1999
Jorda, Meritxell Alberich; Verbakel, Sandra E.; Valk, Peter J. M.; Vankan-Berkhoudt, Yolanda V.; Maccarrone, Mauro; Finazzi-Agro, Allessandro; Lowenberg, Bob; Delwel, Ruud - Hematopoietic Cells Expressing the Peripheral Cannabinoid Receptor Migrate in Response to the Endocannabinoid 2-Arachidonoylglycerol - 15 Apr 2002
George Kunos, Zoltan Jarai, Sandor Batkai, Sravan Kumar Goparaju, Edward J.N. Ishac, Jie Liu, Lei Wang, Jens A. Wagner - Endocannabinoids as cardiovascular modulators - 2000
Lake KD, Compton DR, Varga K, Martin BR, Kunos G - Cannabinoid-Induced Hypotension and Bradycardia in Rats Mediated by CB1-Like Cannabinoid Receptors - Jun 1997
T. Lundqvist, S. Jonsson, S. Warkentin - Frontal lobe dysfunction in long-term cannabis users - 2001
Maccarrone M et.al. - Human Platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor - 2001
AI McCulloch, MD Randall - Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed - 1998
McKallip, Robert J.; Lombard, Catherine; Fisher, Michael; Martin, Billy R.; Ryu, Seongho; Grant, Steven; Nagarkatti, Prakash S.; Nagarkatti, Mitzi - Targeting CB2 Cannabinoid Receptors as a Novel Therapy to Treat Malignant Lymphoblastic Disease - Apr 30 2002
Somnanth Mukhopadhyay , Barry M. Chapnick, Allyn C. Howlett - Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein- dependent and G protein-independent - 2002
Niederhoffer, Nathalie; Szabo, Bela - Cannabinoids Cause Central Sympathoexcitation and Bradycardia in Rabbits - Aug 2000
Pratt PF, Hillard CJ, Edgemond WS, Campbell WB - N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor - 1998 Jan
Michael D. Randall - The other EDRF [Full Length Article] - 19(1):37-38
Josefa Ros, Joan Claria, Jordi To-Figueras, Anna Planaguma, Pilar Cejudo-Marti, Guillermo Fernandez-Varo, Raul Martin-Ruiz, Vicente Arroyo, Francisca Rivera, Juan Rodes, Wladimiro Jimenez - Endogenous Cannabinoids: A New System Involved in the Homeostasis of Arterial Pressure in Experimental Cirrhosis in the Rat - 2002
Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Lowenberg B, Delwel R - Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor is a Novel Synergistic Growth Factor for Hematopoietic Cells - Aug 15, 1997
Vanheel B, Van De Voorde J - Regional Differences in Anandamide- and Methanandamide- Induced Membrane Potential Changes in Rat Mesenteric Arteries - 2001
Karoly Vargaa, Jens A. Wagnera, D. Troy Bridgena, George Kunosa - Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension - 1998
Jens A. Wagner, Zoltan Jarai, Sandor Batkai, George Kunos - Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB receptors 1 - 2001
Wagner JA, Varga K, Kunos G - Cardiovascular Actions of Cannabinoids and Their Generation During Shock - Nov 1998
Jens A. Wagner, Karoly Varga, Zoltan Jarai, George Kunos - Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors - 1999
Yin Wang, Yan Liu, Yasuhiko Ito, Teruto Hashiguchi, Isao Kitajima, Munekazu Yamakuchi, Hideaki Shimizu, Seiichi Matsuo, Hitoshi Imaizumi, Ikuro Maruyama - Simultaneous Measurement of Anandamide and 2-Arachidonoylglycerol by Polymyxin B-Selective Adsorption and Subsequent High-Performance Liquid Chromatography Analysis: Increase in Endogenous Cannabinoids in the Sera of Patients with Endotoxic Shock - (2001)
R White, CR Hiley - A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery - 1997
PM Zygmunt, ED Hogestatt, K Waldeck, G Edwards, AJ Kirkup, AH Weston - Studies on the effects of anandamide in rat hepatic artery - 1997
Peter M. Zygmunt et al - Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide - 1999
Costantino A, Schwartz RH, Kaplan P - Hemp oil ingestion causes positive urine tests for delta 9-tetrahydrocannabinol carboxylic acid - 1997 Oct
Fortner N, Fogerson R, Lindman D, Iversen T, Armbruster D - Marijuana-positive urine test results from consumption of hemp seeds in food products - 1997 Oct
Kerrigan S, Phillips WH - Comparison of ELISAs for Opiates, Methamphetamine, Cocaine Metabolite, Benzodiazepines, Phencyclidine, ans Cannabinoids in Whole Blood and Urine - 2001
Lehmann T, Sager F, Brenneisen R - Excretion of Cannabinoids in Urine After Ingestion of Cannabis Seed Oil - Sep 1997
Skopp G et.al. - Stability of Cannabinoids in Hair Samples Exposed to Sunlight - 2000
Struempler, Richard E.; Nelson, Gordon; Urry, Francis M. - A Positive Cannabinoids Workplace Drug Test Following the Ingestion of Commercially Available Hemp Seed Oil - Jul/Aug 1997
Wingert WE - Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results - 1997 Jan
Achiron A et.al. - Dexabinol (HU-211) effect on experimental auto immune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis - 2000
Baker D et.al. - Cannabinoids Control Spasticity and Tremor in a Multiple Sclerosis Model. - 2000 2 Mar
Massimiliano Beltramo, Fernando Rodrнguez de Fonseca, Miguel Navarro, Antonio Calignano, Miguel Angel Gorriti, Gerasimos Grammatikopoulos, Adolfo G. Sadile, Andrea Giuffrida, Daniele Piomelli - Reversal of Dopamine D2 Receptor Responses by an Anandamide Transport Inhibitor - 2000
Francesca R. Buttarelli, Francesco E. Pontieri, Vito Margotta, Guido Palladini - Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism - 2002
Carlini EA, Leite JR, Tannhauser M, Berardi AC - Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents - 1973 Aug
Consroe PF, Man DP, Chin L, Picchioni AL - Letter: Reduction of audiogenic seizure by delta8- and delta9-tetrahydrocannabinols - 1973 Sep
Consroe PF, Wood GC, Buchsbaum H - Anticonvulsant Nature of Marihuana Smoking - 1975
Consroe P, Musty R, Rein J, Tillery W, Pertwee R - The perceived effects of smoked cannabis on patients with multiple sclerosis - 1997
Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R - Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients - 1980
Dar MS - Cerebellar CB1 receptor mediation of Delta9-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A1 receptor in the mouse - 2000
K.P. DeSanty, M. Saeed Dar - Involvement of the cerebellar adenosine A receptor in cannabinoid- 1 induced motor incoordination in the acute and tolerant state in mice - 2001
Vincenzo Di Marzok, Michael P. Hill, Tiziana Bisogno, Alan R. Crossman, Jonathan M. Brotchie - Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease - 2000
Vincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis - Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'? - 2000
A. Giuffrida, L. H. Parsons, T. M. Kerr, F. Rodrнguez deFonseca, M. Navarro, D. Piomelli - Dopamine activation of endogenous cannabinoid signaling in dorsal striatum - April 1999
A. Giuffrida, D. Piomelli - The endocannabinoid system: a physiological perspective on its role in psychomotor control - 2000
Gottlieb, Scott - Cannabinoids Might Reduce Spasticity in Multiple Sclerosis - Mar. 11, 2000
Karler R, Cely W, Turkanis SA - The anticonvulsant activity of cannabidiol and cannabinol - 1973 Dec 1
I. Lastres-Becker, F. Berrendero, J.J. Lucas, E. Martin-Aparicio, A. Yamamoto, J.A. Ramos, J.J. Fernandez-Ruiz - Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB receptors in the basal ganglia of a transgenic model of Huntington's disease - 2002
J.-C. Lievens, B. Woodman, A. Mahal, O. Spasic-Boscovic, D. Samuel, L. Kerkerian-Le Goff, G. P. Bates - Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice - 2001
Meinck H M, et al. - Effect of cannabinoids on spasticity and ataxia in Multiple Sclerosis - 1989
Meldrum BS, Fariello RG, Puil EA, Derouaux M, Naquet R - Delta9-tetrahydrocannabinol and epilepsy in the photosensitive baboon, Papio papio - 1974 Jun
Menalled, Liliana B.; Chesselet, Marie-Francoise - Mouse Models of Huntington's Disease - Jan 2002
Muller-Vahl, Kirsten R.; Schneider, Udo; Kolbe, Hans; Emrich, Hinderk M. - Treatment of Tourette's Syndrome With Delta-9-Tetrahydrocannabinol - March 1999
Petro D, Ellenberger C Jr - Treatment of Human Spasticity with delta-9-Tetrahydrocannabinol - Aug 1981
Sandyk R, Awerbuch G - Marijuana and Tourette's syndrome [letter] - 1988 Dec
Sanudo-Pena et.al. - Role of the superior colliculus in the motor effects of cannabinoids and dopamine - 2000
M. Clara Sanudo-Pena, Julian Romero, Garrett E. Seale, J. Javier Fernandez-Ruiz, J. Michael Walker - Activational role of cannabinoids on movement - 2000
Sanudo-Pena MC, Walker JM - Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat - 1997 Mar
Self DW - Anandamide: a candidate neurotransmitter heads for the big leagues. Comment on: Nat Neurosci 1999 Apr;2(4):358-63, - 1999 Apr
M. A. Silverdale, S. McGuire, A. McInnes, A. R. Crossman, J. M. Brotchie - Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease - 2001
Wada JA, Sato M, Corcoran ME - Antiepileptic properties of 9-tetrahydrocannabinol - 1973 Apr
Wada JA, Wake A, Sato M, Corcoran ME - Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats - 1975 Sep
Wallace, Melisa J.; Wiley, Jenny L.; Martin, Billy R.; DeLorenzo, Robert J. - Assessment of the Role of CB Receptors in Cannabinoid Anticonvulsant Effects - 2001
Zeng, B.Y.; Dass, B.; Owen, A.; Rose, S.; Cannizzaro, C.; Tel, B.C.; Jenner, P. - Chronic L-DOPA Treatment Increases Striatal Cannabinoid CB1 Receptor mRNA Expression in 6-Hydroxydopamine-Lesioned Rats - Dec 1999
Abood, Mary E.; Rizvi, Gulrukh; Sallapudi, Neetha; McAllister, Sean D. - Activation of the CB1 Cannabinoid Receptor Protects Cultured Mouse Spinal Neurons Against Excitotoxicity - 2001
Block, Robert I.; O'Leary, Daniel S.; Ehrhardt, James C.; Augustinack, Jean C.; Ghoneim, M. M.; Arndt, Stephan; Hall, James A. - Effects of Frequent Marijuana Use on Brain Tissue Volume and Composition - 28 Feb 2000
Chan, Guy Chiu-Kai; Hinds, Thomas R.; Impey, Soren; Storm, Daniel R. - Hippocampal Neurotoxicity of 9-Tetrahydrocannabinol - Jul 1998
Yanqiu Chen and Jochen Buck - Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism - 2000
E. M. Denovan-Wright and H. A. Robertson - Cannabinoid receptor messenger rna levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic huntington's disease mice - 2000
Fishman RHB - Cannabinoid is neuroprotective in head trauma - 1998
Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, Shohami E - Protection Against Septic Shock and Suppression of Tumor Necrosis Factor Alpha and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid - 1997
M. Glass, M. Dragunow and R. L. M. Faull - The pattern of neurodegeneration in huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and gaba a receptor alterations in the human basal ganglia in huntington's disease - 2000
Michelle Glass - The role of cannabinoids in neurodeoenerative diseases - 2001
Gruol DL - Cannabinoids alter neurotoxicity produced by interleukin-6 in central nervous system neurons - 1998
Harald S. Hansen, Birthe Moesgaard, Henrik H. Hansen, Gitte Petersen - N-Acylethanolamines and precursor phospholipids - relation to cell injury - 2000
Gil Lavie, Angella Teichner, Esther Shohami, Haim Ovadia, Ronen R. Leker - Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia - 2001
Louw DF, Yang FW, Sutherland GR - The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat - 2000
Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB - Delta 9- tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis - 1989 Jun
Milton, Nathaniel G - Anandamide and noladin ether prevent neurotoxicity of the human amyloid-b peptide - 2002
Tetsuya Nagayama, Amy D. Sinor, 2, Roger P. Simon, Jun Chen, Steven H. Graham, Kunlin Jin, David A. Greenberg - Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures - Apr 1999
Panikashvili, David; Simeonidou, Constantina; Ben-Shabat, Shimon; Hanusi, Lumar; Breuer, Aviva; Mechoulam, Raphael; Shohami, Esther - An Endogenous Cannabinoid (2-AG) is Neuroprotective After Brain Injury - October 2001
Shen M, Thayer SA - Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity - 1998
van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, Veldink GA, Vliegenthart JFG, Di Marzo V, Nicolay K - Exogenous Anandamide Protects Rat Brain Against Acute Neuronal Injury in Vivo - Nov 2001
Wagner JA. Varga K. Ellis EF. Rzigalinski BA. Martin BR. Kunos G - Activation of Peripheral CB1 Cannabinoid Receptors in Haemorrhagic Shock - 4 Dec 1997

van der Stelt M, Veldhuis WB, Bar PR, Veldink GA, Vliegenthart, JFG Nicolay K - Neuroprotection by 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, Against Ouabain-Induced in Vivo Excitotoxicity - Sep 2001
Pierre Beaulieu, Tiziana Bisogno, Shahid Punwar, W. Paul Farquhar-Smith, Gerolmina Ambrosino, Vincenzo Di Marzo, Andrew S.C. Rice - Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat - 2000
Bloom, Alan S.; Dewey, William L.; Harris, Louis S.; Brosius, Keith K. - 9-nor-9beta-Hydroxyhexahydrocannabinol, a Cannabinoid with Potent Antinociceptive Activity: Comparisons with Morphine - Feb 1977
Sumner H. Burstein - The Cannabinoid Acids: Nonpsychoactive Derivatives with Therapeutic Potential - 1999
Buxbaum DM - Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse. - 1972
Antonio Calignano, Giovanna La Rana, Daniele Piomelli - Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide - 2001
Calignano A, La Rana G, Giuffrida A, Piomelli D - Control of pain initiation by endogenous cannabinoids - 1998 Jul 16
Campbell FA et.al. - Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review - 7 July 2001
Carta, Giovanna; Gessa, Gian Luigi; Nava, Felice - Dopamine D2 Receptor Antagonists Prevent 9-Tetrahydrocannabinol-Induced Antinociception in Rats - 1999
V. Chapman - Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats - 2001
Chapman V - The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat - 1999 Aug
Dajani EZ, Larsen KR, Taylor J, Dajani NE, Shahwan TG, Neeleman SD, Taylor MS, Dayton MT, Mir GN - 1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties - 1999 Oct
Drew LJ et.al. - Activation of spinal cannabinoid 1 receptors inhibits c-fibre driven hyperaxcitable neuronal responses and increases [35S]GTPyS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats - 2000
Formukong EA, Evans AT, Evans FJ - Analgesic and Antiinflammatory Activity of Constituents of Cannabis sativa L - 1988 Aug
Alyson Fox, Adam Kesingland, Clive Gentry, Kara McNair, Sadhana Patel, Laszlo Urban, Iain James - The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain - 2001
Guhring, Hans; Schuster, Johannes; Hamza, May; Ates, Mehmet; Kotalla, Carolin Edith; Brune, Kay - HU-210 Shows Higher Efficacy and Potency than Morphine After Intrathecal Administration in the Mouse Formalin Test - 2001
Herzberg U, Eliav E, Bennett GJ, Kopin IJ - The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain - 1997 Jan 17
Hohmann, Andrea G.; Tsou, Kang; Walker, J. Michael - Cannabinoid Suppression of Noxious Heat-Evoked Activity in Wide Dynamic Range Neurons in the Lumbar Dorsal Horn of the Rat - Feb 1999
Susan J. Houser, Micah Eads, James P. Embrey, Sandra P. Welch - Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, D 9 -THC and anandamide - 2000
Jaggar SI. Hasnie FS. Sellaturay S. Rice AS - The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. - 1998 May.
Lisa M. Johanek, Dwayne R. Heitmiller, Michelle Turner, Nicole Nader, Jim Hodges, Donald A. Simone - Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms - 2001
Kelly, Sara; Chapman, Victoria - Selective Cannabinoid CB 1 Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo - Dec 2001
M.-C. Ko, James H. Woods - rapid communication: Local administration of 9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action - 1999
Kosersky DS, Dewey WL, Harris LS - Antipyretic, Analgesic and Anti-Inflammatory Effects of delta 9-Tetrahydrocannabinol in the Rat - 1973
Lichtman AH, Martin BR - Cannabinoid-Induced Antinociception is Mediated by a Spinal Alpha 2-Noradrenergic Mechanism - Sep 20 1991
Lichtman AH, Martin BR - Spinal and Supraspinal Components of Cannabinoid-Induced Antinociception - Aug 1991
T. Philip Malan Jr, Mohab M. Ibrahim, Hongfeng Deng, Qian Liu, Heriberto P. Mata, Todd Vanderah, Frank Porreca, Alexandros Makriyannis - CB2 cannabinoid receptor-mediated peripheral antinociception - 2001
Malfait AM et.al - The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis - Not available
Mao J et.al. - Two distinctive antinociceptive systems in rats with pathological pain - 2000
Martin, Billy R.; Lichtman, Aron H. - Cannabinoid Transmission and Pain Perception - Dec 1998
Martin, William J,; Hohmann, Andrea G.; Walker, J. Michael - Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects - Oct 15, 1996
Mason, David J. Jr, Loweb, John; Welcha, Sandra P. - Cannabinoid Modulation of Dynorphin A: Correlation to Cannabinoid-Induced Antinociception - 1999
McPartland, John M.; Russo, Ethan B. - Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? - 2001
John E. McKenna, Ronald Melzack - Blocking NMDA Receptors in the Hippocampal Dentate Gyrus with AP5 Produces Analgesia in the Formalin Pain Test - 2001
Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V - Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands that Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid Receptors - Aug 19 1999
Meng ID, Manning BH, Martin WJ, Fields HL - An Analgesia Circuit Activated by Cannabinoids - 24 Sep 1998
Valerie Morisset, Laszlo Urban - Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord. - 2001
Valerie Morisset, Jatinder Ahluwalia, Istvan Nagy, Laszlo Urban - Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. - 2001
Noyes R Jr, Baram DA - Cannabis analgesia - 1974 Nov-Dec
Noyes S J Jr., et al. - The analgesic effect of delta-9-tetrahydrocannabinol - 1975
Noyes S J Jr., et al. - The analgesic properties of delta-9-tetrahydrocannabinol and codeine - 1975
Roger G. Pertwee - Cannabinoid receptors and pain - 2001
Porreca, Frank; Lai, Josephine; Malan, T. Philip - Can Inflammation Relieve Pain? - Dec 1998
Pugh G Jr, Mason DJ Jr, Combs V. Welch SP - Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord - 1997 May
Richardson JD, Aanonsen L, Hargreaves KM - Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia - 1998 Jan
Richardson JD, Kilo S, Hargreaves KM - Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors - 1998 Mar
Rowe, Paul M. - Cannabinoid Analgesia Explained - Sep 26, 1998
Russo E - Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. [Review] [51 refs] - 1998 May
Angela Siegling, Heiko A. Hofmann, Dirk Denzer, Frank Mauler, Jean De Vry - Cannabinoid CB Receptor Upregulation in a Rat Model of Chronic Neuropathic Pain - 2001
Sidney R. Smith, Georgetta Denhardt, Carol Terminelli - The Anti-Inflammatory Activities of Cannabinoid Receptor Ligands in Mouse Peritonitis Models - 2001
Smith FL, Fujimori K, Lowe J, Welch SP - Characterization of delta9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats - May 1998
Sofia RD. Nalepa SD. Harakal JJ. Vassar HB - Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC) - 1973 Sep
Strangman NM, Walker JM - Cannabinoid WIN 55,212-2 inhibits the activity- dependent facilitation of spinal nociceptive responses - 1999 Jul
Alan H. Tseng, Rebecca M. Craft - Sex Differences in Antinociceptive and Motoric Effects of Cannabinoids - 2001
Turner CE, Elsohly MA - Biological Activity of Cannabichromene, Its Homologs and Isomers - Aug 1981
Vivian, Jeffrey A.; Kishioka, Shiroh; Butelman, Eduardo R.; Broadbear, Jillian; Lee, Katherine O.; Woods, James H. - Analgesic, Respiratory and Heart Rate Effects of Cannabinoid and Opioid Agonists in Rhesus Monkeys: Antagonist Effects of SR 141716A - Aug 1998
Walker, J. Michael; Huang, Susan M.; Strangman, Nicole M.; Tsou, Kang; Sanudo-Pena, M. Clara - Pain Modulation by Release of the Endogenous Cannabinoid Anandamide - Oct. 12,1999
Welch, Sandra P.; Huffman, John W.; Lowe, John - Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A1 - Sep 1998
Yaksh TL - The Antinociceptive Effects of Intrathecally Administered Levonantradol and Desacetyllevonantradol in the Rat - 1981 Aug-Sep
Zygmunt, Peter M.; Andersson, David A.; Hogestatt, Edward D. - Delta 9 - Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism - Jun 2002
Aquilino, William S.; Lo Sciuto, Leonard A. - Effects of Interview Mode on Self-Reported Drug Use - Autumn 1990
Bachman, Jerald G.; Johnston, Lloyd D.; O'Malley, Patrick M.; Humphrey, Ronald H. - Explaining the Recent Decline in Marijuana Use: Differentiating the Effects of Perceived Risks, Disapproval, and General Lifestyle Factors - Mar 1998
David Baker - Reply: a sanguine approach to cannabis [Comment] - 2000
Rick Bell, Henry Wechsler, Lloyd D. Johnston - Correlates of college student marijuana use: results of a US National Survey - 1997
Benson, John A., Jr. - Re: Marijuana and Medicine, edited by Gabriel G. Nahas [book review] - September 9, 1999
Bradbury, Jane - Small Part of Cannabis Puzzle Solved by Animal Studies - 2001 July 28
Cimons, Marlene - US to Make Research Marijuana More Accessible - Jul 1999
Cotton P - Government Extinguishes Marijuana Access, Advocates Smell Politics - May 20 1992
Crawford, Vivienne - The Homelie Herbe - Jan 2002
Clyde W. Dent, Ph.D., Steve Sussman, Ph.D., Alan W. Stacy, Ph.D - Project Towards No Drug Abuse: Generalizability to a General High School Sample - 2001
Devane WA - A New dawn of cannabinoid pharmacology - 1994 Feb
William V. Fabricius, Craig T. Nagoshi, David P. Mackinnon - Concepts of drugs: differences in conceptual structure across groups with different levels of drug experience - 1997
Farrell M, Ritson B - Cannabis and Health - 2001
Michael Fendrich, Mary Ellen Mackesy-Amiti - Inconsistencies in lifetime cocaine and marijuana use reports: impact on prevalence and incidence - 1995
Ferriman A - Regulators accused of bias against cannabis based medicines - 24 Mar 2001
Ferron C et.al. - Sport activity in adolescence: associations with health perceptions and experimental behaviours - 1999
Fink, Max - Marijuana, the Forbidden Medicine [book review] - Jul 1994
Goode, Eriche - Marijuana and the Politics of Reality - Jun 1969
Gray, Robert - Marijuana the Forbidden Medicine, book review - Oct. 30, 1993
Hall W, Babor TF - Cannabis use and public health: assessing the burden - 2000
Wayne Hall - The recent Australian debate about the prohibition on cannabis use - 1997
Halpern - Pain: No Medical Necessity Defense to Controlled Substances Act - 2001
Heyman RB, Committee on Substance Abuse - Marijuana: A Continuing Concern for Pediatricians, - October 1999
Hirst RA, Lambert DG, Notcutt WG - Pharmacology and potential therapeutic uses of cannabis - 1998 Jul
Hofler, Michael; Lieb, Roselind; Perkonigg, Axel; Schuster, Peter; Sonntag, Holger; Wittchen, Hans-Ulrich - Covariates of Cannabis Use Progression in a Representative Population Sample of Adolescents: A Prospective Examination of Vulnerability and Risk Factors - 1999
Hollister LE - Marihuana in Man: Three Years Later - 2 Apr 1971
Jackson, T - Cannabis the Wonder Drug? - 10 Nov 2001
Johnson WT, Petersen RE, Wells LE - Arrest Probabilities for Marijuana Users as Indicators of Selective Law Enforcement - Nov 1977
Johnson RA, Gerstein DR - Initiation of Use of Alcohol, Cigarettes, Marijuana, Cocaine, and Other Substances in US Birth Cohorts Since 1919 - Jan 1998
Kalso E - Cannabinoids for pain and nausea, some evidence but is there any need - 2001
Kandel, Denise B.; Adler, Israel - Socialization Into Marijuana Use Among French Adolescents: A Cross-Cultural Comparison with the United States - Dec 1982
Kaplan, Howard B.; Martin, Steven S.; Johnson, Robert J.; Robbins, Cynthia A. - Escalation of Marijuana Use: Application of a General Theory of Deviant Behavior - Mar 1986
Kenneth S. Kendler, Carol A. Prescott - Cannabis Use, Abuse, and Dependence in a Population-Based Sample of Female Twins - 1998
Knight RC, Sheposh JP, Bryson JB - College Student Marijuana Use and Societal Alienation - Mar 1974
Kohn, Paul M.; Mercer, G.W. - Drug Use, Drug-Use Attitudes, and Authoritarian-Rebellion Dimension - Jun 1971
Kondro, Wayne - Medicinal Marijuana Users in Canada Must Carry Identification Cards - Jul 21,2001
John W Kozarich, Daniel H Rich - Looking to the horizon [Editorial overview] - 1998
Paul D Leeson, David C Rees - Next generation therapeutics [Editorial overview] - 1999
Liskow BI - Review of "Marijuana Deceptive Weed" by Gabriel Nahas - April 1973
Michael J. Lyons, Rosemary Toomey, Joanne M. Meyer, Alan I. Green, Seth A. Eisen, Jack Goldberg, William R. True, Ming T. Tsuang - How do genes influence marijuana use? The role of subjective effects - 1997
Manheimer, Dean I.; Mellinger, Glen D. - Marijuana Use Among Urban Adults - Dec 19,1969
Mao, Li; Oh,Yun - Does Marijuana or Crack Cocaine Case Cancer? - Aug 19,1998
Masood E - Cannabis Laws "threaten validity of trials" - 19 Nov 1998
McPartland, J.M.; Pruitt, Patty L. - Side Effects of Pharmaceuticals Not Elicited by Comparable Herbal Medicines: The Case of Tetrahydrocannabinol and Marijuana - Jul 1999
Mensch, Barbara S.; Kandel, Denise B. - Underreporting of Substance Use in a Nation; Longitudinal Youth Cohort: Individual and Interveiwer Effects - Spring 1988
Mockel M et.al. - Severe parnarteritis associated with drug use - 1999
Model KE - The Effect of Marijuana Decriminalization on Hospital Emergency Room Drug Episodes: 1975-1978 - Sep 1993
Mullner M - Medical use of cannabis - 26 May 2001
Nadelman EA - Drug Prohibition in the United States: costs, Consequences, and Alternatives - 1989
Nelson, Christopher B.; Rehm, Jurgen; Bedirhan, T.; Grant; Bridget; Chatterji, Somnath - Factor Structures for DSM-IV Substance Disorder Criteria Endorsed by Alcohol, Cannabis, Cocaine and Opiate Users: Results from the WHO Reliability and Validity Study - 1999
Pertwee, Roger G. - Medical Uses of Cannabinoids: The Way Forward - 1999
Pertwee RG - Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors - 1998 May
Petry, Nancy M.; Bickel, Warren K. - Polydrug Abuse in Heroin Addicts: A Behavioral Economic Analysis - 1998
A. Giuffrida, D. Piomelli - The endocannabinoid system: a physiological perspective on its role in psychomotor control - 2000
Pulmgreen, Philip; Donohew, Lewis; Lorch, Elizabeth Pugzles; Hoyle, Rick H.; Stephenson, Michael T. - Television Campaigns and Adolescent Marijuana Use: Tests of Sensation Seeking Targeting - Feb 2001
J. G. Ramaekers - Emerging Drugs: The Prospect for Improved Medicines (Vol. 3) [Review article] - 1998
Robson P - Cannabis - 1997
Rubenstein H - Reefer Madness Caribbean Style - 2000
Schafer EW - The acute oral toxicity of 369 pesticidal, pharmaceutical and other chemicals to wild birds - 1972
Schwenk CR - Marijuana and Job Performance: Comparing the Major Streams of Research - 1998
Lydia A. Shrier, M.D., M.P.H., Sion Kim Harris, Ph.D., Maya Sternberg, Ph.D., William R. Beardslee, M.D - Associations of Depression, Self-Esteem, and Substance Use with Sexual Risk among Adolescents - 2001
Siegel BZ - Mercury in Marijuna: Some of the problems arising from marijuana use might result from the intake of bioaccumulated mercury - Oct 1988
Smart, Reginald G,; Osbourne, Alan C.; Timney, Carol Birchmore - An Exploratory Study of Physicians Experiences with Patients Who Use Marijuana for Medical Reasons - 1999
Smigel, Kara - Cancer Problems Lead List for Potential Medical Marijuana Research Studies - Sep 3, 1997
Stone R - Reefer Madness At FDA - 4 Feb 1994
Strassman, Rick J. - Book Reveiw, Marijuna: The Forbidden Medicine - Dec 15,1993
Strassman, Rick J. - Book Review, Marijuana: The Forbidden Medicine - Mar 25,1998
Bennet, William M. - Legalisation of Marijuana for Medical Use - Jan 1994
Maugh, Thomas H. - Marihuana (II): Does It Damage The Brain? - Aug 30,1974
Maugh, Thomas H. - Marijuana: New Support for Immune and Reproductive Hazards - Nov. 28, 1975
Maugh, Thomas H., II - Marijuana "Justifies Serious Concern" - Mar 19,1982
Maugh TH - Marihuana: the grass May No Longer Be Greener - Aug 23 1974
Schwartz RH, Voth EA, Sheridan MJ - Marijuana to Prevent Nausea and Vomiting in Cancer Patients: a Survey of Clinical Oncologists - Feb 1997
Ungerleider JT, Andrysiak T - Bias and the Cannabis Researcher - Aug 1981
William Armando Vega, Ethel Alderete, Bohdan Kolody, Sergio Aguilar-Gaxiola - Illicit drug use among Mexicans and Mexican Americans in California: the effects of gender and acculturation - 1998
Annas GJ - Reefer Madness- The Federal Response to California's Medical-Marijuana Law - August 7 1997
Benson, John A., Jr.; Watson, Stanley J.; Joy, Janet E. - From Marijuana to Medicine - Spring 1999
The British Medical Association, - Cannabinoid Medicines Should be Legalized - 20 November 1997
Cimons, Marlene - US to Make Research Marijuana More Accessible - Jul 1999
Doblin RE, Kleiman MA - Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes - 1991
Farrell M - Book Review, Marijuana Myths and Marijuana Facts: A Review of the Scientific Evidence - 17 Jan 1998
Grinspoon, Lester; Bakalar, James B. - Marijuana as Medicine: A Plea for Reconsideration - Jun 21,1996
Grinspoon L - Marijuana - November 1987
Deborah Josefson San Francisco - US judge approves distribution of marijuana - 2000 Jul 29
Kaplan J, Lasagna L - Academy Marijuana Report - Aug 20 1982
MacCoun R, Reuter P - Evaluating alternative cannabis regimes - 2001
Mathre ML - Medicinal use of marijuana - 1997 Nov
Mitka M - Therapeutic Marijuana use Supported While Proposed Study Done - Apr 28 1999
anonymous - Institute of Medicine Report Backs Medical Use of Marijuana - May 1999
anonymous - News Briefs; Study Finds Marijuana Safe for AIDS Patients - Sep 2000
Gingrich Newt - Legal Status of Marijuana - 1982
Skidmore, Mccaffery, Krumm, Glick - Marijuana as a medicine [letter; comment] - 1998 May
Tamaguchi, Kazuo; Kandel, Denise B. - On the Resolution of Role Incompatability: A Life Event History Analysis of Family Roles and Marijuana Use - May 1985
Sallan SE, Zinberg NE, Frei E 3d - Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy - 1975 Oct 16
David Gurwitz - Renewed hope for medicinal marijuana? - 2000
Dalterio S, Bartke A, Burstein S - Cannabinoids Inhibit Testosterone Secretion by Mouse Testes in Vitro - Jun 24,1977
Dalterio S et.al. - Delta-9 tetrahydrocannabinol Increases Plasma testoterone Concentrations in Mice - Jul 31 1981
Dalterio S et.al. - Cannabinoids in Male Mice: Effects on Fertility and Spermatogenesis - April 1982
Das SK, Paria BC, Chakraes I, Dey SK - Cannabinoid Ligand-Receptor Signaling in the Mouse Uterus - May 9,1995
Dreher MC, Nugent K, Hudgins R - Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study - 1994 Feb
Ester Fride, Yoav Ginzburg, Aviva Breuer, Tiziana Bisogno, Vincenzo Di Marzo, Raphael Mechoulam - Critical role of the endogenous cannabinoid system in mouse pup suckling and growth - 2001
P.A. Fried, A.M. Smith - A literature review of the consequences of prenatal marihuana exposure An emerging theme of a deficiency in aspects of executive function - 2001
Garcia-Gill L. et.al. - Perinatal delta-9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA B, but not GABA A, receptor agonists in adult rats - 1999
Mariluz Hernandez, Fernando Berrendero, Isabel Suarez , Lucia Garcia-Gil , Maribel Cebeira , Ken Mackie, Jose A. Ramos, Javier Fernandez-Ruiz - Cannabinoid CB receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. - 2000
Jacobson, Sandra W.; Chiodo, Lisa M.; Sokol, Robert J.; Jacobson, Joseph L. - Validity of Maternal Report of Prenatal Alcohol, Cocaine, and Smoking in Relation to Neurobehavioral Outcome - May 2002
Zoltan Kiss - Anandamide stimulates phospholipase D activity in PC12 cells but not in NIH 3T3 fibroblasts - 26 March 1999
Lester, Barry M.; ElSohly, Mahmoud; Wright, Linda L.; Smeriglio, Vincent L.; Verter,Joel; Bauer, Charles R.; Shankaran, Seetha; Bada, Henrietta S.; Walls, H. Chip; Huestis, Marilyn A.; Finnegan, Loreta P.; Maza, Penelope L. - The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report - Feb 2001
Maccarrone, Mauro; De Felici, Massimo; Bari, Monica; Klinger, Francesca; Siracusa, Gregorio; Finazzi-Agro, Alessandro - Down-Regulation of Anandamide Hydrolase in Mouse Uterus by Sex Hormones - 2000
Maccarrone M et.al. - Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer - 2002
Mani, Shailaja K.; Mitchell, Andrea; O’Malley, Bert W. - Progesterone Receptor and Dopamine Receptors are Required in delta-9-Tetrahydrocannabinol Modulation of Sexual Receptivity in Female Rats - Jan 30,2001
Meyer JS, Kunkle R - Behavioral responses to a D1 dopamine agonist in weanling rats treated neonatally with cocaine and delta9-tetrahydrocannabinol. - 1999 Jul-Aug
Morris, Kelly - "Neural Love Triangle" Leads to Sexual Receptivity - Jan 27,2001
Okey AB, Bondy GP - Delta-9-Tetrahydrocannabinol and 17 beta-Estradiol Bind to Different Macromolecules in Estrogen Target Tissues - Apr 21 1978
Okey AB et.al. - Is Delta-9-tetrahydrocannabinol Estrogenic? - Mar 4 1977
Osama M.H. Habayeb, Stephen C. Bell, Justin C. Konje - Endogenous cannabinoids: Metabolism and their role in reproduction - 2002
Ostrea, Enrique M. Jr; Ostrea, Anthony R.; Simpson, Pippa M. - Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation - Jul 1997
Paria BC, Das SK, Dey SK - The Preimplantation Mouse Embryo is a Target for Cannabinoid Ligand-Receptor Signaling - Oct. 10,1995
B.C. Paria, S.K. Dey, B.C. Paria, S.K. Dey - Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. - 2000
Paria, BC, H. Song, X. Wang, P. C. Schmid, R. J. Krebsbach, H. H. O. Schmid, Tom I. Bonneri, Andreas Zimmer, S. K. Dey - Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation - 2001 Mar 8
BC Paria, W Ma, DM Andrenyak, PC Schmid, HH Schmid, DE Moody, H Deng, A Makriyannis SK Dey - Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. - 1998
Alberto Perez-Rosado, Jorge Manzanares, Javier Fernandez-Ruiz, Jose A. Ramos - Prenatal D 9 -tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences - 2000
Rawitch, Allen B.; Schultz, Gregory S.; Ebner, Kurt E. - Competition of Delta-9-Tetrahydrocannabinol with Estrogen in Rat Uterine Estrogen Receptor Binding - Sep 16, 1977
Rettori, Valeria; Aguila, M. Cecilia; Gimeno, Martha F.; .Franchi, Ana M.; McCann, Samuel M. - In Vitro Effect of Delta-9-Tetrahydrocannabinol to Stimulate Somatostatin Release and Block that of Leutinizing Hormane-Releasing Hormone by Suppression of the Release of Prostaglandin E-2 - Dec 1990
R. A. Sherwood, J. Keating, V. Kavvadia, A. Greenough , T. J. Peters - neonatology: Substance misuse in early pregnancy and relationship to fetal outcome - 1999
Smith, Carol Grace; Almirez, Ramona G.; Berenberg, Jeffrey - Tolerance Develops to the Disruptive Effects of Delta-9-Tetrahydrocannabinol on Primate Menstrual Cycle - Mar 25,1983
Stella, Nephi - How Might Cannabinoids Influence Sexual Behavior? - Jan 30,2001
Tibor Wenger, Catherine Ledent, Valer Csernus, Ida Gerendai - The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions - 2001
Tibor Wenger, Ida Gerendai, Filomena Fezza, Sara Gonzalez, Tiziana Bisogno, Javier Fernandez-Ruiz, Vincenzo Di Marzo - The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats - 2002
Arey SL - Letter: Cannabis for asthma - 1973 Nov 1
Baldwin, Gayle Cocita; Tashkin, Donald P;.Buckley, Dawn M.; Park, Alice N.; Dubinett, Steven M.; Roth, Michael D. - Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production - Nov 1997
Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP - Histopathologic and Molecular Alterations in Bronchial Epithelium in Habitual Smokers of Marijuana, Cocaine, and/or Tobacco - 1998
A. Calignano, I.Katona, F. De sarnaud, A. Giuffrida, G. La Rana, K. Mackie, T. F. Freund, D. Piomelli - Bidirectional control of airway responsiveness by endogenous cannabinoids - 2 November 2000
David W. Carley PhD, Sasa Pavlovic MD, Marika Janelidze, and Miodrag Radulovacki MD PhD - Functional Role for Cannabinoids in Respiratory Stability During Sleep - 2002
David Cunnington, MB BS, Harry Teichtahl, MB BS(Hons), FCCP; John M. Hunt, MB BS, Chris Dow, MB BS, Renata Valentine, MB,BS - Necrotizing Pulmonary Granulomata in a Marijuana Smoker - 2000
Stanley S. Davis - Delivery of peptide and non-peptide drugs through the respiratory tract [Research focus] - 1999
Jerome Dempsey PhD - Functional Role for Cannabinoids in Respiratory Stability During Sleep by D.W. Carley, et al. - 2002
Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP - Tracheobronchial Histopathology in Habitual Smokers of Cocaine, Marijuana, and/or Tobacco - Aug 1997
Hall W - The respiratory risks of cannabis smoking - 1998
Johnson, Martin K.; Smith, Robin P.; Morrison, Douglas; Laszlo, Gabriel; White, Roger J. - Case Reports: Large Lung Bullae in Marijuana Smokers - 2000
Lichtman, Aron H.; Peart, Joanne; Poklis, Justin L.; Bridgen, D. Troy; Razdan, Raj K.; Wilson, David M.; Poklis, Alphonse; Meng, Yun; Byron, Peter R.; Martin, Billy R. - Pharmacological Evaluation of Aerosolized Cannabinoids in Mice - 2000
Roth, Michael D.; Arora, Ashim; Barsky, Sanford H.; Kleerup, Eric C.; Simmons, Michael; Tashkin, Donald P. - Airway Inflammation in Young Marijuana and Tobacco Smokers - Mar 1998
Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD - Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids - 1999 Jun
Tashkin DP, Shapiro BJ, Lee YE, Harper CE - Effects of smoked marijuana in experimentally induced asthma - 1975 Sep
Tashkin, Donald P.; Simmons, Michael S.; Sherrill, Duane L.; Coulson, Anne H. - Heavy Habitual Marijuana Smoking Does Not Cause an Accelerated Decline in FEV1 with Age - Jan 1997
E. Sylvester Vizi, Istvan Katona, Tamas F. Freund - Evidence for presynaptic cannabinoid CB receptor-mediated inhibition of noradrenaline release in the guinea pig lung - 2001
Wallace JM, Lim R, Browdy BL, Hopewell PC, Glassroth J, Rosen MJ, Reichman LB, Kvale PA - Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group - 1998 Jul
Yousif, Mariam H.M.; Oriowo, Mabayoje A. - Inhibitory Effects of Cannabinoid Receptor Ligands on Electrically-Evoked Responses in Rat Isolated Tracheal Ring Segments - Nov 1999
Nathalie Auclair, Satoru Otani, Philippe Soubrie, and Francis Crepel - Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons - 2000 Jun
Bouaboula, Monsif; Desnoyer, Nathalie; Carayon, Pierre; Combes, Therese; Casellas, Pierre - Gi Protein Modulation Induced by a Selective Inverse Agonist for the Peripheral Cannabinoid Receptor CB2: Implication for Intracellular Signalization Cross-Regulation - 1999
M. Bouaboula, L. Bianchini, F.R. McKenzie, J. Pouyssegur, P. Casellas - Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi- mediated mitogen activated protein kinase signaling transduction pathways - 1999
Chan PK, Yung WH - Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium - 1998 Jun 12
Cheer JF, Marsden CA, Kendall DA, Mason R - Lack of Response Suppression Follows Repeated Ventral Tegmental Cannabinoid Administration: An in Vitro Electrophysiological Study - 2000
Cravatt, Benjamin F.; Demarest, Kristin; Patricelli, Matthew P.; Bracey, Michael H.; Giang, Dan K.; Martin, Billy R.; Lichtman, Aron H. - Supersensitivity to Anandamide and Enhanced Endogenous Cannabinoid Signaling in Mice Lacking Fatty Acid Amide Hydrolase - Jul 31,2001
H. Daniel, F. Crepel - Rapid Report Control of Ca 2+ influx by cannabinoid and metabotropic glutamate receptors in rat cerebelar cortex requires K+ channels - 2001
Pascal Derkinderen, Madeleine Toutant, Gress Kadare, Catherine Ledent, Marc Parmentier, Jean-Antoine Girault - Dual Role of Fyn in the Regulation of FAK 6,7 by Cannabinoids in Hippocampus* - 2001 Oct 12
Diana, Marco A.; Levenes, Carole; Mackie, Ken; Marty, Alain - Short-Term Retrograde Inhibition of GABAergic Synaptic Currents in Rat Purkinje Cells is Mediated by Endogenous Cannabinoids - Jan 1,2002
Diana M et.al - Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids - 1998
Egertova, Michaela; Giang, Dan K.; Cravatt, Benjamin F.; Elphick, Maurice R. - A New Perspective on Cannabinoid Signalling: Complimentary Localization of Fatty Acid Amide Hydrolase and the CB1 Receptor in Rat Brain - 1998
Fan P - Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons - 1995 Feb
Irina Fedorova, Akihiro Hashimoto, Robert A. Fecik, Michael P. Hedrick, Lumir O. Hanu S, Dale L. Boger, Kenner C. Rice, Anthony S. Basile - Behavioral Evidence for the Interaction of Oleamide with Multiple Neurotransmitter Systems - 2001
Ferraro L. et.al. - The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmissiion in Rat Cerebral Cortex: an In Vivo and In Vitro Study. - Aug 2001
Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR - Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current - 1999 Jun
Gerdeman G, Lovinger DM - CB1 Cannabinoid Receptor Inhibits Release of Glutamate in Rat Dorsolateral Striatum - 2000
Hajos N, et.al. - Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations - 2000
Hampson RE et.al. - Cannabinoid and Kappa opioid Receptors Reduce potassium K Current via Activation of G5 Proteins in Cultured Hippocampal Neurons - 2000
Henry DJ, Chavkin C - Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. - 1995 Feb 17
Hoffman, Alexander F.; Lupica, Carl R. - Mechanisms of Cannabinoid Inhibition of GABAA Synaptic Transmission in the Hippocampus - 2000
Allyn C. Howlett, Somnath Mukhopadhyay - Cellular signal transduction by anandamide and 2-arachidonoylglycerol - 2000
Huang, Chiung-Chun; Lo, Shiow-Win; Hsu, Ku i-S n - Presynaptic Echaniss Underlying Cannabinoid Inhibition of Excitatory Synaptic Transission in Rat Striatal Neurons - 2001
Norio Ishioka, Richard D. Bukoski - A Role for N-Arachidonylethanolamine (Anandamide) as the Mediator of Sensory Nerve-Dependent Ca2+-Induced Relaxation - April 1999
Lily Yeh Jan, Yuh Nung Jan - Receptor-regulated ion channels [Review article] - 1997
E. A. Jennings, C. W. Vaughan, M. J. Christie - Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro - 2001
Jin, Wenzhen; Brown, Sean; Roche, John P.; Hsieh, Candace; Celver, Jeremy P.; Kovoor, Abraham; Chavkin, Charles; Mackie, Ken - Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization - May 15, 1999
Katona, Istvan; Rancz, Ede A.; Acsady, Laszlo; Ledent, Catherine; Mackie, Ken ; Hajos, Norbert; Freund, Tamas F. - Distribution of CB1 Cannabinoid Receptors in the Amygdala and Their Role in the Control of GABAergic Transmission - Dec 1,2001
Katona, Istvan; Sperlagh, Beata; Sik, Attila; Kafalvi, Attila; Vizi, E. Sylvester; Mackie, Ken; Freund, Tamas F. - Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons - Jun 1,1999
Daniel J. Kim, Stanley A. Thayer - Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures - 2000
Anatol C. Kreitzer, Wade G. Regehr - Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids - 2001
Ceng Luo, Eiichi Kumamoto, Hidemasa Furue, Jun Chen, Megumu Yoshimura - Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of apsai in - 2002
Mackie K., Lai Y., Westenbroek R., Mitchell R - Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor - 1995 Oct
Takashi Maejima, Takako Ohno-Shosaku, Masanobu Kano - Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals - 2001
McAllister, Sean D.; Griffin, Graeme; Satin, Leslie S.; Abood, Mary E. - Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System - Nov 1999
Justin P. Meschler, Allyn C. Howlett - Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum - 2001
Misner DL, Sullivan JM - Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons - 1999 Aug 15
G.J. Molderings, H. Bonisch, R. Hammermann, M. Gothert, M. Bruss - Noradrenaline release-inhibiting receptors on PC12 cells devoid of 2 and CB1 receptors: similarities to presynaptic imidazoline and edg receptors. - 2002
Mu, Jian; Zhuang, Shou-yuan ; Kirby ,M. Todd ; Hampson, Robert E.; Deadwyler, Sam A. - Cannabinoid Receptors Differentially Modulate Potassium A and D Currents in Hippocampal Neurons in Culture - November 1999
Netzeband, Jeffrey G.; Conroy, Shannon M.; Parsons, Kathy L.; Gruol, Donna L. - Cannabinoids Enhance NMDA-Elicited Ca2+ Signals in Cerebellar Granule Neurons in Culture - Oct. 15, 1999
Ohno-Shosaku, Takako; Tsubokawa, Hiroshi; Mizushima, Ichiro; Yoneda, Norihide; Zimmer, Andreas; Kano, Masanobu - Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses - May 15, 2002
Paton GS, Pertwee RG, Davies SN - Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice - 1998 Sep
Vera Ralevic, David A. Kendall - Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed - 2001
Robbe, David; Alonso, Gerard; Duchamp, Florence; Bockaert, Joe; Manzoni, Olivier J. - Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens - Jan 1, 2001
Robbe, David; Kopf, Manfred; Remaury, Anne; Bockaert, Joel; Manzoni, Olivier J. - Endogenous Cannabinoids Mediate Long-Term Synaptic Depression in the Nucleus Accumbens - Jun 11,2002
Schlicker, Eberhard; Kathmann, Markus - Modulation of Transmitter Release via Presynaptic Cannabinoid Receptors - Nov 2001
Schweitzer, Paul - Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 Neurons - Jan 2000
Shen, Maoxing; Thayer, Stanley A. - 9-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture - 1999
Shen M, Piser TM, Seybold VS, Thayer SA - Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures - 1996
Stella N, Schweitzer P, Piomelli D - A second endogenous cannabinoid that modulates long-term potentiation - 1997 Aug 21
Sullivan, Jane M. - Mechanisms of Cannabinoid-Receptor-Mediated Inhibition of Synaptic Transmission in Cultured Hippocampal Pyramidal Neurons - September 1999
B. Szabo, I. Wallmichrath, P. Mathonia and C. Pfreundtner - Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. - 2000
Szabo B, Dorner L, Pfreundtner C, Norenberg W, Starke K - Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum - 1998 Jul
Kanji A. Takahashi, David J. Linden - Cannabinoid Receptor Modulation of Synapses Received by Cerebellar Purkinje Cells - 2000
Kim D, Thayer SA - Cannabinids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture - 2001
Twitchell W, Brown S, Mackie W - Cannabinoids Inhibit N- and P/Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons - Jul 1997
Eleni T. Tzavara, Kenneth W. Perry, Dana E. Rodriguez, Frank P. Bymaster, George G. Nomikos - The cannabinoid CB receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus - 2001
Vaughan, Christopher W.; Connor, Mark; Bagley, Elena E.; Christie, Macdonald J. - Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro - 2000
Vaughan CW, McGregor IS, Christie MJ - Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro - 1999 Jun
Velasco L et.al. - Delta-9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells: Involvement of CB1 cannabinoid receptor and Raf-1 - 2001
Wilson, Rachel I.; Nicoll, Roger A. - Endogenous Cannabinoids Mediate Retrograde Signalling at Hippocampal Synapses - Mar 2001
Yoshida, Takayuki; Hashimoto, Kouichi; Zimmer, Andreas; Maejima, Takashi; Araishi, Kenji; Kano, Masanobu - The Cannabinoid CB1 Receptor Mediates Retrograde Signals for Depolarization-Induced Suppression of Inhibition in Cerebellar Purkinje Cells - Mar 1 2002
Griggs EA, Ward M - LSD toxicity: a suspected cause of death - 1977
Menon MK, Clark WG, Masuoka DT - Possible Involvement of the Central Dopaminergic System in the Antireserpine Effect of LSD - 1977
Pradhan SN, Hollister LE - Abuse Of LSD And Other Hallucinogenic Drugs - 1977
Shulgin AT, Nichols DE - Characterization of Three New Psychotomimetics - 1978
van Ree, JM, Witter A, Leysen JE - Interaction of Des-Tyrosine-y-Endorphin (DTyE, beta-LPH62-77) With Neuroleptic Binding Sites in Various Areas of Rat Brain - 1978
Shulgin AT - What is MDMA? - 1985
Yensen, Richard - LSD and Psychotherapy - 1985
Shulgin AT - The Background and Chemistry of MDMA - 1986
Perry DC - [3H]Tryptamine Autoradiography in Rat Brain and Choroid Plexus Reveals Two Distinct Sites - 1986
Bilsky EJ, Hubbell CL, Delconte JD, Reid LD - MDMA Produces a Conditioned Place Preference and Elicits Ejaculation in Male Rats: A Modulatory Role for the Endogenous Opioids - 1991
Greer G - Ecstasy and the Dance of Death - 1992
Hermle L, Spitzer M, Borchardt D, Kovar KA, Gouzoulis E - Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents? - 1993
Denborough MA, Hopkinson KC - Dantrolene and 'ecstasy' - 1997
Doblin R - A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA - 2002
Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD - Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA (“Ecstasy”) - 2002
Curran HV, Verheyden SL - Altered Response to Tryptophan Supplementation After Long-Term Abstention from MDMA (Ecstasy) is Highly Correlated with Human Memory Function - 2003
Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD - Retraction - 2003
Schenk S, Gittings D, Johnstone M, Daniela E - Development, Maintenance and Temporal Pattern of Self-Administration Maintained by Ecstasy (MDMA) in Rats - 2003
Sprague JE, Banks ML, Cook VJ, Mills EM - Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in the Hyperthermia iIduced by 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) - 2003
Thomasius R, Petersen K, Buchert R, Andersen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt, A - Mood, Cognition and Serotonin Transporter Availability in Current and Former Ecstasy (MDMA) Users - 2003
Halpern JH, Pope HG, Sherwood AR, Barry S. - Residual Neuropsychological Effects of Illicit - 2004
Quednow BB, Kuhn KU, Hoenig K, Maier W, Wagner M - Prepulse Inhibition and Habituation of Acoustic Startle Response in Male MDMA ('Ecstasy') Users, Cannabis Users, and Healthy Controls - May 2004
de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J - Human Pharmacology of MDMA: Pharmacokinetics, Metabolism, and Disposition - 2004
Fantegrossi WE, Kiessel CL, De La Garza R, Woods JH - Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. - 2005
Fisk JE, Montgomery C, Wareing M, Murphy PN - Reasoning deficits in ecstasy (MDMA) polydrug users. - 2005 Jul 16
Freedman RR, Johanson CE, Tancer ME - Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. - 2005
Green AR, O'shea E, Saadat KS, Elliott JM, Colado MI - Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. - 2005
McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA - Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [(11)C]McN5652 and [(11)C]DASB - Apr 2005
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR - Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease - 2005
Allott K, Redman J - Patterns of use and harm reduction practices of ecstasy users in Australia. - 2006
Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA - Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. - 2006
Griffiths RR, Richards WA, McCann U, Jesse R - Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. - 2006
Kleber HD - Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - 2006 Jul 7
Kuypers KP, Ramaekers JG - Acute Dose of MDMA (75 mg) Impairs Spatial Memory for Location but Leaves Contextual Processing of Visuospatial Information Unaffected - 2006
Kuypers KP, Samyn N, Ramaekers JG - MDMA and Alcohol Effects, Combined and Alone, On Objective and Subjective Measures of Actual Driving Performance and Psychomotor Function - 2006
Nichols DE - Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - 2006
Riba J, Romero S, Grasa E, Mena E, Carrió I, Barbanoj MJ - Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant. - 2006
Schuster CR - Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - 2006
Sessa B - Is there a case for MDMA-assisted psychotherapy in the UK? - 2006 Oct 18
Snyder SH - Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. - 2006
Tancer M, Johanson CE - The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. - 2007
Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX - Effects of Psilocybin on Time Perception and Temporal Control of Behaviour in Humans. - 2007
Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, Ricaurte G - Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines. - 31(12)
Banks ML, Czoty PW, Gage HD, Bounds MC, Garg PK, Garg S, Nader MA - Effects of Cocaine and MDMA Self-Administration on Serotonin Transporter Availability in Monkeys. - 2008
Banks ML, Sprague JE, Czoty PW, Nader MA - Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys. - 2007 Published Online
Baumann MH, Wang X, Rothman RB - 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. - 2007
Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX - Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. - 2007
Farre M, Abanades S, Roset PN, Peiro AM, Torrens M, O' Mathuna B, Segura M, de la Torre R - Pharmacological Interaction Between 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and Paroxetine: Pharmacological effects and pharmacokinetics. - 2007
Hoshi R, Mullins K, Boundy C, Brignell C, Piccini P, Curran HV - Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls. - 2007 Jul 1
Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF - Assessment of Cognitive Brain Function in Ecstasy Users and Contributions of Other Drugs of Abuse: Results from an fMRI Study. - Apr 25 2007
Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF - Incidental Use of Ecstasy: No Evidence for Harmful Effects on Cognitive Brain Function in a Prospective fMRI sSudy. - 2007
McCann UD, Peterson SC, Ricaurte GA - The Effect of Catecholamine Depletion by Alpha-Methyl-Para-Tyrosine on Measures of Cognitive Performance and Sleep in Abstinent MDMA Users. - 2007 Jan 3
Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB - The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval. - 2007
Bedi G, Redman J - Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. - 2008
Doly S, Valjent E, Setola V, Callebert J, Hervé D, Launay JM, Maroteaux L - Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. - 2008 Mar 12
Dumont GJ, Wezenberg E, Valkenberg MM, de Jong CA, Buitelaar JK, van Gerven JM, Verkes RJ - Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers. - 2008
Griffiths RR, Richards WA, Johnson HW, McCann UD, Jesse R - Mystical-Type Experiences Occasioned by Psilocybin Mediate the Attribution of Personal Meaning and Spiritual Significance 14 Months Later - 2008
Johnson MW, Richards, WA, Griffiths, RR - Human Hallucinogen Research: Guidelines for Safety - 2008
Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS - Dissociation of the Neurochemical and Behavioral Toxicology of MDMA ('Ecstasy') by Citalopram. - 2008
Trigo JM, Cabrero-Castel A, Berrendero F, Maldonado R, Robledo P - MDMA modifies active avoidance learning and recall in mice. - 2008
Bedi G, Phan KL, Angstadt M, de Wit H - Effects of MDMA on sociability and neural response to social threat and social reward. - 2009
Dumont G, Kramers C, Sweep F, Touw D, van Hasselt J, de Kam M, van Gerven J, Buitelaar J, Verkes R - Cannabis Coadministration Potentiates the Effects of "Ecstasy" on Heart Rate and Temperature in Humans. - 2009
Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, Howell LL - Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates. - 2009
Johansen P, Krebs T - How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale. - 2009
Kuypers KP, Wingen M, Ramaekers JG - Memory and mood during the night and in the morning after repeated evening doses of MDMA. - 2009
Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA - Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. - 2009
Baggott MJ, Erowid E, Erowid F, Galloway GP, Mendelson J - Use Patterns and Self-Reported Effects of Salvia Divinorum: An Internet-Based Survey - 2010
Blagrove M, Seddon J, George S, Parrott AC, Stickgold R, Walker MP, Jones KA, Morgan MJ - Procedural and Declarative Memory Task Performance, and the Memory Consolidation Function of Sleep, in Recent and Abstinent Ecstasy/Mdma Users. - 2010 Jul 8
Bosker WM, Kuypers KP, Conen S, Ramaekers JG - Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss. - 2010
Fábregas JM, González D, Fondevila S, Cutchet M, Fernández X, Barbosa PC, Alcázar-Córcoles MA, Barbanoj MJ, Riba J, Bouso JC - Assessment of addiction severity among ritual users of ayahuasca. - 2010
Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I - Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study. - 2010
Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, Brenneisen R, Huwyler J, Liechti ME - The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA ("Ecstasy") in Humans. - 2011
Kuypers KP, Wingen M, Heinecke A, Formisano E, Ramaekers JG - MDMA intoxication and verbal memory performance: a placebo-controlled pharmaco-MRI study. - 2011
van Wel JH, Kuypers KP, Theunissen EL, Bosker WM, Bakker K, Ramaekers JG - Blockade of 5-HT(2) Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment. - 2011
Peters FT, Samyn N, Wahl M, Kraemer T, De Boeck G, Maurer HH - Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. - Not available
Tramer, Martin R.; Carroll, Dawn; Campbell, Fiona A.; Reynolds, D. John M.; Moore, R. Andrew; McQuay, Henry J. - Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic Review - Jul 2001